
<html lang="en"     class="pb-page"  data-request-id="4741bf9e-50cb-4ef8-90fe-a5e14190b6dc"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;issue:issue:10.1021/jmcmar.2017.60.issue-20;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/acs.jmedchem.7b01215;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Selective Nonsteroidal Glucocorticoid Receptor Modulators for the Inhaled Treatment of Pulmonary Diseases" /></meta><meta name="dc.Creator" content="Martin  Hemmerling" /></meta><meta name="dc.Creator" content="Stinabritt  Nilsson" /></meta><meta name="dc.Creator" content="Karl  Edman" /></meta><meta name="dc.Creator" content="Stefan  Eirefelt" /></meta><meta name="dc.Creator" content="Wayne  Russell" /></meta><meta name="dc.Creator" content="Ramon  Hendrickx" /></meta><meta name="dc.Creator" content="Eskil  Johnsson" /></meta><meta name="dc.Creator" content="Carina  Kärrman Mårdh" /></meta><meta name="dc.Creator" content="Markus  Berger" /></meta><meta name="dc.Creator" content="Hartmut  Rehwinkel" /></meta><meta name="dc.Creator" content="Anna  Abrahamsson" /></meta><meta name="dc.Creator" content="Jan  Dahmén" /></meta><meta name="dc.Creator" content="Anders R.  Eriksson" /></meta><meta name="dc.Creator" content="Balint  Gabos" /></meta><meta name="dc.Creator" content="Krister  Henriksson" /></meta><meta name="dc.Creator" content="Nafizal  Hossain" /></meta><meta name="dc.Creator" content="Svetlana  Ivanova" /></meta><meta name="dc.Creator" content="Anne-Helene  Jansson" /></meta><meta name="dc.Creator" content="Tina J.  Jensen" /></meta><meta name="dc.Creator" content="Anders  Jerre" /></meta><meta name="dc.Creator" content="Henrik  Johansson" /></meta><meta name="dc.Creator" content="Tomas  Klingstedt" /></meta><meta name="dc.Creator" content="Matti  Lepistö" /></meta><meta name="dc.Creator" content="Martin  Lindsjö" /></meta><meta name="dc.Creator" content="Irene  Mile" /></meta><meta name="dc.Creator" content="Grigorios  Nikitidis" /></meta><meta name="dc.Creator" content="John  Steele" /></meta><meta name="dc.Creator" content="Ulrika  Tehler" /></meta><meta name="dc.Creator" content="Lisa  Wissler" /></meta><meta name="dc.Creator" content="Thomas  Hansson" /></meta><meta name="dc.Description" content="A class of potent, nonsteroidal, selective indazole ether-based glucocorticoid receptor modulators (SGRMs) was developed for the inhaled treatment of respiratory diseases. Starting from an orally a..." /></meta><meta name="Description" content="A class of potent, nonsteroidal, selective indazole ether-based glucocorticoid receptor modulators (SGRMs) was developed for the inhaled treatment of respiratory diseases. Starting from an orally a..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 12, 2017" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b01215" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2017 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01215" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b01215" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01215" /></link>
        
    
    

<title>Selective Nonsteroidal Glucocorticoid Receptor Modulators for the Inhaled Treatment of Pulmonary Diseases | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b01215" /></meta><meta property="og:title" content="Selective Nonsteroidal Glucocorticoid Receptor Modulators for the Inhaled Treatment of Pulmonary Diseases" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01215/20171020/images/large/jm-2017-01215g_0013.jpeg" /></meta><meta property="og:description" content="A class of potent, nonsteroidal, selective indazole ether-based glucocorticoid receptor modulators (SGRMs) was developed for the inhaled treatment of respiratory diseases. Starting from an orally available compound with demonstrated anti-inflammatory activity in rat, a soft-drug strategy was implemented to ensure rapid elimination of drug candidates to minimize systemic GR activation. The first clinical candidate 1b (AZD5423) displayed a potent inhibition of lung edema in a rat model of allergic airway inflammation following dry powder inhalation combined with a moderate systemic GR-effect, assessed as thymic involution. Further optimization of inhaled drug properties provided a second, equally potent, candidate, 15m (AZD7594), that demonstrated an improved therapeutic ratio over the benchmark inhaled corticosteroid 3 (fluticasone propionate) and prolonged the inhibition of lung edema, indicating potential for once-daily treatment." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b01215"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b01215">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b01215&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b01215&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b01215&amp;href=/doi/10.1021/acs.jmedchem.7b01215" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 20</span><span class="cit-fg-pageRange">, 8591-8605</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/20" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b01133" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.7b01222" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Selective Nonsteroidal Glucocorticoid Receptor Modulators for the Inhaled Treatment of Pulmonary Diseases</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Martin++Hemmerling">Martin Hemmerling</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0003-4662-0080" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stinabritt++Nilsson">Stinabritt Nilsson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Karl++Edman">Karl Edman</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stefan++Eirefelt">Stefan Eirefelt</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wayne++Russell">Wayne Russell</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ramon++Hendrickx">Ramon Hendrickx</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Eskil++Johnsson">Eskil Johnsson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Carina++K%C3%A4rrman+M%C3%A5rdh">Carina Kärrman Mårdh</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Markus++Berger">Markus Berger</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0001-6676-6090" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hartmut++Rehwinkel">Hartmut Rehwinkel</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anna++Abrahamsson">Anna Abrahamsson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jan++Dahm%C3%A9n">Jan Dahmén</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anders+R.++Eriksson">Anders R. Eriksson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-6224-3644" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Balint++Gabos">Balint Gabos</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Krister++Henriksson">Krister Henriksson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nafizal++Hossain">Nafizal Hossain</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Svetlana++Ivanova">Svetlana Ivanova</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anne-Helene++Jansson">Anne-Helene Jansson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tina+J.++Jensen">Tina J. Jensen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anders++Jerre">Anders Jerre</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Henrik++Johansson">Henrik Johansson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tomas++Klingstedt">Tomas Klingstedt</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Matti++Lepist%C3%B6">Matti Lepistö</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Martin++Lindsj%C3%B6">Martin Lindsjö</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Irene++Mile">Irene Mile</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Grigorios++Nikitidis">Grigorios Nikitidis</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John++Steele">John Steele</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ulrika++Tehler">Ulrika Tehler</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lisa++Wissler">Lisa Wissler</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Thomas++Hansson">Thomas Hansson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Respiratory, Inflammation & Autoimmunity, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Pepparedsleden 1, Mölndal, SE 43183, Sweden</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Discovery Sciences, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Pepparedsleden 1, Mölndal, SE 43183, Sweden</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Pharmaceutical Sciences, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Pepparedsleden 1, Mölndal, SE 43183, Sweden</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">#</span> <span class="aff-text">Medicinal Chemistry Berlin, Drug Discovery, Pharmaceuticals, Bayer AG, Berlin 13353, Germany</span></div><div class="aff-info" id="aff5"><span class="aff-symbol">∥</span> <span class="aff-text">AstraZeneca R&D Lund, Scheelevägen 1, Lund, SE 22187, Sweden</span></div><div class="corresp-info"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#b3ded2c1c7dadd9ddbd6deded6c1dfdaddd4f3d2c0c7c1d2c9d6ddd6d0d29dd0dcde"><span class="__cf_email__" data-cfemail="204d415254494e0e48454d4d45524c494e476041535452415a454e4543410e434f4d">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01215&amp;href=/doi/10.1021%2Facs.jmedchem.7b01215" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 20</span><span class="cit-pageRange">, 8591–8605</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">September 22, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>18 August 2017</li><li><span class="item_label"><b>Published</b> online</span>12 October 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 26 October 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b01215" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01215</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D8591%26pageCount%3D15%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMartin%2BHemmerling%252C%2BStinabritt%2BNilsson%252C%2BKarl%2BEdman%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D60%26issueNum%3D20%26contentID%3Dacs.jmedchem.7b01215%26title%3DSelective%2BNonsteroidal%2BGlucocorticoid%2BReceptor%2BModulators%2Bfor%2Bthe%2BInhaled%2BTreatment%2Bof%2BPulmonary%2BDiseases%26numPages%3D15%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D8605%26publicationDate%3DOctober%2B2017">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b01215"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3012</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">21</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b01215" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Selective Nonsteroidal Glucocorticoid Receptor Modulators for the Inhaled Treatment of Pulmonary Diseases&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Martin&quot;,&quot;last_name&quot;:&quot;Hemmerling&quot;},{&quot;first_name&quot;:&quot;Stinabritt&quot;,&quot;last_name&quot;:&quot;Nilsson&quot;},{&quot;first_name&quot;:&quot;Karl&quot;,&quot;last_name&quot;:&quot;Edman&quot;},{&quot;first_name&quot;:&quot;Stefan&quot;,&quot;last_name&quot;:&quot;Eirefelt&quot;},{&quot;first_name&quot;:&quot;Wayne&quot;,&quot;last_name&quot;:&quot;Russell&quot;},{&quot;first_name&quot;:&quot;Ramon&quot;,&quot;last_name&quot;:&quot;Hendrickx&quot;},{&quot;first_name&quot;:&quot;Eskil&quot;,&quot;last_name&quot;:&quot;Johnsson&quot;},{&quot;first_name&quot;:&quot;Carina&quot;,&quot;last_name&quot;:&quot;Kärrman Mårdh&quot;},{&quot;first_name&quot;:&quot;Markus&quot;,&quot;last_name&quot;:&quot;Berger&quot;},{&quot;first_name&quot;:&quot;Hartmut&quot;,&quot;last_name&quot;:&quot;Rehwinkel&quot;},{&quot;first_name&quot;:&quot;Anna&quot;,&quot;last_name&quot;:&quot;Abrahamsson&quot;},{&quot;first_name&quot;:&quot;Jan&quot;,&quot;last_name&quot;:&quot;Dahmén&quot;},{&quot;first_name&quot;:&quot;Anders&quot;,&quot;last_name&quot;:&quot;R. Eriksson&quot;},{&quot;first_name&quot;:&quot;Balint&quot;,&quot;last_name&quot;:&quot;Gabos&quot;},{&quot;first_name&quot;:&quot;Krister&quot;,&quot;last_name&quot;:&quot;Henriksson&quot;},{&quot;first_name&quot;:&quot;Nafizal&quot;,&quot;last_name&quot;:&quot;Hossain&quot;},{&quot;first_name&quot;:&quot;Svetlana&quot;,&quot;last_name&quot;:&quot;Ivanova&quot;},{&quot;first_name&quot;:&quot;Anne-Helene&quot;,&quot;last_name&quot;:&quot;Jansson&quot;},{&quot;first_name&quot;:&quot;Tina&quot;,&quot;last_name&quot;:&quot;J. Jensen&quot;},{&quot;first_name&quot;:&quot;Anders&quot;,&quot;last_name&quot;:&quot;Jerre&quot;},{&quot;first_name&quot;:&quot;Henrik&quot;,&quot;last_name&quot;:&quot;Johansson&quot;},{&quot;first_name&quot;:&quot;Tomas&quot;,&quot;last_name&quot;:&quot;Klingstedt&quot;},{&quot;first_name&quot;:&quot;Matti&quot;,&quot;last_name&quot;:&quot;Lepistö&quot;},{&quot;first_name&quot;:&quot;Martin&quot;,&quot;last_name&quot;:&quot;Lindsjö&quot;},{&quot;first_name&quot;:&quot;Irene&quot;,&quot;last_name&quot;:&quot;Mile&quot;},{&quot;first_name&quot;:&quot;Grigorios&quot;,&quot;last_name&quot;:&quot;Nikitidis&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;Steele&quot;},{&quot;first_name&quot;:&quot;Ulrika&quot;,&quot;last_name&quot;:&quot;Tehler&quot;},{&quot;first_name&quot;:&quot;Lisa&quot;,&quot;last_name&quot;:&quot;Wissler&quot;},{&quot;first_name&quot;:&quot;Thomas&quot;,&quot;last_name&quot;:&quot;Hansson&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;12&quot;,&quot;issue&quot;:&quot;20&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;8591-8605&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b01215&quot;},&quot;abstract&quot;:&quot;A class of potent, nonsteroidal, selective indazole ether-based glucocorticoid receptor modulators (SGRMs) was developed for the inhaled treatment of respiratory diseases. Starting from an orally available compound with demonstrated anti-inflammatory activity in rat, a soft-drug strategy was implemented to ensure rapid elimination of drug candidates to minimize systemic GR activation. The first clinical candidate 1b (AZD5423) displayed a potent inhibition of lung edema in a rat model of allergic airway inflammation following dry powder inhalation combined with a moderate systemic GR-effect, assessed as thymic involution. Further optimization of inhaled drug properties provided a second, equally potent, candidate, 15m (AZD7594), that demonstrated an improved therapeutic ratio over the benchmark inhaled corticosteroid 3 (fluticasone propionate) and prolonged the inhibition of lung edema, indicating potential for once-daily treatment.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01215&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01215" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01215&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01215" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01215&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01215" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01215&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01215&amp;href=/doi/10.1021/acs.jmedchem.7b01215" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b01215" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b01215" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01215&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b01215%26sid%3Dliteratum%253Aachs%26pmid%3D28937774%26genre%3Darticle%26aulast%3DHemmerling%26date%3D2017%26atitle%3DSelective%2BNonsteroidal%2BGlucocorticoid%2BReceptor%2BModulators%2Bfor%2Bthe%2BInhaled%2BTreatment%2Bof%2BPulmonary%2BDiseases%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D20%26spage%3D8591%26epage%3D8605%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290658" title="Amides">Amides</a>,</li><li><a href="/action/doSearch?ConceptID=291285" title="Ethers">Ethers</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292016" title="Therapeutics">Therapeutics</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/20" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/jmcmar.2017.60.issue-20/20171026/jmcmar.2017.60.issue-20.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01215/20171020/images/medium/jm-2017-01215g_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01215/20171020/images/large/jm-2017-01215g_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01215&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">A class of potent, nonsteroidal, selective indazole ether-based glucocorticoid receptor modulators (SGRMs) was developed for the inhaled treatment of respiratory diseases. Starting from an orally available compound with demonstrated anti-inflammatory activity in rat, a soft-drug strategy was implemented to ensure rapid elimination of drug candidates to minimize systemic GR activation. The first clinical candidate <b>1b</b> (AZD5423) displayed a potent inhibition of lung edema in a rat model of allergic airway inflammation following dry powder inhalation combined with a moderate systemic GR-effect, assessed as thymic involution. Further optimization of inhaled drug properties provided a second, equally potent, candidate, <b>15m</b> (AZD7594), that demonstrated an improved therapeutic ratio over the benchmark inhaled corticosteroid <b>3</b> (fluticasone propionate) and prolonged the inhibition of lung edema, indicating potential for once-daily treatment.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28000" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28000" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In 1948, the introduction of glucocorticoids (GCs) into clinical practice constituted a breakthrough in anti-inflammatory therapy.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Further developments led to synthetic steroids with improved therapeutic profiles that are, to date, the mainstay of inflammatory and autoimmune disease therapy.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> GCs act through binding to the glucocorticoid receptor (GR), triggering the up- and down-regulation of gene transcription and ultimately modulation of the immune response and energy homeostasis.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> The latter GR function is associated with clinical adverse effects and limits the prolonged use of traditional steroidal GR agonists.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> The search for glucocorticoids with reduced adverse effects led to the discovery of nonsteroidal GR modulators, which have the potential to dissociate the desired anti-inflammatory activity from metabolic adverse effects at a mechanistic level through differential DNA binding and coregulator recruitment. For pulmonary diseases such as asthma and chronic obstructive pulmonary disease (COPD), an inhalation approach may limit systemically driven adverse effects.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> While inhalation delivery effectively reduces circulating drug levels, chronic treatment with inhaled corticosteroids (ICS) can still lead to suppression of the hypothalamic-pituitary-adrenal (HPA) axis, an indicator of systemic GR activation.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Documented adverse effects associated with ICS include growth retardation in children, bone mineral loss, and development of type II diabetes in the elderly population.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> In addition, patients with severe asthma and COPD often exhibit reduced responsiveness to current ICS therapy, and more efficacious alternatives are highly anticipated.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Herein we describe the medicinal chemistry program leading to the discovery of two inhaled nonsteroidal clinical drug candidates, <b>1b</b> and <b>15m</b>, aimed at the control of pulmonary diseases with an inflammatory component such as asthma and COPD.</div><div class="NLM_p">We recently reported the discovery of indazole ethers as a novel class of highly potent nonsteroidal GR modulators covering a wide range of the physicochemical property space and thus with the potential to be optimized for different routes of administration.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a></div><div class="NLM_p">In this series, compound <b>1a</b> not only demonstrated excellent oral efficacy in a rat arthritis model but also exhibited several properties consistent with the inhalation design guidelines for pulmonary targeting via inhaled administration.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Overall, <b>1a</b> possesses suitable solid-state properties such as crystallinity and low hygroscopicity to facilitate dry powder inhalation (DPI) formulations. More specifically, <b>1a</b> displayed picomolar cellular potency (transrepression activity) in a range similar to current ICS (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>), preferred to overcome dose limitations set by the device capacity.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> In addition, compound <b>1a</b> exhibited high nonspecific binding to rat plasma protein (99.99% bound) coupled to a high steady state volume of distribution in rat (<i>V</i><sub>ss</sub> 13.5 L/kg).<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> As large volumes result when nonspecific binding to lipids exceeds the nonspecific binding to plasma protein,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> it was hypothesized that high tissue affinity would contribute to increased local drug levels following inhalation. We concluded that compound <b>1a</b> was a suitable starting point for a chemistry program to identify an inhaled, selective nonsteroidal GR modulator (SGRM) to provide a safer treatment of asthma than current ICS. For the preclinical evaluation, a precedented methodology was adopted to assess the therapeutic ratio in the rat, derived from the inhibition of allergen-induced lung edema and the systemic involuting effect on the thymus.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01215/20171020/images/medium/jm-2017-01215g_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01215/20171020/images/large/jm-2017-01215g_0001.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. GR ligands with picomolar transrepression potency.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01215/20171020/images/large/jm-2017-01215g_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01215&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08841" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08841" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The general synthetic strategy for the indazole series follows the route outlined in <a class="ref internalNav" href="#sch1" aria-label="Schemes 1">Schemes 1</a> and <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. To facilitate a building block approach, the basic indazole ether core was assembled by an ether formation, fusing a 5-iodo-indazole with a substituted norephedrine <b>7</b>. The modified norephedrines were available through the Weinreb–Nahm ketone synthesis reacting the Weinreb amide of a suitably protected <span class="smallcaps smallerCapital">l</span>-alanine derivative (<b>4</b>) with a freshly prepared aryl-Grignard reagent to form the phenylalkyl ketone <b>5</b>.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> A stereoselective Meerwein–Ponndorf–Verley reduction<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> provided the carbamoyl-protected substituted norephedrines <b>6</b> as single stereoisomers that following deprotection yielded the corresponding (1<i>R</i>,2<i>S</i>)-norephedrines <b>7</b>, having the same absolute configuration as natural (−)-norephedrine. The enantiomers with the (1<i>S</i>,2<i>R</i>)-configuration are accessible from <span class="smallcaps smallerCapital">d</span>-alanine applying the same diasteroselective route. Specific rotations obtained for the (1<i>R</i>,2<i>S</i>)-intermediate <b>7c</b> were similar to the reported value for (−)-norephedrine,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> supporting the assignment of the absolute configuration. The opposite, positive rotation was measured for the (1<i>S</i>,2<i>R</i>)-enantiomer <b>ent-7c</b>. To access the <i>syn</i>-diastereomers with (<i>S</i>,<i>S</i>)- and (<i>R</i>,<i>R</i>)-configurations, a published method was applied to transform the <i>tert</i>-butyl carbamoyl-protected amino alcohols in <b>6c</b> to 4-methyl-5-aryl-substituted oxazolidine-2-one <b>9</b> with concomitant inversion of the benzylic stereocenter.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Proton NMR comparison with the 4,5-<i>cis</i>-substituted oxazolidin-2-one <b>8</b>, formed with conservation of both stereocenters, confirmed the relative configuration of the diastereomers. Hydrolysis of the oxazolidinone with retention of stereoconfiguration released the norpseudoephedrine <b>10</b>. The final steps to the putative GR-ligands are shown in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. The indazole ether core was synthesized by an Ullmann coupling of a substituted norephedrine <b>7</b> and an iodoindazole to produce the primary amine intermediates <b>11</b> and <b>12</b>.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Further conversion to carboxamides using standard amide coupling conditions provided the final indazole ether ligands <b>1</b> and <b>14</b> or the isobutyl ester intermediate <b>13</b>. Saponification and a second amide coupling yielded the extended indazole ether ligands <b>15</b>.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01215/20171020/images/medium/jm-2017-01215g_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01215/20171020/images/large/jm-2017-01215g_0006.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Diastereoselective Synthesis of Phenylpropanolamine Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01215/20171020/images/large/jm-2017-01215g_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01215&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>i</i>-PrMgCl·LiCl, 0–10 °C; (b) <i>i</i>-PrMgCl, THF, 0 °C to rt; (c) aq HCl (1.5 N), EtOAc, 10 °C; (d) Al(OiPr)<sub>3</sub> (0.2 equiv), <i>i</i>-PrOH (11 equiv), toluene, 50 °C; (e) HCl; (f) triphosgene, THF, −15 °C to rt; (g) MeSO<sub>2</sub>Cl, Et<sub>3</sub>N, THF, 50 °C; (h) LiOH, THF/H<sub>2</sub>O, 90 °C.</p></p></figure><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01215/20171020/images/medium/jm-2017-01215g_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01215/20171020/images/large/jm-2017-01215g_0007.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Indazole Ethers<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01215/20171020/images/large/jm-2017-01215g_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01215&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>For specified substituents NR<sup>4</sup>R<sup>5</sup> refer to <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>. Reagents and conditions: (a) 1-(4-fluorophenyl)-5-iodo-indazole (<b>16</b>), CuI (0.05 equiv), Cs<sub>2</sub>CO<sub>3</sub> (2.2 equiv), <i>n</i>-PrCN, 125 °C; (b) [R<sup>1</sup>C(O)]<sub>2</sub>O; NEt<sub>3</sub>; (c) R<sup>1</sup>CO<sub>2</sub>H, NEt<sub>3</sub>, T3P, MeCN; (d) isobutyl 3-(5-iodoindazol-1-yl)benzoate (<b>17</b>), CuI (0.05 equiv) Cs<sub>2</sub>CO<sub>3</sub> (2.2 equiv), <i>n</i>-PrCN, 110 °C; (e) 2,2-difluoropropionic acid, HATU, DIPEA, DCM; (f) LiOH, THF/H<sub>2</sub>O (1:1); (g) HNR<sup>4</sup>R<sup>5</sup>, HBTU, DIPEA, DMF.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65416" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65416" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The inhaled administration of GR modulators aims to minimize adverse effects, and the improved safety profile of the current marketed agents is largely attributable to reduced systemic concentrations compared to oral treatments.<a onclick="showRef(event, 'cit7a'); return false;" href="javascript:void(0);" class="ref cit7a">(7a)</a> However, once absorbed into the systemic circulation, rapid inactivation is important to reduce the risk of side effects. The most prescribed ICS are all antedrugs, where metabolically labile motifs are appended to the otherwise stable steroidal core.<a onclick="showRef(event, 'cit10a'); return false;" href="javascript:void(0);" class="ref cit10a">(10a)</a> Three prominent examples, budesonide (<b>2</b>), fluticasone propionate (<b>3</b>), and fluticasone furoate, achieve hepatic deactivation through oxidative degradation of labile substituents at the 16α, 17α, or 17β position of the familiar tetracyclic steroid core,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> and a similar strategy was considered for the evolution of the starting point <b>1a</b>, which was characterized by high resistance to hepatic degradation and high systemic stability.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Analysis of the binding conformation of <b>1a</b> and <b>2</b> reveals that parts of the indazole ether scaffold superimpose or are in close proximity with the substituents of the steroidal positions 17 and 16 (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). From a design perspective, it was plausible to introduce metabolically labile substituents either as modified amide residues, or in the meta and para positions of the norephedrine aryl group, designed to mimic the 17β group and the 16α and 17α group, respectively. The metabolic clearance was assessed in human hepatocytes, with the resulting data used for the prediction of in vivo hepatic extraction.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></div><figure id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01215/20171020/images/medium/jm-2017-01215g_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01215/20171020/images/large/jm-2017-01215g_0002.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Superimposition of the GR complexes of <b>1a</b> (magenta) and <b>2</b> (blue); protein not shown (RMSD 0.44 for 984 main chain atoms). Steroid sites with precedent for metabolic deactivation are marked with yellow circles.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01215/20171020/images/large/jm-2017-01215g_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01215&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Designing in metabolic liability needed to be achieved within the established SAR for GR agonism, as subnanomolar potency is commonplace for commercial ICS. To this end, it was critical to monitor potency and also crystallinity of the new ligands, since both properties play a pivotal role in successful inhaled delivery and efficacy. Cellular potency was assessed both as repression of AP-1 dependent transcription (cell TR) and as inhibition of LPS-stimulated TNF-α production in human peripheral blood mononuclear cells (PBMCs).</div><div class="NLM_p">The first metabolic inactivation option, the introduction of amides, was limited by the structure–activity relationship of the series. As reported in a recent study on the indazole ether series, small substituents including cyclopropyl, <i>tert</i>-butyl, and trifluoromethyl amides with low conversion in hepatocytes were preferred for potency.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Therefore, the plan to achieve metabolic inactivation focused on the exploration of the norephedrine phenyl moiety where lipophilic extensions were well tolerated.</div><div class="NLM_p">This alternative approach was built on the introduction of a metabolically labile methoxy group to the norephedrine phenyl. An anisole derivative was expected to be metabolically stable in organ tissue but could serve as a substrate for cytochrome-mediated degradation in the liver. In principle, oxidative demethylation and subsequent conjugation of the resulting phenol by secondary metabolism should render compounds inactive at the GR. In practice, the introduction of a methoxy group provided compound <b>1b</b> with a combined excellent potency in both the reporter gene cell assay and in human PBMCs with rapid conversion in hepatocytes, corresponding to a predicted extraction in man of a liver blood flow of 67% (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. In Vitro Properties of <i>N</i>-Fluoro-phenyl Indazole Ethers in Comparison with the ICS <b>2</b> and <b>3</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01215/20171020/images/medium/jm-2017-01215g_0008.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01215/20171020/images/medium/jm-2017-01215g_0009.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">Value as mean ± SD (number of replicates).</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">Transrepression activity (TR), assessed as inhibition of AP-1-mediated transcription.</p></div><div class="footnote" id="t1fn3"><sup>Table c</sup><p class="last">Efficacy, maximum response relative to Dexamethasone (100%).</p></div><div class="footnote" id="t1fn4"><sup>Table d</sup><p class="last">LPS-induced TNF-α release in peripheral blood mononuclear cells (PBMCs).</p></div><div class="footnote" id="t1fn5"><sup>Table e</sup><p class="last">The intrinsic clearance (Cl<sub>int</sub>; μL/min/10<sup>6</sup> cells) in human hepatocytes was scaled to give an estimate for the in vivo hepatic clearance and the extraction ratio (E<sub>H</sub>) at hepatic blood flow of 20 mL/min/kg.</p></div><div class="footnote" id="t1fn6"><sup>Table f</sup><p class="last">Melting point of crystalline material only, assessed by differential scanning calorimetry. NA, not applicable. NT, not tested.</p></div></div><div></div></div><div class="NLM_p">To summarize the initial effort to tailor the properties of the lead compound <b>1a</b>, few examples were found that met the in vitro requirements for functional cellular potency combined with rapid degradation in hepatocytes. Between these, <b>1b</b> was the only compound that could be crystallized (mp = 82 °C), indicating the potential for dry powder inhalation. The systemic rat pharmacokinetics (PK) of compound <b>1b</b> indicated that the clearance from circulation (CL 38 mL/min/kg) was well predicted from clearance in rat hepatocytes. The large volume of distribution <i>V</i><sub>ss</sub> (23 L/kg) indicated a high tissue affinity of <b>1b</b> and led to an extended terminal half-life of 4.7 h. A high fraction of the oral dose was absorbed from the gastrointestinal tract and led to a moderate oral bioavailability of 37% (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>).</div><div class="NLM_p">To validate the soft-drug principle, the metabolic fate of <b>1b</b> was studied in hepatocytes from different species. In human and dog hepatocytes, the GR-inactive sulfate <b>1d</b> was the only major metabolite, suggesting that an efficient deactivation of <b>1b</b> could be achieved. However, in rat hepatocytes, the active phenol <b>1c</b> (rat PBMC IC<sub>50</sub> 0.56 nM) was predominantly formed and is expected to provide a minor contribution to the systemic GR activity in the rat but not in dog or man (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01215/suppl_file/jm7b01215_si_001.pdf" class="ext-link">Supporting Information</a>, Scheme S1).</div><div class="NLM_p">Having demonstrated satisfactory plasma pharmacokinetics, the inhalation properties of <b>1b</b> were investigated in advanced dry powder inhalation systems, which allow for pulmonary particle distribution by active breathing.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> A delayed distribution into the systemic circulation is desirable to prolong the pulmonary residence time of the drug to favor local over systemic effects.<a onclick="showRef(event, 'cit10a cit10d ref21'); return false;" href="javascript:void(0);" class="ref cit10a cit10d ref21">(10a, 10d, 21)</a> In our hands, the mean retention times (MRT) in rat lung for established ICS were found to be 0.74 and 6.5 h for <b>2</b> and <b>3</b>, respectively. Inhaled <b>1b</b> displayed a mean retention time of 1.5 h, similar to the faster absorbed <b>2</b> (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>), which supported a further evaluation of its anti-inflammatory efficacy in a rat PD model of allergic asthma.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Following dry powder inhalation, <b>1b</b> potently inhibited a Sephadex-induced lung edema in a dose-dependent manner with an ED<sub>50</sub> of 1.2 μg/kg, 4-fold more potent than the comparator <b>3</b> in this model (<a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>).</div><div class="NLM_p">As a sensitive marker of systemic GR agonism, thymic involution was evaluated in the same Sephadex-challenged animals, measured as an ED<sub>25</sub> value: reduction of thymus weight by 25%.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> In this model, both <b>1b</b> and <b>3</b> exerted a similar effect on thymus weight. Thus, <b>1b</b> displayed a 4–5-fold improvement in the therapeutic ratio (TR) in the rat over the benchmark ICS <b>3</b> when using the formula TR = ED<sub>25</sub> thymus involution/ED<sub>50</sub> lung edema (<a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>).</div><div class="NLM_p">We therefore decided to nominate <b>1b</b> for clinical evaluation in asthma patients as a development candidate drug, 2,2,2-trifluoro-<i>N</i>-((1<i>R</i>,2<i>S</i>)-1-(1-(4-fluorophenyl)-1<i>H</i>-indazol-5-yloxy)-1-(3-methoxyphenyl)propan-2-yl)acetamide (AZD5423).<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></div><div class="NLM_p">With <b>1b</b> progressing into clinical studies, a follow-up program set out to expand the indazole ether series and deliver a second candidate drug. The key achievements of <b>1b</b>, in particular picomolar cellular potency and efficient deactivation in human hepatocytes, needed to be retained, but there was still a scope to improve the lung retention. A compound with a slower distribution from lung to circulation could provide two benefits: first, a reduction in peak systemic drug levels and second, an extended duration of efficacy in lung tissue, thereby providing a once-daily dosing platform. An additional design ambition was to avoid active rat metabolites and thereby simplify the efficacy and safety evaluations.</div><div class="NLM_p">The first modifications of <b>1b</b> were built on the methoxyphenyl motif, which provided the rat-specific phenol metabolite <b>1c</b>. Guided by previous indazole ether SAR, electron-rich bicyclic residues (R<sup>2</sup> in <b>14</b>, <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>) were expected to maintain high potency. Annulation into a cyclic ether motif would preserve the metabolically labile site, as hepatic degradation would be expected to occur α to the ether oxygen, resulting in more polar, ring-opened metabolites with reduced GR activity.</div><div class="NLM_p">Example <b>14a</b>, containing a dihydro-1,4-benzodioxane R<sup>2</sup> group, showed a modest 2-fold increase in potency over the first candidate <b>1b</b> in both the cellular transrepression assay and the PBMCs. A further change from trifluoroacetamide to 2,2-difluoropropionamide introduced an additional dipole and provided the equipotent and crystalline <b>14b</b> and <b>14c</b> (a dihydrobenzofuran analogue). Importantly, the accelerated clearance in human hepatocytes indicated that the benzodioxane heterocycle could enhance the soft-drug potential. The use of the other isomeric and slightly more polar benzodioxanes at R<sup>2</sup> was less promising, giving reduced potencies and amorphous products, examples <b>14d</b> and <b>14e</b>.</div><div class="NLM_p">Compound <b>14b</b> showed improved potency and intrinsic crystallinity compared to <b>1b</b> and was thus further profiled for rat pharmacokinetics in vivo. Following intravenous (<i>iv</i>) administration, plasma PK of the two compounds was similar, although the oral bioavailability of <b>14b</b> decreased to 11% (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>). Following intratracheal (<i>it</i>) administration, the lung PK showed a rapid absorption of <b>14b</b> with a slightly improved lung retention after 4 h (4.5% of dose, <a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>) compared to the first candidate <b>1b</b> (1% of dose).</div><div class="NLM_p">Although <b>14b</b> represented progress, its high lipophilicity and intrinsic crystallinity were similar to the first selected candidate <b>1b</b> and resulted in an almost identical pharmacokinetic profile. To obtain a truly differentiated drug candidate, the target profile was revised in two ways. First, to significantly delay absorption from the lung, slow dissolution driven by high crystallinity was prioritized. Second, an increase in polarity would lower the volume of distribution to reduce exposure in the peripheral tissue. As more drastic structural changes would be needed to achieve this, a structure-guided approach was adopted to identify opportunities for the addition of polar interactions within the GR binding pocket.</div><div class="NLM_p">The X-ray structure of <b>1b</b> in complex with the GR LBD and a NCOA2 peptide (residues 740–753) confirmed that <b>1b</b> exploits all regions of the receptor used by traditional, steroidal glucocorticoids (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>A). As such, the ligand binding pocket offers limited scope to significantly modify the chemical scaffold. However, in common with compound <b>1a</b> and other GR ligands displaying a similar indazole motif,<a onclick="showRef(event, 'ref9 ref25'); return false;" href="javascript:void(0);" class="ref ref9 ref25">(9, 25)</a> the fluorophenyl group of <b>1b</b> rearranged the gatekeeper residues <i>Gln570</i> and <i>Arg611</i>, expanding the binding pocket between helices 3 and 5. As a result, the ligand-binding pocket is fused with a large cavity beneath <i>Trp577</i> (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>B). This cavity is lined with hydrophilic residues, and the crystal structure is filled with ordered water molecules and an ethylene glycol derived from the crystallization conditions. This presented an opportunity to extend the indazole ether core to exploit the solvated cavity with new ligands of increased size and polar surface area, in line with the revised target profile. As an added benefit, the additional polar groups could facilitate intermolecular interactions in the crystalline state and consequently increase the melting point.</div><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01215/20171020/images/medium/jm-2017-01215g_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01215/20171020/images/large/jm-2017-01215g_0003.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. GR LBD (green) in complex with compound <b>1b</b> (magenta). Putative hydrogen bonds are marked with dashed lines. (A) Compound <b>1b</b> places the amide within hydrogen bonding distance of <i>Asn564</i> and <i>Glu642</i> of helices 3 and 7, respectively. The fluorophenyl motif is inserted in the induced pocket in between helices 3 and 5. (B) The meta position of the fluorophenyl motif is directed toward a large cavity beneath <i>Trp577</i>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01215/20171020/images/large/jm-2017-01215g_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01215&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">On the basis of the crystallographic data, the familiar phenyl indazole moiety was extended from the meta position of the <i>N</i>-phenyl group. By analogy to published GR modulators,<a onclick="showRef(event, 'cit25d'); return false;" href="javascript:void(0);" class="ref cit25d">(25d)</a> a carboxamide was selected as a polar linker to position side chains along the preferred vector into the induced solvent stabilized cleft (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>). Amino acid amides were initially explored as polar substituents to form amides of the general structure <b>15</b>, exemplified by the prolines <b>15a</b>–<b>15d</b> (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). The <span class="smallcaps smallerCapital">d</span>-prolinamide residue proved to be the preferred stereoisomer, and excellent potency was achieved for all aryl substituents A–C. However, the reduced lipophilicity limited intrinsic clearance in hepatocytes. Furthermore, the polar prolinamide functionality increased solubility and derailed our attempts to reduce aqueous solubility by increasing crystallinity and melting point. Switching to the related γ-butyrolactone instead of a proline in <b>15e</b> and <b>15f</b> resulted in a breakthrough, providing compounds that were easily crystallized, melting in the region of 200 °C, an increase of about 100 °C compared to the first candidate <b>1b</b>. Importantly, for this matched pair of butyrolactones, the bicyclic aryl variant B in <b>15f</b> improved potency by an order of magnitude over its partner <b>15e</b>. In human hepatocytes, <b>15f</b> was more rapidly cleared than the more polar prolines <b>15c</b> and <b>15d</b>, reaching the target of >60% of predicted hepatic extraction (E<sub>H</sub>). Overall, <b>15f</b> achieved all of the a priori target criteria and is a key bridgehead for the design of improved analogues.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Carboxamide Extended Indazole Ethers</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01215/20171020/images/medium/jm-2017-01215g_0010.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01215/20171020/images/medium/jm-2017-01215g_0011.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">Value as mean ± SD (number of replicates).</p></div><div class="footnote" id="t2fn2"><sup>Table b</sup><p class="last">Transrepression activity (TR), assessed as the inhibition of AP-1-mediated transcription.</p></div><div class="footnote" id="t2fn3"><sup>Table c</sup><p class="last">Efficacy, maximum response relative to Dexamethasone (100%).</p></div><div class="footnote" id="t2fn4"><sup>Table d</sup><p class="last">LPS-induced TNF-α release in peripheral blood mononuclear cells (PBMCs).</p></div><div class="footnote" id="t2fn5"><sup>Table e</sup><p class="last">The intrinsic clearance (Cl<sub>int</sub>; μL/min/10<sup>6</sup> cells) in human hepatocytes was scaled to give an estimate for the in vivo hepatic clearance and the extraction ratio (E<sub>H</sub>) at hepatic blood flow of 20 mL/min/kg.</p></div><div class="footnote" id="t2fn6"><sup>Table f</sup><p class="last">Melting point of the crystalline material only, assessed by differential scanning calorimetry. NA, not applicable. NT, not tested.</p></div><div class="footnote" id="t2fn7"><sup>Table g</sup><p class="last">Solubility in 0.1 M phosphate buffer (pH 7.4). S: at 20 °C, starting from 10 mM DMSO stock solution. C: at 23 °C, starting from crystalline solid. NA, not applicable. NT, not tested.</p></div></div><div></div></div><div class="NLM_p">The sulfolane amides <b>15h</b> and <b>15i</b> maintained the high-melting crystalline profile and further improved potency, with a preference for the <i>R</i> isomer in <b>15i</b>. Both isomers were rapidly cleared by human hepatocytes, and compound <b>15i</b> was progressed as a potential clinical candidate for further profiling. The pyridylmethyl amide pair <b>15j</b> and <b>15k</b>, differentiated only by the regiochemistry of the norephedrine aryl group, both improved on potency over the sulfolane <b>15i</b> and retained rapid clearance in hepatocytes. While measured lipophilicity was similar for the regioisomeric pair, the significant difference in melting temperatures led to a very different solubility. As a result, <b>15j</b> and <b>15k</b> provided an opportunity to study the impact of differentiated solid-state properties on in vivo pharmacokinetics and pharmacology, and both compounds were subjected to additional in vivo studies. From the triad of <i>N</i>-tetrahydrofuran-3-yl amides <b>15l</b>–<b>15n</b>, the epimers <b>15l</b> and <b>15m</b> could not be differentiated in vitro. Both compounds displayed the highest observed potencies in human and rat PBMCs and provided an increased melting point, indicating a higher intrinsic crystallinity. <b>15m</b> was arbitrarily selected for further progression. The benzodioxane regioisomer <b>15n</b> showed reduced potency and was not progressed.</div><div class="NLM_p">As recently reported, indazole ether-based GR modulators are, in general, highly selective.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> In contrast to marketed ICS that typically display nanomolar affinities at the progesterone receptor (PR) and mineralocorticoid receptor (MR),<a onclick="showRef(event, 'cit10a'); return false;" href="javascript:void(0);" class="ref cit10a">(10a)</a> the indazole ether-based GR modulators improve the PR selectivity by at least 100-fold and show no binding to the MR up to the limit of binding assay detection (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). A substantial improvement in steroid hormone receptor selectivity could potentially contribute to clinical safety and differentiates selective GR modulators from conventional steroids.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Hormone Receptor Selectivity<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cpd</th><th class="colsep0 rowsep0" align="center">GR (μM)</th><th class="colsep0 rowsep0" align="center">PR (μM)</th><th class="colsep0 rowsep0" align="center">MR (μM)</th><th class="colsep0 rowsep0" align="center">AR (μM)</th><th class="colsep0 rowsep0" align="center">ERα (μM)</th><th class="colsep0 rowsep0" align="center">ERβ (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1b</b></td><td class="colsep0 rowsep0" align="left">0.0009 ± 0.0002 (2)</td><td class="colsep0 rowsep0" align="left">1.76 ± 0.63 (3)</td><td class="colsep0 rowsep0" align="left">>5 (7)</td><td class="colsep0 rowsep0" align="left">>10 (4)</td><td class="colsep0 rowsep0" align="left">>10 (3)</td><td class="colsep0 rowsep0" align="left">>10 (3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15i</b></td><td class="colsep0 rowsep0" align="left">0.0015 ± 0.0005 (5)</td><td class="colsep0 rowsep0" align="left">>10 (5)</td><td class="colsep0 rowsep0" align="left">>10 (6)</td><td class="colsep0 rowsep0" align="left">>10 (4)</td><td class="colsep0 rowsep0" align="left">>10 (4)</td><td class="colsep0 rowsep0" align="left">>10 (4)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15j</b></td><td class="colsep0 rowsep0" align="left">0.0010 ± 0.0011 (6)</td><td class="colsep0 rowsep0" align="left">8.28 ± 1.45 (3)</td><td class="colsep0 rowsep0" align="left">>10 (3)</td><td class="colsep0 rowsep0" align="left">>10 (3)</td><td class="colsep0 rowsep0" align="left">>10 (2)</td><td class="colsep0 rowsep0" align="left">>10 (2)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15k</b></td><td class="colsep0 rowsep0" align="left">0.0008 ± 0.0001 (6)</td><td class="colsep0 rowsep0" align="left">>10 (6)</td><td class="colsep0 rowsep0" align="left">>10 (7)</td><td class="colsep0 rowsep0" align="left">>10 (6)</td><td class="colsep0 rowsep0" align="left">>10 (6)</td><td class="colsep0 rowsep0" align="left">>10 (6)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15m</b></td><td class="colsep0 rowsep0" align="left">0.0009 ± 0.0007 (3)</td><td class="colsep0 rowsep0" align="left">>10 (3)</td><td class="colsep0 rowsep0" align="left">>10 (3)</td><td class="colsep0 rowsep0" align="left">>10 (3)</td><td class="colsep0 rowsep0" align="left">>10 (2)</td><td class="colsep0 rowsep0" align="left">>10 (2)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">0.0038<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a> ± 0.0019 (7)</td><td class="colsep0 rowsep0" align="left">0.028 ± 0.0065 (6)</td><td class="colsep0 rowsep0" align="left">0.014 ± 0.010 (6)</td><td class="colsep0 rowsep0" align="left">0.71 ± 0.17 (4)</td><td class="colsep0 rowsep0" align="left">>10 (3)</td><td class="colsep0 rowsep0" align="left">>10 (3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">0.0009 ± 0.0009 (333)</td><td class="colsep0 rowsep0" align="left">0.021 ± 0.014 (6)</td><td class="colsep0 rowsep0" align="left">0.149 ± 0.166 (4)</td><td class="colsep0 rowsep0" align="left">>10 (3)</td><td class="colsep0 rowsep0" align="left">>10 (3)</td><td class="colsep0 rowsep0" align="left">>10 (3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">FF<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">0.0008 ± 0.0003 (5)</td><td class="colsep0 rowsep0" align="left">0.021 ± 0.007 (4)</td><td class="colsep0 rowsep0" align="left">0.166 ± 0.016 (2)</td><td class="colsep0 rowsep0" align="left">1.88 ± 0.28 (2)</td><td class="colsep0 rowsep0" align="left">>5 (2)</td><td class="colsep0 rowsep0" align="left">>5 (2)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Values as mean ± SD (number of replicates).</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">For assay descriptions, refer to the <a href="/doi/suppl/10.1021/acs.jmedchem.7b01215/suppl_file/jm7b01215_si_001.pdf" class="ext-link">Supporting Information</a>.</p></div><div class="footnote" id="t3fn3"><sup>c</sup><p class="last">Assessed in fluorescence polarization assay format. FF; fluticasone furoate.</p></div></div></div><div class="NLM_p">The primary goal of the follow-up program was to identify a candidate with a differentiated PK profile leading to improved lung targeting. For the short-listed examples of the subseries <b>15</b>, rapid clearance from circulation was similar to that observed for the first drug candidate <b>1b</b>. Furthermore, compounds <b>15i</b>–<b>15m</b> demonstrated a greatly reduced volume of distribution (<i>V</i><sub>ss</sub>), shortening half-lives substantially. Most critically, the significant bioavailability observed for <b>1b</b> did not translate to <b>15i</b> – <b>15m</b>, confirming that this subclass did have improved PK properties, resulting in reduced systemic exposure (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Plasma PK in Rat<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="rowsep1 colsep0" align="center">cpd</th><th class="rowsep1 colsep0" align="center" char=".">rat hep CL<sub>int</sub></th><th class="rowsep1 colsep0" align="center" char=".">predicted in vivo CL<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th><th class="rowsep1 colsep0" align="center" char=".">CL [<i>iv</i>]</th><th class="rowsep1 colsep0" align="center"><i>V</i><sub>ss</sub> [<i>iv</i>]</th><th class="rowsep1 colsep0" align="center" char="."><i>t</i><sub>1/2</sub> [<i>iv</i>]</th><th class="rowsep1 colsep0" align="center" char=".">F [po]</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char=".">(μL/min/10<sup>6</sup> cells)</th><th class="colsep0 rowsep0" align="center" char=".">(mL/min/kg)</th><th class="colsep0 rowsep0" align="center" char=".">(mL/min/kg)</th><th class="colsep0 rowsep0" align="center">(L/kg)</th><th class="colsep0 rowsep0" align="center" char=".">(h)</th><th class="colsep0 rowsep0" align="center" char=".">(%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1b</b></td><td class="colsep0 rowsep0" align="char" char=".">13</td><td class="colsep0 rowsep0" align="char" char=".">34</td><td class="colsep0 rowsep0" align="char" char=".">38</td><td class="colsep0 rowsep0" align="left">23</td><td class="colsep0 rowsep0" align="char" char=".">4.7</td><td class="colsep0 rowsep0" align="char" char=".">37</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14b</b></td><td class="colsep0 rowsep0" align="char" char=".">22</td><td class="colsep0 rowsep0" align="char" char=".">43</td><td class="colsep0 rowsep0" align="char" char=".">42</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="char" char=".">7.4</td><td class="colsep0 rowsep0" align="char" char=".">11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15i</b></td><td class="colsep0 rowsep0" align="char" char=".">31</td><td class="colsep0 rowsep0" align="char" char=".">48</td><td class="colsep0 rowsep0" align="char" char=".">102</td><td class="colsep0 rowsep0" align="left">2.8</td><td class="colsep0 rowsep0" align="char" char=".">0.3</td><td class="colsep0 rowsep0" align="char" char="."><0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15j</b></td><td class="colsep0 rowsep0" align="char" char=".">25</td><td class="colsep0 rowsep0" align="char" char=".">45</td><td class="colsep0 rowsep0" align="char" char=".">68</td><td class="colsep0 rowsep0" align="left">0.97</td><td class="colsep0 rowsep0" align="char" char=".">0.2</td><td class="colsep0 rowsep0" align="char" char=".">0.16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15k</b></td><td class="colsep0 rowsep0" align="char" char=".">25</td><td class="colsep0 rowsep0" align="char" char=".">45</td><td class="colsep0 rowsep0" align="char" char=".">73</td><td class="colsep0 rowsep0" align="left">0.81</td><td class="colsep0 rowsep0" align="char" char=".">0.1</td><td class="colsep0 rowsep0" align="char" char=".">0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15m</b></td><td class="colsep0 rowsep0" align="char" char=".">34</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">30</td><td class="colsep0 rowsep0" align="left">0.16</td><td class="colsep0 rowsep0" align="char" char=".">0.1</td><td class="colsep0 rowsep0" align="char" char="."><0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="char" char=".">28</td><td class="colsep0 rowsep0" align="char" char=".">46</td><td class="colsep0 rowsep0" align="char" char=".">103</td><td class="colsep0 rowsep0" align="left">31</td><td class="colsep0 rowsep0" align="char" char=".">3.3</td><td class="colsep0 rowsep0" align="char" char="."><0.1</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Male Han Wistar rat.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">Predicted hepatic clearance in the rat, based on intrinsic clearance in rat hepatocytes<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></p></div></div></div><div class="NLM_p">For all selected examples with the generic structure <b>15</b>, the combined analysis of the pharmacokinetic profiles after intravenous and inhaled administration indicated an absorption rate-limited elimination.<a onclick="showRef(event, 'cit7a cit10d'); return false;" href="javascript:void(0);" class="ref cit7a cit10d">(7a, 10d)</a> This was demonstrated by the prolonged terminal lung half-lives observed after DPI (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>), which were invariably 1–2 orders of magnitude larger than the corresponding plasma half-lives obtained after <i>iv</i> administration (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>). The underlying mechanism is likely a dissolution-limited absorption because experimental solubility in human intestinal fluid (HIF), rather than lipophilicity, correlates with the observed lung retention (MRT) (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>). Slow particle dissolution, particularly in the less-perfused regions of the central lung, was previously shown to drive a favorable concentration gradient from the lung epithelium to the circulation, improving the lung selectivity.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Inhalation PK in Rat<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="rowsep1 colsep0" align="center">cpd</th><th class="rowsep1 colsep0" align="center">sol [HIF]<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></th><th class="rowsep1 colsep0" colspan="2" align="center">% dose in lung<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></th><th class="rowsep1 colsep0" align="center" char=".">AUC<sub>0-∞</sub><a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></th><th class="rowsep1 colsep0" align="center"><i>t</i><sub>1/2</sub><a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></th><th class="rowsep1 colsep0" align="center">MRT<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></th><th class="rowsep1 colsep0" align="center"><i>C</i><sub>max</sub> [plasma]</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">(μM)</th><th class="colsep0 rowsep0" align="center">at 4 h (%)</th><th class="colsep0 rowsep0" align="center">at 24 h (%)</th><th class="colsep0 rowsep0" align="center" char=".">(μM × h)</th><th class="colsep0 rowsep0" align="center">(h)</th><th class="colsep0 rowsep0" align="center">(h)</th><th class="colsep0 rowsep0" align="center">(nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1b</b></td><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left">0.7</td><td class="colsep0 rowsep0" align="left">0–0.4</td><td class="colsep0 rowsep0" align="char" char=".">18</td><td class="colsep0 rowsep0" align="left">7.5</td><td class="colsep0 rowsep0" align="left">1.5</td><td class="colsep0 rowsep0" align="left">122</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14b</b><a class="ref internalNav" href="#t5fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">6.2</td><td class="colsep0 rowsep0" align="left">0.8</td><td class="colsep0 rowsep0" align="char" char=".">12</td><td class="colsep0 rowsep0" align="left">8.9</td><td class="colsep0 rowsep0" align="left">8.8</td><td class="colsep0 rowsep0" align="left">30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15i</b></td><td class="colsep0 rowsep0" align="left">0.30</td><td class="colsep0 rowsep0" align="left">93</td><td class="colsep0 rowsep0" align="left">91</td><td class="colsep0 rowsep0" align="char" char=".">5200</td><td class="colsep0 rowsep0" align="left">179</td><td class="colsep0 rowsep0" align="left">210</td><td class="colsep0 rowsep0" align="left">4.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15j</b></td><td class="colsep0 rowsep0" align="left">2.1</td><td class="colsep0 rowsep0" align="left">4.1</td><td class="colsep0 rowsep0" align="left">0.18</td><td class="colsep0 rowsep0" align="char" char=".">26</td><td class="colsep0 rowsep0" align="left">4.9</td><td class="colsep0 rowsep0" align="left">2.6</td><td class="colsep0 rowsep0" align="left">21</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15k</b></td><td class="colsep0 rowsep0" align="left">1.30</td><td class="colsep0 rowsep0" align="left">41</td><td class="colsep0 rowsep0" align="left">8.6</td><td class="colsep0 rowsep0" align="char" char=".">190</td><td class="colsep0 rowsep0" align="left">9.0</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15m</b></td><td class="colsep0 rowsep0" align="left">0.60</td><td class="colsep0 rowsep0" align="left">73</td><td class="colsep0 rowsep0" align="left">32</td><td class="colsep0 rowsep0" align="char" char=".">740</td><td class="colsep0 rowsep0" align="left">17</td><td class="colsep0 rowsep0" align="left">23</td><td class="colsep0 rowsep0" align="left">7.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">0.62</td><td class="colsep0 rowsep0" align="left">43</td><td class="colsep0 rowsep0" align="left">1.9</td><td class="colsep0 rowsep0" align="char" char=".">200</td><td class="colsep0 rowsep0" align="left">4.5</td><td class="colsep0 rowsep0" align="left">6.0</td><td class="colsep0 rowsep0" align="left">24</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Dry powder inhalation; normalized lung dose 0.1 μmol/kg.</p></div><div class="footnote" id="t5fn2"><sup>b</sup><p class="last">Thermodynamic solubility in human intestinal fluid at 37 °C.</p></div><div class="footnote" id="t5fn3"><sup>c</sup><p class="last">In total lung; <i>t</i><sub>1/2</sub>, apparent terminal half-life in the total lung; MRT, mean residence time.</p></div><div class="footnote" id="t5fn4"><sup>d</sup><p class="last"><i>it</i> instillation of the lung dose. NT, not tested.</p></div></div></div><div class="NLM_p">The lipophilic examples <b>1b</b> and <b>14b</b> displayed similar terminal half-lives in the lung and plasma after DPI and <i>iv</i> administration, respectively (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a> and <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). This indicates that for these compounds only a transient lung selectivity was achieved through the inhalation route.</div><div class="NLM_p">The inhaled anti-inflammatory potential of the compounds <b>15i</b>, <b>15k</b>, and <b>15m</b> was evaluated in the rat model of Sephadex-induced airway inflammation. Compound <b>15j</b> shares the generic structure of <b>15</b> but displayed similar lung PK properties to the first candidate, <b>1b</b>, and was included to allow a pharmacological assessment of the chemotype.</div><div class="NLM_p">All of the profiled indazole ethers were potent with ED<sub>50</sub> values below 10 μg/kg in the rat Sephadex PD model, comparable to, or even superior to the benchmark ICS <b>3</b>. Neither potency in rat PBMCs nor total compound levels in rat lung (AUC) would predict the same efficacy ranking as observed in the PD model, which is likely to be a complex result of these and additional parameters. However, the systemic GR effect, measured by thymus involution, correlated with the peak levels of the total drug in blood (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a> and <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). As a consequence, the observed therapeutic ratio (TR) is largely dominated by the lung retention of the drug.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. PD Effects in the Rat Model of Sephadex-Induced Airway Inflammation</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center">sephadex-induced airway inflammation model (rat)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cpd</th><th class="colsep0 rowsep0" align="center">rat PBMC<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">lung edema inhibition ED<sub>50</sub></th><th class="colsep0 rowsep0" align="center">thymic involution ED<sub>25</sub></th><th class="colsep0 rowsep0" align="center">therapeutic ratio ED<sub>25</sub>/ED<sub>50</sub></th><th class="colsep0 rowsep0" align="center" char="."><i>n</i><a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">nM (% eff)<a class="ref internalNav" href="#t6fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="center">μg/kg (CI 95%)<a class="ref internalNav" href="#t6fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="center">μg/kg (CI 95%)<a class="ref internalNav" href="#t6fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="center">(CI 95%)<a class="ref internalNav" href="#t6fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="center" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1b</b></td><td class="colsep0 rowsep0" align="left">0.14 (78)</td><td class="colsep0 rowsep0" align="left">1.3 (0.30, 5.6)</td><td class="colsep0 rowsep0" align="left">4.6 (1.7, 12)</td><td class="colsep0 rowsep0" align="left">3.7 (0.64, 21)</td><td class="colsep0 rowsep0" align="char" char=".">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15i</b></td><td class="colsep0 rowsep0" align="left">0.34 (95)</td><td class="colsep0 rowsep0" align="left">2.4 (0.60, 9.3)</td><td class="colsep0 rowsep0" align="left">>130 (NA)</td><td class="colsep0 rowsep0" align="left">>54 (NA)</td><td class="colsep0 rowsep0" align="char" char=".">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15j</b></td><td class="colsep0 rowsep0" align="left">0.29 (92)</td><td class="colsep0 rowsep0" align="left">8.7 (4.7, 16)</td><td class="colsep0 rowsep0" align="left">12 (7.1, 19)</td><td class="colsep0 rowsep0" align="left">1.4 (0.61, 3.1)</td><td class="colsep0 rowsep0" align="char" char=".">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15k</b></td><td class="colsep0 rowsep0" align="left">0.10 (100)</td><td class="colsep0 rowsep0" align="left">2.7 (0.96, 7.6)</td><td class="colsep0 rowsep0" align="left">27 (15, 46)</td><td class="colsep0 rowsep0" align="left">10 (3.0, 33)</td><td class="colsep0 rowsep0" align="char" char=".">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15m</b></td><td class="colsep0 rowsep0" align="left">0.30 (95)</td><td class="colsep0 rowsep0" align="left">0.8 (0.45, 1.5)</td><td class="colsep0 rowsep0" align="left">40 (17, 92)</td><td class="colsep0 rowsep0" align="left">50 (18, 140)</td><td class="colsep0 rowsep0" align="char" char=".">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">0.14 (81)</td><td class="colsep0 rowsep0" align="left">6.0 (1.5, 23)</td><td class="colsep0 rowsep0" align="left">3.9 (1.9, 8.1)</td><td class="colsep0 rowsep0" align="left">0.7 (0.14, 3.1)</td><td class="colsep0 rowsep0" align="char" char=".">3</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">Value as the mean of at least two experiments.</p></div><div class="footnote" id="t6fn2"><sup>b</sup><p class="last">Number of experiments. Each experiment included a minimum of 18 treated animals, divided between 3−7 dose groups with at least 4 animals in each dose group, and 12–20 untreated animals, divided between 2 groups, native and challenged.</p></div><div class="footnote" id="t6fn3"><sup>c</sup><p class="last">Efficacy, maximum response relative to Dexamethasone (100%).</p></div><div class="footnote" id="t6fn4"><sup>d</sup><p class="last">CI, 95% confidence interval.</p></div></div></div><div class="NLM_p">On the basis of the results obtained in the rat Sephadex model, the pyridylmethyl amide ligands (<b>15j</b>, <b>15k</b>) were parked due to inferior potency and therapeutic ratio. Nonetheless, this matched pair with very similar molecular, structural, and in vitro pharmacological properties demonstrated that divergent solid-state properties do translate into differentiated inhalation PK and PD. Ultimately, <b>15i</b>, which displayed the highest therapeutic ratio, was discarded in favor of <b>15m</b>, which most efficiently inhibited rat lung edema. This selection was driven by a theoretical safety risk of <b>15i</b> associated with a long retention exceeding 24 h in the lung of presumably undissolved material that could be compounded by repeat dosing. The therapeutic ratio obtained was 70-fold higher for <b>15m</b> than for <b>3</b>. The experimental settings presented here do not allow a differentiation between the pharmacokinetic and mechanistic drivers of the observed therapeutic ratio.</div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01215/20171020/images/medium/jm-2017-01215g_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01215/20171020/images/large/jm-2017-01215g_0004.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Dose–response study of <b>15m</b> in a 4-day rat model of Sephadex-induced airway inflammation. The anti-inflammatory effect was assessed as inhibition of the induced lung edema, determined as a reduction of the left lung lobe weight (A). The systemic GR agonism was assessed as a thymus weight reduction (involution) in the same animals (B). The data points shown represent single animals; the bars indicate the mean and the standard deviation. DPI inhalation with <b>15m</b> (black dots) reduced the edema by 39–109% (<i>p</i> < 0.001) with a significant effect already at the lowest dose (0.6 μg/kg, <i>p</i> < 0.002). Significant effects of <b>15m</b> were observed on the weight of the thymus only at the highest dose (47.9 μg/kg, <i>p</i> = 0.041). Two doses of <b>3</b> (gray dots) were included as a control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01215/20171020/images/large/jm-2017-01215g_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01215&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The slow dissolution of inhaled <b>15m</b>, resulting in a slow absorption into the systemic circulation, could potentially prolong the anti-inflammatory effect in the airways. To experimentally address the duration of the effect, the Sephadex rat PD model was modified in two ways. The time span between the administration of the drug and the Sephadex challenge was increased to either 9 or 24 h to investigate the potential for a once-daily treatment. This experimental design did not support multiple doses, and a single dose was given (DPI). To obtain significant results, the dose was increased to 30 μg/kg (approximately 3-fold over ED<sub>90</sub> of <b>15m</b>). As a head-to-head benchmark, an approximately equal dose of the ICS <b>3</b> was profiled in the same experiments.</div><div class="NLM_p">Compound <b>15m</b> achieved full inhibition when predosed 9 h prior to challenge and still preserved a significant effect, reducing the lung edema by 76%, when dosed 24 h prior to challenge. In this model, <b>15m</b> demonstrated superiority over <b>3</b>, which showed only a partial effect when predosed 9 h and had no significant effect when dosed 24 h prior to challenge. The superior performance of <b>15m</b> compared with <b>3</b> is not necessarily related to the longer sustained drug release into the lung tissue but could be explained by a better potency in the rat model. Nonetheless, the 10-fold lower systemic activity observed for inhaled <b>15m</b> suggests that equal or higher doses than used for <b>3</b> might be applied without increasing the risk of adverse effects.</div><figure id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01215/20171020/images/medium/jm-2017-01215g_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01215/20171020/images/large/jm-2017-01215g_0005.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Duration of effect for inhibiting Sephadex-induced lung edema. <b>15m</b> (black dots) showed a full inhibition effect when predosed 9 h prior to challenge (<i>p</i> < 0.001) and 76% inhibition when dosed 24 h prior to challenge (<i>p</i> < 0.001). <b>3</b> (gray dots) inhibited the challenge-induced lung edema by 61% when dosed 9 h prior to challenge (<i>p</i> < 0.01) but had no significant inhibitory effect when dosed 24 h prior to challenge.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01215/20171020/images/large/jm-2017-01215g_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01215&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As compound <b>15m</b> displayed only a moderate effect on the thymus size in the rat, it can be concluded that the distribution of <b>15m</b> and any potential active metabolites to the thymus is less efficient compared to FP. This can be rationalized by the improved lung PK profile of <b>15m</b>, which led to a slower absorption and subsequently lower plasma concentrations of the parent. In addition, the higher polarity of <b>15m</b> results in a drastically reduced volume of distribution (<i>V</i><sub>ss</sub> 0.16 L/kg), reducing peripheral tissue affinity. Coupled to this is the rapid clearance of <b>15m</b> from circulation by efficient degradation and elimination. To investigate the metabolic fate of the parent compound, <sup>14</sup>C-radiolabeled <b>15m</b> was prepared and profiled in human, rat, and dog hepatocytes. Multiple degradation pathways were found to be active, generating a complex mixture of metabolites, which was similar across the three species. Hepatic degradation proceeded predominantly by oxidation of the heterocycle of the benzodioxane moiety, followed by ring opening and glucuronidation. Another major pathway led to the cleavage of the indazole ether pharmacophore to release a 5-hydroxy-indazole fragment (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01215/suppl_file/jm7b01215_si_001.pdf" class="ext-link">Supporting Information</a>, Table S4). On the basis of our understanding of the series SAR, it is very likely that the GR activity is eliminated or greatly reduced in all major metabolites. Furthermore, unlike the first candidate <b>1b</b>, the risk of generating a species-specific active metabolite in a preclinical safety species was successfully mitigated. In summary, compound <b>15m</b> combined excellent potency and a favorable therapeutic ratio in the rat and was nominated as a second clinical candidate, 3-(5-((1<i>R</i>,2<i>S</i>)-2-(2,2-difluoropropanamido)-1-(2,3-dihydrobenzo[<i>b</i>][1,4]dioxin-6-yl)propoxy)-1<i>H</i>-indazol-1-yl)-<i>N</i>-((<i>R</i>)-tetrahydrofuran-3-yl)benzamide (AZD7594).<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div><div class="NLM_p">To conclude the structural investigation, the stereoisomers of candidate <b>15m</b> were prepared and tested for transrepression activity (<a class="ref internalNav" href="#tbl7" aria-label="Table 7">Table 7</a>). In the central 1-aryl-2-amino-propanoxy moiety, the (1<i>R</i>,2<i>S</i>) configuration is clearly preferred, while the configuration of the 3-aminotetrahydrofuran had no influence on potency. For the other stereoisomers, only the <i>anti</i>-stereoisomeric pair with (1<i>S</i>,2<i>S</i>) configuration retained limited activity with the repression potency reduced by more than 100-fold.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Transrepression Activity of Stereoisomers of <b>15m</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01215/20171020/images/medium/jm-2017-01215g_0012.gif" alt="" id="fx5" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="rowsep1 colsep0" align="center">cpd</th><th class="rowsep1 colsep0" align="center"><b>15m</b></th><th class="rowsep1 colsep0" align="center"><b>15l</b></th><th class="rowsep1 colsep0" align="center"><b>18</b></th><th class="rowsep1 colsep0" align="center"><b>19</b></th><th class="rowsep1 colsep0" align="center"><b>20</b></th><th class="rowsep1 colsep0" align="center"><b>21</b></th><th class="rowsep1 colsep0" align="center"><b>22</b></th><th class="rowsep1 colsep0" align="center"><b>23</b></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">configuration</th><th class="colsep0 rowsep0" align="center">(1<i>R</i>,2<i>S</i>,3′<i>R</i>)</th><th class="colsep0 rowsep0" align="center">(1<i>R</i>,2<i>S</i>,3′<i>S</i>)</th><th class="colsep0 rowsep0" align="center">(1<i>S</i>,2<i>R</i>,3′<i>R</i>)</th><th class="colsep0 rowsep0" align="center">(1<i>S</i>,2<i>R</i>,3′<i>S</i>)</th><th class="colsep0 rowsep0" align="center">(1<i>S</i>,2<i>S</i>,3′<i>R</i>)</th><th class="colsep0 rowsep0" align="center">(1<i>S</i>,2<i>S</i>,3′<i>S</i>)</th><th class="colsep0 rowsep0" align="center">(1<i>R</i>,2<i>R</i>,3′<i>R</i>)</th><th class="colsep0 rowsep0" align="center">(1<i>R</i>,2<i>R</i>,3′<i>S</i>)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cell TR IC<sub>50</sub></td><td class="colsep0 rowsep0" align="left">0.055 ± 0.021 (4)</td><td class="colsep0 rowsep0" align="left">0.051 ± 0.004 (2)</td><td class="colsep0 rowsep0" align="left">>1000 (2)</td><td class="colsep0 rowsep0" align="left">>1000 (2)</td><td class="colsep0 rowsep0" align="left">12.7 ± 4.0 (2)</td><td class="colsep0 rowsep0" align="left">24.3 ± 5.3 (2)</td><td class="colsep0 rowsep0" align="left">>1000 (2)</td><td class="colsep0 rowsep0" align="left">>1000 (2)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">% efficacy</td><td class="colsep0 rowsep0" align="left">107</td><td class="colsep0 rowsep0" align="left">105</td><td class="colsep0 rowsep0" align="left">6.6</td><td class="colsep0 rowsep0" align="left">9.3</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">99</td><td class="colsep0 rowsep0" align="left">35</td><td class="colsep0 rowsep0" align="left">30</td></tr></tbody></table></div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58677" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58677" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">A class of highly potent, nonsteroidal GR modulators, highly selective across the steroid hormone receptor family, served as the starting point for optimization into two inhaled drug candidates for the treatment of airway inflammation. Initially, a soft-drug strategy was developed to ensure rapid clearance from systemic circulation. This approach delivered the first inhaled candidate <b>1b</b>, which was more rapidly absorbed than the benchmark ICS <b>3</b> (fluticasone propionate), and possessed a high availability in lung tissue during the first 2 h following inhaled administration to the rat. Compared to <b>3</b>, compound <b>1b</b> demonstrated a marginally improved potency with respect to inhibition of lung edema in a rat model of airway inflammation.</div><div class="NLM_p">Further optimization increased lung targeting: prolonging exposure in lung tissue, while limiting systemic levels. A revised strategy aimed to retard drug absorption via a differentiated profile featuring a decreased dissolution rate, increased polarity, and increased molecular size. This delivered the second inhalation candidate drug <b>15m</b>, which achieved the requisite low solubility profile but retained the potency of the first candidate and demonstrated a robust local anti-inflammatory effect in rat lung airways at the same dose. The prolonged retention in the lung tissue was balanced by limited systemic exposure, minimizing the GR-driven effect on the rat thymus. As a consequence, the therapeutic ratio of <b>15m</b> was increased over the first candidate <b>1b</b> and the comparator ICS <b>3</b> by an order of magnitude. Head-to-head with <b>3</b> at equivalent doses, <b>15m</b> displayed a more enduring efficacy, indicating potential for once-daily dosing.</div><div class="NLM_p last">Although the development of <b>1b</b> was halted due to the lack of efficacy in a phase 2 study in COPD patients,<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a><b>15m</b> has recently demonstrated dose-dependent efficacy in a phase 2 lung function study in asthmatics.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78265" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78265" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Synthesis</h3><div id="sec5_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> General Conditions</h4><div class="NLM_p last">Commercial solvents and reagents were used without further purification. Anhydrous solvents were dried over molecular sieves (4 Å). Water was filtered and demineralized (Milli-Q). Purification by flash chromatography was carried out using silica gel 60 (0.040–0.063 mm, Merck) or using prepacked Biotage KP-SIL or Isolute columns. Purification by HPLC was performed on a Gilson HPLC system with the following columns: Kromasil KR-100–5-C18 (250 × 20 mm), Kromasil 100–10-C18 (250 × 50 mm); gradient of acetonitrile/water (containing 0.1% TFA). Alternatively XBridge Prep C18, 5 μm (150 × 30 mm) or XTerra Prep MS C18, 5 μm (50 × 19 mm); gradient of acetonitrile/water containing 2 mL 28% aq NH<sub>4</sub>OH. In the NMR spectra, the chemical shifts (δ) were internally referenced to the residual solvent peak. Low-resolution LCMS (APCI) was determined using the following methods: Column Waters Symmetry C18 2.1 × 30 mm; flow 0.7 mL/min; eluents A H<sub>2</sub>O, B acetonitrile with both solvents containing 0.1% TFA; gradient 15–95% B in 2.7 min, 95% B for 0.3 min; UV detection at 254 nM. Purity was determined by HPLC: Column Kromasil C18, 5 μm 3.0 × 100 mm; eluents A H<sub>2</sub>O, B acetonitrile with both solvents containing TFA (0.1%); gradient B 10–100% in 20 min; flow 0.6 mL/min; detection at 220, 252, and 280 nM. All test compounds were of ≥95% purity. Chiral purity was determined using the following systems: Chiral SFC: LUX Amylose-1 (AD) 3 μm, 0.46 × 15 cm; 40% EtOH/DEA (100:0.5) in CO<sub>2</sub>, 120 bar, 3.5 mL/min diode array detection 215–330 nm. Chiral HPLC was determined using the following methods. Method A: Chiralpak IA 5 μm. Method B: Chiralpak IB 5 μm. Both method A and B: 4.6 × 250 mm, eluent <i>i</i>-hexane/DCM/MeOH 68:30:2; flow 1 mL/min; UV = 254 nm. Chiral HPLC, method C: Chiralpak IB 5 μm, 4.6 × 100 mm; eluent <i>iso</i>-Hexane/DCM/MeOH/EtOH 65:29:2:4, flow 1 mL/min; UV = 254 nm. Method D: Chiralpak AS-H 5 μm, 4.6 × 50 mm, eluent <i>i</i>-hexane/<i>i</i>-PrOH 95:5, flow 1 mL/min; UV = 220 nm. Method E: Chiralpak AD-H 5 μm, 4.6 × 250 mm, eluent <i>i</i>-hexane/EtOH 80:20, flow 1 mL/min, UV = 220 nm.</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> 2,2,2-Trifluoro-<i>N</i>-((1<i>R</i>,2<i>S</i>)-1-(1-(4-fluorophenyl)-1<i>H</i>-indazol-5-yloxy)-1-(3-methoxyphenyl)propan-2-yl)acetamide (<b>1b</b>)</h4><div class="NLM_p last">Prepared essentially as described for <b>13b</b>, starting from <b>11b</b> (21.5 g, 55 mmol), triethylamine (23 mL, 165 mmol) and trifluoroacetic anhydride (23 mL, 165 mmol). Flash chromatography on silica gel (20% EtOAc in isohexane) afforded <b>1b</b> (22.0 g, 82%) as a yellow foam. The material was crystallized from MTBE/isohexane, assisted by seed crystals, to yield <b>1b</b> as a white solid (14.0 g, 52%), mp = 82 °C. LCMS <i>m</i>/<i>z</i>: 488 (MH<sup>+</sup>). [α]<sub class="stack">D</sub><sup class="stack">20</sup> −44° (<i>c</i> 1.1, MeOH). HPLC <sup><i>t</i></sup>R 14.23, > 99%. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.52 (d, <i>J</i> = 8.3 Hz, 1H), 8.17 (s, 1H), 7.71–7.76 (m, 2H), 7.69 (d, <i>J</i> = 9.2 Hz, 1H), 7.35–7.42 (m, 2H), 7.26 (t, <i>J</i> = 7.9 Hz, 1H), 7.21 (dd, <i>J</i> = 2.3, 9.2 Hz, 1H), 7.13 (d, <i>J</i> = 2.3 Hz, 1H), 6.99 (d, <i>J</i> = 7.7 Hz, 1H), 6.96 (s, 1H), 6.84 (dd, <i>J</i> = 2.4, 8.2 Hz, 1H), 5.27 (d, <i>J</i> = 6.3 Hz, 1H), 4.21–4.3 (m, 1H), 3.72 (s, 3H), 1.33 (d, <i>J</i> = 6.8 Hz, 3H). <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>): δ 160.20 (d, <i>J</i> = 243.6 Hz), 159.10, 155.50 (q, <i>J</i> = 36.3 Hz), 152.74, 139.66, 136.07 (d, <i>J</i> = 2.6 Hz), 135.01, 134.09, 129.41, 125.26, 123.92 (d, <i>J</i> = 8.5 Hz), 119.83, 118.91, 116.34 (d, <i>J</i> = 22.8 Hz), 115.79 (q, <i>J</i> = 288.4 Hz), 113.15, 112.46, 111.41, 104.21, 81.23, 54.89, 50.68, 15.15. Chiral HPLC (method E): <i>t</i><sub>R</sub> = 5.5 min, 100% (1<i>R</i>,2<i>S</i> enantiomer), <i>t</i><sub>R</sub> = 7.1 min, 0% (1<i>S</i>,2<i>R</i>-enantiomer). Chiral Purity: >99.9% ee.</div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> (<i>S</i>)-<i>tert</i>-Butyl 1-(3-Methoxyphenyl)-1-oxopropan-2-ylcarbamate (<b>5b</b>)</h4><div class="NLM_p last">Essentially prepared as described for <b>5c</b>, starting from (3-methoxyphenyl)magnesium bromide, 1 M in THF (276 mL, 276 mmol). Yield after recrystallization from methyl <i>tert</i>-butyl ether (490 mL) 58.9 g (84%) as a colorless crystalline solid. LCMS <i>m</i>/<i>z</i>: 180 (MH<sup>+</sup> – BOC). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.55 (d, <i>J</i> = 7.6 Hz, 1H), 7.49 (t, <i>J</i> = 1.9 Hz, 1H), 7.39 (t, <i>J</i> = 8.0 Hz, 1H), 7.15 (dd, <i>J</i> = 8.2, 2.0 Hz, 1H), 5.56 (d, <i>J</i> = 6.9 Hz, 1H), 5.28 (quint, <i>J</i> = 7.2 Hz, 1H), 3.86 (s, 3H), 1.47 (s, 9H), 1.41 (d, <i>J</i> = 7.1 Hz, 3H). Chiral HPLC (method D): <i>t</i><sub>R</sub> = 2.36 min, 99.95% (<i>S</i>-enantiomer), <i>t</i><sub>R</sub> = 1.70 min, 0.05% (<i>R</i>-enantiomer). Chiral Purity: 99.9% ee.</div></div><div id="sec5_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> (<i>S</i>)-<i>tert</i>-Butyl 1-(2,3-Dihydrobenzo[<i>b</i>][1,4]dioxin-6-yl)-1-oxopropan-2-ylcarbamate (<b>5c</b>)</h4><div class="NLM_p last">Magnesium turnings (0.46 g, 18.9 mmol) and one small iodine crystall were suspended in dry THF (3 mL) under an argon atmosphere. A solution of 6-bromo-2,3-dihydrobenzo[<i>b</i>][1,4]dioxine (4.03 g, 18.7 mmol) in dry THF (17 mL) was added. The mixture was gently heated to initiate the reaction, after a few minutes the iodine color vanished, the external heating was removed and continued stirring for 1 h resulted in a green solution. GC/MS analysis of a small sample, quenched with iodine in THF, indicated a conversion of 75% of the starting bromide to the Grignard reagent to form a solution of (2,3-dihydrobenzo[<i>b</i>][1,4]dioxin-6-yl)magnesium bromide in THF (0.7 M, 20 mL, 14.0 mmol) that was used directly in next step. In a separate vessel, a suspension of (<i>S</i>)-<i>tert</i>-butyl 1-(methoxy(methyl)amino)-1-oxopropan-2-ylcarbamate (<b>4</b>) (3.0 g, 12.9 mmol) in THF (30 mL) was cooled to −15 °C and isopropyl magnesium chloride (2 M in THF, 6.5 mL, 13.0 mmol) was added keeping the temperature below −10 °C. The solid started to dissolve, the reaction temperature was allowed to reach 0 °C and the freshly prepared solution of (2,3-dihydrobenzo[<i>b</i>][1,4]dioxin-6-yl)magnesium bromide, 0.7 M in THF (20 mL, 14.0 mmol) was added. The temperature was allowed to reach room temperature and stirring was continued for 17 h. Thereafter the reaction mixture was poured into 1 N HCl (300 mL) at 10 °C, methyl <i>tert</i>-butyl ether (300 mL) was added and the mixture was transferred to a separation funnel. The water phase was extracted with methyl <i>tert</i>-butyl ether (200 mL). The ether phases were washed with water, brine and dried (Na<sub>2</sub>SO<sub>4</sub>). The crude product was purified by flash chromatography (MTBE/heptane 1:2) to yield <b>5c</b> as a slightly yellow sticky oil/gum (3.76 g, 95%). LCMS <i>m</i>/<i>z</i>: 208 (MH<sup>+</sup> – BOC). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.50 (dd, <i>J</i> = 2.1, 8.5 Hz, 1H), 7.46 (d, <i>J</i> = 2.0 Hz, 1H), 7.23 (d, <i>J</i> = 7.5 Hz, 1H), 6.97 (d, <i>J</i> = 8.4 Hz, 1H), 4.9–5.03 (m, 1H), 4.24–4.35 (m, 4H), 1.35 (s, 9H), 1.19 (d, <i>J</i> = 7.2 Hz, 3H).</div></div><div id="sec5_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> <i>tert</i>-Butyl (1<i>R</i>,2<i>S</i>)-1-Hydroxy-1-(3-methoxyphenyl)propan-2-ylcarbamate (<b>6b</b>)</h4><div class="NLM_p last">Prepared as described for <b>6c</b>, starting from <b>5b</b> (17.5 g, 62.6 mmol). Yield: 17.5 g (92%). LCMS <i>m</i>/<i>z</i>: 182 (MH<sup>+</sup> – BOC). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.20 (t, <i>J</i> = 8.0 Hz, 1H), 6.84–6.92 (m, 2H), 6.72–6.8 (m, 1H), 6.56 (d, <i>J</i> = 8.5 Hz, 1H), 5.27 (d, <i>J</i> = 4.7 Hz, 1H), 4.47 (t, <i>J</i> = 4.9 Hz, 1H), 3.73 (s, 3H), 3.47–3.63 (m, 1H), 1.31 (s, 9H), 0.94 (d, <i>J</i> = 6.7 Hz, 3H).</div></div><div id="sec5_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> <i>tert</i>-Butyl (1<i>R</i>,2<i>S</i>)-1-(2,3-Dihydrobenzo[<i>b</i>][1,4]dioxin-6-yl)-1-hydroxypropan-2-ylcarbamate (<b>6c</b>)</h4><div class="NLM_p last"><b>5c</b> (144 g, 469 mmol), Al(OiPr)<sub>3</sub> (47.9 g, 235 mmol) and propan-2-ol (464 mL, 6.1 mol) in toluene (840 mL) were stirred at 50 °C under argon atmosphere for 16 h. The reaction mixture was cooled and poured into ice-cooled 1.5 M aq HCl (2.0 L), ethyl acetate (1.0 L) was added and a white precipitate was formed. Additional ethyl acetate (5 L) was added to dissolve the solid, the phases were separated and the organic phase was washed with water (4 × 1 L) and evaporated. The residue (145 g) was suspended in MTBE (700 mL) and stirred at 50 °C for 30 min, then stirred at room temperature overnight. The solid was collected by suction filtration, washed with MTBE, and dried to afford <b>6c</b> as a colorless solid (130 g, 90%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 6.71–6.8 (m, 3H), 6.50 (d, <i>J</i> = 8.6 Hz, 1H), 5.17 (d, <i>J</i> = 4.6 Hz, 1H), 4.36 (t, <i>J</i> = 4.9 Hz, 1H), 4.19 (s, 4H), 3.43–3.54 (m, 1H), 1.31 (s, 9H), 0.93 (d, <i>J</i> = 6.7 Hz, 3H).</div></div><div id="sec5_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> <i>tert</i>-Butyl (1<i>S</i>,2<i>R</i>)-1-(2,3-Dihydrobenzo[<i>b</i>][1,4]dioxin-6-yl)-1-hydroxypropan-2-ylcarbamate (<b>ent-6c</b>)</h4><div class="NLM_p last">Following the procedures described for compound <b>6c</b> via <b>5c</b>, but starting from <b>ent-4</b>, afforded <b>ent-6c</b>. LCMS <i>m</i>/<i>z</i>: 210 (MH<sup>+</sup> – BOC). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 6.71–6.82 (m, 3H), 6.50 (d, <i>J</i> = 8.6 Hz, 1H), 5.17 (d, <i>J</i> = 4.6 Hz, 1H), 4.36 (t, <i>J</i> = 4.8 Hz, 1H), 4.19 (s, 4H), 3.42–3.54 (m, 1H), 1.31 (s, 9H), 0.93 (d, <i>J</i> = 6.6 Hz, 3H).</div></div><div id="sec5_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> (1<i>R</i>,2<i>S</i>)-2-Amino-1-(3-methoxyphenyl)propan-1-ol hydrochloride (<b>7b</b>)</h4><div class="NLM_p last">Prepared as described for <b>7c</b>, starting from <b>6b</b> (16.1 g, 57.2 mmol) Yield: 11.4 g (92%) as an colorless salt. [α]<sub class="stack">D</sub><sup class="stack">20</sup> −37.5° (<i>c</i> 1.0, MeOH). LCMS <i>m</i>/<i>z</i>: 182 (MH<sup>+</sup>). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.18 (br s, 3H), 7.28 (t, <i>J</i> = 7.9 Hz, 1H), 6.89–6.95 (m, 2H), 6.81–6.87 (m, 1H), 6.04 (d, <i>J</i> = 4.3 Hz, 1H), 4.93 (t, <i>J</i> = 3.3 Hz, 1H), 3.75 (s, 3H), 3.3–3.43 (m, 1H), 0.94 (d, <i>J</i> = 6.8 Hz, 3H). <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>): δ 159.20, 142.95, 129.28, 118.15, 112.69, 111.60, 71.22, 55.02, 51.77, 11.57. Chiral SFC (method C): <i>t</i><sub>R</sub> = 0.97 min, 99.6%. <i>t</i><sub>R</sub> = 0.68 min, 0.4% (1<i>S</i>,2<i>R</i> enantiomer). Chiral purity: 99.2% ee.</div></div><div id="sec5_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> (1<i>R</i>,2<i>S</i>)-2-Amino-1-(2,3-dihydrobenzo[<i>b</i>][1,4]dioxin-6-yl)propan-1-ol hydrochloride (<b>7c</b>)</h4><div class="NLM_p last">To a suspension of <b>6c</b> (129 g, 0.47 mol) in ethyl acetate (1050 mL) was added 6 N HCl in 2-propanol (250 mL, 1.5 mol). The mixture was stirred at 50 °C for 3 h and the resulting suspension was allowed to reach room temperature. The precipitate was filtered off, washed twice with ethyl acetate and dried under reduced pressure at 60 °C overnight to afford <b>7c</b> as a colorless solid (80 g, 78%). [α]<sub class="stack">D</sub><sup class="stack">20</sup> −39° (c 1.0, MeOH). Chiral purity:, 99.4% ee, 100% de. LCMS <i>m</i>/<i>z</i>: 210 (MH<sup>+</sup> – HCl). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.95 (br s, 3H), 6.75–6.87 (m, 3H), 5.93 (d, <i>J</i> = 4.2 Hz, 1H), 4.77 (t, <i>J</i> = 3.6 Hz, 1H), 4.22 (s, 4H), 3.27–3.36 (m, 1H), 0.94 (d, <i>J</i> = 6.7 Hz, 3H). <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>): δ C 143.07, 142.53, 134.27, 118.73, 116.74, 114.73, 70.89, 64.09, 64.03, 51.86, 11.67. Chiral SFC: <i>t</i><sub>R</sub> = 2.15 min, 99%, <i>t</i><sub>R</sub> = 0.91 min, 0.3%. Chiral purity: 99.4% ee, 100% de.</div></div><div id="sec5_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> (1<i>S</i>,2<i>R</i>)-2-Amino-1-(2,3-dihydrobenzo[<i>b</i>][1,4]dioxin-6-yl)propan-1-ol hydrochloride (<b>ent-7c</b>)</h4><div class="NLM_p last">Prepared essentially as described for <b>7c</b>, but starting from <b>ent-6c</b>. Yield 1.49 g (88%) of a colorless solid. [α]<sub class="stack">D</sub><sup class="stack">20</sup> +37° (c 1.0, MeOH). LCMS <i>m</i>/<i>z</i>: 210 (MH<sup>+</sup> – HCl). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.11 (br s, 3H), 6.76–6.87 (m, 3H), 5.94 (brd, <i>J</i> = 3.2 Hz, 1H), 4.8–4.86 (brm, 1H), 4.19–4.24 (brm, 4H), 3.21–3.34 (brm, 1H), 0.94 (d, <i>J</i> = 6.8 Hz, 3H).<sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>): δ 143.07, 142.54, 134.25, 118.73, 116.74, 114.73, 70.90, 64.08, 64.03, 51.83, 40.06, 11.69. Chiral SFC: <i>t</i><sub>R</sub> = 0.91 min, 99.9%, <i>t</i><sub>R</sub> = 2.15 min. Chiral purity: >99.9% ee. 100% de.</div></div><div id="sec5_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> (4<i>S</i>,5<i>R</i>)-5-(2,3-Dihydrobenzo[<i>b</i>][1,4]dioxin-6-yl)-4-methyloxazolidin-2-one (<b>8</b>)</h4><div class="NLM_p last">A suspension of <b>7c</b> (0.49 g, 1.99 mmol) and triethylamine (0.85 g, 1.2 mL, 8.39 mmol) in dry THF (35 mL) was cooled to −30 °C, and bis(trichloromethyl) carbonate (0.726 g, 2.45 mmol) in dry THF (5.0 mL) was slowly added. The reaction mixture was stirred at −10 °C for 1 h and at room temperature for 1 h. To the suspension was added water (1 mL), and the mixture was evaporated. The residue was taken up in ethyl acetate (50 mL) and washed with aq HCl (0.2 N), brine, and saturated aq bicarbonate. The organic phase was dried over anhydrous sodium sulfate, filtered, and evaporated. The residue was purified by flash chromatography (ethyl acetate in heptane, 50–100%). The solvent was removed, and the residue was taken up in a mixture of DCM and heptane. Evaporation afforded <b>8</b> as colorless solid (0.31 g, 66%). LCMS (ESI) <i>m</i>/<i>z</i>: 236 (MH<sup>+</sup>). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.73 (s, 1H), 6.87 (d, <i>J</i> = 8.3 Hz, 1H), 6.7–6.78 (m, 2H), 5.55 (d, <i>J</i> = 8.0 Hz, 1H), 4.24 (s, 4H), 4.04–4.12 (m, 1H), 0.64 (d, <i>J</i> = 6.5 Hz, 3H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>): δ 158.20, 143.12, 143.08, 128.96, 118.87, 116.94, 114.83, 79.03, 64.07, 64.03, 51.21, 17.01.</div></div><div id="sec5_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> (4<i>S</i>,5<i>S</i>)-5-(2,3-Dihydrobenzo[<i>b</i>][1,4]dioxin-6-yl)-4-methyloxazolidin-2-one (<b>9</b>)</h4><div class="NLM_p">To a solution of <b>6c</b> (2.00 g, 6.47 mmol) and triethylamine (0.99 mL, 7.11 mmol) in THF (24 mL) was added methanesulfonyl chloride (0.58 mL, 7.11 mmol) dropwise at 0 °C. The ice-cooled mixture was stirred for 30 min; thereafter stirring was continued at 50 °C overnight. After the addition of water (30 mL), the mixture was extracted with 3 portions of DCM, and the organic phases were evaporated. The residue was purified by preparative HPLC (Kromasil KR-100–10-C18, 250 × 50 mm, 25–50% MeCN in water, 25 min) to yield <b>9</b> as a colorless solid (1.26 g, 83%). LCMS <i>m</i>/<i>z</i>: 236 (MH<sup>+</sup>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.78 (s, 1H), 6.83–6.91 (m, 3H), 4.92 (d, <i>J</i> = 7.1 Hz, 1H), 4.24 (s, 4H), 3.66 (quint, <i>J</i> = 6.4 Hz, 1H), 1.18 (d, <i>J</i> = 6.1 Hz, 3H).</div><div class="NLM_p last">The assignment of the relative configuration of the diastereomers <b>8</b> and <b>9</b> is supported by the chemical shifts in the <sup>1</sup>H NMR for 2-CH<sub>3</sub> (<b>8</b>: δ 0.64; <b>9</b>: δ 1.18) and 5-H (<b>8</b>: δ 5.55; <b>9</b>: δ 4.92), which are in agreement with the reported data.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></div></div><div id="sec5_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> (4<i>R</i>,5<i>R</i>)-5-(2,3-Dihydrobenzo[<i>b</i>][1,4]dioxin-6-yl)-4-methyloxazolidin-2-one (<b>ent</b>-<b>9</b>)</h4><div class="NLM_p last">Compound <b>ent</b>-<b>9</b> was prepared essentially as described for <b>9</b>, starting from <b>ent-6c</b>, as a foamy solid. Yield: 1.73 g (68%). LCMS <i>m</i>/<i>z</i>: 236 (MH<sup>+</sup>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.78 (s, 1H), 6.83–6.91 (m, 3H), 4.92 (d, <i>J</i> = 7.1 Hz, 1H), 4.24 (s, 4H), 3.66 (quint, <i>J</i> = 6.3 Hz, 1H), 1.18 (d, <i>J</i> = 6.1 Hz, 3H).</div></div><div id="sec5_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> (1<i>S</i>,2<i>S</i>)-2-Amino-1-(2,3-dihydrobenzo[<i>b</i>][1,4]dioxin-6-yl)propan-1-ol Hydrochloride (<b>10</b>)</h4><div class="NLM_p last">To a solution of <b>9</b> (1.13 g, 4.82 mmol) in THF (10 mL) was added aq LiOH (10%, 15 mL, 62.7 mmol), and the mixture was stirred at 90 °C for 5 h. Thereafter, the mixture was allowed to reach room temperature, diluted with water, and extracted with 3 portions of DCM. The combined organic phases were passed through a phase separator, and the evaporation of the solvent afforded the crude material as an oil. The residue was taken up in DCM, and HCl (1 M in diethyl ether) was added. After the evaporation of the solvent, a solid was obtained. Drying at a reduced pressure afforded <b>10</b> as a colorless solid (0.83 g, 70%). LCMS <i>m</i>/<i>z</i>: 210 (MH<sup>+</sup> – HCl). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.91 (br s, 3H), 6.76–6.88 (m, 3H), 6.07 (d, <i>J</i> = 3.8 Hz, 1H), 4.32 (dd, <i>J</i> = 3.5, 8.6 Hz, 1H), 4.23 (s, 4H), 3.12–3.24 (m, 1H), 0.96 (d, <i>J</i> = 6.6 Hz, 3H).</div></div><div id="sec5_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> (1<i>R</i>,2<i>R</i>)-2-Amino-1-(2,3-dihydrobenzo[<i>b</i>][1,4]dioxin-6-yl)propan-1-ol Hydrochloride (<b>ent</b>-<b>10</b>)</h4><div class="NLM_p last">Compound <b>ent</b>-<b>10</b> was prepared essentially as described for <b>10</b>, starting from <b>ent-9</b> (1.73 g, 7.36 mmol), as a colorless solid. Yield: 1.83 g (98%). LCMS <i>m</i>/<i>z</i>: 210 (MH<sup>+</sup> – HCl). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.88 (s, 3H), 6.78–6.89 (m, 3H), 6.08 (d, <i>J</i> = 3.8 Hz, 1H), 4.31 (dd, <i>J</i> = 3.7, 8.4 Hz, 1H), 4.23 (s, 4H), 3.12–3.25 (m, 1H), 0.96 (d, <i>J</i> = 6.6 Hz, 3H).</div></div><div id="sec5_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> (1<i>R</i>,2<i>S</i>)-1-(1-(4-Fluorophenyl)-1<i>H</i>-indazol-5-yloxy)-1-(3-methoxyphenyl)propan-2-amine (<b>11b</b>)</h4><div class="NLM_p last">Compound <b>11b</b> was prepared essentially as described for <b>12b</b>, starting from <b>7b</b> (0.5 g, 2.30 mmol) and <b>16</b> (0.93 g, 2.75 mmol), as a colorless solid. Yield (HCl salt): 0.47 g (47%). LCMS <i>m</i>/<i>z</i>: 392 (MH<sup>+</sup>). <sup>1</sup>H NMR (500 MHz, MeOD): δ 8.03 (d, <i>J</i> = 0.9 Hz, 1H), 7.62–7.69 (m, 3H), 7.27–7.36 (m, 4H), 7.13 (d, <i>J</i> = 2.2 Hz, 1H), 6.99–7.03 (m, 2H), 6.92 (ddd, <i>J</i> = 8.3, 2.5, 0.7 Hz, 1H), 5.60 (d, <i>J</i> = 3.3 Hz, 1H), 3.79–3.83 (m, 1H), 3.78 (s, 3H), 1.33 (d, <i>J</i> = 6.8 Hz, 3H). <sup>13</sup>C NMR (126 MHz, MeOD): δ 162.70 (d, <i>J</i> = 245.3 Hz), 161.72, 153.74, 138.45, 137.47 (d, <i>J</i> = 2.9 Hz), 136.38, 135.97, 131.27, 126.67, 125.80 (d, <i>J</i> = 8.6 Hz), 121.12, 119.98, 117.35 (d, <i>J</i> = 23.2 Hz), 114.99, 113.70, 112.38, 105.51, 80.54, 55.75, 53.15, 13.19.</div></div><div id="sec5_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> Isobutyl 3-(5-((1<i>R</i>,2<i>S</i>)-2-Amino-1-(2,3-dihydrobenzo[<i>b</i>][1,4]dioxin-6-yl)propoxy)-1<i>H</i>-indazol-1-yl)benzoate (<b>12b</b>)</h4><div class="NLM_p last">A mixture of <b>7c</b> (20.5 g, 83.3 mmol), 2-(dimethylamino)acetic acid (4.29 g, 41.6 mmol), cuprous iodide (3.97 g, 20.8 mmol), and cesium carbonate (84 g, 258 mmol) in butyronitrile (200 mL) was stirred at 110 °C for 30 min. To that mixture was added a solution of <b>17</b> (35 g, 83.28 mmol) in butyronitrile (33 mL), generated by heating at 80 °C for 10 min. The grayish reaction mixture was sealed and stirred at 110 °C for 19 h. To the cooled reaction mixture were added water and ethyl acetate (1.5 L). The organic phase was washed with water (3 × 700 mL). The evaporation of the solvents afforded a gummy greenish residue (43 g). The purification by flash chromatography on silica gel, eluting with ethyl acetate in heptane (50–100%, containing 2% triethylamine), afforded <b>12b</b> (14 g, 34%) as a solid foam. LCMS <i>m</i>/<i>z</i>: 502 (MH<sup>+</sup>). HPLC: <i>t</i><sub>R</sub> = 10.7 min, purity 97%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.25 (t, <i>J</i> = 1.9 Hz, 1H), 8.24 (d, <i>J</i> = 0.7 Hz, 1H), 8.05 (ddd, <i>J</i> = 0.9, 2.2, 8.1 Hz, 1H), 7.94 (dt, <i>J</i> = 1.1, 7.8 Hz, 1H), 7.69–7.77 (m, 2H), 7.22 (dd, <i>J</i> = 2.4, 9.1 Hz, 1H), 7.17 (d, <i>J</i> = 2.1 Hz, 1H), 6.85–6.91 (m, 2H), 6.81 (d, <i>J</i> = 8.2 Hz, 1H), 4.97 (d, <i>J</i> = 5.4 Hz, 1H), 4.19 (s, 4H), 4.12 (d, <i>J</i> = 6.5 Hz, 2H), 3.06–3.17 (m, 1H), 2–2.1 (m, 1H), 1.36 (br s, 2H), 1.07 (d, <i>J</i> = 6.4 Hz, 3H), 0.98 (d, <i>J</i> = 6.7 Hz, 6H).</div></div><div id="sec5_1_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> Isobutyl 3-(5-((1<i>R</i>,2<i>S</i>)-2-(2,2-Difluoropropanamido)-1-(2,3-dihydrobenzo[<i>b</i>][1,4]dioxin-6-yl)propoxy)-1<i>H</i>-indazol-1-yl)benzoate (<b>13b</b>)</h4><div class="NLM_p last">To a mixture of <b>12b</b> (3.95 g, 7.88 mmol) and 2,2-difluoropropanoic acid (1.25 g, 11.4 mmol) in DCM (40 mL) were added solid HATU (4.35 g, 11.5 mmol) and DIPEA (4.1 mL, 23.6 mmol). The mixture was stirred at room temperature for 2.5 h, and the clear red solution obtained was washed with water. The water phase was extracted once with DCM. The organic phases were further washed with water at pH = 4 and at pH = 8 and finally with brine and dried over MgSO<sub>4</sub>. The removal of the solvents afforded the crude material as a red sticky oil. The crude product was dissolved in DCM, and the purification by flash chromatography on silica gel (ethyl acetate in heptane, 0–50%) afforded <b>13b</b> (3.7 g, 79%) as a glassy solid. LCMS <i>m</i>/<i>z</i>: 594 (MH<sup>+</sup>), <i>t</i><sub>R</sub> = 2.77 min, 98%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.65 (d, <i>J</i> = 9.0 Hz, 1H), 8.26 (d, <i>J</i> = 0.7 Hz, 1H), 8.24–8.26 (m, 1H), 8.05 (ddd, <i>J</i> = 0.9, 2.2, 8.1 Hz, 1H), 7.95 (dt, <i>J</i> = 1.2, 7.9 Hz, 1H), 7.78 (d, <i>J</i> = 9.2 Hz, 1H), 7.73 (t, <i>J</i> = 7.9 Hz, 1H), 7.22 (dd, <i>J</i> = 2.4, 9.1 Hz, 1H), 7.14 (d, <i>J</i> = 2.2 Hz, 1H), 6.78–6.89 (m, 3H), 5.17 (d, <i>J</i> = 6.9 Hz, 1H), 4.14–4.23 (m, 5H), 4.12 (d, <i>J</i> = 6.5 Hz, 2H), 2–2.11 (m, 1H), 1.55 (t, <i>J</i> = 19.5 Hz, 3H), 1.29 (d, <i>J</i> = 6.8 Hz, 3H), 0.99 (d, <i>J</i> = 6.7 Hz, 6H).</div></div><div id="sec5_1_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 3-(5-((1<i>R</i>,2<i>S</i>)-2-(2,2-Difluoropropanamido)-1-(2,3-dihydrobenzo[<i>b</i>][1,4]dioxin-6-yl)propoxy)-1<i>H</i>-indazol-1-yl)-<i>N</i>-((<i>S</i>)-tetrahydrofuran-3-yl)benzamide (<b>15l</b>)</h4><div class="NLM_p last">Following the procedure described for compound <b>15m</b> using <b>24b</b> (100 mg, 0.19 mmol) and (<i>S</i>)-tetrahydrofuran-3-amine hydrochloride (26 mg, 0.21 mmol) as starting materials, <b>15l</b> was obtained as a colorless crystalline solid. Yield: 85 mg (75%). Mp = 175 °C. LCMS <i>m</i>/<i>z</i>: 607 (MH+). HPLC: <i>t</i><sub>R</sub> = 12.02 min, 99%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.71 (d, <i>J</i> = 6.4 Hz, 1H), 8.65 (d, <i>J</i> = 8.5 Hz, 1H), 8.24 (d, <i>J</i> = 0.6 Hz, 1H), 8.18 (t, <i>J</i> = 1.7 Hz, 1H), 7.83–7.91 (m, 2H), 7.77 (d, <i>J</i> = 9.1 Hz, 1H), 7.65 (t, <i>J</i> = 7.9 Hz, 1H), 7.21 (dd, <i>J</i> = 2.3, 9.1 Hz, 1H), 7.13 (d, <i>J</i> = 2.2 Hz, 1H), 6.77–6.9 (m, 3H), 5.17 (d, <i>J</i> = 6.8 Hz, 1H), 4.44–4.52 (m, 1H), 4.11–4.23 (m, 5H), 3.8–3.91 (m, 2H), 3.66–3.77 (m, 1H), 3.61 (dd, <i>J</i> = 4.2, 8.9 Hz, 1H), 2.09–2.23 (m, 1H), 1.89–1.99 (m, 1H), 1.55 (t, <i>J</i> = 19.5 Hz, 3H), 1.29 (d, <i>J</i> = 6.8 Hz, 3H). Chiral HPLC (method A): <i>t</i><sub>R</sub> = 16.50 min, 98.7%. Chiral HPLC (method B): <i>t</i><sub>R</sub> = 25.67 min, 98.7%. Chiral HPLC (method C): <i>t</i><sub>R</sub> = 13.63 min, 100%. Chiral purity: 100% ee, 97.8% de.</div></div><div id="sec5_1_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 3-(5-((1<i>R</i>,2<i>S</i>)-2-(2,2-Difluoropropanamido)-1-(2,3-dihydrobenzo[<i>b</i>][1,4]dioxin-6-yl)propoxy)-1<i>H</i>-indazol-1-yl)-<i>N</i>-((<i>R</i>)-tetrahydrofuran-3-yl)benzamide (<b>15m</b>)</h4><div class="NLM_p last">A mixture of <b>24b</b> (100 mg, 0.19 mmol), (<i>R</i>)-tetrahydrofuran-3-amine 4-methylbenzenesulfonate (53 mg, 0.20 mmol), and HBTU (78 mg, 0.20 mmol) in DMF (2 mL) was treated with DIPEA (0.097 mL, 0.56 mmol). After stirring at room temperature for 1 h, the reaction mixture was diluted with water (2.5 mL) and MeCN (0.5 mL). The clear solution was purified by HPLC (Kromasil 100–10-C18, 50 × 250 mm, MeCN/water (0.1% TFA) 30–90%, 40 mL/min, 25 min). After freeze-drying the solution, 109 mg of a glassy solid was obtained. After dissolving the solid in warm ethyl acetate (3 mL), heptane (8 mL added in portions) was added, and a precipitate formed. The suspension was stirred at room temperature for 20 h, and the solid was collected by filtration, washed with a small volume of heptane, and dried at 40 °C under reduced pressure to afford the title compound <b>15m</b> as a colorless crystalline solid (88 mg, 78%). Mp = 177 °C. LCMS <i>m</i>/<i>z</i>: 607 (MH<sup>+</sup>). HPLC: <i>t</i><sub>R</sub> = 12.03 min, 99%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.71 (d, <i>J</i> = 6.4 Hz, 1H), 8.65 (d, <i>J</i> = 8.7 Hz, 1H), 8.24 (s, 1H), 8.17–8.2 (m, 1H), 7.84–7.9 (m, 2H), 7.77 (d, <i>J</i> = 9.1 Hz, 1H), 7.65 (t, <i>J</i> = 7.9 Hz, 1H), 7.21 (dd, <i>J</i> = 2.3, 9.1 Hz, 1H), 7.14 (d, <i>J</i> = 2.1 Hz, 1H), 6.79–6.89 (m, 3H), 5.17 (d, <i>J</i> = 6.8 Hz, 1H), 4.44–4.53 (m, 1H), 4.11–4.24 (m, 5H), 3.82–3.9 (m, 2H), 3.72 (td, <i>J</i> = 6.0, 8.0 Hz, 1H), 3.61 (dd, <i>J</i> = 4.3, 8.9 Hz, 1H), 2.11–2.22 (m, 1H), 1.89–1.99 (m, 1H), 1.55 (t, <i>J</i> = 19.5 Hz, 3H), 1.30 (d, <i>J</i> = 6.7 Hz, 3H). <sup>13</sup>C NMR (100.6 MHz, DMSO-<i>d</i><sub>6</sub>): δ 165.58, 162.96 (t, <i>J</i> = 29.3 Hz), 152.96, 142.93, 142.85, 139.63, 135.74, 135.39, 133.93, 131.40, 129.60, 125.53, 125.26, 124.21, 120.58, 119.93, 119.62, 117.09 (t, <i>J</i> = 248.1 Hz), 116.80, 115.44, 111.58, 104.22, 81.10, 72.20, 66.49, 63.96, 63.93, 50.39, 50.00, 31.79, 21.00 (t, <i>J</i> = 25.4 Hz), 15.73. Chiral HPLC (method A): <i>t</i><sub>R</sub> = 19.18 min, 99.8%. Chiral HPLC (method B): <i>t</i><sub>R</sub> = 21.92 min, 99.8%. Chiral HPLC (method C): <i>t</i><sub>R</sub> = 13.26 min, 100%. Chiral purity: 100% ee, 100% de.</div></div><div id="sec5_1_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 1-(4-Fluorophenyl)-5-iodo-<i>1H</i>-indazole (<b>16</b>)</h4><div class="NLM_p last">A mixture of (4-fluorophenyl)hydrazine hydrochloride (29.8 g, 183 mmol) and 2-fluoro-5-iodobenzaldehyde (45.8 g, 183 mmol) in NMP (600 mL) was stirred at room temperature for 5 h. K<sub>2</sub>CO<sub>3</sub> (76 g, 550 mmol) was added, and the resulting suspension was stirred at 150 °C overnight. The mixture was cooled to room temperature and poured into ice water (4 L), and the resulting brown suspension was stirred overnight. A red brown solid was collected by filtration, washed with water, and dried to leave a crude product (47 g). The crude material was dissolved in DCM/heptane (1:1), and the mixture was filtered through silica gel. The first fractions collected of red color were discarded, and the succeeding yellow fractions were combined and concentrated to give a suspension. After the addition of ethyl acetate and heptane, the mixture was repeatedly concentrated and diluted with heptane. The collection of the precipitate by suction filtration yielded <b>16</b> as a yellow solid (20.9 g, 34%). LCMS <i>m</i>/<i>z</i>: 339 (MH<sup>+</sup>). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.32 (d, <i>J</i> = 0.9 Hz, 1H), 8.31 (dd, <i>J</i> = 0.6, 1.6 Hz, 1H), 7.75–7.8 (m, 2H), 7.72 (dd, <i>J</i> = 1.6, 8.8 Hz, 1H), 7.63 (dt, <i>J</i> = 0.7, 8.9 Hz, 1H), 7.4–7.47 (m, 2H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>): δ 160.52 (d, <i>J</i> = 244.2 Hz), 137.34, 135.62 (d, <i>J</i> = 2.7 Hz), 135.35, 134.71, 130.00, 127.37, 124.51 (d, <i>J</i> = 8.6 Hz), 116.49 (d, <i>J</i> = 22.9 Hz), 112.53, 85.41.</div></div><div id="sec5_1_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> Isobutyl 3-(5-Iodo-1<i>H</i>-indazol-1-yl)benzoate (<b>17</b>)</h4><div class="NLM_p last">Step 1. A solution of 2-fluoro-5-iodobenzaldehyde (5.12 g, 20.48 mmol), 3-hydrazinylbenzoic acid (3.22 g, 21.13 mmol), and Cs<sub>2</sub>CO<sub>3</sub> (6.89 g, 21.13 mmol) in NMP (25 mL) was stirred at room temperature under an argon atmosphere for 80 min. Water (100 mL) was added. The red solution was acidified with HCl (2 M, 25 mL), and the formed suspension was stirred for 15 min. The solid was collected by filtration, washed with water (×3), and dried at +50 °C under reduced pressure overnight to afford the intermediate hydrazone 3-(2-(2-fluoro-5-iodobenzylidene)hydrazinyl)benzoic acid (<b>17a</b>) as a beige powder (80 wt %, 9.35 g, 95%). <sup>1</sup>H NMR showed the presence of 20 wt % NMP. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.88 (s, 1H), 10.86 (s, 1H), 8.17 (dd, <i>J</i> = 2.1, 6.9 Hz, 1H), 7.94 (s, 1H), 7.63–7.68 (m, 1H), 7.61 (s, 1H), 7.32–7.41 (m, 3H), 7.09 (dd, <i>J</i> = 8.7, 10.7 Hz, 1H). Step 2. To a solution of <b>17a</b> (80 wt %, 9.35 g, 19.5 mmol) dissolved in NMP (100 mL) was added potassium 2-methylpropan-2-olate (5.0 g, 44.9 mmol). The dark red solution was stirred at 160 °C for 30 min. The mixture was allowed to cool to room temperature, diluted with water (200 mL), acidified with HCl (2 M, 25 mL), and extracted with EtOAc (3 × 300 mL). The combined organic phases were washed three times with water (3 × 400 mL). The organic phases were evaporated to afford 7.3 g of a brownish solid. Recrystallization from ethanol (50 mL) yielded the intermediate 3-(5-iodo-1<i>H</i>-indazol-1-yl)benzoic acid (<b>17b</b>) (4.3 g, 60%) as a colorless solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 13.32 (s, 1H), 8.38 (d, <i>J</i> = 0.8 Hz, 1H), 8.34 (d, <i>J</i> = 0.9 Hz, 1H), 8.23–8.26 (m, 1H), 8.04 (ddd, <i>J</i> = 1.0, 2.3, 8.0 Hz, 1H), 7.97 (dt, <i>J</i> = 1.2, 7.7 Hz, 1H), 7.69–7.8 (m, 3H). Step 3. To a stirred mixture of <b>17b</b> (2.19 g, 6 mmol) and sodium carbonate (0.7 g, 6.6 mmol) in NMP (15 mL) at 40 °C was added 1-bromo-2-methylpropane (0.97 mL, 9.0 mmol) in one portion. After 1 h, the temperature was raised to 55 °C, and another portion of 1-bromo-2-methylpropane (0.97 mL, 9.0 mmol) was added. The stirring was continued overnight. After cooling, the reaction mixture was partitioned between water and ethyl acetate. The organic phase was washed twice with water, dried over sodium sulfate, filtered, and evaporated to dryness to afford <b>17</b> as a syrup that solidified to a beige material upon standing (2.5 g, 99%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 8.36–8.37 (m, 1H), 8.17 (d, <i>J</i> = 1.1 Hz, 1H), 8.14 (d, <i>J</i> = 0.7 Hz, 1H), 8.06 (dt, <i>J</i> = 7.8, 1.2 Hz, 1H), 7.91 (ddd, <i>J</i> = 8.0, 2.2, 1.0 Hz, 1H), 7.68 (dd, <i>J</i> = 8.8, 1.6 Hz, 1H), 7.63 (t, <i>J</i> = 7.9 Hz, 1H), 7.55 (d, <i>J</i> = 8.8 Hz, 1H), 4.16 (d, <i>J</i> = 6.7 Hz, 2H), 2.07–2.16 (m, 1H), 1.04 (d, <i>J</i> = 6.8 Hz, 6H). <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ 165.84, 140.08, 137.95, 135.87, 134.87, 132.14, 130.49, 129.89, 128.00, 127.98, 127.02, 123.31, 112.18, 85.10, 71.56, 28.02, 19.35.</div></div><div id="sec5_1_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 3-(5-((1<i>R</i>,2<i>S</i>)-2-(2,2-Difluoropropanamido)-1-(2,3-dihydrobenzo[<i>b</i>][1,4]dioxin-6-yl)propoxy)-1<i>H</i>-indazol-1-yl)benzoic Acid (<b>24b</b>)</h4><div class="NLM_p last">To a solution of <b>13b</b> (3.67 g, 6.18 mmol), THF (15 mL), and MeOH (15 mL) was added a 2.0 M LiOH solution in water (6.1 mL, 12.4 mmol). After stirring for 3 h, the reaction mixture was poured into water (400 mL), cooled in an ice–water bath, and acidified to pH 2 by the slow addition of 1 M HCl while stirring. The precipitated solid was collected by filtration, washed with 0.1 M HCl (50 mL) and water (100 mL), and dried at reduced pressure. In order to remove the hydrolyzed amide, the solid was redissolved in a mixture of MeOH/water/AcOH (90:10:10, 150 mL), and the mixture was filtered through a 10 g ISOLUTE-SCX column. The slightly yellow solution was concentrated to about 25 mL and diluted with water (400 mL). The pH was adjusted to pH = 2 by the addition of 1 M HCl. The suspension was stirred for 30 min. The solid was filtered off, washed with water, and dried under reduced pressure at 40 °C to afford <b>24b</b> as a slightly yellow solid (2.9 g, 87%). LCMS <i>m</i>/<i>z</i>: 538 (MH<sup>+</sup>). HPLC: <i>t</i><sub>R</sub> = 12.55 min, 97%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 13.27 (s, 1H), 8.65 (d, <i>J</i> = 8.7 Hz, 1H), 8.25 (d, <i>J</i> = 0.7 Hz, 1H), 8.21–8.23 (m, 1H), 8.00 (ddd, <i>J</i> = 1.0, 2.3, 8.1 Hz, 1H), 7.92 (dt, <i>J</i> = 1.2, 7.8 Hz, 1H), 7.77 (d, <i>J</i> = 9.1 Hz, 1H), 7.69 (t, <i>J</i> = 7.9 Hz, 1H), 7.22 (dd, <i>J</i> = 2.3, 9.1 Hz, 1H), 7.14 (d, <i>J</i> = 2.2 Hz, 1H), 6.79–6.89 (m, 3H), 5.17 (d, <i>J</i> = 6.8 Hz, 1H), 4.11–4.23 (m, 5H), 1.55 (t, <i>J</i> = 19.5 Hz, 3H), 1.29 (d, <i>J</i> = 6.7 Hz, 3H). <sup>13</sup>C NMR (100.6 MHz, DMSO-<i>d</i><sub>6</sub>): δ 166.64, 162.98 (t, <i>J</i> = 29.0 Hz), 153.01, 142.95, 142.88, 139.90, 135.68, 133.82, 132.30, 131.39, 130.08, 126.81, 125.70, 125.39, 121.93, 120.06, 119.65, 117.10 (t, <i>J</i> = 248.2 Hz), 116.81, 115.46, 111.47, 104.31, 81.10, 63.98, 63.94, 50.01, 21.01 (t, <i>J</i> = 25.4 Hz), 15.76.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i39"><a href="/doi/suppl/10.1021/acs.jmedchem.7b01215">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02650" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02650" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b01215" class="ext-link">10.1021/acs.jmedchem.7b01215</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Additional synthetic procedures and analytical data; X-ray structure determination; hormone receptor binding assays; in vitro pharmacology; dry powder inhalation protocol; protocol for pharmacokinetic studies in a rat; rat Sephadex model; cross-species in vitro metabolism (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01215/suppl_file/jm7b01215_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01215/suppl_file/jm7b01215_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01215/suppl_file/jm7b01215_si_001.pdf">jm7b01215_si_001.pdf (675.16 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01215/suppl_file/jm7b01215_si_002.csv">jm7b01215_si_002.csv (3.06 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Authors will release the atomic coordinates and experimental data upon article publication for 5NFP (compound <b>2</b>) and 5NFT (compound <b>1b</b>).</p><div class="testing" data-doi="10.1021/acs.jmedchem.7b01215" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22021" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22021" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Martin Hemmerling</span> - <span class="hlFld-Affiliation affiliation">Respiratory,
Inflammation & Autoimmunity, Innovative Medicines and Early Development
Biotech Unit, AstraZeneca, Pepparedsleden 1, Mölndal, SE 43183, Sweden</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-4662-0080" title="Orcid link">http://orcid.org/0000-0003-4662-0080</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#7914180b0d101757111c14141c0b1510171e39180a0d0b18031c171c1a18571a1614"><span class="__cf_email__" data-cfemail="c6aba7b4b2afa8e8aea3ababa3b4aaafa8a186a7b5b2b4a7bca3a8a3a5a7e8a5a9ab">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stinabritt Nilsson</span> - <span class="hlFld-Affiliation affiliation">AstraZeneca
R&D Lund, Scheelevägen
1, Lund, SE 22187, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Karl Edman</span> - <span class="hlFld-Affiliation affiliation">Discovery
Sciences, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Pepparedsleden 1, Mölndal, SE 43183, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stefan Eirefelt</span> - <span class="hlFld-Affiliation affiliation">AstraZeneca
R&D Lund, Scheelevägen
1, Lund, SE 22187, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wayne Russell</span> - <span class="hlFld-Affiliation affiliation">AstraZeneca
R&D Lund, Scheelevägen
1, Lund, SE 22187, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ramon Hendrickx</span> - <span class="hlFld-Affiliation affiliation">Respiratory,
Inflammation & Autoimmunity, Innovative Medicines and Early Development
Biotech Unit, AstraZeneca, Pepparedsleden 1, Mölndal, SE 43183, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eskil Johnsson</span> - <span class="hlFld-Affiliation affiliation">Respiratory,
Inflammation & Autoimmunity, Innovative Medicines and Early Development
Biotech Unit, AstraZeneca, Pepparedsleden 1, Mölndal, SE 43183, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Carina Kärrman Mårdh</span> - <span class="hlFld-Affiliation affiliation">Respiratory,
Inflammation & Autoimmunity, Innovative Medicines and Early Development
Biotech Unit, AstraZeneca, Pepparedsleden 1, Mölndal, SE 43183, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Markus Berger</span> - <span class="hlFld-Affiliation affiliation">Medicinal
Chemistry Berlin, Drug Discovery, Pharmaceuticals, Bayer AG, Berlin 13353, Germany</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6676-6090" title="Orcid link">http://orcid.org/0000-0001-6676-6090</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hartmut Rehwinkel</span> - <span class="hlFld-Affiliation affiliation">Medicinal
Chemistry Berlin, Drug Discovery, Pharmaceuticals, Bayer AG, Berlin 13353, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anna Abrahamsson</span> - <span class="hlFld-Affiliation affiliation">Respiratory,
Inflammation & Autoimmunity, Innovative Medicines and Early Development
Biotech Unit, AstraZeneca, Pepparedsleden 1, Mölndal, SE 43183, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jan Dahmén</span> - <span class="hlFld-Affiliation affiliation">AstraZeneca
R&D Lund, Scheelevägen
1, Lund, SE 22187, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anders R. Eriksson</span> - <span class="hlFld-Affiliation affiliation">Respiratory,
Inflammation & Autoimmunity, Innovative Medicines and Early Development
Biotech Unit, AstraZeneca, Pepparedsleden 1, Mölndal, SE 43183, Sweden</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6224-3644" title="Orcid link">http://orcid.org/0000-0002-6224-3644</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Balint Gabos</span> - <span class="hlFld-Affiliation affiliation">AstraZeneca
R&D Lund, Scheelevägen
1, Lund, SE 22187, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Krister Henriksson</span> - <span class="hlFld-Affiliation affiliation">AstraZeneca
R&D Lund, Scheelevägen
1, Lund, SE 22187, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nafizal Hossain</span> - <span class="hlFld-Affiliation affiliation">AstraZeneca
R&D Lund, Scheelevägen
1, Lund, SE 22187, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Svetlana Ivanova</span> - <span class="hlFld-Affiliation affiliation">AstraZeneca
R&D Lund, Scheelevägen
1, Lund, SE 22187, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anne-Helene Jansson</span> - <span class="hlFld-Affiliation affiliation">AstraZeneca
R&D Lund, Scheelevägen
1, Lund, SE 22187, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tina J. Jensen</span> - <span class="hlFld-Affiliation affiliation">Respiratory,
Inflammation & Autoimmunity, Innovative Medicines and Early Development
Biotech Unit, AstraZeneca, Pepparedsleden 1, Mölndal, SE 43183, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anders Jerre</span> - <span class="hlFld-Affiliation affiliation">AstraZeneca
R&D Lund, Scheelevägen
1, Lund, SE 22187, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Henrik Johansson</span> - <span class="hlFld-Affiliation affiliation">AstraZeneca
R&D Lund, Scheelevägen
1, Lund, SE 22187, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tomas Klingstedt</span> - <span class="hlFld-Affiliation affiliation">AstraZeneca
R&D Lund, Scheelevägen
1, Lund, SE 22187, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matti Lepistö</span> - <span class="hlFld-Affiliation affiliation">Respiratory,
Inflammation & Autoimmunity, Innovative Medicines and Early Development
Biotech Unit, AstraZeneca, Pepparedsleden 1, Mölndal, SE 43183, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Martin Lindsjö</span> - <span class="hlFld-Affiliation affiliation">Pharmaceutical
Sciences, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Pepparedsleden 1, Mölndal, SE 43183, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Irene Mile</span> - <span class="hlFld-Affiliation affiliation">AstraZeneca
R&D Lund, Scheelevägen
1, Lund, SE 22187, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Grigorios Nikitidis</span> - <span class="hlFld-Affiliation affiliation">AstraZeneca
R&D Lund, Scheelevägen
1, Lund, SE 22187, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John Steele</span> - <span class="hlFld-Affiliation affiliation">Respiratory,
Inflammation & Autoimmunity, Innovative Medicines and Early Development
Biotech Unit, AstraZeneca, Pepparedsleden 1, Mölndal, SE 43183, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ulrika Tehler</span> - <span class="hlFld-Affiliation affiliation">Pharmaceutical
Sciences, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Pepparedsleden 1, Mölndal, SE 43183, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lisa Wissler</span> - <span class="hlFld-Affiliation affiliation">Discovery
Sciences, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Pepparedsleden 1, Mölndal, SE 43183, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thomas Hansson</span> - <span class="hlFld-Affiliation affiliation">Respiratory,
Inflammation & Autoimmunity, Innovative Medicines and Early Development
Biotech Unit, AstraZeneca, Pepparedsleden 1, Mölndal, SE 43183, Sweden</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d234e4954-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i41">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_81352" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_81352" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank Göran Carlström for the NMR-support, Marianne Juhlin, Inger Remse, and Charlotte Kåse for the contributions to in vitro pharmacology, Mikael Lundqvist, Ann Tjörnebo, Gösta Hallström, and Karin Sjödin for their contributions to the metabolite identification studies, and Cristian Bodin and Hongwei Guo for the experimental contributions to protein crystallization.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i42" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i42"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i43" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i43"> Abbreviations Used</h2><tr><td class="NLM_term">APCI</td><td class="NLM_def"><p class="first last">atmospheric-pressure chemical ionization</p></td></tr><tr><td class="NLM_term">AR</td><td class="NLM_def"><p class="first last">androgen receptor</p></td></tr><tr><td class="NLM_term">Chrom logD</td><td class="NLM_def"><p class="first last">logD by HPLC method</p></td></tr><tr><td class="NLM_term">CL<sub>int</sub></td><td class="NLM_def"><p class="first last">intrinsic clearance</p></td></tr><tr><td class="NLM_term">COPD</td><td class="NLM_def"><p class="first last">chronic obstructive pulmonary disease</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-diisopropylethylamine</p></td></tr><tr><td class="NLM_term">DPI</td><td class="NLM_def"><p class="first last">dry powder inhalation</p></td></tr><tr><td class="NLM_term">ER</td><td class="NLM_def"><p class="first last">estrogen receptor</p></td></tr><tr><td class="NLM_term">F</td><td class="NLM_def"><p class="first last">oral bioavailibility</p></td></tr><tr><td class="NLM_term">FF</td><td class="NLM_def"><p class="first last">fluticasone furoate</p></td></tr><tr><td class="NLM_term">GR</td><td class="NLM_def"><p class="first last">glucocorticoid receptor</p></td></tr><tr><td class="NLM_term">HATU</td><td class="NLM_def"><p class="first last">1-[bis(dimethylamino)methylene]-1<i>H</i>-1,2,3-triazolo[4,5-<i>b</i>]pyridinium 3-oxid hexafluorophosphate</p></td></tr><tr><td class="NLM_term">HBTU</td><td class="NLM_def"><p class="first last">2-(1<i>H</i>-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate</p></td></tr><tr><td class="NLM_term">ICS</td><td class="NLM_def"><p class="first last">inhaled corticosteroid</p></td></tr><tr><td class="NLM_term"><i>it</i></td><td class="NLM_def"><p class="first last">intratracheal</p></td></tr><tr><td class="NLM_term"><i>iv</i></td><td class="NLM_def"><p class="first last">intravenous</p></td></tr><tr><td class="NLM_term">LBD</td><td class="NLM_def"><p class="first last">ligand binding domain</p></td></tr><tr><td class="NLM_term">LPS</td><td class="NLM_def"><p class="first last">lipopolysaccharide</p></td></tr><tr><td class="NLM_term">MR</td><td class="NLM_def"><p class="first last">mineralocorticoid receptor</p></td></tr><tr><td class="NLM_term">MRT</td><td class="NLM_def"><p class="first last">mean retention time</p></td></tr><tr><td class="NLM_term">PBMC</td><td class="NLM_def"><p class="first last">peripheral blood mononuclear cell</p></td></tr><tr><td class="NLM_term">po</td><td class="NLM_def"><p class="first last">oral (per os)</p></td></tr><tr><td class="NLM_term">PR</td><td class="NLM_def"><p class="first last">progesterone receptor</p></td></tr><tr><td class="NLM_term">TNF</td><td class="NLM_def"><p class="first last">tumor necrosis factor</p></td></tr><tr><td class="NLM_term">TR</td><td class="NLM_def"><p class="first last">therapeutic ratio</p></td></tr><tr><td class="NLM_term">T3P</td><td class="NLM_def"><p class="first last">1-propanephosphonic acid cyclic anhydride</p></td></tr><tr><td class="NLM_term">XRPD</td><td class="NLM_def"><p class="first last">X-ray powder diagram</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i44">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03333" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03333" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 30 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Hirschmann, R.</span><span> </span><span class="NLM_article-title">Medicinal chemistry in the golden age of biology: lessons from steroid and peptide research</span> <span class="citation_source-journal">Angew. Chem., Int. Ed. Engl.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">1278</span><span class="NLM_x">–</span> <span class="NLM_lpage">1301</span><span class="refDoi"> DOI: 10.1002/anie.199112781</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=10.1002%2Fanie.199112781" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1991&pages=1278-1301&author=R.+Hirschmann&title=Medicinal+chemistry+in+the+golden+age+of+biology%3A+lessons+from+steroid+and+peptide+research&doi=10.1002%2Fanie.199112781"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1002%2Fanie.199112781&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.199112781%26sid%3Dliteratum%253Aachs%26aulast%3DHirschmann%26aufirst%3DR.%26atitle%3DMedicinal%2520chemistry%2520in%2520the%2520golden%2520age%2520of%2520biology%253A%2520lessons%2520from%2520steroid%2520and%2520peptide%2520research%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%2520Engl.%26date%3D1991%26volume%3D30%26spage%3D1278%26epage%3D1301%26doi%3D10.1002%2Fanie.199112781" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Barnes, P. J.</span><span> </span><span class="NLM_article-title">Glucocorticosteroids: current and future directions</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">163</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="NLM_x">–</span> <span class="NLM_lpage">43</span><span class="refDoi"> DOI: 10.1111/j.1476-5381.2010.01199.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=10.1111%2Fj.1476-5381.2010.01199.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=21198556" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=1%3ACAS%3A528%3ADC%252BC3MXls1GjtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=163&publication_year=2011&pages=29-43&author=P.+J.+Barnes&title=Glucocorticosteroids%3A+current+and+future+directions&doi=10.1111%2Fj.1476-5381.2010.01199.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Glucocorticosteroids: current and future directions</span></div><div class="casAuthors">Barnes, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">163</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">29-43</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Glucocorticoids are the most effective anti-inflammatory therapy for asthma yet are relatively ineffective in chronic obstructive pulmonary disease.  Glucocorticoids suppress inflammation via several mol. mechanisms.  Glucocorticoids suppress the multiple inflammatory genes that are activated in chronic inflammatory diseases, such as asthma, by reversing histone acetylation of activated inflammatory genes through binding of ligand-bound glucocorticoid receptors (GR) to co-activator mols. and recruitment of histone deacetylase-2 to the activated inflammatory gene transcription complex (trans-repression).  At higher concns. of glucocorticoids GR homodimers interact with DNA recognition sites to activate transcription through increased histone acetylation of anti-inflammatory genes and transcription of several genes linked to glucocorticoid side effects (trans-activation).  Glucocorticoids also have post-transcriptional effects and decrease stability of some pro-inflammatory mRNA species.  Decreased glucocorticoid responsiveness is found in patients with severe asthma and asthmatics who smoke, as well as in all patients with chronic obstructive pulmonary disease.  Several mol. mechanisms of glucocorticoid resistance have now been identified which involve post-translational modifications of GR.  Histone deacetylase-2 is markedly reduced in activity and expression as a result of oxidative/nitrative stress so that inflammation becomes resistant to the anti-inflammatory actions of glucocorticoids.  Dissocd. glucocorticoids and selective GR modulators which show improved trans-repression over trans-activation effects have been developed to reduce side effects, but so far it has been difficult to dissoc. anti-inflammatory effects from adverse effects.  In patients with glucocorticoid resistance alternative anti-inflammatory treatments are being investigated as well as drugs that may reverse the mol. mechanisms of glucocorticoid resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrws5bc7ZkJ1rVg90H21EOLACvtfcHk0ljBhrOVbXV97Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXls1GjtL4%253D&md5=98b6a1ef4f61f1155ce876645b9c38e1</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2010.01199.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2010.01199.x%26sid%3Dliteratum%253Aachs%26aulast%3DBarnes%26aufirst%3DP.%2BJ.%26atitle%3DGlucocorticosteroids%253A%2520current%2520and%2520future%2520directions%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2011%26volume%3D163%26spage%3D29%26epage%3D43%26doi%3D10.1111%2Fj.1476-5381.2010.01199.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Goulding, N. J.</span><span> </span><span class="NLM_article-title">The molecular complexity of glucocorticoid actions in inflammation - a four-ring circus</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">629</span><span class="NLM_x">–</span> <span class="NLM_lpage">636</span><span class="refDoi"> DOI: 10.1016/j.coph.2004.06.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=10.1016%2Fj.coph.2004.06.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=15525555" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptl2ktrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=629-636&author=N.+J.+Goulding&title=The+molecular+complexity+of+glucocorticoid+actions+in+inflammation+-+a+four-ring+circus&doi=10.1016%2Fj.coph.2004.06.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">The molecular complexity of glucocorticoid actions in inflammation - a four-ring circus</span></div><div class="casAuthors">Goulding, Nicolas J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">629-636</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Glucocorticoids have been the mainstay of anti-inflammatory therapy for the past 50 years despite the significant risks assocd. with their long-term use.  Recent research into the mol. mechanisms of action of these compds. can be aggregated into two major themes: first, those that focus on the involvement of the glucocorticoid receptor in regulating the transcription of pro-inflammatory genes; and second, studies that seek to identify alternative pathways of glucocorticoid action either via the induction of anti-inflammatory mediators or through rapid non-genomic mechanisms.  Understanding the temporal-spatial patterns of these multiple mechanisms on relevant cell types will be key to explaining the profound effects that these four-ring steroids exert on the inflammatory process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp41TxF3Gx54LVg90H21EOLACvtfcHk0ljBhrOVbXV97Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptl2ktrs%253D&md5=967a99d4e315bec670914f905893bb13</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2004.06.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2004.06.009%26sid%3Dliteratum%253Aachs%26aulast%3DGoulding%26aufirst%3DN.%2BJ.%26atitle%3DThe%2520molecular%2520complexity%2520of%2520glucocorticoid%2520actions%2520in%2520inflammation%2520-%2520a%2520four-ring%2520circus%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2004%26volume%3D4%26spage%3D629%26epage%3D636%26doi%3D10.1016%2Fj.coph.2004.06.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Barnes, P. J.</span><span> </span><span class="NLM_article-title">Molecular mechanisms and cellular effects of glucocorticosteroids</span> <span class="citation_source-journal">Immunol. Allergy Clin. North Am.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">451</span><span class="NLM_x">–</span> <span class="NLM_lpage">468</span><span class="refDoi"> DOI: 10.1016/j.iac.2005.05.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=10.1016%2Fj.iac.2005.05.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=16054537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=1%3ACAS%3A280%3ADC%252BD2MzpsFymsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=451-468&author=P.+J.+Barnes&title=Molecular+mechanisms+and+cellular+effects+of+glucocorticosteroids&doi=10.1016%2Fj.iac.2005.05.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanisms and cellular effects of glucocorticosteroids</span></div><div class="casAuthors">Barnes Peter J</div><div class="citationInfo"><span class="NLM_cas:title">Immunology and allergy clinics of North America</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">451-68</span>
        ISSN:<span class="NLM_cas:issn">0889-8561</span>.
    </div><div class="casAbstract">GCSs exert their anti-inflammatory effects through influencing multiple signal transduction pathways.  Their most important action is switching off multiple activated inflammatory genes through inhibition of HAT and recruitment of HDAC2 activity to the inflammatory gene transcriptional complex.  In addition, GCSs may activate several anti-inflammatory genes and increase the degradation of mRNA encoding certain inflammatory proteins.  This broad array of actions may account for the striking effectiveness of GCSs in complex inflammatory diseases such as asthma and the difficulty in finding alternative anti-inflammatory drugs.  There is now a better understanding of how the responsiveness to GCSs is reduced in patients who have severe asthma, who have asthma and smoke, and who have COPD.  An important mechanism now emerging is a reduction in HDAC2 activity as a result of oxidative stress.  These new insights into GCS action may lead to new approaches to treating inflammatory lung diseases and in particular to increasing effectiveness of steroids in situations where they are less effective.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSix-AbkCPCprt7lRqEFUJVfW6udTcc2eYaXzKES2tLHbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2MzpsFymsw%253D%253D&md5=0cab7e9cf2da0d15262d989d57359721</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1016%2Fj.iac.2005.05.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.iac.2005.05.003%26sid%3Dliteratum%253Aachs%26aulast%3DBarnes%26aufirst%3DP.%2BJ.%26atitle%3DMolecular%2520mechanisms%2520and%2520cellular%2520effects%2520of%2520glucocorticosteroids%26jtitle%3DImmunol.%2520Allergy%2520Clin.%2520North%2520Am.%26date%3D2005%26volume%3D25%26spage%3D451%26epage%3D468%26doi%3D10.1016%2Fj.iac.2005.05.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Weikum, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knuesel, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortlund, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, K. R.</span><span> </span><span class="NLM_article-title">Glucocorticoid receptor control of transcription: precision and plasticity via allostery</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">159</span><span class="NLM_x">–</span> <span class="NLM_lpage">174</span><span class="refDoi"> DOI: 10.1038/nrm.2016.152</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=10.1038%2Fnrm.2016.152" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=28053348" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjs1Khsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2017&pages=159-174&author=E.+R.+Weikumauthor=M.+T.+Knueselauthor=E.+A.+Ortlundauthor=K.+R.+Yamamoto&title=Glucocorticoid+receptor+control+of+transcription%3A+precision+and+plasticity+via+allostery&doi=10.1038%2Fnrm.2016.152"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3cR"><div class="casContent"><span class="casTitleNuber">3c</span><div class="casTitle"><span class="NLM_cas:atitle">Glucocorticoid receptor control of transcription: precision and plasticity via allostery</span></div><div class="casAuthors">Weikum, Emily R.; Knuesel, Matthew T.; Ortlund, Eric A.; Yamamoto, Keith R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">159-174</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The glucocorticoid receptor (GR) is a constitutively expressed transcriptional regulatory factor (TRF) that controls many distinct gene networks, each uniquely detd. by particular cellular and physiol. contexts.  The precision of GR-mediated responses seems to depend on combinatorial, context-specific assembly of GR-nucleated transcription regulatory complexes at genomic response elements.  In turn, evidence suggests that context-driven plasticity is conferred by the integration of multiple signals, each serving as an allosteric effector of GR conformation, a key determinant of regulatory complex compn. and activity.  This structural and mechanistic perspective on GR regulatory specificity is likely to extend to other eukaryotic TRFs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCbT51NeMMPbVg90H21EOLACvtfcHk0lgSJpngUlvN5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjs1Khsw%253D%253D&md5=70ab0a72fa2297038493fe68ba609594</span></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=10.1038%2Fnrm.2016.152&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm.2016.152%26sid%3Dliteratum%253Aachs%26aulast%3DWeikum%26aufirst%3DE.%2BR.%26aulast%3DKnuesel%26aufirst%3DM.%2BT.%26aulast%3DOrtlund%26aufirst%3DE.%2BA.%26aulast%3DYamamoto%26aufirst%3DK.%2BR.%26atitle%3DGlucocorticoid%2520receptor%2520control%2520of%2520transcription%253A%2520precision%2520and%2520plasticity%2520via%2520allostery%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2017%26volume%3D18%26spage%3D159%26epage%3D174%26doi%3D10.1038%2Fnrm.2016.152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Fardet, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feve, B.</span><span> </span><span class="NLM_article-title">Systemic glucocorticoid therapy: a review of its metabolic and cardiovascular adverse events</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">1731</span><span class="NLM_x">–</span> <span class="NLM_lpage">1745</span><span class="refDoi"> DOI: 10.1007/s40265-014-0282-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=10.1007%2Fs40265-014-0282-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2014&pages=1731-1745&author=L.+Fardetauthor=B.+Feve&title=Systemic+glucocorticoid+therapy%3A+a+review+of+its+metabolic+and+cardiovascular+adverse+events&doi=10.1007%2Fs40265-014-0282-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1007%2Fs40265-014-0282-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40265-014-0282-9%26sid%3Dliteratum%253Aachs%26aulast%3DFardet%26aufirst%3DL.%26aulast%3DFeve%26aufirst%3DB.%26atitle%3DSystemic%2520glucocorticoid%2520therapy%253A%2520a%2520review%2520of%2520its%2520metabolic%2520and%2520cardiovascular%2520adverse%2520events%26jtitle%3DDrugs%26date%3D2014%26volume%3D74%26spage%3D1731%26epage%3D1745%26doi%3D10.1007%2Fs40265-014-0282-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Uings, I. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrow, S. N.</span><span> </span><span class="NLM_article-title">A pharmacological approach to enhancing the therapeutic index of corticosteroids in airway inflammatory disease</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">221</span><span class="NLM_x">–</span> <span class="NLM_lpage">226</span><span class="refDoi"> DOI: 10.1016/j.coph.2004.12.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=10.1016%2Fj.coph.2004.12.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=15907906" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=1%3ACAS%3A528%3ADC%252BD2MXktlejtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=221-226&author=I.+J.+Uingsauthor=S.+N.+Farrow&title=A+pharmacological+approach+to+enhancing+the+therapeutic+index+of+corticosteroids+in+airway+inflammatory+disease&doi=10.1016%2Fj.coph.2004.12.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">A pharmacological approach to enhancing the therapeutic index of corticosteroids in airway inflammatory disease</span></div><div class="casAuthors">Uings, Iain J.; Farrow, Stuart N.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">221-226</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Inhaled corticosteroids are highly effective agents for the treatment of asthma and chronic obstructive pulmonary disease.  Although local delivery to the lung has led to significant progress towards minimizing side effects assocd. with systemic exposure, addnl. opportunities exist for further enhancement of the therapeutic index.  Recent developments in the mol. and structural understanding of corticosteroid biol. have made it increasingly clear that novel corticosteroids with intrinsically different pharmacol. can be designed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpk4sVgiAxHWrVg90H21EOLACvtfcHk0lgSJpngUlvN5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXktlejtLs%253D&md5=de853f43df4395ba06a7b5da80bc2ea7</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2004.12.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2004.12.003%26sid%3Dliteratum%253Aachs%26aulast%3DUings%26aufirst%3DI.%2BJ.%26aulast%3DFarrow%26aufirst%3DS.%2BN.%26atitle%3DA%2520pharmacological%2520approach%2520to%2520enhancing%2520the%2520therapeutic%2520index%2520of%2520corticosteroids%2520in%2520airway%2520inflammatory%2520disease%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2005%26volume%3D5%26spage%3D221%26epage%3D226%26doi%3D10.1016%2Fj.coph.2004.12.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">White, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crisalida, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Economides, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaliner, M.</span><span> </span><span class="NLM_article-title">Effects of long-term inhaled corticosteroids on adrenal function in patients with asthma</span> <span class="citation_source-journal">Ann. Allergy, Asthma, Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">437</span><span class="NLM_x">–</span> <span class="NLM_lpage">444</span><span class="refDoi"> DOI: 10.1016/S1081-1206(10)60911-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=10.1016%2FS1081-1206%2810%2960911-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=16597078" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=1%3ACAS%3A528%3ADC%252BD28XjsFyjtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2006&pages=437-444&author=M.+Whiteauthor=T.+Crisalidaauthor=H.+Liauthor=A.+Economidesauthor=M.+Kaliner&title=Effects+of+long-term+inhaled+corticosteroids+on+adrenal+function+in+patients+with+asthma&doi=10.1016%2FS1081-1206%2810%2960911-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of long-term inhaled corticosteroids on adrenal function in patients with asthma</span></div><div class="casAuthors">White, Martha; Crisalida, Tera; Li, Henry; Economides, Athena; Kaliner, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Allergy, Asthma, & Immunology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">437-444</span>CODEN:
                <span class="NLM_cas:coden">ALAIF6</span>;
        ISSN:<span class="NLM_cas:issn">1081-1206</span>.
    
            (<span class="NLM_cas:orgname">American College of Allergy, Asthma, & Immunology</span>)
        </div><div class="casAbstract">Background: Inhaled corticosteroids (ICSs) are effective asthma controllers, but long-term use could lead to adverse effects.  Objective: To examine adrenal responsiveness of patients with persistent asthma treated with long-term ICSs.  Methods: Morning plasma cortisol levels before and 30 min after adrenocorticotropic hormone (ACTH) (1 μg i.v.) stimulation were compared.  Primary end points included mean prestimulation and poststimulation cortisol levels; secondary end points included morning cortisol level of 5 μg/dL or less, post-ACTH stimulation cortisol level of 18 μg/dL or less, and/or a net change of 7 μg/dL or less from baseline.  Results: A total of 103 asthmatic patients (29 in the triamcinolone acetonide group, 18 in the flunisolide group, 45 in the fluticasone propionate group, and 11 in the oral corticosteroids group [pos. controls]) completed the study.  Mean daily ICS doses and durations were as follows: triamcinolone acetonide: 448 μg for 36 mo; flunisolide: 1,181 μg for 41 mo; and fluticasone propionate: 745 μg for 19 mo.  Eleven of 30 patients taking high-dose ICSs (10 of 28 taking fluticasone propionate and 1 of 2 taking flunisolide) had both low morning cortisol levels and abnormal post-ACTH stimulation cortisol levels.  Few patients taking lower doses of any ICS had abnormal results.  Conclusions: Patients who require long-term treatment with high-dose ICSs may have abnormal morning plasma cortisol levels and reduced responsiveness to ACTH stimulation.  Careful monitoring of adrenal function should be considered in such patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodWqQIKyWcaLVg90H21EOLACvtfcHk0lgSJpngUlvN5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjsFyjtL0%253D&md5=e0685d108913770f6f4fbbb859700637</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2FS1081-1206%2810%2960911-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1081-1206%252810%252960911-8%26sid%3Dliteratum%253Aachs%26aulast%3DWhite%26aufirst%3DM.%26aulast%3DCrisalida%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DEconomides%26aufirst%3DA.%26aulast%3DKaliner%26aufirst%3DM.%26atitle%3DEffects%2520of%2520long-term%2520inhaled%2520corticosteroids%2520on%2520adrenal%2520function%2520in%2520patients%2520with%2520asthma%26jtitle%3DAnn.%2520Allergy%252C%2520Asthma%252C%2520Immunol.%26date%3D2006%26volume%3D96%26spage%3D437%26epage%3D444%26doi%3D10.1016%2FS1081-1206%2810%2960911-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Allen, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bielory, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derendorf, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dluhy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colice, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szefler, S. J.</span><span> </span><span class="NLM_article-title">Inhaled corticosteroids: past lessons and future issues</span> <span class="citation_source-journal">J. Allergy Clin. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">S1</span><span class="NLM_x">–</span> <span class="NLM_lpage">40</span><span class="refDoi"> DOI: 10.1016/S0091-6749(03)01859-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=10.1016%2FS0091-6749%2803%2901859-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=14515117" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=1%3ACAS%3A528%3ADC%252BD3sXotFCrtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2003&pages=S1-40&author=D.+B.+Allenauthor=L.+Bieloryauthor=H.+Derendorfauthor=R.+Dluhyauthor=G.+L.+Coliceauthor=S.+J.+Szefler&title=Inhaled+corticosteroids%3A+past+lessons+and+future+issues&doi=10.1016%2FS0091-6749%2803%2901859-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">Inhaled corticosteroids: past lessons and future issues</span></div><div class="casAuthors">Allen, David B.; Bielory, Leonard; Derendorf, Hartmut; Dluhy, Robert; Colice, Gene L.; Szefler, Stanley J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Allergy and Clinical Immunology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">3, Suppl.</span>),
    <span class="NLM_cas:pages">S1-S40</span>CODEN:
                <span class="NLM_cas:coden">JACIBY</span>;
        ISSN:<span class="NLM_cas:issn">0091-6749</span>.
    
            (<span class="NLM_cas:orgname">Mosby, Inc.</span>)
        </div><div class="casAbstract">A review.  Inhaled corticosteroids play a pivotal role in the treatment of asthma.  Inhalation permits effective delivery of the corticosteroid in high concn. to target sites within the lung while minimizing systemic exposure.  Consequently, the safety profile of inhaled corticosteroids is markedly better than that of oral corticosteroid therapy.  However, although it was first thought that direct delivery might eliminate systemic adverse effects, this has not been confirmed by clin. trials and experience.  Inhaled corticosteroids are absorbed from the lungs into the systemic circulation, in which they can acutely decrease growth velocity in children, an effect that fortunately appears to be temporary and might have no effect on final adult height.  In sufficient dosages, they also produce bone mineral loss leading to osteoporosis and might increase the risk of cataracts, glaucoma, skin atrophy, and vascular changes that increase the risk of ecchymoses.  Effective evaluation of the severity and significance of these complications is challenging because highly sensitive tests do not reliably predict clin. significant events, and short-term observations do not predict long-term consequences.  Also, compliance wanes with long-term treatment, and susceptibility to a particular adverse event can vary over time, even in the same individual, because of developmental or hormonal changes.  This journal supplement will review what has been learned about the safety of inhaled corticosteroids during the past decade, discussing some of the questions that remain and considering the characteristics of an "ideal" inhaled corticosteroid: one with high local activity in the lung and minimal or no adverse systemic effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoslEtGgUTTFbVg90H21EOLACvtfcHk0lh8RsvadVoihw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXotFCrtrc%253D&md5=09b1486992216963aef367dc3a3705d4</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1016%2FS0091-6749%2803%2901859-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0091-6749%252803%252901859-1%26sid%3Dliteratum%253Aachs%26aulast%3DAllen%26aufirst%3DD.%2BB.%26aulast%3DBielory%26aufirst%3DL.%26aulast%3DDerendorf%26aufirst%3DH.%26aulast%3DDluhy%26aufirst%3DR.%26aulast%3DColice%26aufirst%3DG.%2BL.%26aulast%3DSzefler%26aufirst%3DS.%2BJ.%26atitle%3DInhaled%2520corticosteroids%253A%2520past%2520lessons%2520and%2520future%2520issues%26jtitle%3DJ.%2520Allergy%2520Clin.%2520Immunol.%26date%3D2003%26volume%3D112%26spage%3DS1%26epage%3D40%26doi%3D10.1016%2FS0091-6749%2803%2901859-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Pruteanu, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chauhan, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prietsch, S. O. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ducharme, F. M.</span><span> </span><span class="NLM_article-title">Inhaled corticosteroids in children with persistent asthma: is there a dose response impact on growth? An overview of Cochrane reviews</span> <span class="citation_source-journal">Paediatr. Respir. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">51</span><span class="NLM_x">–</span> <span class="NLM_lpage">52</span><span class="refDoi"> DOI: 10.1016/j.prrv.2014.10.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=10.1016%2Fj.prrv.2014.10.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=25458795" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=1%3ACAS%3A280%3ADC%252BC2Mzjt1entg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2015&pages=51-52&author=A.+I.+Pruteanuauthor=B.+F.+Chauhanauthor=L.+Zhangauthor=S.+O.+M.+Prietschauthor=F.+M.+Ducharme&title=Inhaled+corticosteroids+in+children+with+persistent+asthma%3A+is+there+a+dose+response+impact+on+growth%3F+An+overview+of+Cochrane+reviews&doi=10.1016%2Fj.prrv.2014.10.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7bR"><div class="casContent"><span class="casTitleNuber">7b</span><div class="casTitle"><span class="NLM_cas:atitle">Inhaled corticosteroids in children with persistent asthma: is there a dose response impact on growth? An overview of Cochrane reviews</span></div><div class="casAuthors">Pruteanu Aniela I; Chauhan Bhupendrasinh F; Zhang Linjie; Prietsch Silvio O M; Ducharme Francine M</div><div class="citationInfo"><span class="NLM_cas:title">Paediatric respiratory reviews</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">51-2</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ7IjhC0TlLzdK0qsdY6Nc1fW6udTcc2eZ8a0Ver0-qJLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2Mzjt1entg%253D%253D&md5=1060330585109c1e3963e3ac982f4746</span></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1016%2Fj.prrv.2014.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.prrv.2014.10.002%26sid%3Dliteratum%253Aachs%26aulast%3DPruteanu%26aufirst%3DA.%2BI.%26aulast%3DChauhan%26aufirst%3DB.%2BF.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DPrietsch%26aufirst%3DS.%2BO.%2BM.%26aulast%3DDucharme%26aufirst%3DF.%2BM.%26atitle%3DInhaled%2520corticosteroids%2520in%2520children%2520with%2520persistent%2520asthma%253A%2520is%2520there%2520a%2520dose%2520response%2520impact%2520on%2520growth%253F%2520An%2520overview%2520of%2520Cochrane%2520reviews%26jtitle%3DPaediatr.%2520Respir.%2520Rev.%26date%3D2015%26volume%3D16%26spage%3D51%26epage%3D52%26doi%3D10.1016%2Fj.prrv.2014.10.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Rossi, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zanardi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamboni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossi, A.</span><span> </span><span class="NLM_article-title">Optimizing treatment of elderly COPD patients: what role for inhaled corticosteroids?</span> <span class="citation_source-journal">Drugs Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">679</span><span class="NLM_x">–</span> <span class="NLM_lpage">687</span><span class="refDoi"> DOI: 10.1007/s40266-015-0291-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=10.1007%2Fs40266-015-0291-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=26297533" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVSqs7%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2015&pages=679-687&author=A.+P.+Rossiauthor=E.+Zanardiauthor=M.+Zamboniauthor=A.+Rossi&title=Optimizing+treatment+of+elderly+COPD+patients%3A+what+role+for+inhaled+corticosteroids%3F&doi=10.1007%2Fs40266-015-0291-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7cR"><div class="casContent"><span class="casTitleNuber">7c</span><div class="casTitle"><span class="NLM_cas:atitle">Optimizing Treatment of Elderly COPD Patients: What Role for Inhaled Corticosteroids?</span></div><div class="casAuthors">Rossi, Andrea P.; Zanardi, Erika; Zamboni, Mauro; Rossi, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Drugs & Aging</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">679-687</span>CODEN:
                <span class="NLM_cas:coden">DRAGE6</span>;
        ISSN:<span class="NLM_cas:issn">1170-229X</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">The most recent international documents on the management and therapy of chronic obstructive pulmonary disease (COPD) recommend inhaled corticosteroids (ICS) in addn. to long-acting bronchodilators as maintenance treatment for patients at high risk of exacerbations, namely patients with forced expiratory vol. in 1 s (FEV1) of <50 % predicted and/or more than one exacerbation per yr.  However, ICS are widely used in up to 70 % of COPD patients, including those at low risk of exacerbations.  In recent years, concerns about the potential adverse effects of this drug category have been raised, and both observational and clin. studies have shown that elderly subjects with COPD treated with ICS are at high risk of developing cataracts and diabetes and more severe and life-threatening conditions such as pneumonia and osteoporotic fractures.  Moreover, aging is characterized by memory impairment, decline in muscle strength and body mass impaired coordination, as well as alterations in eyesight and hearing that can impede proper use of devices currently available for ICS administration.  Thus, regular use of ICS in more elderly patients with COPD should follow guideline recommendations, be considered with caution, and be based upon carefully weighing up expected benefits with the risk of undesired, adverse effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjjaBcy_MZNrVg90H21EOLACvtfcHk0lh8RsvadVoihw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVSqs7%252FP&md5=3082998a6532fd79b28011ae3c09b18c</span></div><a href="/servlet/linkout?suffix=cit7c&amp;dbid=16384&amp;doi=10.1007%2Fs40266-015-0291-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40266-015-0291-8%26sid%3Dliteratum%253Aachs%26aulast%3DRossi%26aufirst%3DA.%2BP.%26aulast%3DZanardi%26aufirst%3DE.%26aulast%3DZamboni%26aufirst%3DM.%26aulast%3DRossi%26aufirst%3DA.%26atitle%3DOptimizing%2520treatment%2520of%2520elderly%2520COPD%2520patients%253A%2520what%2520role%2520for%2520inhaled%2520corticosteroids%253F%26jtitle%3DDrugs%2520Aging%26date%3D2015%26volume%3D32%26spage%3D679%26epage%3D687%26doi%3D10.1007%2Fs40266-015-0291-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Barnes, P. J.</span><span> </span><span class="NLM_article-title">Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease</span> <span class="citation_source-journal">J. Allergy Clin. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">131</span><span class="NLM_x">, </span> <span class="NLM_fpage">636</span><span class="NLM_x">–</span> <span class="NLM_lpage">645</span><span class="refDoi"> DOI: 10.1016/j.jaci.2012.12.1564</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=10.1016%2Fj.jaci.2012.12.1564" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=23360759" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFWmtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2013&pages=636-645&author=P.+J.+Barnes&title=Corticosteroid+resistance+in+patients+with+asthma+and+chronic+obstructive+pulmonary+disease&doi=10.1016%2Fj.jaci.2012.12.1564"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease</span></div><div class="casAuthors">Barnes, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Allergy and Clinical Immunology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">636-645</span>CODEN:
                <span class="NLM_cas:coden">JACIBY</span>;
        ISSN:<span class="NLM_cas:issn">0091-6749</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Reduced responsiveness to the anti-inflammatory effects of corticosteroids is a major barrier to effective management of asthma in smokers and patients with severe asthma and in the majority of patients with chronic obstructive pulmonary disease (COPD).  The mol. mechanisms leading to steroid resistance are now better understood, and this has identified new targets for therapy.  In patients with severe asthma, several mol. mechanisms have been identified that might account for reduced steroid responsiveness, including reduced nuclear translocation of glucocorticoid receptor (GR) α after binding corticosteroids.  This might be due to modification of the GR by means of phosphorylation as a result of activation of several kinases (p38 mitogen-activated protein kinase α, p38 mitogen-activated protein kinase γ, and c-Jun N-terminal kinase 1), which in turn might be due to reduced activity and expression of phosphatases, such as mitogen-activated protein kinase phosphatase 1 and protein phosphatase A2.  Other mechanisms proposed include increased expression of GRβ, which competes with and thus inhibits activated GRα; increased secretion of macrophage migration inhibitory factor; competition with the transcription factor activator protein 1; and reduced expression of histone deacetylase (HDAC) 2.  HDAC2 appears to mediate the action of steroids to switch off activated inflammatory genes, but in patients with COPD, patients with severe asthma, and smokers with asthma, HDAC2 activity and expression are reduced by oxidative stress through activation of phosphoinositide 3-kinase δ.  Strategies for managing steroid resistance include alternative anti-inflammatory drugs, but a novel approach is to reverse steroid resistance by increasing HDAC2 expression, which can be achieved with theophylline and phosphoinositide 3-kinase δ inhibitors.  Long-acting β2-agonists can also increase steroid responsiveness by reversing GRα phosphorylation.  Identifying the mol. mechanisms of steroid resistance in asthmatic patients and patients with COPD can thus lead to more effective anti-inflammatory treatments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7NxvF8RwhRrVg90H21EOLACvtfcHk0lhK7DrRVRrjaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFWmtrY%253D&md5=b9f464c23387722c42b85280cc106d07</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.jaci.2012.12.1564&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jaci.2012.12.1564%26sid%3Dliteratum%253Aachs%26aulast%3DBarnes%26aufirst%3DP.%2BJ.%26atitle%3DCorticosteroid%2520resistance%2520in%2520patients%2520with%2520asthma%2520and%2520chronic%2520obstructive%2520pulmonary%2520disease%26jtitle%3DJ.%2520Allergy%2520Clin.%2520Immunol.%26date%3D2013%26volume%3D131%26spage%3D636%26epage%3D645%26doi%3D10.1016%2Fj.jaci.2012.12.1564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Hemmerling, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lepisto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ivanova, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahmen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rehwinkel, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendrickx, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dearman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wissler, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansson, T.</span><span> </span><span class="NLM_article-title">Discovery of indazole ethers as novel, potent, non-steroidal glucocorticoid receptor modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">5741</span><span class="NLM_x">–</span> <span class="NLM_lpage">5748</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2016.10.052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=10.1016%2Fj.bmcl.2016.10.052" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=27810243" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslygurvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=5741-5748&author=M.+Hemmerlingauthor=K.+Edmanauthor=M.+Lepistoauthor=A.+Erikssonauthor=S.+Ivanovaauthor=J.+Dahmenauthor=H.+Rehwinkelauthor=M.+Bergerauthor=R.+Hendrickxauthor=M.+Dearmanauthor=T.+J.+Jensenauthor=L.+Wisslerauthor=T.+Hansson&title=Discovery+of+indazole+ethers+as+novel%2C+potent%2C+non-steroidal+glucocorticoid+receptor+modulators&doi=10.1016%2Fj.bmcl.2016.10.052"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of indazole ethers as novel, potent, non-steroidal glucocorticoid receptor modulators</span></div><div class="casAuthors">Hemmerling, Martin; Edman, Karl; Lepistoe, Matti; Eriksson, Anders; Ivanova, Svetlana; Dahmen, Jan; Rehwinkel, Hartmut; Berger, Markus; Hendrickx, Ramon; Dearman, Matthew; Jensen, Tina Jellesmark; Wissler, Lisa; Hansson, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">5741-5748</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A structure-based design approach led to the identification of a novel class of indazole ether based, non-steroidal glucocorticoid receptor (GR) modulators.  Several examples were identified that displayed cell potency in the picomolar range, inhibiting LPS-induced TNF-α release by primary peripheral blood mononuclear cells (PBMCs).  Addnl., an improved steroid hormone receptor binding selectivity profile, compared to classical steroidal GR agonists, was demonstrated.  The indazole ether core tolerated a broad range of substituents allowing for modulation of the physiochem. parameters.  A small sub-set of indazole ethers, with pharmacokinetic properties suitable for oral administration, was investigated in a rat antigen-induced joint inflammation model and demonstrated excellent anti-inflammatory efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvuqQEmlkDK7Vg90H21EOLACvtfcHk0lhK7DrRVRrjaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslygurvM&md5=e380906833269e83d54ca04b96b74dfc</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.10.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.10.052%26sid%3Dliteratum%253Aachs%26aulast%3DHemmerling%26aufirst%3DM.%26aulast%3DEdman%26aufirst%3DK.%26aulast%3DLepisto%26aufirst%3DM.%26aulast%3DEriksson%26aufirst%3DA.%26aulast%3DIvanova%26aufirst%3DS.%26aulast%3DDahmen%26aufirst%3DJ.%26aulast%3DRehwinkel%26aufirst%3DH.%26aulast%3DBerger%26aufirst%3DM.%26aulast%3DHendrickx%26aufirst%3DR.%26aulast%3DDearman%26aufirst%3DM.%26aulast%3DJensen%26aufirst%3DT.%2BJ.%26aulast%3DWissler%26aufirst%3DL.%26aulast%3DHansson%26aufirst%3DT.%26atitle%3DDiscovery%2520of%2520indazole%2520ethers%2520as%2520novel%252C%2520potent%252C%2520non-steroidal%2520glucocorticoid%2520receptor%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D5741%26epage%3D5748%26doi%3D10.1016%2Fj.bmcl.2016.10.052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Biggadike, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uings, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrow, S. N.</span><span> </span><span class="NLM_article-title">Designing corticosteroid drugs for pulmonary selectivity</span> <span class="citation_source-journal">Proc. Am. Thorac. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">352</span><span class="NLM_x">–</span> <span class="NLM_lpage">355</span><span class="refDoi"> DOI: 10.1513/pats.200409-048TA</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=10.1513%2Fpats.200409-048TA" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=16113457" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsFGjsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2004&pages=352-355&author=K.+Biggadikeauthor=I.+Uingsauthor=S.+N.+Farrow&title=Designing+corticosteroid+drugs+for+pulmonary+selectivity&doi=10.1513%2Fpats.200409-048TA"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10aR"><div class="casContent"><span class="casTitleNuber">10a</span><div class="casTitle"><span class="NLM_cas:atitle">Designing corticosteroid drugs for pulmonary selectivity</span></div><div class="casAuthors">Biggadike, Keith; Uings, Iain; Farrow, Stuart N.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the American Thoracic Society</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">352-355</span>CODEN:
                <span class="NLM_cas:coden">PATSBB</span>;
        ISSN:<span class="NLM_cas:issn">1546-3222</span>.
    
            (<span class="NLM_cas:orgname">American Thoracic Society</span>)
        </div><div class="casAbstract">A review.  Inhaled corticosteroids have become indispensable for the treatment of asthma and chronic obstructive pulmonary disease.  Significant progress has been made toward minimizing side effects through the use of increasingly selective mols., and through a variety of lung targeting strategies.  Many of these developments have occurred in advance of a greatly improved understanding of corticosteroid biol. at the mol. and pharmacol. level, and it has become clear that addnl. opportunities exist for the further enhancement of therapeutic index.  This article discusses significant recent developments in the chem., biol., and pharmacol. of corticosteroids, and considers the implications for the future use of inhaled corticosteroids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIFZ3xjxbEJbVg90H21EOLACvtfcHk0lhK7DrRVRrjaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsFGjsLY%253D&md5=096a442d16e6fb9a3bf5203846348d9d</span></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1513%2Fpats.200409-048TA&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1513%252Fpats.200409-048TA%26sid%3Dliteratum%253Aachs%26aulast%3DBiggadike%26aufirst%3DK.%26aulast%3DUings%26aufirst%3DI.%26aulast%3DFarrow%26aufirst%3DS.%2BN.%26atitle%3DDesigning%2520corticosteroid%2520drugs%2520for%2520pulmonary%2520selectivity%26jtitle%3DProc.%2520Am.%2520Thorac.%2520Soc.%26date%3D2004%26volume%3D1%26spage%3D352%26epage%3D355%26doi%3D10.1513%2Fpats.200409-048TA" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Millan, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunnage, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butcher, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodd, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairman, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kilty, I. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemaitre, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewthwaite, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahnke, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathias, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philip, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefaniak, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeadon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, C.</span><span> </span><span class="NLM_article-title">Design and synthesis of inhaled p38 inhibitors for the treatment of chronic obstructive pulmonary disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">7797</span><span class="NLM_x">–</span> <span class="NLM_lpage">7814</span><span class="refDoi"> DOI: 10.1021/jm200677b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200677b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlOqu73E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=7797-7814&author=D.+S.+Millanauthor=M.+E.+Bunnageauthor=J.+L.+Burrowsauthor=K.+J.+Butcherauthor=P.+G.+Doddauthor=T.+J.+Evansauthor=D.+A.+Fairmanauthor=S.+J.+Hughesauthor=I.+C.+Kiltyauthor=A.+Lemaitreauthor=R.+A.+Lewthwaiteauthor=A.+Mahnkeauthor=J.+P.+Mathiasauthor=J.+Philipauthor=R.+T.+Smithauthor=M.+H.+Stefaniakauthor=M.+Yeadonauthor=C.+Phillips&title=Design+and+synthesis+of+inhaled+p38+inhibitors+for+the+treatment+of+chronic+obstructive+pulmonary+disease&doi=10.1021%2Fjm200677b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10bR"><div class="casContent"><span class="casTitleNuber">10b</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of Inhaled p38 Inhibitors for the Treatment of Chronic Obstructive Pulmonary Disease</span></div><div class="casAuthors">Millan, David S.; Bunnage, Mark E.; Burrows, Jane L.; Butcher, Kenneth J.; Dodd, Peter G.; Evans, Timothy J.; Fairman, David A.; Hughes, Samantha J.; Kilty, Iain C.; Lemaitre, Arnaud; Lewthwaite, Russell A.; Mahnke, Axel; Mathias, John P.; Philip, James; Smith, Robert T.; Stefaniak, Mark H.; Yeadon, Michael; Phillips, Christopher</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7797-7814</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This paper describes the identification and optimization of a novel series of DFG-out binding p38 inhibitors as inhaled agents for the treatment of chronic obstructive pulmonary disease.  Structure based drug design and "inhalation by design" principles have been applied to the optimization of the lead series exemplified by compd. I.  Analogs have been designed to be potent and selective for p38, with an emphasis on slow enzyme dissocn. kinetics to deliver prolonged lung p38 inhibition.  Pharmacokinetic properties were tuned with high intrinsic clearance and low oral bioavailability in mind, to minimize systemic exposure and reduce systemically driven adverse events.  High CYP mediated clearance and glucuronidation were targeted to achieve high intrinsic clearance coupled with multiple routes of clearance to minimize drug-drug interactions.  Furthermore, pharmaceutical properties such as stability, crystallinity, and soly. were considered to ensure compatibility with a dry powder inhaler.  P38 Inhibitor II (PF-03715455) was subsequently identified as a clin. candidate from this series with efficacy and safety profiles confirming its potential as an inhaled agent for the treatment of COPD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzy5ivwDBL6rVg90H21EOLACvtfcHk0ljCbTv7RpYTFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlOqu73E&md5=9bc6cccf04a78831f50fb402bf7cb4b1</span></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.1021%2Fjm200677b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200677b%26sid%3Dliteratum%253Aachs%26aulast%3DMillan%26aufirst%3DD.%2BS.%26aulast%3DBunnage%26aufirst%3DM.%2BE.%26aulast%3DBurrows%26aufirst%3DJ.%2BL.%26aulast%3DButcher%26aufirst%3DK.%2BJ.%26aulast%3DDodd%26aufirst%3DP.%2BG.%26aulast%3DEvans%26aufirst%3DT.%2BJ.%26aulast%3DFairman%26aufirst%3DD.%2BA.%26aulast%3DHughes%26aufirst%3DS.%2BJ.%26aulast%3DKilty%26aufirst%3DI.%2BC.%26aulast%3DLemaitre%26aufirst%3DA.%26aulast%3DLewthwaite%26aufirst%3DR.%2BA.%26aulast%3DMahnke%26aufirst%3DA.%26aulast%3DMathias%26aufirst%3DJ.%2BP.%26aulast%3DPhilip%26aufirst%3DJ.%26aulast%3DSmith%26aufirst%3DR.%2BT.%26aulast%3DStefaniak%26aufirst%3DM.%2BH.%26aulast%3DYeadon%26aufirst%3DM.%26aulast%3DPhillips%26aufirst%3DC.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520inhaled%2520p38%2520inhibitors%2520for%2520the%2520treatment%2520of%2520chronic%2520obstructive%2520pulmonary%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D7797%26epage%3D7814%26doi%3D10.1021%2Fjm200677b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Cooper, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferguson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grime, K.</span><span> </span><span class="NLM_article-title">Optimisation of DMPK by the inhaled route: challenges and approaches</span> <span class="citation_source-journal">Curr. Drug Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">457</span><span class="NLM_x">–</span> <span class="NLM_lpage">473</span><span class="refDoi"> DOI: 10.2174/138920012800166571</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=10.2174%2F138920012800166571" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=22299825" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=1%3ACAS%3A528%3ADC%252BC38XmsVeitbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=457-473&author=A.+E.+Cooperauthor=D.+Fergusonauthor=K.+Grime&title=Optimisation+of+DMPK+by+the+inhaled+route%3A+challenges+and+approaches&doi=10.2174%2F138920012800166571"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10cR"><div class="casContent"><span class="casTitleNuber">10c</span><div class="casTitle"><span class="NLM_cas:atitle">Optimisation of DMPK by the inhaled route: challenges and approaches</span></div><div class="casAuthors">Cooper, Anne E.; Ferguson, Douglas; Grime, Ken</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">457-473</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The renewed interest in inhalation delivery over recent years has led to an expansion in the understanding of lung pharmacokinetics.  Historically optimization of inhaled drugs focused largely on development of material properties, consistent with achieving a good lung deposition, alongside demonstrating appropriate in vivo efficacy with little understanding of the relationship to pharmacokinetics in the lung.  Recent efforts have led to an increased understanding of lung concns. and how to maximize exposure to achieve the desired pharmacol. response at a dose consistent with development of an inhaled product.  Although there is a prerequisite for excellent potency in inhalation delivery, it is essential that this be combined with pharmacokinetic properties that allow sufficient free concn. at the effect site in lung to exert the pharmacol. response for an appropriate dosing interval.  Increases in basicity, polarity and/or decreases in aq. soly. can extend pharmacokinetic duration and assist in finding the right balance between lung and systemic exposure.  Current evidence suggests there are similarities in lung retention in rat and dog and that animal lung concn. data can enable pharmacokinetic-pharmacodynamic relationships to be derived thus providing more confidence in the requirements for man.  Although inhaled delivery is challenging from a pharmacokinetic point of view, direct evaluation of exposure in the target organ has enabled further understanding of the drivers for drug disposition and highlighted the need for further development of predictive lung pharmacokinetic tools in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxztkVtHyCeLVg90H21EOLACvtfcHk0ljCbTv7RpYTFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmsVeitbg%253D&md5=1dec4f52aeda55fe6ea888c289216d94</span></div><a href="/servlet/linkout?suffix=cit10c&amp;dbid=16384&amp;doi=10.2174%2F138920012800166571&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138920012800166571%26sid%3Dliteratum%253Aachs%26aulast%3DCooper%26aufirst%3DA.%2BE.%26aulast%3DFerguson%26aufirst%3DD.%26aulast%3DGrime%26aufirst%3DK.%26atitle%3DOptimisation%2520of%2520DMPK%2520by%2520the%2520inhaled%2520route%253A%2520challenges%2520and%2520approaches%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2012%26volume%3D13%26spage%3D457%26epage%3D473%26doi%3D10.2174%2F138920012800166571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Tayab, Z. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hochhaus, G.</span><span> </span><span class="NLM_article-title">Pharmacokinetic/pharmacodynamic evaluation of inhalation drugs: application to targeted pulmonary delivery systems</span> <span class="citation_source-journal">Expert Opin. Drug Delivery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">519</span><span class="NLM_x">–</span> <span class="NLM_lpage">532</span><span class="refDoi"> DOI: 10.1517/17425247.2.3.519</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=10.1517%2F17425247.2.3.519" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=519-532&author=Z.+R.+Tayabauthor=G.+Hochhaus&title=Pharmacokinetic%2Fpharmacodynamic+evaluation+of+inhalation+drugs%3A+application+to+targeted+pulmonary+delivery+systems&doi=10.1517%2F17425247.2.3.519"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10d&amp;dbid=16384&amp;doi=10.1517%2F17425247.2.3.519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425247.2.3.519%26sid%3Dliteratum%253Aachs%26aulast%3DTayab%26aufirst%3DZ.%2BR.%26aulast%3DHochhaus%26aufirst%3DG.%26atitle%3DPharmacokinetic%252Fpharmacodynamic%2520evaluation%2520of%2520inhalation%2520drugs%253A%2520application%2520to%2520targeted%2520pulmonary%2520delivery%2520systems%26jtitle%3DExpert%2520Opin.%2520Drug%2520Delivery%26date%3D2005%26volume%3D2%26spage%3D519%26epage%3D532%26doi%3D10.1517%2F17425247.2.3.519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Claus, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiewe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friess, W.</span><span> </span><span class="NLM_article-title">How can we bring high drug doses to the lung?</span> <span class="citation_source-journal">Eur. J. Pharm. Biopharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">6</span><span class="refDoi"> DOI: 10.1016/j.ejpb.2013.11.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=10.1016%2Fj.ejpb.2013.11.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=24300444" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=1%3ACAS%3A528%3ADC%252BC3sXitVSgsrzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2014&pages=1-6&author=S.+Clausauthor=C.+Weilerauthor=J.+Schieweauthor=W.+Friess&title=How+can+we+bring+high+drug+doses+to+the+lung%3F&doi=10.1016%2Fj.ejpb.2013.11.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">How can we bring high drug doses to the lung?</span></div><div class="casAuthors">Claus, Sarah; Weiler, Claudius; Schiewe, Joerg; Friess, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutics and Biopharmaceutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-6</span>CODEN:
                <span class="NLM_cas:coden">EJPBEL</span>;
        ISSN:<span class="NLM_cas:issn">0939-6411</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  In the last decades, dry powder inhalation has become a very attractive option for pulmonary drug delivery to treat lung diseases like cystic fibroses and lung infections.  In contrast to the traditional pulmonary application of drugs for asthma and chronic obstructive pulmonary disease, these therapies require higher lung doses to be administered.  The developments and improvements toward high dose powder pulmonary drug delivery are summarized and discussed in this chapter.  These include the invention and improvement of novel inhaler devices as well as the further development of formulation principles and new powder engineering methods.  The implementation of these strategies is subsequently described for some prototypes and formulations in research and development stage as well as for already marketed dry powder products.  Finally, possible adverse effects that can occur after inhalation of high powder doses are shortly addressed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqV5Llh5PaWsrVg90H21EOLACvtfcHk0ljCbTv7RpYTFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXitVSgsrzN&md5=a0bd5801e0c672b787282b3c2636a1df</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.ejpb.2013.11.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejpb.2013.11.005%26sid%3Dliteratum%253Aachs%26aulast%3DClaus%26aufirst%3DS.%26aulast%3DWeiler%26aufirst%3DC.%26aulast%3DSchiewe%26aufirst%3DJ.%26aulast%3DFriess%26aufirst%3DW.%26atitle%3DHow%2520can%2520we%2520bring%2520high%2520drug%2520doses%2520to%2520the%2520lung%253F%26jtitle%3DEur.%2520J.%2520Pharm.%2520Biopharm.%26date%3D2014%26volume%3D86%26spage%3D1%26epage%3D6%26doi%3D10.1016%2Fj.ejpb.2013.11.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blomgren, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ekholm, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edsbaecker, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hochhaus, G.</span><span> </span><span class="NLM_article-title">Budesonide and ciclesonide: effect of tissue binding on pulmonary receptor binding</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">1421</span><span class="NLM_x">–</span> <span class="NLM_lpage">1426</span><span class="refDoi"> DOI: 10.1124/dmd.108.026039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=10.1124%2Fdmd.108.026039" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2009&pages=1421-1426&author=K.+Wuauthor=A.+L.+Blomgrenauthor=K.+Ekholmauthor=B.+Weberauthor=S.+Edsbaeckerauthor=G.+Hochhaus&title=Budesonide+and+ciclesonide%3A+effect+of+tissue+binding+on+pulmonary+receptor+binding&doi=10.1124%2Fdmd.108.026039"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=10.1124%2Fdmd.108.026039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.108.026039%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DK.%26aulast%3DBlomgren%26aufirst%3DA.%2BL.%26aulast%3DEkholm%26aufirst%3DK.%26aulast%3DWeber%26aufirst%3DB.%26aulast%3DEdsbaecker%26aufirst%3DS.%26aulast%3DHochhaus%26aufirst%3DG.%26atitle%3DBudesonide%2520and%2520ciclesonide%253A%2520effect%2520of%2520tissue%2520binding%2520on%2520pulmonary%2520receptor%2520binding%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2009%26volume%3D37%26spage%3D1421%26epage%3D1426%26doi%3D10.1124%2Fdmd.108.026039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Schmidt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derendorf, H.</span><span> </span><span class="NLM_article-title">Significance of protein binding in pharmacokinetics and pharmacodynamics</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">1107</span><span class="NLM_x">–</span> <span class="NLM_lpage">1122</span><span class="refDoi"> DOI: 10.1002/jps.21916</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=10.1002%2Fjps.21916" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=19852037" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmvVGisA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2010&pages=1107-1122&author=S.+Schmidtauthor=D.+Gonzalezauthor=H.+Derendorf&title=Significance+of+protein+binding+in+pharmacokinetics+and+pharmacodynamics&doi=10.1002%2Fjps.21916"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12bR"><div class="casContent"><span class="casTitleNuber">12b</span><div class="casTitle"><span class="NLM_cas:atitle">Significance of protein binding in pharmacokinetics and pharmacodynamics</span></div><div class="casAuthors">Schmidt, Stephan; Gonzalez, Daniel; Derendorf, Hartmut</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1107-1122</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  The significance of plasma protein binding on drug efficacy and, subsequently, the clin. relevance of changes in protein binding has been controversially discussed for decades.  The uncertainty concerning the impact of plasma protein binding on a drug's pharmacol. activity is, in part, related to the approach used when investigating and interpreting protein binding effects in vitro and in vivo.  Frequently, a generalized one-size-fits-all approach, such as "protein binding does matter/does not matter," may not be applicable.  An appropriate anal. requires careful consideration of both pharmacokinetic and pharmacodynamic processes, as they both contribute to the safety and efficacy of drugs.  Therefore, the aim of this article is to provide a concise review of the theor. concepts of protein binding, and to discuss relevant examples where applicable. © 2009 Wiley-Liss, Inc. and the American Pharmacists Assocn. J Pharm Sci 99: 1107-1122, 2010.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohMNppQyZR1rVg90H21EOLACvtfcHk0liiyMgPHcoF4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmvVGisA%253D%253D&md5=5de129d76e3beb35b73d31de0bc831d2</span></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=10.1002%2Fjps.21916&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.21916%26sid%3Dliteratum%253Aachs%26aulast%3DSchmidt%26aufirst%3DS.%26aulast%3DGonzalez%26aufirst%3DD.%26aulast%3DDerendorf%26aufirst%3DH.%26atitle%3DSignificance%2520of%2520protein%2520binding%2520in%2520pharmacokinetics%2520and%2520pharmacodynamics%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2010%26volume%3D99%26spage%3D1107%26epage%3D1122%26doi%3D10.1002%2Fjps.21916" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Belvisi, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bundschuh, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoeck, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wicks, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Underwood, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Battram, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haddad, E. -B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webber, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, M. L.</span><span> </span><span class="NLM_article-title">Preclinical profile of ciclesonide, a novel corticosteroid for the treatment of asthma</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">314</span><span class="NLM_x">, </span> <span class="NLM_fpage">568</span><span class="NLM_x">–</span> <span class="NLM_lpage">574</span><span class="refDoi"> DOI: 10.1124/jpet.105.085217</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=10.1124%2Fjpet.105.085217" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=15878996" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=1%3ACAS%3A528%3ADC%252BD2MXntVSisr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=314&publication_year=2005&pages=568-574&author=M.+G.+Belvisiauthor=D.+S.+Bundschuhauthor=M.+Stoeckauthor=S.+Wicksauthor=S.+Underwoodauthor=C.+H.+Battramauthor=E.+-B.+Haddadauthor=S.+E.+Webberauthor=M.+L.+Foster&title=Preclinical+profile+of+ciclesonide%2C+a+novel+corticosteroid+for+the+treatment+of+asthma&doi=10.1124%2Fjpet.105.085217"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical profile of ciclesonide, a novel corticosteroid for the treatment of asthma</span></div><div class="casAuthors">Belvisi, Maria G.; Bundschuh, Daniela S.; Stoeck, Michael; Wicks, Sharon; Underwood, Stephen; Battram, Clifford H.; El-Bdaoui, Haddad; Webber, Stephen E.; Foster, Martyn L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">314</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">568-574</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Ciclesonide is a novel, inhaled corticosteroid under development for the treatment of asthma.  Ciclesonide is activated to desisobutyryl-ciclesonide (des-CIC) in the lungs to provide potent anti-inflammatory activity.  The investigations herein compared the activity of ciclesonide with fluticasone in animal models to assess efficacy/potency as an airway anti-inflammatory and the comparative side effect potential to consider the therapeutic ratio of each compd.  In radioligand binding assays, des-CIC and fluticasone exhibited comparable high-affinity binding to the glucocorticoid receptor, whereas ciclesonide exhibited 100-fold less binding affinity.  In the Brown Norway rat model of antigen-induced airway eosinophilia and in a model of Sephadex-induced lung edema, ciclesonide and fluticasone exhibited comparable efficacy.  Interestingly, following 7-day intratracheal administration, ciclesonide elicited adrenal involution with a potency that was 44-fold less than fluticasone.  Furthermore, ciclesonide was 22-fold less active than fluticasone in eliciting hypoplasia of the femoral growth plate.  These data support the concept that ciclesonide acts as a parent compd. that, when delivered to the airways, can be transformed into the active metabolite des-CIC, resulting in local high anti-inflammatory activity.  Furthermore, ciclesonide possesses equiv. anti-inflammatory efficacy through pulmonary activation with a significantly improved safety profile in preclin. animal models compared with fluticasone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocDeoKkmEWTrVg90H21EOLACvtfcHk0liiyMgPHcoF4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXntVSisr8%253D&md5=c883d33797cddbcdcb0188f355e9ba0e</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1124%2Fjpet.105.085217&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.105.085217%26sid%3Dliteratum%253Aachs%26aulast%3DBelvisi%26aufirst%3DM.%2BG.%26aulast%3DBundschuh%26aufirst%3DD.%2BS.%26aulast%3DStoeck%26aufirst%3DM.%26aulast%3DWicks%26aufirst%3DS.%26aulast%3DUnderwood%26aufirst%3DS.%26aulast%3DBattram%26aufirst%3DC.%2BH.%26aulast%3DHaddad%26aufirst%3DE.%2B-B.%26aulast%3DWebber%26aufirst%3DS.%2BE.%26aulast%3DFoster%26aufirst%3DM.%2BL.%26atitle%3DPreclinical%2520profile%2520of%2520ciclesonide%252C%2520a%2520novel%2520corticosteroid%2520for%2520the%2520treatment%2520of%2520asthma%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2005%26volume%3D314%26spage%3D568%26epage%3D574%26doi%3D10.1124%2Fjpet.105.085217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Conrad, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsiao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, R.</span><span> </span><span class="NLM_article-title">A practical one-pot process for α-amino aryl ketone synthesis</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">8587</span><span class="NLM_x">–</span> <span class="NLM_lpage">8589</span><span class="refDoi"> DOI: 10.1016/j.tetlet.2005.09.183</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=10.1016%2Fj.tetlet.2005.09.183" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFOrs7fM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2005&pages=8587-8589&author=K.+Conradauthor=Y.+Hsiaoauthor=R.+Miller&title=A+practical+one-pot+process+for+%CE%B1-amino+aryl+ketone+synthesis&doi=10.1016%2Fj.tetlet.2005.09.183"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">A practical one-pot process for α-amino aryl ketone synthesis</span></div><div class="casAuthors">Conrad, Karen; Hsiao, Yi; Miller, Ross</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">8587-8589</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">An efficient, convenient, high-yielding synthesis of α-amino aryl ketones (S)-RCOCHMeNHCbz (R = Ph, 2-MeC6H4, 3-MeOC6H4, 4-NCC6H4, 3-pyridyl, 2-thiazolyl, etc., Cbz = PhCH2O2C) is described, involving the one-pot deprotonation-transmetalation-arylation of Weinreb amide (S)-MeONMeCOCHMeNHCbz while retaining chirality of the original amide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSZrNG15mhfrVg90H21EOLACvtfcHk0ljEs7KwuSceng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFOrs7fM&md5=9c915b629f1c7c42b56a78ace525a9ae</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2005.09.183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2005.09.183%26sid%3Dliteratum%253Aachs%26aulast%3DConrad%26aufirst%3DK.%26aulast%3DHsiao%26aufirst%3DY.%26aulast%3DMiller%26aufirst%3DR.%26atitle%3DA%2520practical%2520one-pot%2520process%2520for%2520%25CE%25B1-amino%2520aryl%2520ketone%2520synthesis%26jtitle%3DTetrahedron%2520Lett.%26date%3D2005%26volume%3D46%26spage%3D8587%26epage%3D8589%26doi%3D10.1016%2Fj.tetlet.2005.09.183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Yin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huffman, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conrad, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armstrong, J. D.,  3rd</span><span> </span><span class="NLM_article-title">Highly diastereoselective catalytic Meerwein-Ponndorf-Verley reductions</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">840</span><span class="NLM_x">–</span> <span class="NLM_lpage">843</span><span class="refDoi"> DOI: 10.1021/jo052121t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo052121t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2006&pages=840-843&author=J.+Yinauthor=M.+A.+Huffmanauthor=K.+M.+Conradauthor=J.+D.+Armstrong&title=Highly+diastereoselective+catalytic+Meerwein-Ponndorf-Verley+reductions&doi=10.1021%2Fjo052121t"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjo052121t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo052121t%26sid%3Dliteratum%253Aachs%26aulast%3DYin%26aufirst%3DJ.%26aulast%3DHuffman%26aufirst%3DM.%2BA.%26aulast%3DConrad%26aufirst%3DK.%2BM.%26aulast%3DArmstrong%26aufirst%3DJ.%2BD.%26atitle%3DHighly%2520diastereoselective%2520catalytic%2520Meerwein-Ponndorf-Verley%2520reductions%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2006%26volume%3D71%26spage%3D840%26epage%3D843%26doi%3D10.1021%2Fjo052121t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Davies, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doisneau, G. J.-M.</span><span> </span><span class="NLM_article-title">Base induced C-5 epimerisation of 4-methyl-5-phenyl oxazolidinones: chiral auxiliaries derived from norephedrine and norpseudoephedrine</span> <span class="citation_source-journal">Tetrahedron: Asymmetry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">2513</span><span class="NLM_x">–</span> <span class="NLM_lpage">2516</span><span class="refDoi"> DOI: 10.1016/S0957-4166(00)82231-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=10.1016%2FS0957-4166%2800%2982231-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1993&pages=2513-2516&author=S.+G.+Daviesauthor=G.+J.-M.+Doisneau&title=Base+induced+C-5+epimerisation+of+4-methyl-5-phenyl+oxazolidinones%3A+chiral+auxiliaries+derived+from+norephedrine+and+norpseudoephedrine&doi=10.1016%2FS0957-4166%2800%2982231-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2FS0957-4166%2800%2982231-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0957-4166%252800%252982231-4%26sid%3Dliteratum%253Aachs%26aulast%3DDavies%26aufirst%3DS.%2BG.%26aulast%3DDoisneau%26aufirst%3DG.%2BJ.-M.%26atitle%3DBase%2520induced%2520C-5%2520epimerisation%2520of%25204-methyl-5-phenyl%2520oxazolidinones%253A%2520chiral%2520auxiliaries%2520derived%2520from%2520norephedrine%2520and%2520norpseudoephedrine%26jtitle%3DTetrahedron%253A%2520Asymmetry%26date%3D1993%26volume%3D4%26spage%3D2513%26epage%3D2516%26doi%3D10.1016%2FS0957-4166%2800%2982231-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Job, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchwald, S. L.</span><span> </span><span class="NLM_article-title">Copper-catalyzed arylation of beta-amino alcohols</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">3703</span><span class="NLM_x">–</span> <span class="NLM_lpage">3706</span><span class="refDoi"> DOI: 10.1021/ol026655h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol026655h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2002&pages=3703-3706&author=G.+E.+Jobauthor=S.+L.+Buchwald&title=Copper-catalyzed+arylation+of+beta-amino+alcohols&doi=10.1021%2Fol026655h"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fol026655h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol026655h%26sid%3Dliteratum%253Aachs%26aulast%3DJob%26aufirst%3DG.%2BE.%26aulast%3DBuchwald%26aufirst%3DS.%2BL.%26atitle%3DCopper-catalyzed%2520arylation%2520of%2520beta-amino%2520alcohols%26jtitle%3DOrg.%2520Lett.%26date%3D2002%26volume%3D4%26spage%3D3703%26epage%3D3706%26doi%3D10.1021%2Fol026655h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Edsbacker, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonsson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindberg, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryrfeldt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thalen, A.</span><span> </span><span class="NLM_article-title">Metabolic pathways of the topical glucocorticoid budesonide in man</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">590</span><span class="NLM_x">–</span> <span class="NLM_lpage">596</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1983&pages=590-596&author=S.+Edsbackerauthor=S.+Jonssonauthor=C.+Lindbergauthor=A.+Ryrfeldtauthor=A.+Thalen&title=Metabolic+pathways+of+the+topical+glucocorticoid+budesonide+in+man"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEdsbacker%26aufirst%3DS.%26aulast%3DJonsson%26aufirst%3DS.%26aulast%3DLindberg%26aufirst%3DC.%26aulast%3DRyrfeldt%26aufirst%3DA.%26aulast%3DThalen%26aufirst%3DA.%26atitle%3DMetabolic%2520pathways%2520of%2520the%2520topical%2520glucocorticoid%2520budesonide%2520in%2520man%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D1983%26volume%3D11%26spage%3D590%26epage%3D596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit18b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hughes, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shardlow, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollis, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Motivaras, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rousell, V. M.</span><span> </span><span class="NLM_article-title">Metabolism and disposition of fluticasone furoate, an enhanced-affinity glucocorticoid, in humans</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">2337</span><span class="NLM_x">–</span> <span class="NLM_lpage">2344</span><span class="refDoi"> DOI: 10.1124/dmd.108.022137</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=10.1124%2Fdmd.108.022137" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=18694910" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlWiu77L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2008&pages=2337-2344&author=S.+C.+Hughesauthor=P.+C.+Shardlowauthor=F.+J.+Hollisauthor=R.+J.+Scottauthor=D.+S.+Motivarasauthor=A.+Allenauthor=V.+M.+Rousell&title=Metabolism+and+disposition+of+fluticasone+furoate%2C+an+enhanced-affinity+glucocorticoid%2C+in+humans&doi=10.1124%2Fdmd.108.022137"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18bR"><div class="casContent"><span class="casTitleNuber">18b</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolism and disposition of fluticasone furoate, an enhanced-affinity glucocorticoid, in humans</span></div><div class="casAuthors">Hughes, Stephen C.; Shardlow, Peter C.; Hollis, Frank J.; Scott, Rebecca J.; Motivaras, Dimple S.; Allen, Ann; Rousell, Victoria M.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2337-2344</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The purpose of this study was to investigate the metab. and disposition of fluticasone furoate, an enhanced-affinity glucocorticoid receptor agonist, in humans.  In a two-part, open-label design study, five healthy male subjects received a p.o. dose of 2 mg of [14C]fluticasone furoate, followed 4 wk later by an i.v. dose of 0.25 mg of [14C]fluticasone furoate (as a 30-min infusion).  Oral absorption was rapid and estd. at approx. 30%, although the oral bioavailability was markedly lower at 1.6%, limited by extensive first-pass metab.  Plasma clearance was 58.3 L/h, with a vol. of distribution of 642 L and a terminal elimination half-life of 15.3 h.  The major circulating component identified in plasma exts. after i.v. and p.o. dosing was unchanged parent compd., with 17β-carboxylic acid (GW 694301X) also being notable after p.o. administration.  Mean recovery of radioactivity was approx. 92 and 102% at 216 and 168 h after i.v. and p.o. administration, resp., with most (at least 90%) recovered in the feces.  Fluticasone furoate was extensively metabolized, with only trace amts. of unchanged parent compd. obsd. in feces following either route of administration.  The predominant pathway was removal of the S-fluoromethyl carbothioate group to yield GW 694301X.  Other pathways included oxidative defluorination to yield a hydroxyl at the C6 position.  There was no evidence for metabolic loss of the furoate group from fluticasone furoate or any of its metabolites.  Evidence presented suggests that enterocytes have a role in the metab. of unabsorbed fluticasone furoate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTOa3bL8acNrVg90H21EOLACvtfcHk0lgqIQPPckbmPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlWiu77L&md5=d51c628e6fdc783fa5fd8dc58d4cdaa6</span></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=10.1124%2Fdmd.108.022137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.108.022137%26sid%3Dliteratum%253Aachs%26aulast%3DHughes%26aufirst%3DS.%2BC.%26aulast%3DShardlow%26aufirst%3DP.%2BC.%26aulast%3DHollis%26aufirst%3DF.%2BJ.%26aulast%3DScott%26aufirst%3DR.%2BJ.%26aulast%3DMotivaras%26aufirst%3DD.%2BS.%26aulast%3DAllen%26aufirst%3DA.%26aulast%3DRousell%26aufirst%3DV.%2BM.%26atitle%3DMetabolism%2520and%2520disposition%2520of%2520fluticasone%2520furoate%252C%2520an%2520enhanced-affinity%2520glucocorticoid%252C%2520in%2520humans%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2008%26volume%3D36%26spage%3D2337%26epage%3D2344%26doi%3D10.1124%2Fdmd.108.022137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Jacobson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middleton, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmgren, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eirefelt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frojd, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blomgren, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustavsson, L.</span><span> </span><span class="NLM_article-title">An optimized automated assay for determination of metabolic stability using hepatocytes: assay validation, variance component analysis, and in vivo relevance</span> <span class="citation_source-journal">Assay Drug Dev. Technol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">403</span><span class="NLM_x">–</span> <span class="NLM_lpage">415</span><span class="refDoi"> DOI: 10.1089/adt.2007.059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=10.1089%2Fadt.2007.059" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2007&pages=403-415&author=L.+Jacobsonauthor=B.+Middletonauthor=J.+Holmgrenauthor=S.+Eirefeltauthor=M.+Frojdauthor=A.+Blomgrenauthor=L.+Gustavsson&title=An+optimized+automated+assay+for+determination+of+metabolic+stability+using+hepatocytes%3A+assay+validation%2C+variance+component+analysis%2C+and+in+vivo+relevance&doi=10.1089%2Fadt.2007.059"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1089%2Fadt.2007.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fadt.2007.059%26sid%3Dliteratum%253Aachs%26aulast%3DJacobson%26aufirst%3DL.%26aulast%3DMiddleton%26aufirst%3DB.%26aulast%3DHolmgren%26aufirst%3DJ.%26aulast%3DEirefelt%26aufirst%3DS.%26aulast%3DFrojd%26aufirst%3DM.%26aulast%3DBlomgren%26aufirst%3DA.%26aulast%3DGustavsson%26aufirst%3DL.%26atitle%3DAn%2520optimized%2520automated%2520assay%2520for%2520determination%2520of%2520metabolic%2520stability%2520using%2520hepatocytes%253A%2520assay%2520validation%252C%2520variance%2520component%2520analysis%252C%2520and%2520in%2520vivo%2520relevance%26jtitle%3DAssay%2520Drug%2520Dev.%2520Technol.%26date%3D2007%26volume%3D5%26spage%3D403%26epage%3D415%26doi%3D10.1089%2Fadt.2007.059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Sellers, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horodnik, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">House, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wylie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mauser, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donovan, B.</span><span> </span><span class="NLM_article-title">The in vitro and in vivo investigation of a novel small chamber dry powder inhalation delivery system for preclinical dosing to rats</span> <span class="citation_source-journal">Inhalation Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">706</span><span class="NLM_x">–</span> <span class="NLM_lpage">716</span><span class="refDoi"> DOI: 10.3109/08958378.2015.1089959</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=10.3109%2F08958378.2015.1089959" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=26452700" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVGmsrnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2015&pages=706-716&author=S.+Sellersauthor=W.+Horodnikauthor=A.+Houseauthor=J.+Wylieauthor=P.+Mauserauthor=B.+Donovan&title=The+in+vitro+and+in+vivo+investigation+of+a+novel+small+chamber+dry+powder+inhalation+delivery+system+for+preclinical+dosing+to+rats&doi=10.3109%2F08958378.2015.1089959"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">The in vitro and in vivo investigation of a novel small chamber dry powder inhalation delivery system for preclinical dosing to rats</span></div><div class="casAuthors">Sellers, Shari; Horodnik, Walter; House, Aileen; Wylie, Jennifer; Mauser, Peter; Donovan, Brent</div><div class="citationInfo"><span class="NLM_cas:title">Inhalation Toxicology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">706-716</span>CODEN:
                <span class="NLM_cas:coden">INHTE5</span>;
        ISSN:<span class="NLM_cas:issn">0895-8378</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Purpose: This research describes a novel "minitower" dry powder delivery system for nose-only delivery of dry powder aerosols to spontaneously breathing rats.  Methods: The minitower system forces pressurized air through pre-filled capsules to deliver aerosolized drug to four nose ports; three of which house spontaneously breathing rats, with the fourth used as a control.  Within each port are vent filters which capture drug that was not inhaled for further quantitation.  These vent filters along with a novel control system referred to as the "artificial rat lung", allow for the theor. amt. of drug delivered and subsequently inhaled by each rat to be calcd.  Results: In vitro and in vivo studies have demonstrated this system's ability to deliver aerosolized drug to rats.  The in vitro study showed that ∼30% of the starting dose reached the 4 ports and was available for inhalation.  During in-vivo studies, rats inhaled ∼34% of the delivered dose.  Of the estd. inhaled dose, 12-18% was detectable in the various tissue samples, with over 30% of the recovered dose found in the rat's lungs.  Conclusion: Results show that this system is capable of reproducibly delivering drug to the lungs of spontaneously breathing rats.  Advantages over current delivery methods include being amenable to the administration of multiple doses and using less (milligram) amt. of starting material.  In addn., this technique avoids anesthesia which is typically required for instillation or insufflation, and thus has the potential as an efficient and noninvasive aerosol delivery method for preclin. drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2YJ_QMSJKIrVg90H21EOLACvtfcHk0lgqIQPPckbmPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVGmsrnP&md5=2dca00844e7a2b54dc608c0139b122d6</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.3109%2F08958378.2015.1089959&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F08958378.2015.1089959%26sid%3Dliteratum%253Aachs%26aulast%3DSellers%26aufirst%3DS.%26aulast%3DHorodnik%26aufirst%3DW.%26aulast%3DHouse%26aufirst%3DA.%26aulast%3DWylie%26aufirst%3DJ.%26aulast%3DMauser%26aufirst%3DP.%26aulast%3DDonovan%26aufirst%3DB.%26atitle%3DThe%2520in%2520vitro%2520and%2520in%2520vivo%2520investigation%2520of%2520a%2520novel%2520small%2520chamber%2520dry%2520powder%2520inhalation%2520delivery%2520system%2520for%2520preclinical%2520dosing%2520to%2520rats%26jtitle%3DInhalation%2520Toxicol.%26date%3D2015%26volume%3D27%26spage%3D706%26epage%3D716%26doi%3D10.3109%2F08958378.2015.1089959" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Valotis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hogger, P.</span><span> </span><span class="NLM_article-title">Human receptor kinetics and lung tissue retention of the enhanced-affinity glucocorticoid fluticasone furoate</span> <span class="citation_source-journal">Respir. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">54</span><span class="refDoi"> DOI: 10.1186/1465-9921-8-54</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=10.1186%2F1465-9921-8-54" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=17650349" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=1%3ACAS%3A280%3ADC%252BD2svpsVagsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=54&author=A.+Valotisauthor=P.+Hogger&title=Human+receptor+kinetics+and+lung+tissue+retention+of+the+enhanced-affinity+glucocorticoid+fluticasone+furoate&doi=10.1186%2F1465-9921-8-54"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Human receptor kinetics and lung tissue retention of the enhanced-affinity glucocorticoid fluticasone furoate</span></div><div class="casAuthors">Valotis Anagnostis; Hogger Petra</div><div class="citationInfo"><span class="NLM_cas:title">Respiratory research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">54</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Fluticasone furoate (FF)--USAN approved name, a new topically active glucocorticoid has been recently identified.  The aim of this study was to characterise the binding affinity of this compound to the human lung glucocorticoid receptor in relation to other glucocorticoids.  Additionally, we sought to determine the binding behaviour of fluticasone furoate to human lung tissue.  The glucocorticoid receptor binding kinetics of fluticasone furoate revealed a remarkably fast association and a slow dissociation resulting in a relative receptor affinity (RRA) of 2989 +/- 135 with reference to dexamethasone (RRA: 100 +/- 5).  Thus, the RRA of FF exceeds the RRAs of all currently clinically used corticosteroids such as mometasone furoate (MF; RRA 2244), fluticasone propionate (FP; RRA 1775), ciclesonide's active metabolite (RRA 1212 - rat receptor data) or budesonide (RRA 855).  FP and FF displayed pronounced retention in human lung tissue in vitro.  Lowest tissue binding was found for MF.  There was no indication of instability or chemical modification of FF in human lung tissue.  These advantageous binding attributes may contribute to a highly efficacious profile for FF as a topical treatment for inflammatory disorders of the respiratory tract.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRu0ZxK3zk3vAwxfk_AGB-EfW6udTcc2ebuXR0tOjhMvrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2svpsVagsA%253D%253D&md5=f10e38e08cf94837bbe1969c193d8dcb</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1186%2F1465-9921-8-54&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1465-9921-8-54%26sid%3Dliteratum%253Aachs%26aulast%3DValotis%26aufirst%3DA.%26aulast%3DHogger%26aufirst%3DP.%26atitle%3DHuman%2520receptor%2520kinetics%2520and%2520lung%2520tissue%2520retention%2520of%2520the%2520enhanced-affinity%2520glucocorticoid%2520fluticasone%2520furoate%26jtitle%3DRespir.%2520Res.%26date%3D2007%26volume%3D8%26spage%3D54%26doi%3D10.1186%2F1465-9921-8-54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kallstrom, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brattsand, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovgren, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensjo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roempke, K.</span><span> </span><span class="NLM_article-title">A rat model for testing anti-inflammatory action in lung and the effect of glucocorticosteroids (GCS) in this model</span> <span class="citation_source-journal">Agents Actions</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">355</span><span class="NLM_x">–</span> <span class="NLM_lpage">357</span><span class="refDoi"> DOI: 10.1007/BF01982644</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=10.1007%2FBF01982644" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=3962784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=1%3ACAS%3A280%3ADyaL287otlersQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1986&pages=355-357&author=L.+Kallstromauthor=R.+Brattsandauthor=U.+Lovgrenauthor=E.+Svensjoauthor=K.+Roempke&title=A+rat+model+for+testing+anti-inflammatory+action+in+lung+and+the+effect+of+glucocorticosteroids+%28GCS%29+in+this+model&doi=10.1007%2FBF01982644"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22aR"><div class="casContent"><span class="casTitleNuber">22a</span><div class="casTitle"><span class="NLM_cas:atitle">A rat model for testing anti-inflammatory action in lung and the effect of glucocorticosteroids (GCS) in this model</span></div><div class="casAuthors">Kallstrom L; Brattsand R; Lovgren U; Svensjo E; Roempke K</div><div class="citationInfo"><span class="NLM_cas:title">Agents and actions</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">355-7</span>
        ISSN:<span class="NLM_cas:issn">0065-4299</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQSxDcBZCv6NwyMywPm6HgQfW6udTcc2eaaVP25eV1gmrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL287otlersQ%253D%253D&md5=c92c87e53e7e0e7674c365e06b593e24</span></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=10.1007%2FBF01982644&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF01982644%26sid%3Dliteratum%253Aachs%26aulast%3DKallstrom%26aufirst%3DL.%26aulast%3DBrattsand%26aufirst%3DR.%26aulast%3DLovgren%26aufirst%3DU.%26aulast%3DSvensjo%26aufirst%3DE.%26aulast%3DRoempke%26aufirst%3DK.%26atitle%3DA%2520rat%2520model%2520for%2520testing%2520anti-inflammatory%2520action%2520in%2520lung%2520and%2520the%2520effect%2520of%2520glucocorticosteroids%2520%2528GCS%2529%2520in%2520this%2520model%26jtitle%3DAgents%2520Actions%26date%3D1986%26volume%3D17%26spage%3D355%26epage%3D357%26doi%3D10.1007%2FBF01982644" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit22b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kubin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deschl, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linssen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilhelms, O. H.</span><span> </span><span class="NLM_article-title">Intratracheal application of Sephadex in rats leads to massive pulmonary eosinophilia without bronchial hyperreactivity to acetylcholine</span> <span class="citation_source-journal">Int. Arch. Allergy Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">266</span><span class="NLM_x">–</span> <span class="NLM_lpage">272</span><span class="refDoi"> DOI: 10.1159/000236196</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=10.1159%2F000236196" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2004&pages=266-272&author=R.+Kubinauthor=U.+Deschlauthor=M.+Linssenauthor=O.+H.+Wilhelms&title=Intratracheal+application+of+Sephadex+in+rats+leads+to+massive+pulmonary+eosinophilia+without+bronchial+hyperreactivity+to+acetylcholine&doi=10.1159%2F000236196"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=10.1159%2F000236196&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000236196%26sid%3Dliteratum%253Aachs%26aulast%3DKubin%26aufirst%3DR.%26aulast%3DDeschl%26aufirst%3DU.%26aulast%3DLinssen%26aufirst%3DM.%26aulast%3DWilhelms%26aufirst%3DO.%2BH.%26atitle%3DIntratracheal%2520application%2520of%2520Sephadex%2520in%2520rats%2520leads%2520to%2520massive%2520pulmonary%2520eosinophilia%2520without%2520bronchial%2520hyperreactivity%2520to%2520acetylcholine%26jtitle%3DInt.%2520Arch.%2520Allergy%2520Immunol.%26date%3D2004%26volume%3D98%26spage%3D266%26epage%3D272%26doi%3D10.1159%2F000236196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Gomez-Sanchez, C. E.</span><span> </span><span class="NLM_article-title">Glucocorticoid production and regulation in thymus: of mice and birds</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">150</span><span class="NLM_x">, </span> <span class="NLM_fpage">3977</span><span class="NLM_x">–</span> <span class="NLM_lpage">3979</span><span class="refDoi"> DOI: 10.1210/en.2009-0615</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=10.1210%2Fen.2009-0615" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=150&publication_year=2009&pages=3977-3979&author=C.+E.+Gomez-Sanchez&title=Glucocorticoid+production+and+regulation+in+thymus%3A+of+mice+and+birds&doi=10.1210%2Fen.2009-0615"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23a&amp;dbid=16384&amp;doi=10.1210%2Fen.2009-0615&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fen.2009-0615%26sid%3Dliteratum%253Aachs%26aulast%3DGomez-Sanchez%26aufirst%3DC.%2BE.%26atitle%3DGlucocorticoid%2520production%2520and%2520regulation%2520in%2520thymus%253A%2520of%2520mice%2520and%2520birds%26jtitle%3DEndocrinology%26date%3D2009%26volume%3D150%26spage%3D3977%26epage%3D3979%26doi%3D10.1210%2Fen.2009-0615" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit23b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Bar-Dayan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Afek, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bar-Dayan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopolovic, J.</span><span> </span><span class="NLM_article-title">Proliferation, apoptosis and thymic involution</span> <span class="citation_source-journal">Tissue Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">391</span><span class="NLM_x">–</span> <span class="NLM_lpage">396</span><span class="refDoi"> DOI: 10.1054/tice.1999.0001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=10.1054%2Ftice.1999.0001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=10522388" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=1%3ACAS%3A280%3ADyaK1MvltFyrtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1999&pages=391-396&author=Y.+Bar-Dayanauthor=A.+Afekauthor=Y.+Bar-Dayanauthor=I.+Goldbergauthor=J.+Kopolovic&title=Proliferation%2C+apoptosis+and+thymic+involution&doi=10.1054%2Ftice.1999.0001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23bR"><div class="casContent"><span class="casTitleNuber">23b</span><div class="casTitle"><span class="NLM_cas:atitle">Proliferation, apoptosis and thymic involution</span></div><div class="casAuthors">Bar-Dayan Y; Afek A; Bar-Dayan Y; Goldberg I; Kopolovic J</div><div class="citationInfo"><span class="NLM_cas:title">Tissue & cell</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">391-6</span>
        ISSN:<span class="NLM_cas:issn">0040-8166</span>.
    </div><div class="casAbstract">The thymus reaches its maximal size at the age of 1 month in ICR mice and thereafter, the thymic cortex undergoes an exponential decline.  This study was designed to compare the proliferation and apoptosis of thymocytes in different parts of the thymus of ICR female mice at the beginning and after the rapid phase of decline of the thymic cortical cellularity.  The pattern of proliferation and apoptosis of the thymus was studied in situ in 1-month-old ICR female mice (10 mice) compared to mice at 7 months of age (10 mice).  Staining for argyrophylic nucleolar organizer region by histochemistry was used to determine the proportion of type 2 thymocytes, which are considered as cells at S phase of the cell cycle.  The mean number of type 2 cells in four random samples of 50 cells in each part of the thymus was defined as the proliferation index of this part of the thymus.  In situ detection of apoptosis of thymocytes was carried out using the Apoptag kit, which can detect a single cell apoptosis.  The mean number of apoptotic cells in five randomly selected fields of each part of the thymus was defined as the apoptotic index of this part of the thymus.  The proliferation index of the peripheral cortex of the 1-month-old mice was 3.6 times higher than the proliferation index of the deep cortex and 5.8 times higher than the proliferation index of the medulla (P < 0.0001).  The proliferation index of the peripheral cortex of the 7-month-old mice was reduced by 45% compared to the 1-month-old mice (P < 0.005).  The apoptotic index of the corticomedullary junction of the 1-month-old mice was six times higher than the apoptotic index of the cortex and 18 times higher than the apoptotic index of the medulla.  The apoptotic index of the thymic cortex was elevated by 66% in the 7-month-old mice compared to the 1-month-old mice (P < 0.0001).  We conclude that there is a reduction of the proliferation index and an elevation of the apoptotic index of the thymic cortex in adult mice compared to young mice.  These changes might account for the reduction of thymic cortical cellularity during thymic involution.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRBDY3296f5KpggzHGM8X5CfW6udTcc2eaaVP25eV1gmrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1MvltFyrtA%253D%253D&md5=0386c67a288c64cae3c3f27509377852</span></div><a href="/servlet/linkout?suffix=cit23b&amp;dbid=16384&amp;doi=10.1054%2Ftice.1999.0001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1054%252Ftice.1999.0001%26sid%3Dliteratum%253Aachs%26aulast%3DBar-Dayan%26aufirst%3DY.%26aulast%3DAfek%26aufirst%3DA.%26aulast%3DBar-Dayan%26aufirst%3DY.%26aulast%3DGoldberg%26aufirst%3DI.%26aulast%3DKopolovic%26aufirst%3DJ.%26atitle%3DProliferation%252C%2520apoptosis%2520and%2520thymic%2520involution%26jtitle%3DTissue%2520Cell%26date%3D1999%26volume%3D31%26spage%3D391%26epage%3D396%26doi%3D10.1054%2Ftice.1999.0001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit23c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Vacchio, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashwell, J. D.</span><span> </span><span class="NLM_article-title">Glucocorticoids and thymocyte development</span> <span class="citation_source-journal">Semin. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">475</span><span class="NLM_x">–</span> <span class="NLM_lpage">485</span><span class="refDoi"> DOI: 10.1006/smim.2000.0265</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=10.1006%2Fsmim.2000.0265" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=11085180" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=1%3ACAS%3A528%3ADC%252BD3cXot1Cksb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2000&pages=475-485&author=M.+S.+Vacchioauthor=J.+D.+Ashwell&title=Glucocorticoids+and+thymocyte+development&doi=10.1006%2Fsmim.2000.0265"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23cR"><div class="casContent"><span class="casTitleNuber">23c</span><div class="casTitle"><span class="NLM_cas:atitle">Glucocorticoids and thymocyte development</span></div><div class="casAuthors">Vacchio, Melanie S.; Ashwell, Jonathan D.</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Immunology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">475-485</span>CODEN:
                <span class="NLM_cas:coden">SEIME2</span>;
        ISSN:<span class="NLM_cas:issn">1044-5323</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">A review with 84 refs.  The thymus has a central role in the differentiation and selection of functional T cells.  The cells that ultimately differentiate into mature T cells are derived from pluripotent hematopoietic stem cells that migrate into the thymus from either the fetal liver or bone marrow.  This review will focus on the role glucocorticoids play in mediating the cell differentiation that occurs within the thymocyte.  (c) 2000 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquUTCX2bAAdrVg90H21EOLACvtfcHk0liGqqOt_EnQyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXot1Cksb0%253D&md5=ff20d9c489239c2c53c07c5f3c0370c0</span></div><a href="/servlet/linkout?suffix=cit23c&amp;dbid=16384&amp;doi=10.1006%2Fsmim.2000.0265&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fsmim.2000.0265%26sid%3Dliteratum%253Aachs%26aulast%3DVacchio%26aufirst%3DM.%2BS.%26aulast%3DAshwell%26aufirst%3DJ.%2BD.%26atitle%3DGlucocorticoids%2520and%2520thymocyte%2520development%26jtitle%3DSemin.%2520Immunol.%26date%3D2000%26volume%3D12%26spage%3D475%26epage%3D485%26doi%3D10.1006%2Fsmim.2000.0265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Gauvreau, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boulet, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leigh, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cockcroft, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Killian, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deschesnes, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swystun, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mardh, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wessman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jorup, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aurivillius, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Byrne, P. M.</span><span> </span><span class="NLM_article-title">A nonsteroidal glucocorticoid receptor agonist inhibits allergen-induced late asthmatic responses</span> <span class="citation_source-journal">Am. J. Respir. Crit. Care Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">191</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">167</span><span class="refDoi"> DOI: 10.1164/rccm.201404-0623OC</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=10.1164%2Frccm.201404-0623OC" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=25473939" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=1%3ACAS%3A528%3ADC%252BC2MXislWht7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=191&publication_year=2015&pages=161-167&author=G.+M.+Gauvreauauthor=L.+P.+Bouletauthor=R.+Leighauthor=D.+W.+Cockcroftauthor=K.+J.+Killianauthor=B.+E.+Davisauthor=F.+Deschesnesauthor=R.+M.+Watsonauthor=V.+Swystunauthor=C.+K.+Mardhauthor=P.+Wessmanauthor=C.+Jorupauthor=M.+Aurivilliusauthor=P.+M.+O%E2%80%99Byrne&title=A+nonsteroidal+glucocorticoid+receptor+agonist+inhibits+allergen-induced+late+asthmatic+responses&doi=10.1164%2Frccm.201404-0623OC"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24aR"><div class="casContent"><span class="casTitleNuber">24a</span><div class="casTitle"><span class="NLM_cas:atitle">A nonsteroidal glucocorticoid receptor agonist inhibits allergen-induced late asthmatic responses</span></div><div class="casAuthors">Gauvreau, Gail M.; Boulet, Louis-Philippe; Leigh, Richard; Cockcroft, Donald W.; Killian, Kieran J.; Davis, Beth E.; Deschesnes, Francine; Watson, Richard M.; Swystun, Veronica; Mardh, Carina Karrman; Wessman, Peter; Jorup, Carin; Aurivillius, Magnus; O'Byrne, Paul M.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory and Critical Care Medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">191</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">161-167, 7 pp.</span>CODEN:
                <span class="NLM_cas:coden">AJCMED</span>;
        ISSN:<span class="NLM_cas:issn">1073-449X</span>.
    
            (<span class="NLM_cas:orgname">American Thoracic Society</span>)
        </div><div class="casAbstract">Rationale: Effective antiinflammatory therapies are needed for the treatment of asthma, but preferably without the systemic adverse effects of glucocorticosteroids.  Objectives: We evaluated the effect of an inhaled nonsteroidal glucocorticoid receptor agonist, AZD5423, on allergen-induced responses.  Methods: Twenty subjects with mild allergic asthma were randomized to receive 7 days of treatment with nebulized AZD5423 (75 or 300 μg) once daily, budesonide 200 μg twice daily via Turbuhaler, or placebo in a double-blind, four-period, crossover design study.  Allergen challenge was performed on Day 6.  Measurements and Main Results: FEV1 was measured repeatedly for 7 h after allergen challenge for early and late asthmatic responses.  Sputum inflammatory cells was measured before and at 7 and 24 h after allergen challenge, and methacholine airway responsiveness was measured before and 24 h after allergen challenge.  AZD5423 significantly attenuated the fall in FEV1 during the late asthmatic response (both doses led to an 8.7% fall) vs. placebo (14% fall) (P < 0.05) with no effect of budesonide (12.5% fall) vs. placebo (P > 0.05).  There was no effect on the fall in FEV1 during early asthmatic response.  AZD5423 300 and 75 μg significantly attenuated allergen-induced sputum eosinophilia by 63 and 61% at 7 h, resp., and by 46 and 34% at 24 h after allergen challenge, resp., vs. placebo (all P < 0.05).  Budesonide did not reduce allergen-induced sputum eosinophilia vs. placebo.  AZD5423 at 300 μg significantly attenuated allergen-induced airway hyperresponsiveness at 24 h after allergen challenge vs. placebo (P < 0.05).  Both doses of AZD5423 were well tolerated.  Conclusions: Seven-day treatment with inhalation of the nonsteroidal glucocorticoid receptor agonist AZD5423 effectively reduced allergen-induced responses in subjects with mild allergic asthma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeWRfg5pVQxLVg90H21EOLACvtfcHk0lhvCpPFPO-5bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXislWht7Y%253D&md5=78fce39c7b6b2577ad8d3ae29eff52d8</span></div><a href="/servlet/linkout?suffix=cit24a&amp;dbid=16384&amp;doi=10.1164%2Frccm.201404-0623OC&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1164%252Frccm.201404-0623OC%26sid%3Dliteratum%253Aachs%26aulast%3DGauvreau%26aufirst%3DG.%2BM.%26aulast%3DBoulet%26aufirst%3DL.%2BP.%26aulast%3DLeigh%26aufirst%3DR.%26aulast%3DCockcroft%26aufirst%3DD.%2BW.%26aulast%3DKillian%26aufirst%3DK.%2BJ.%26aulast%3DDavis%26aufirst%3DB.%2BE.%26aulast%3DDeschesnes%26aufirst%3DF.%26aulast%3DWatson%26aufirst%3DR.%2BM.%26aulast%3DSwystun%26aufirst%3DV.%26aulast%3DMardh%26aufirst%3DC.%2BK.%26aulast%3DWessman%26aufirst%3DP.%26aulast%3DJorup%26aufirst%3DC.%26aulast%3DAurivillius%26aufirst%3DM.%26aulast%3DO%25E2%2580%2599Byrne%26aufirst%3DP.%2BM.%26atitle%3DA%2520nonsteroidal%2520glucocorticoid%2520receptor%2520agonist%2520inhibits%2520allergen-induced%2520late%2520asthmatic%2520responses%26jtitle%3DAm.%2520J.%2520Respir.%2520Crit.%2520Care%2520Med.%26date%3D2015%26volume%3D191%26spage%3D161%26epage%3D167%26doi%3D10.1164%2Frccm.201404-0623OC" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit24b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Berger, M.; Dahmen, J.; Eriksson, A.; Gabos, B.; Hansson, T.; Hemmerling, M.; Henriksson, K.; Ivanova, S.; Lepistoe, M.; McKerrecher, D.; Munck Af Rosenschoeld, M.; Nilsson, S.; Rehwinkel, H.; Taflin, C.</span><span> </span><span class="NLM_article-title">Indazolyl ester and amide derivatives for the treatment of glucocorticoid receptor mediated disorders and their preparation</span>. Patent WO 2008076048, June 26,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=M.+Berger&author=J.+Dahmen&author=A.+Eriksson&author=B.+Gabos&author=T.+Hansson&author=M.+Hemmerling&author=K.+Henriksson&author=S.+Ivanova&author=M.+Lepistoe&author=D.+McKerrecher&author=M.+Munck+Af+Rosenschoeld&author=S.+Nilsson&author=H.+Rehwinkel&author=C.+Taflin&title=Indazolyl+ester+and+amide+derivatives+for+the+treatment+of+glucocorticoid+receptor+mediated+disorders+and+their+preparation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBerger%26aufirst%3DM.%26atitle%3DIndazolyl%2520ester%2520and%2520amide%2520derivatives%2520for%2520the%2520treatment%2520of%2520glucocorticoid%2520receptor%2520mediated%2520disorders%2520and%2520their%2520preparation%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Edman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahlgren, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bengtsson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bladh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Backstrom, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahmen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henriksson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hillertz, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hulikal, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jerre, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinchin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kase, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lepisto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mile, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smailagic, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tjornebo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wissler, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansson, T.</span><span> </span><span class="NLM_article-title">The discovery of potent and selective non-steroidal glucocorticoid receptor modulators, suitable for inhalation</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">2571</span><span class="NLM_x">–</span> <span class="NLM_lpage">2577</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2014.03.070</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=10.1016%2Fj.bmcl.2014.03.070" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=2571-2577&author=K.+Edmanauthor=R.+Ahlgrenauthor=M.+Bengtssonauthor=H.+Bladhauthor=S.+Backstromauthor=J.+Dahmenauthor=K.+Henrikssonauthor=P.+Hillertzauthor=V.+Hulikalauthor=A.+Jerreauthor=L.+Kinchinauthor=C.+Kaseauthor=M.+Lepistoauthor=I.+Mileauthor=S.+Nilssonauthor=A.+Smailagicauthor=J.+Taylorauthor=A.+Tjorneboauthor=L.+Wisslerauthor=T.+Hansson&title=The+discovery+of+potent+and+selective+non-steroidal+glucocorticoid+receptor+modulators%2C+suitable+for+inhalation&doi=10.1016%2Fj.bmcl.2014.03.070"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.03.070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.03.070%26sid%3Dliteratum%253Aachs%26aulast%3DEdman%26aufirst%3DK.%26aulast%3DAhlgren%26aufirst%3DR.%26aulast%3DBengtsson%26aufirst%3DM.%26aulast%3DBladh%26aufirst%3DH.%26aulast%3DBackstrom%26aufirst%3DS.%26aulast%3DDahmen%26aufirst%3DJ.%26aulast%3DHenriksson%26aufirst%3DK.%26aulast%3DHillertz%26aufirst%3DP.%26aulast%3DHulikal%26aufirst%3DV.%26aulast%3DJerre%26aufirst%3DA.%26aulast%3DKinchin%26aufirst%3DL.%26aulast%3DKase%26aufirst%3DC.%26aulast%3DLepisto%26aufirst%3DM.%26aulast%3DMile%26aufirst%3DI.%26aulast%3DNilsson%26aufirst%3DS.%26aulast%3DSmailagic%26aufirst%3DA.%26aulast%3DTaylor%26aufirst%3DJ.%26aulast%3DTjornebo%26aufirst%3DA.%26aulast%3DWissler%26aufirst%3DL.%26aulast%3DHansson%26aufirst%3DT.%26atitle%3DThe%2520discovery%2520of%2520potent%2520and%2520selective%2520non-steroidal%2520glucocorticoid%2520receptor%2520modulators%252C%2520suitable%2520for%2520inhalation%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D2571%26epage%3D2577%26doi%3D10.1016%2Fj.bmcl.2014.03.070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit25b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Sheppeck, J. E.,  2nd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilmore, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhar, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nirschl, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doweyko, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sack, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corbett, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malley, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gougoutas, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKay, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cunningham, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habte, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodd, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nadler, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Somerville, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrish, J. C.</span><span> </span><span class="NLM_article-title">Discovery of potent and selective nonsteroidal indazolyl amide glucocorticoid receptor agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">5442</span><span class="NLM_x">–</span> <span class="NLM_lpage">5447</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2013.06.089</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=10.1016%2Fj.bmcl.2013.06.089" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=5442-5447&author=J.+E.+Sheppeckauthor=J.+L.+Gilmoreauthor=H.+Y.+Xiaoauthor=T.+G.+Dharauthor=D.+Nirschlauthor=A.+M.+Doweykoauthor=J.+S.+Sackauthor=M.+J.+Corbettauthor=M.+F.+Malleyauthor=J.+Z.+Gougoutasauthor=L.+McKayauthor=M.+D.+Cunninghamauthor=S.+F.+Habteauthor=J.+H.+Doddauthor=S.+G.+Nadlerauthor=J.+E.+Somervilleauthor=J.+C.+Barrish&title=Discovery+of+potent+and+selective+nonsteroidal+indazolyl+amide+glucocorticoid+receptor+agonists&doi=10.1016%2Fj.bmcl.2013.06.089"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.06.089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.06.089%26sid%3Dliteratum%253Aachs%26aulast%3DSheppeck%26aufirst%3DJ.%2BE.%26aulast%3DGilmore%26aufirst%3DJ.%2BL.%26aulast%3DXiao%26aufirst%3DH.%2BY.%26aulast%3DDhar%26aufirst%3DT.%2BG.%26aulast%3DNirschl%26aufirst%3DD.%26aulast%3DDoweyko%26aufirst%3DA.%2BM.%26aulast%3DSack%26aufirst%3DJ.%2BS.%26aulast%3DCorbett%26aufirst%3DM.%2BJ.%26aulast%3DMalley%26aufirst%3DM.%2BF.%26aulast%3DGougoutas%26aufirst%3DJ.%2BZ.%26aulast%3DMcKay%26aufirst%3DL.%26aulast%3DCunningham%26aufirst%3DM.%2BD.%26aulast%3DHabte%26aufirst%3DS.%2BF.%26aulast%3DDodd%26aufirst%3DJ.%2BH.%26aulast%3DNadler%26aufirst%3DS.%2BG.%26aulast%3DSomerville%26aufirst%3DJ.%2BE.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26atitle%3DDiscovery%2520of%2520potent%2520and%2520selective%2520nonsteroidal%2520indazolyl%2520amide%2520glucocorticoid%2520receptor%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D5442%26epage%3D5447%26doi%3D10.1016%2Fj.bmcl.2013.06.089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit25c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Yates, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patten, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holt, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maglich, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angell, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasse, R. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uings, I. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trump, R. P.</span><span> </span><span class="NLM_article-title">Structure guided design of 5-arylindazole glucocorticoid receptor agonists and antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">4531</span><span class="NLM_x">–</span> <span class="NLM_lpage">4544</span><span class="refDoi"> DOI: 10.1021/jm100447c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100447c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=4531-4544&author=C.+M.+Yatesauthor=P.+J.+Brownauthor=E.+L.+Stewartauthor=C.+Pattenauthor=R.+J.+Austinauthor=J.+A.+Holtauthor=J.+M.+Maglichauthor=D.+C.+Angellauthor=R.+Z.+Sasseauthor=S.+J.+Taylorauthor=I.+J.+Uingsauthor=R.+P.+Trump&title=Structure+guided+design+of+5-arylindazole+glucocorticoid+receptor+agonists+and+antagonists&doi=10.1021%2Fjm100447c"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25c&amp;dbid=16384&amp;doi=10.1021%2Fjm100447c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100447c%26sid%3Dliteratum%253Aachs%26aulast%3DYates%26aufirst%3DC.%2BM.%26aulast%3DBrown%26aufirst%3DP.%2BJ.%26aulast%3DStewart%26aufirst%3DE.%2BL.%26aulast%3DPatten%26aufirst%3DC.%26aulast%3DAustin%26aufirst%3DR.%2BJ.%26aulast%3DHolt%26aufirst%3DJ.%2BA.%26aulast%3DMaglich%26aufirst%3DJ.%2BM.%26aulast%3DAngell%26aufirst%3DD.%2BC.%26aulast%3DSasse%26aufirst%3DR.%2BZ.%26aulast%3DTaylor%26aufirst%3DS.%2BJ.%26aulast%3DUings%26aufirst%3DI.%2BJ.%26aulast%3DTrump%26aufirst%3DR.%2BP.%26atitle%3DStructure%2520guided%2520design%2520of%25205-arylindazole%2520glucocorticoid%2520receptor%2520agonists%2520and%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D4531%26epage%3D4544%26doi%3D10.1021%2Fjm100447c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit25d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Biggadike, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bledsoe, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coe, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">House, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iannone, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madauss, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLay, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shipley, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uings, I. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weller, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, S. P.</span><span> </span><span class="NLM_article-title">Design and x-ray crystal structures of high-potency nonsteroidal glucocorticoid agonists exploiting a novel binding site on the receptor</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">18114</span><span class="NLM_x">–</span> <span class="NLM_lpage">18119</span><span class="refDoi"> DOI: 10.1073/pnas.0909125106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=10.1073%2Fpnas.0909125106" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=18114-18119&author=K.+Biggadikeauthor=R.+K.+Bledsoeauthor=D.+M.+Coeauthor=T.+W.+Cooperauthor=D.+Houseauthor=M.+A.+Iannoneauthor=S.+J.+Macdonaldauthor=K.+P.+Madaussauthor=I.+M.+McLayauthor=T.+J.+Shipleyauthor=S.+J.+Taylorauthor=T.+B.+Tranauthor=I.+J.+Uingsauthor=V.+Wellerauthor=S.+P.+Williams&title=Design+and+x-ray+crystal+structures+of+high-potency+nonsteroidal+glucocorticoid+agonists+exploiting+a+novel+binding+site+on+the+receptor&doi=10.1073%2Fpnas.0909125106"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25d&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0909125106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0909125106%26sid%3Dliteratum%253Aachs%26aulast%3DBiggadike%26aufirst%3DK.%26aulast%3DBledsoe%26aufirst%3DR.%2BK.%26aulast%3DCoe%26aufirst%3DD.%2BM.%26aulast%3DCooper%26aufirst%3DT.%2BW.%26aulast%3DHouse%26aufirst%3DD.%26aulast%3DIannone%26aufirst%3DM.%2BA.%26aulast%3DMacdonald%26aufirst%3DS.%2BJ.%26aulast%3DMadauss%26aufirst%3DK.%2BP.%26aulast%3DMcLay%26aufirst%3DI.%2BM.%26aulast%3DShipley%26aufirst%3DT.%2BJ.%26aulast%3DTaylor%26aufirst%3DS.%2BJ.%26aulast%3DTran%26aufirst%3DT.%2BB.%26aulast%3DUings%26aufirst%3DI.%2BJ.%26aulast%3DWeller%26aufirst%3DV.%26aulast%3DWilliams%26aufirst%3DS.%2BP.%26atitle%3DDesign%2520and%2520x-ray%2520crystal%2520structures%2520of%2520high-potency%2520nonsteroidal%2520glucocorticoid%2520agonists%2520exploiting%2520a%2520novel%2520binding%2520site%2520on%2520the%2520receptor%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2009%26volume%3D106%26spage%3D18114%26epage%3D18119%26doi%3D10.1073%2Fpnas.0909125106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Salter, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biggadike, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haase, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrow, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uings, I. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, D. W.</span><span> </span><span class="NLM_article-title">Pharmacological properties of the enhanced-affinity glucocorticoid fluticasone furoate in vitro and in an in vivo model of respiratory inflammatory disease</span> <span class="citation_source-journal">Am. J. Physiol.. Lung Cell. Mol. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">293</span><span class="NLM_x">, </span> <span class="NLM_fpage">L660</span><span class="NLM_x">–</span> <span class="NLM_lpage">667</span><span class="refDoi"> DOI: 10.1152/ajplung.00108.2007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=10.1152%2Fajplung.00108.2007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=17575011" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVOqsbbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=293&publication_year=2007&pages=L660-667&author=M.+Salterauthor=K.+Biggadikeauthor=J.+L.+Matthewsauthor=M.+R.+Westauthor=M.+V.+Haaseauthor=S.+N.+Farrowauthor=I.+J.+Uingsauthor=D.+W.+Gray&title=Pharmacological+properties+of+the+enhanced-affinity+glucocorticoid+fluticasone+furoate+in+vitro+and+in+an+in+vivo+model+of+respiratory+inflammatory+disease&doi=10.1152%2Fajplung.00108.2007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26aR"><div class="casContent"><span class="casTitleNuber">26a</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological properties of the enhanced-affinity glucocorticoid fluticasone furoate in vitro and in an in vivo model of respiratory inflammatory disease</span></div><div class="casAuthors">Salter, Mark; Biggadike, Keith; Matthews, Joyce L.; West, Michael R.; Haase, Michael V.; Farrow, Stuart N.; Uings, Iain J.; Gray, David W.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Physiology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">293</span>
        (<span class="NLM_cas:issue">3, Pt. 1</span>),
    <span class="NLM_cas:pages">L660-L667</span>CODEN:
                <span class="NLM_cas:coden">AJPHAP</span>;
        ISSN:<span class="NLM_cas:issn">0002-9513</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">Fluticasone furoate (FF) is a novel enhanced-affinity glucocorticoid that has been developed as topical therapy for allergic rhinitis.  The pharmacol. properties of FF have been investigated using a no. of in vitro exptl. systems.  FF demonstrated very potent glucocorticoid activity in several key pathways downstream of the glucocorticoid receptor (GR) as follows: the transrepression nuclear factor-κB (NF-κB) pathway, the transactivation glucocorticoid response element pathway, and inhibition of the proinflammatory cytokine tumor necrosis factor-α.  Furthermore, FF showed the greatest potency compared with other glucocorticoids for preserving epithelial integrity and reducing epithelial permeability in response to protease- and mech.-induced cell damage.  FF showed a 30- to >330,000-fold selectivity for GR-mediated inhibition of NF-κB vs. the other steroid hormone receptors, substantially better than a no. of other clin. used glucocorticoids.  In studies examg. the respiratory tissue binding properties of glucocorticoids, FF had the largest cellular accumulation and slowest rate of efflux compared with other clin. used glucocorticoids, consistent with greater tissue retention.  The in vivo anti-inflammatory activity of FF was assessed in the Brown Norway rat ovalbumin-induced lung eosinophilial model of allergic lung inflammation.  At a dose of only 30 μg, FF achieved almost total inhibition of eosinophil influx in the lung, an inhibition that was greater than that seen with the same dose of fluticasone propionate.  In conclusion, the potent and selective pharmacol. profile of FF described here could deliver an effective, safe, and sustained topical treatment of respiratory inflammatory diseases such as allergic rhinitis and asthma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIRSsUJqaLP7Vg90H21EOLACvtfcHk0ljMTDdR9DkwnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVOqsbbN&md5=897a0c672a28ff0b3102825b2dcc5300</span></div><a href="/servlet/linkout?suffix=cit26a&amp;dbid=16384&amp;doi=10.1152%2Fajplung.00108.2007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajplung.00108.2007%26sid%3Dliteratum%253Aachs%26aulast%3DSalter%26aufirst%3DM.%26aulast%3DBiggadike%26aufirst%3DK.%26aulast%3DMatthews%26aufirst%3DJ.%2BL.%26aulast%3DWest%26aufirst%3DM.%2BR.%26aulast%3DHaase%26aufirst%3DM.%2BV.%26aulast%3DFarrow%26aufirst%3DS.%2BN.%26aulast%3DUings%26aufirst%3DI.%2BJ.%26aulast%3DGray%26aufirst%3DD.%2BW.%26atitle%3DPharmacological%2520properties%2520of%2520the%2520enhanced-affinity%2520glucocorticoid%2520fluticasone%2520furoate%2520in%2520vitro%2520and%2520in%2520an%2520in%2520vivo%2520model%2520of%2520respiratory%2520inflammatory%2520disease%26jtitle%3DAm.%2520J.%2520Physiol..%2520Lung%2520Cell.%2520Mol.%2520Physiol.%26date%3D2007%26volume%3D293%26spage%3DL660%26epage%3D667%26doi%3D10.1152%2Fajplung.00108.2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit26b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Grossmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scholz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rochel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bumke-Vogt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oelkers, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfeiffer, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diederich, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bahr, V.</span><span> </span><span class="NLM_article-title">Transactivation via the human glucocorticoid and mineralocorticoid receptor by therapeutically used steroids in CV-1 cells: a comparison of their glucocorticoid and mineralocorticoid properties</span> <span class="citation_source-journal">Eur. J. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">151</span><span class="NLM_x">, </span> <span class="NLM_fpage">397</span><span class="NLM_x">–</span> <span class="NLM_lpage">406</span><span class="refDoi"> DOI: 10.1530/eje.0.1510397</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=10.1530%2Feje.0.1510397" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=15362971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=1%3ACAS%3A528%3ADC%252BD2cXot1Khtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=151&publication_year=2004&pages=397-406&author=C.+Grossmannauthor=T.+Scholzauthor=M.+Rochelauthor=C.+Bumke-Vogtauthor=W.+Oelkersauthor=A.+F.+Pfeifferauthor=S.+Diederichauthor=V.+Bahr&title=Transactivation+via+the+human+glucocorticoid+and+mineralocorticoid+receptor+by+therapeutically+used+steroids+in+CV-1+cells%3A+a+comparison+of+their+glucocorticoid+and+mineralocorticoid+properties&doi=10.1530%2Feje.0.1510397"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26bR"><div class="casContent"><span class="casTitleNuber">26b</span><div class="casTitle"><span class="NLM_cas:atitle">Transactivation via the human glucocorticoid and mineralocorticoid receptor by therapeutically used steroids in CV-1 cells: A comparison of their glucocorticoid and mineralocorticoid properties</span></div><div class="casAuthors">Grossmann, Claudia; Scholz, Tim; Rochel, Marina; Bumke-Vogt, Christiane; Oelkers, Wolfgang; Pfeiffer, Andreas F. H.; Diederich, Sven; Baehr, Volker</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Endocrinology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">151</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">397-406</span>CODEN:
                <span class="NLM_cas:coden">EJOEEP</span>;
        ISSN:<span class="NLM_cas:issn">0804-4643</span>.
    
            (<span class="NLM_cas:orgname">BioScientifica Ltd.</span>)
        </div><div class="casAbstract">Background: Glucocorticoids (GCs) are commonly used for long-term medication in immunosuppressive and anti-inflammatory therapy.  However, the data describing gluco- and mineralo-corticoid (MC) properties of widely applied synthetic GCs are often based on diverse clin. observations and on a variety of in vitro tests under various conditions, which makes a quant. comparison questionable.  Method: We compared MC and GC properties of different steroids, often used in clin. practice, in the same in vitro test system (luciferase transactivation assay in CV-1 cells transfected with either hMR or hGRα expression vectors) complemented by a system to test the steroid binding affinities at the hMR (protein expression in T7-coupled rabbit reticulocyte lysate).  Results and Conclusions: While the potency of a GC is increased by an 11-hydroxy group, both its potency and its selectivity are increased by the Δ1-dehydro-configuration and a hydrophobic residue in position 16 (16-methylene, 16α-Me or 16β-Me group).  Almost ideal GCs in terms of missing MC effects, as defined by our in vitro assay, are therefore prednylidene, budesonide, beclomethasone and betamethasone.  The MC potency of a steroid is increased by a 9α- or a 6α-fluoro substituent.  A hydrophilic substituent in position 16 (like 16-hydroxylation in triamcinolone) decreases both MC and GC properties.  As no substituent that leads to an isolated redn. of GC activity could be characterized in our expts., 9α-fluorocortisol, the most frequently used steroid for MC substitution, seems to be the best choice of available steroids for this purpose.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUHzxUe-TpIbVg90H21EOLACvtfcHk0limx4FBow2caw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXot1Khtr0%253D&md5=7fec132cbded41ca9ebf940c1f292e63</span></div><a href="/servlet/linkout?suffix=cit26b&amp;dbid=16384&amp;doi=10.1530%2Feje.0.1510397&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1530%252Feje.0.1510397%26sid%3Dliteratum%253Aachs%26aulast%3DGrossmann%26aufirst%3DC.%26aulast%3DScholz%26aufirst%3DT.%26aulast%3DRochel%26aufirst%3DM.%26aulast%3DBumke-Vogt%26aufirst%3DC.%26aulast%3DOelkers%26aufirst%3DW.%26aulast%3DPfeiffer%26aufirst%3DA.%2BF.%26aulast%3DDiederich%26aufirst%3DS.%26aulast%3DBahr%26aufirst%3DV.%26atitle%3DTransactivation%2520via%2520the%2520human%2520glucocorticoid%2520and%2520mineralocorticoid%2520receptor%2520by%2520therapeutically%2520used%2520steroids%2520in%2520CV-1%2520cells%253A%2520a%2520comparison%2520of%2520their%2520glucocorticoid%2520and%2520mineralocorticoid%2520properties%26jtitle%3DEur.%2520J.%2520Endocrinol.%26date%3D2004%26volume%3D151%26spage%3D397%26epage%3D406%26doi%3D10.1530%2Feje.0.1510397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Boger, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chappell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundqvist, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ewing, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigenborg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friden, M.</span><span> </span><span class="NLM_article-title">Systems pharmacology approach for prediction of pulmonary and systemic pharmacokinetics and receptor occupancy of inhaled drugs</span> <span class="citation_source-journal">CPT: Pharmacometrics Syst. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">201</span><span class="NLM_x">–</span> <span class="NLM_lpage">210</span><span class="refDoi"> DOI: 10.1002/psp4.12074</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=10.1002%2Fpsp4.12074" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=27104089" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=1%3ACAS%3A528%3ADC%252BC28XmtVSns7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2016&pages=201-210&author=E.+Bogerauthor=N.+Evansauthor=M.+Chappellauthor=A.+Lundqvistauthor=P.+Ewingauthor=A.+Wigenborgauthor=M.+Friden&title=Systems+pharmacology+approach+for+prediction+of+pulmonary+and+systemic+pharmacokinetics+and+receptor+occupancy+of+inhaled+drugs&doi=10.1002%2Fpsp4.12074"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Systems Pharmacology Approach for Prediction of Pulmonary and Systemic Pharmacokinetics and Receptor Occupancy of Inhaled Drugs</span></div><div class="casAuthors">Boger, E.; Evans, N.; Chappell, M.; Lundqvist, A.; Ewing, P.; Wigenborg, A.; Friden, M.</div><div class="citationInfo"><span class="NLM_cas:title">CPT: Pharmacometrics & Systems Pharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">201-210</span>CODEN:
                <span class="NLM_cas:coden">CPSPBR</span>;
        ISSN:<span class="NLM_cas:issn">2163-8306</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Pulmonary drug disposition after inhalation is complex involving mechanisms, such as regional drug deposition, dissoln., and mucociliary clearance.  This study aimed to develop a systems pharmacol. approach to mechanistically describe lung disposition in rats and thereby provide an integrated understanding of the system.  When drug- and formulation-specific properties for the poorly sol. drug fluticasone propionate were fed into the model, it proved predictive of the pharmacokinetics and receptor occupancy after i.v. administration and nose-only inhalation.  As the model clearly distinguishes among drug-specific, formulation-specific, and system-specific properties, it was possible to identify key determinants of pulmonary selectivity of receptor occupancy of inhaled drugs: slow particle dissoln. and slow drug-receptor dissocn.  Hence, it enables assessment of factors for lung targeting, including mol. properties, formulation, as well as the physiol. of the animal species, thereby providing a general framework for rational drug design and facilitated translation of lung targeting from animal to man.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOGLFgvgeHpbVg90H21EOLACvtfcHk0limx4FBow2caw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmtVSns7c%253D&md5=2f63b8d5445f8294dd4c6d6fdb269003</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1002%2Fpsp4.12074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpsp4.12074%26sid%3Dliteratum%253Aachs%26aulast%3DBoger%26aufirst%3DE.%26aulast%3DEvans%26aufirst%3DN.%26aulast%3DChappell%26aufirst%3DM.%26aulast%3DLundqvist%26aufirst%3DA.%26aulast%3DEwing%26aufirst%3DP.%26aulast%3DWigenborg%26aufirst%3DA.%26aulast%3DFriden%26aufirst%3DM.%26atitle%3DSystems%2520pharmacology%2520approach%2520for%2520prediction%2520of%2520pulmonary%2520and%2520systemic%2520pharmacokinetics%2520and%2520receptor%2520occupancy%2520of%2520inhaled%2520drugs%26jtitle%3DCPT%253A%2520Pharmacometrics%2520Syst.%2520Pharmacol.%26date%3D2016%26volume%3D5%26spage%3D201%26epage%3D210%26doi%3D10.1002%2Fpsp4.12074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Berger, M.; Dahmen, J.; Edman, K.; Eriksson, A.; Hansson, T.; Hemmerling, M.; Hossain, N.; Klingstedt, T.; Lepistö, M.; Nilsson, S.; Rehwinkel, H.</span><span> </span><span class="NLM_article-title">Phenyl and benzodioxinyl substituted indazole derivatives</span>. Patent WO 2009142571, November 26,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=M.+Berger&author=J.+Dahmen&author=K.+Edman&author=A.+Eriksson&author=T.+Hansson&author=M.+Hemmerling&author=N.+Hossain&author=T.+Klingstedt&author=M.+Lepist%C3%B6&author=S.+Nilsson&author=H.+Rehwinkel&title=Phenyl+and+benzodioxinyl+substituted+indazole+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBerger%26aufirst%3DM.%26atitle%3DPhenyl%2520and%2520benzodioxinyl%2520substituted%2520indazole%2520derivatives%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Kuna, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aurivillius, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jorup, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prothon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taib, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edsbacker, S.</span><span> </span><span class="NLM_article-title">Efficacy and tolerability of an inhaled selective glucocorticoid receptor modulator - AZD5423 - in COPD patients: Phase II Study Results</span> <span class="citation_source-journal">Basic Clin. Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">121</span><span class="NLM_x">, </span> <span class="NLM_fpage">279</span><span class="refDoi"> DOI: 10.1111/bcpt.12768</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=10.1111%2Fbcpt.12768" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=28212463" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFOis7vP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2017&pages=279&author=P.+Kunaauthor=M.+Aurivilliusauthor=C.+Jorupauthor=S.+Prothonauthor=Z.+Taibauthor=S.+Edsbacker&title=Efficacy+and+tolerability+of+an+inhaled+selective+glucocorticoid+receptor+modulator+-+AZD5423+-+in+COPD+patients%3A+Phase+II+Study+Results&doi=10.1111%2Fbcpt.12768"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy and Tolerability of an Inhaled Selective Glucocorticoid Receptor Modulator - AZD5423 - in Chronic Obstructive Pulmonary Disease Patients: Phase II Study Results</span></div><div class="casAuthors">Kuna, Piotr; Aurivillius, Magnus; Jorup, Carin; Prothon, Susanne; Taib, Ziad; Edsbaecker, Staffan</div><div class="citationInfo"><span class="NLM_cas:title">Basic & Clinical Pharmacology & Toxicology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">279-289</span>CODEN:
                <span class="NLM_cas:coden">BCPTBO</span>;
        ISSN:<span class="NLM_cas:issn">1742-7835</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">AZD5423 is a novel, inhaled, selective glucocorticoid receptor modulator (SGRM), which in an allergen challenge model in asthma patients improved lung function and airway hyper-reactivity.  In the current trial, AZD5423 was for the first time tested in patients with chronic obstructive pulmonary disease (COPD).  In this double-blind, randomized and parallel group study, we examd. airway and systemic effects of two doses of AZD5423, inhaled via Turbuhaler for 12 wk, in 353 symptomatic patients with COPD (av. pre-bronchodilator forced expiratory vol. in one-second (FEV1) at screening was 50-52% of predicted normal).  Pre-bronchodilator FEV1 was primary variable, with other lung function parameters plus symptoms and 24-h plasma cortisol being secondary variables.  Plasma concns. of AZD5423 were also measured.  Effects were compared against placebo and a ref. glucocorticoid receptor agonist control.  Neither AZD5423, at doses which have shown to be efficacious in allergen-induced asthma, nor the ref. control, at double the approved dose, had any clin. meaningful effect in the patient population studied in regard to lung function or markers of inflammation.  Both GR modulators were well tolerated and did suppress 24-h cortisol.  This study suggests that the selected population of patients with COPD does not respond to treatment with AZD5423 as regards lung function, while showing the expected systemic effects.  It cannot be ruled out that a favorable lung function response of AZD5423 can be evoked using another exptl. setting and/or within a different population of patients with COPD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoS0vLqoJJ0_bVg90H21EOLACvtfcHk0limx4FBow2caw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFOis7vP&md5=4ec796ea03402874bc9b02ae59d5bfaa</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1111%2Fbcpt.12768&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbcpt.12768%26sid%3Dliteratum%253Aachs%26aulast%3DKuna%26aufirst%3DP.%26aulast%3DAurivillius%26aufirst%3DM.%26aulast%3DJorup%26aufirst%3DC.%26aulast%3DProthon%26aufirst%3DS.%26aulast%3DTaib%26aufirst%3DZ.%26aulast%3DEdsbacker%26aufirst%3DS.%26atitle%3DEfficacy%2520and%2520tolerability%2520of%2520an%2520inhaled%2520selective%2520glucocorticoid%2520receptor%2520modulator%2520-%2520AZD5423%2520-%2520in%2520COPD%2520patients%253A%2520Phase%2520II%2520Study%2520Results%26jtitle%3DBasic%2520Clin.%2520Pharmacol.%2520Toxicol.%26date%3D2017%26volume%3D121%26spage%3D279%26doi%3D10.1111%2Fbcpt.12768" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span>ClinicalTrials.gov identifier NCT02479412. A multiple dosing (14 days) study to assess efficacy and safety of three dosing levels of AZD7594, given once daily by inhalation, in patients with mild to moderate asthma. <a href="https://clinicaltrials.gov/show/NCT02479412" class="extLink">https://clinicaltrials.gov/show/NCT02479412</a> (accessed September 13,<span class="NLM_x"> </span><span class="NLM_year">2017</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ClinicalTrials.gov+identifier+NCT02479412.+A+multiple+dosing+%2814+days%29+study+to+assess+efficacy+and+safety+of+three+dosing+levels+of+AZD7594%2C+given+once+daily+by+inhalation%2C+in+patients+with+mild+to+moderate+asthma.+https%3A%2F%2Fclinicaltrials.gov%2Fshow%2FNCT02479412+%28accessed+September+13%2C+2017%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3a','cit3b','cit3c'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7a','cit7b','cit7c'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10a','cit10b','cit10c','cit10d'],'ref11':['cit11'],'ref12':['cit12a','cit12b'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18a','cit18b'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22a','cit22b'],'ref23':['cit23a','cit23b','cit23c'],'ref24':['cit24a','cit24b'],'ref25':['cit25a','cit25b','cit25c','cit25d'],'ref26':['cit26a','cit26b'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 21 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Wengang Guo, Yuzheng Luo, Herman H.-Y. Sung, Ian D. Williams, Pingfan Li, <span class="NLM_string-name hlFld-ContribAuthor">Jianwei Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Chiral Phosphoric Acid Catalyzed Enantioselective Synthesis of α-Tertiary Amino Ketones from Sulfonium Ylides. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2020,</strong> <em>142 </em>
                                    (33)
                                     , 14384-14390. <a href="https://doi.org/10.1021/jacs.0c07210" title="DOI URL">https://doi.org/10.1021/jacs.0c07210</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.0c07210&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.0c07210%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DChiral%252BPhosphoric%252BAcid%252BCatalyzed%252BEnantioselective%252BSynthesis%252Bof%252B%2525CE%2525B1-Tertiary%252BAmino%252BKetones%252Bfrom%252BSulfonium%252BYlides%26aulast%3DGuo%26aufirst%3DWengang%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D05072020%26date%3D07082020%26date%3D22072020%26volume%3D142%26issue%3D33%26spage%3D14384%26epage%3D14390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Zhenhua Li, Xuchao Zhang, Jinjing Qin, Zhiyong Tan, Meizhen Han, <span class="NLM_string-name hlFld-ContribAuthor">Guoqiang Jin</span>. </span><span class="cited-content_cbyCitation_article-title">Efficient and Practical Synthesis of 3′,4′,5′-Trifluoro-[1,1′-biphenyl]-2-amine: A Key Intermediate of Fluxapyroxad. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2019,</strong> <em>23 </em>
                                    (9)
                                     , 1881-1886. <a href="https://doi.org/10.1021/acs.oprd.9b00208" title="DOI URL">https://doi.org/10.1021/acs.oprd.9b00208</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.oprd.9b00208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.oprd.9b00208%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DEfficient%252Band%252BPractical%252BSynthesis%252Bof%252B3%2525E2%252580%2525B2%25252C4%2525E2%252580%2525B2%25252C5%2525E2%252580%2525B2-Trifluoro-%25255B1%25252C1%2525E2%252580%2525B2-biphenyl%25255D-2-amine%25253A%252BA%252BKey%252BIntermediate%252Bof%252BFluxapyroxad%26aulast%3DLi%26aufirst%3DZhenhua%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D05052019%26date%3D27082019%26date%3D14082019%26volume%3D23%26issue%3D9%26spage%3D1881%26epage%3D1886" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Angus E. McMillan, Alan Steven, Ian W. Ashworth, Alexander K. Mullen, Lai C. Chan, Maria Rita Galan Espinosa, Michael J. Pilling, Steven A. Raw, <span class="NLM_string-name hlFld-ContribAuthor">Martin F. Jones</span>. </span><span class="cited-content_cbyCitation_article-title">Stereoretentive Etherification of an α-Aryl-β-amino Alcohol Using a Selective Aziridinium Ring Opening for the Synthesis of AZD7594. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>84 </em>
                                    (8)
                                     , 4629-4638. <a href="https://doi.org/10.1021/acs.joc.8b01062" title="DOI URL">https://doi.org/10.1021/acs.joc.8b01062</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.8b01062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.8b01062%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DStereoretentive%252BEtherification%252Bof%252Ban%252B%2525CE%2525B1-Aryl-%2525CE%2525B2-amino%252BAlcohol%252BUsing%252Ba%252BSelective%252BAziridinium%252BRing%252BOpening%252Bfor%252Bthe%252BSynthesis%252Bof%252BAZD7594%26aulast%3DMcMillan%26aufirst%3DAngus%2BE.%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D05052018%26date%3D03072018%26date%3D19062018%26volume%3D84%26issue%3D8%26spage%3D4629%26epage%3D4638" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Eleonora Ghidini, Gessica Marchini, Anna Maria Capelli, Chiara Carnini, Valentina Cenacchi, Alessandro Fioni, Fabrizio Facchinetti, <span class="NLM_string-name hlFld-ContribAuthor">Fabio Rancati</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Pyrrolidine Derivatives of Budesonide as Long Acting Inhaled Corticosteroids for the Treatment of Pulmonary Inflammatory Diseases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (11)
                                     , 4757-4773. <a href="https://doi.org/10.1021/acs.jmedchem.7b01873" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01873</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01873&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01873%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BPyrrolidine%252BDerivatives%252Bof%252BBudesonide%252Bas%252BLong%252BActing%252BInhaled%252BCorticosteroids%252Bfor%252Bthe%252BTreatment%252Bof%252BPulmonary%252BInflammatory%252BDiseases%26aulast%3DGhidini%26aufirst%3DEleonora%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D19122017%26date%3D24052018%26date%3D09052018%26volume%3D61%26issue%3D11%26spage%3D4757%26epage%3D4773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Lena Ripa, Karl Edman, Matthew Dearman, Goran Edenro, Ramon Hendrickx, Victoria Ullah, Hui-Fang Chang, Matti Lepistö, Dave Chapman, Stefan Geschwindner, Lisa Wissler, Petter Svanberg, Karolina Lawitz, Jesper Malmberg, Antonios Nikitidis, Roine I. Olsson, James Bird, Antoni Llinas, Tove Hegelund-Myrbäck, Markus Berger, Philip Thorne, Richard Harrison, Christian Köhler, <span class="NLM_string-name hlFld-ContribAuthor">Tomas Drmota</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a Novel Oral Glucocorticoid Receptor Modulator (AZD9567) with Improved Side Effect Profile. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (5)
                                     , 1785-1799. <a href="https://doi.org/10.1021/acs.jmedchem.7b01690" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01690</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01690&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01690%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252BNovel%252BOral%252BGlucocorticoid%252BReceptor%252BModulator%252B%252528AZD9567%252529%252Bwith%252BImproved%252BSide%252BEffect%252BProfile%26aulast%3DRipa%26aufirst%3DLena%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D17112017%26date%3D16022018%26date%3D09022018%26volume%3D61%26issue%3D5%26spage%3D1785%26epage%3D1799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anna  Kaziales</span>, <span class="hlFld-ContribAuthor ">Florian  Rührnößl</span>, <span class="hlFld-ContribAuthor ">Klaus  Richter</span>. </span><span class="cited-content_cbyCitation_article-title">Glucocorticoid resistance conferring mutation in the C-terminus of GR alters the receptor conformational dynamics. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2021,</strong> <em>11 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-021-92039-9" title="DOI URL">https://doi.org/10.1038/s41598-021-92039-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-021-92039-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-021-92039-9%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DGlucocorticoid%252Bresistance%252Bconferring%252Bmutation%252Bin%252Bthe%252BC-terminus%252Bof%252BGR%252Balters%252Bthe%252Breceptor%252Bconformational%252Bdynamics%26aulast%3DKaziales%26aufirst%3DAnna%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Samar A.  Alsudir</span>, <span class="hlFld-ContribAuthor ">Abdulaziz  Almalik</span>, <span class="hlFld-ContribAuthor ">Ali H.  Alhasan</span>. </span><span class="cited-content_cbyCitation_article-title">Catalogue of self-targeting nano-medical inventions to accelerate clinical trials. </span><span class="cited-content_cbyCitation_journal-name">Biomaterials Science</span><span> <strong>2021,</strong> <em>9 </em>
                                    (11)
                                     , 3898-3910. <a href="https://doi.org/10.1039/D1BM00235J" title="DOI URL">https://doi.org/10.1039/D1BM00235J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1BM00235J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1BM00235J%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomaterials%2520Science%26atitle%3DCatalogue%252Bof%252Bself-targeting%252Bnano-medical%252Binventions%252Bto%252Baccelerate%252Bclinical%252Btrials%26aulast%3DAlsudir%26aufirst%3DSamar%2BA.%26date%3D2021%26date%3D2021%26volume%3D9%26issue%3D11%26spage%3D3898%26epage%3D3910" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zachary  Enlo-Scott</span>, <span class="hlFld-ContribAuthor ">Erica  Bäckström</span>, <span class="hlFld-ContribAuthor ">Ian  Mudway</span>, <span class="hlFld-ContribAuthor ">Ben  Forbes</span>. </span><span class="cited-content_cbyCitation_article-title">Drug metabolism in the lungs: opportunities for optimising inhaled medicines. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Metabolism & Toxicology</span><span> <strong>2021,</strong> <em>17 </em>
                                    (5)
                                     , 611-625. <a href="https://doi.org/10.1080/17425255.2021.1908262" title="DOI URL">https://doi.org/10.1080/17425255.2021.1908262</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17425255.2021.1908262&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17425255.2021.1908262%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Metabolism%2520%2526%2520Toxicology%26atitle%3DDrug%252Bmetabolism%252Bin%252Bthe%252Blungs%25253A%252Bopportunities%252Bfor%252Boptimising%252Binhaled%252Bmedicines%26aulast%3DEnlo-Scott%26aufirst%3DZachary%26date%3D2021%26date%3D2021%26volume%3D17%26issue%3D5%26spage%3D611%26epage%3D625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yaquan  Cao</span>, <span class="hlFld-ContribAuthor ">Chunying  Luo</span>, <span class="hlFld-ContribAuthor ">Pu  Yang</span>, <span class="hlFld-ContribAuthor ">Pan  Li</span>, <span class="hlFld-ContribAuthor ">Chunli  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Indazole scaffold: a generalist for marketed and clinical drugs. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2021,</strong> <em>30 </em>
                                    (3)
                                     , 501-518. <a href="https://doi.org/10.1007/s00044-020-02665-7" title="DOI URL">https://doi.org/10.1007/s00044-020-02665-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-020-02665-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-020-02665-7%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DIndazole%252Bscaffold%25253A%252Ba%252Bgeneralist%252Bfor%252Bmarketed%252Band%252Bclinical%252Bdrugs%26aulast%3DCao%26aufirst%3DYaquan%26date%3D2021%26date%3D2020%26volume%3D30%26issue%3D3%26spage%3D501%26epage%3D518" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anna  Kaziales</span>, <span class="hlFld-ContribAuthor ">Katalin  Barkovits</span>, <span class="hlFld-ContribAuthor ">Katrin  Marcus</span>, <span class="hlFld-ContribAuthor ">Klaus  Richter</span>. </span><span class="cited-content_cbyCitation_article-title">Glucocorticoid receptor complexes form cooperatively with the Hsp90 co-chaperones Pp5 and FKBPs. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2020,</strong> <em>10 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-020-67645-8" title="DOI URL">https://doi.org/10.1038/s41598-020-67645-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-020-67645-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-020-67645-8%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DGlucocorticoid%252Breceptor%252Bcomplexes%252Bform%252Bcooperatively%252Bwith%252Bthe%252BHsp90%252Bco-chaperones%252BPp5%252Band%252BFKBPs%26aulast%3DKaziales%26aufirst%3DAnna%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Federica  Lo Bello</span>, <span class="hlFld-ContribAuthor ">Philip M.  Hansbro</span>, <span class="hlFld-ContribAuthor ">Chantal  Donovan</span>, <span class="hlFld-ContribAuthor ">Irene  Coppolino</span>, <span class="hlFld-ContribAuthor ">Sharon  Mumby</span>, <span class="hlFld-ContribAuthor ">Ian M.  Adcock</span>, <span class="hlFld-ContribAuthor ">Gaetano  Caramori</span>. </span><span class="cited-content_cbyCitation_article-title">New drugs under development for COPD. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Emerging Drugs</span><span> <strong>2020,</strong> <em>25 </em>
                                    (4)
                                     , 419-431. <a href="https://doi.org/10.1080/14728214.2020.1819982" title="DOI URL">https://doi.org/10.1080/14728214.2020.1819982</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14728214.2020.1819982&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14728214.2020.1819982%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Emerging%2520Drugs%26atitle%3DNew%252Bdrugs%252Bunder%252Bdevelopment%252Bfor%252BCOPD%26aulast%3DLo%2BBello%26aufirst%3DFederica%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D4%26spage%3D419%26epage%3D431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kevin N.  Dack</span>, <span class="hlFld-ContribAuthor ">Patrick S.  Johnson</span>, <span class="hlFld-ContribAuthor ">Krister  Henriksson</span>, <span class="hlFld-ContribAuthor ">Stefan  Eirefelt</span>, <span class="hlFld-ContribAuthor ">Martin A.  Carnerup</span>, <span class="hlFld-ContribAuthor ">Martin  Stahlhut</span>, <span class="hlFld-ContribAuthor ">Anna K.  Ollerstam</span>. </span><span class="cited-content_cbyCitation_article-title">Topical ‘dual-soft’ glucocorticoid receptor agonist for dermatology. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (17)
                                     , 127402. <a href="https://doi.org/10.1016/j.bmcl.2020.127402" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.127402</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.127402&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.127402%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DTopical%252B%2525E2%252580%252598dual-soft%2525E2%252580%252599%252Bglucocorticoid%252Breceptor%252Bagonist%252Bfor%252Bdermatology%26aulast%3DDack%26aufirst%3DKevin%2BN.%26date%3D2020%26volume%3D30%26issue%3D17%26spage%3D127402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cristiano  Bolchi</span>, <span class="hlFld-ContribAuthor ">Francesco  Bavo</span>, <span class="hlFld-ContribAuthor ">Rebecca  Appiani</span>, <span class="hlFld-ContribAuthor ">Gabriella  Roda</span>, <span class="hlFld-ContribAuthor ">Marco  Pallavicini</span>. </span><span class="cited-content_cbyCitation_article-title">1,4-Benzodioxane, an evergreen, versatile scaffold in medicinal chemistry: A review of its recent applications in drug design. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>200 </em>, 112419. <a href="https://doi.org/10.1016/j.ejmech.2020.112419" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112419</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112419&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112419%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3D1%25252C4-Benzodioxane%25252C%252Ban%252Bevergreen%25252C%252Bversatile%252Bscaffold%252Bin%252Bmedicinal%252Bchemistry%25253A%252BA%252Breview%252Bof%252Bits%252Brecent%252Bapplications%252Bin%252Bdrug%252Bdesign%26aulast%3DBolchi%26aufirst%3DCristiano%26date%3D2020%26volume%3D200%26spage%3D112419" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luigino  Calzetta</span>, <span class="hlFld-ContribAuthor ">Beatrice Ludovica  Ritondo</span>, <span class="hlFld-ContribAuthor ">Maria Gabriella  Matera</span>, <span class="hlFld-ContribAuthor ">Gabriella  Pezzuto</span>, <span class="hlFld-ContribAuthor ">Mario  Cazzola</span>, <span class="hlFld-ContribAuthor ">Paola  Rogliani</span>. </span><span class="cited-content_cbyCitation_article-title">Investigational treatments in phase I and II clinical trials: a systematic review in chronic obstructive pulmonary disease (COPD). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Investigational Drugs</span><span> <strong>2020,</strong> <em>29 </em>
                                    (7)
                                     , 723-738. <a href="https://doi.org/10.1080/13543784.2020.1769064" title="DOI URL">https://doi.org/10.1080/13543784.2020.1769064</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543784.2020.1769064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543784.2020.1769064%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Investigational%2520Drugs%26atitle%3DInvestigational%252Btreatments%252Bin%252Bphase%252BI%252Band%252BII%252Bclinical%252Btrials%25253A%252Ba%252Bsystematic%252Breview%252Bin%252Bchronic%252Bobstructive%252Bpulmonary%252Bdisease%252B%252528COPD%252529%26aulast%3DCalzetta%26aufirst%3DLuigino%26date%3D2020%26date%3D2020%26volume%3D29%26issue%3D7%26spage%3D723%26epage%3D738" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark  Zak</span>, <span class="hlFld-ContribAuthor ">Hart S.  Dengler</span>, <span class="hlFld-ContribAuthor ">Naomi S.  Rajapaksa</span>. </span><span class="cited-content_cbyCitation_article-title">Inhaled Janus Kinase (JAK) inhibitors for the treatment of asthma. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (20)
                                     , 126658. <a href="https://doi.org/10.1016/j.bmcl.2019.126658" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.126658</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.126658&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.126658%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DInhaled%252BJanus%252BKinase%252B%252528JAK%252529%252Binhibitors%252Bfor%252Bthe%252Btreatment%252Bof%252Basthma%26aulast%3DZak%26aufirst%3DMark%26date%3D2019%26volume%3D29%26issue%3D20%26spage%3D126658" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Donglu  Zhang</span>, <span class="hlFld-ContribAuthor ">Cornelis E.C.A.  Hop</span>, <span class="hlFld-ContribAuthor ">Gabriela  Patilea-Vrana</span>, <span class="hlFld-ContribAuthor ">Gautham  Gampa</span>, <span class="hlFld-ContribAuthor ">Herana Kamal  Seneviratne</span>, <span class="hlFld-ContribAuthor ">Jashvant D.  Unadkat</span>, <span class="hlFld-ContribAuthor ">Jane R.  Kenny</span>, <span class="hlFld-ContribAuthor ">Karthik  Nagapudi</span>, <span class="hlFld-ContribAuthor ">Li  Di</span>, <span class="hlFld-ContribAuthor ">Lian  Zhou</span>, <span class="hlFld-ContribAuthor ">Mark  Zak</span>, <span class="hlFld-ContribAuthor ">Matthew R.  Wright</span>, <span class="hlFld-ContribAuthor ">Namandjé N.  Bumpus</span>, <span class="hlFld-ContribAuthor ">Richard  Zang</span>, <span class="hlFld-ContribAuthor ">Xingrong  Liu</span>, <span class="hlFld-ContribAuthor ">Yurong  Lai</span>, <span class="hlFld-ContribAuthor ">S. Cyrus  Khojasteh</span>. </span><span class="cited-content_cbyCitation_article-title">Drug Concentration Asymmetry in Tissues and Plasma for Small Molecule–Related Therapeutic Modalities. </span><span class="cited-content_cbyCitation_journal-name">Drug Metabolism and Disposition</span><span> <strong>2019,</strong> <em>47 </em>
                                    (10)
                                     , 1122-1135. <a href="https://doi.org/10.1124/dmd.119.086744" title="DOI URL">https://doi.org/10.1124/dmd.119.086744</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/dmd.119.086744&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fdmd.119.086744%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Metabolism%2520and%2520Disposition%26atitle%3DDrug%252BConcentration%252BAsymmetry%252Bin%252BTissues%252Band%252BPlasma%252Bfor%252BSmall%252BMolecule%2525E2%252580%252593Related%252BTherapeutic%252BModalities%26aulast%3DZhang%26aufirst%3DDonglu%26date%3D2019%26date%3D2019%26volume%3D47%26issue%3D10%26spage%3D1122%26epage%3D1135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Holly L.  Carter</span>, <span class="hlFld-ContribAuthor ">Amand W.  Connor</span>, <span class="hlFld-ContribAuthor ">Richard  Hart</span>, <span class="hlFld-ContribAuthor ">James  McCabe</span>, <span class="hlFld-ContribAuthor ">Allyson C.  McIntyre</span>, <span class="hlFld-ContribAuthor ">Angus E.  McMillan</span>, <span class="hlFld-ContribAuthor ">Natalie R.  Monks</span>, <span class="hlFld-ContribAuthor ">Alexander K.  Mullen</span>, <span class="hlFld-ContribAuthor ">Thomas O.  Ronson</span>, <span class="hlFld-ContribAuthor ">Alan  Steven</span>, <span class="hlFld-ContribAuthor ">Simone  Tomasi</span>, <span class="hlFld-ContribAuthor ">Simon D.  Yates</span>. </span><span class="cited-content_cbyCitation_article-title">Rapid route design of AZD7594. </span><span class="cited-content_cbyCitation_journal-name">Reaction Chemistry & Engineering</span><span> <strong>2019,</strong> <em>4 </em>
                                    (9)
                                     , 1658-1673. <a href="https://doi.org/10.1039/C9RE00118B" title="DOI URL">https://doi.org/10.1039/C9RE00118B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9RE00118B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9RE00118B%26sid%3Dliteratum%253Aachs%26jtitle%3DReaction%2520Chemistry%2520%2526%2520Engineering%26atitle%3DRapid%252Broute%252Bdesign%252Bof%252BAZD7594%26aulast%3DCarter%26aufirst%3DHolly%2BL.%26date%3D2019%26date%3D2019%26volume%3D4%26issue%3D9%26spage%3D1658%26epage%3D1673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">S. A.  Usanov</span>, <span class="hlFld-ContribAuthor ">A. V.  Kliuchenovich</span>, <span class="hlFld-ContribAuthor ">N. V.  Strushkevich</span>. </span><span class="cited-content_cbyCitation_article-title">Drug design strategies for Cushing’s syndrome. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2019,</strong> <em>14 </em>
                                    (2)
                                     , 143-151. <a href="https://doi.org/10.1080/17460441.2019.1559146" title="DOI URL">https://doi.org/10.1080/17460441.2019.1559146</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17460441.2019.1559146&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17460441.2019.1559146%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DDrug%252Bdesign%252Bstrategies%252Bfor%252BCushing%2525E2%252580%252599s%252Bsyndrome%26aulast%3DUsanov%26aufirst%3DS.%2BA.%26date%3D2019%26date%3D2018%26volume%3D14%26issue%3D2%26spage%3D143%26epage%3D151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jith C.  Janardhanan</span>, <span class="hlFld-ContribAuthor ">Rakesh K.  Mishra</span>, <span class="hlFld-ContribAuthor ">Gourab  Das</span>, <span class="hlFld-ContribAuthor ">Suresh  Sini</span>, <span class="hlFld-ContribAuthor ">Purushothaman  Jayamurthy</span>, <span class="hlFld-ContribAuthor ">Cherumuttathu H.  Suresh</span>, <span class="hlFld-ContribAuthor ">Vakayil K.  Praveen</span>, <span class="hlFld-ContribAuthor ">Narayanapillai  Manoj</span>, <span class="hlFld-ContribAuthor ">Beneesh P.  Babu</span>. </span><span class="cited-content_cbyCitation_article-title">Functionalizable 1
              H
              -Indazoles by Palladium Catalyzed Aza-Nenitzescu Reaction: Pharmacophores to Donor-Acceptor Type Multi-Luminescent Fluorophores. </span><span class="cited-content_cbyCitation_journal-name">Asian Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>7 </em>
                                    (10)
                                     , 2094-2104. <a href="https://doi.org/10.1002/ajoc.201800413" title="DOI URL">https://doi.org/10.1002/ajoc.201800413</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ajoc.201800413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fajoc.201800413%26sid%3Dliteratum%253Aachs%26jtitle%3DAsian%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DFunctionalizable%252B1%252BH%252B-Indazoles%252Bby%252BPalladium%252BCatalyzed%252BAza-Nenitzescu%252BReaction%25253A%252BPharmacophores%252Bto%252BDonor-Acceptor%252BType%252BMulti-Luminescent%252BFluorophores%26aulast%3DJanardhanan%26aufirst%3DJith%2BC.%26date%3D2018%26date%3D2018%26volume%3D7%26issue%3D10%26spage%3D2094%26epage%3D2104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Astrid  Luypaert</span>, <span class="hlFld-ContribAuthor ">Wim  Vanden Berghe</span>, <span class="hlFld-ContribAuthor ">Jan  Tavernier</span>, <span class="hlFld-ContribAuthor ">Claude  Libert</span>, <span class="hlFld-ContribAuthor ">Karolien  De Bosscher</span>. </span><span class="cited-content_cbyCitation_article-title">Strategies and Compounds to Circumvent Glucocorticoid-Induced Side Effects. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 283-305. <a href="https://doi.org/10.1007/978-3-319-77658-3_13" title="DOI URL">https://doi.org/10.1007/978-3-319-77658-3_13</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-319-77658-3_13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-319-77658-3_13%26sid%3Dliteratum%253Aachs%26atitle%3DStrategies%252Band%252BCompounds%252Bto%252BCircumvent%252BGlucocorticoid-Induced%252BSide%252BEffects%26aulast%3DLuypaert%26aufirst%3DAstrid%26date%3D2018%26date%3D2018%26spage%3D283%26epage%3D305%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DImmunopharmacology%252Band%252BInflammation%26aulast%3DRiccardi%26aufirst%3DCarlo%26date%3D2018%26volume%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Diego  Muñoz-Torrero</span>, <span class="hlFld-ContribAuthor ">Arduino  Mangoni</span>, <span class="hlFld-ContribAuthor ">Hong  Liu</span>, <span class="hlFld-ContribAuthor ">Christopher  Hulme</span>, <span class="hlFld-ContribAuthor ">Jarkko  Rautio</span>, <span class="hlFld-ContribAuthor ">Rafik  Karaman</span>, <span class="hlFld-ContribAuthor ">Maria  De Sousa</span>, <span class="hlFld-ContribAuthor ">Katalin  Prokai-Tatrai</span>, <span class="hlFld-ContribAuthor ">Jean-Marc  Sabatier</span>, <span class="hlFld-ContribAuthor ">Carlo  Siciliano</span>, <span class="hlFld-ContribAuthor ">F.  Luque</span>, <span class="hlFld-ContribAuthor ">George  Kokotos</span>, <span class="hlFld-ContribAuthor ">Rino  Ragno</span>, <span class="hlFld-ContribAuthor ">Simona  Collina</span>, <span class="hlFld-ContribAuthor ">Catherine  Guillou</span>, <span class="hlFld-ContribAuthor ">Michael  Gütschow</span>, <span class="hlFld-ContribAuthor ">Luigi  Agrofoglio</span>. </span><span class="cited-content_cbyCitation_article-title">Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes–2. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2018,</strong> <em>23 </em>
                                    (1)
                                     , 65. <a href="https://doi.org/10.3390/molecules23010065" title="DOI URL">https://doi.org/10.3390/molecules23010065</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules23010065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules23010065%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DBreakthroughs%252Bin%252BMedicinal%252BChemistry%25253A%252BNew%252BTargets%252Band%252BMechanisms%25252C%252BNew%252BDrugs%25252C%252BNew%252BHopes%2525E2%252580%2525932%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DDiego%26date%3D2018%26date%3D2017%26volume%3D23%26issue%3D1%26spage%3D65" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01215/20171020/images/medium/jm-2017-01215g_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01215/20171020/images/large/jm-2017-01215g_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01215&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01215/20171020/images/medium/jm-2017-01215g_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01215/20171020/images/large/jm-2017-01215g_0001.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. GR ligands with picomolar transrepression potency.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01215/20171020/images/large/jm-2017-01215g_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01215&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01215/20171020/images/medium/jm-2017-01215g_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01215/20171020/images/large/jm-2017-01215g_0006.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Diastereoselective Synthesis of Phenylpropanolamine Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01215/20171020/images/large/jm-2017-01215g_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01215&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>i</i>-PrMgCl·LiCl, 0–10 °C; (b) <i>i</i>-PrMgCl, THF, 0 °C to rt; (c) aq HCl (1.5 N), EtOAc, 10 °C; (d) Al(OiPr)<sub>3</sub> (0.2 equiv), <i>i</i>-PrOH (11 equiv), toluene, 50 °C; (e) HCl; (f) triphosgene, THF, −15 °C to rt; (g) MeSO<sub>2</sub>Cl, Et<sub>3</sub>N, THF, 50 °C; (h) LiOH, THF/H<sub>2</sub>O, 90 °C.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01215/20171020/images/medium/jm-2017-01215g_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01215/20171020/images/large/jm-2017-01215g_0007.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Indazole Ethers<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01215/20171020/images/large/jm-2017-01215g_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01215&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>For specified substituents NR<sup>4</sup>R<sup>5</sup> refer to <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>. Reagents and conditions: (a) 1-(4-fluorophenyl)-5-iodo-indazole (<b>16</b>), CuI (0.05 equiv), Cs<sub>2</sub>CO<sub>3</sub> (2.2 equiv), <i>n</i>-PrCN, 125 °C; (b) [R<sup>1</sup>C(O)]<sub>2</sub>O; NEt<sub>3</sub>; (c) R<sup>1</sup>CO<sub>2</sub>H, NEt<sub>3</sub>, T3P, MeCN; (d) isobutyl 3-(5-iodoindazol-1-yl)benzoate (<b>17</b>), CuI (0.05 equiv) Cs<sub>2</sub>CO<sub>3</sub> (2.2 equiv), <i>n</i>-PrCN, 110 °C; (e) 2,2-difluoropropionic acid, HATU, DIPEA, DCM; (f) LiOH, THF/H<sub>2</sub>O (1:1); (g) HNR<sup>4</sup>R<sup>5</sup>, HBTU, DIPEA, DMF.</p></p></figure><figure data-id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01215/20171020/images/medium/jm-2017-01215g_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01215/20171020/images/large/jm-2017-01215g_0002.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Superimposition of the GR complexes of <b>1a</b> (magenta) and <b>2</b> (blue); protein not shown (RMSD 0.44 for 984 main chain atoms). Steroid sites with precedent for metabolic deactivation are marked with yellow circles.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01215/20171020/images/large/jm-2017-01215g_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01215&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01215/20171020/images/medium/jm-2017-01215g_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01215/20171020/images/large/jm-2017-01215g_0003.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. GR LBD (green) in complex with compound <b>1b</b> (magenta). Putative hydrogen bonds are marked with dashed lines. (A) Compound <b>1b</b> places the amide within hydrogen bonding distance of <i>Asn564</i> and <i>Glu642</i> of helices 3 and 7, respectively. The fluorophenyl motif is inserted in the induced pocket in between helices 3 and 5. (B) The meta position of the fluorophenyl motif is directed toward a large cavity beneath <i>Trp577</i>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01215/20171020/images/large/jm-2017-01215g_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01215&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01215/20171020/images/medium/jm-2017-01215g_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01215/20171020/images/large/jm-2017-01215g_0004.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Dose–response study of <b>15m</b> in a 4-day rat model of Sephadex-induced airway inflammation. The anti-inflammatory effect was assessed as inhibition of the induced lung edema, determined as a reduction of the left lung lobe weight (A). The systemic GR agonism was assessed as a thymus weight reduction (involution) in the same animals (B). The data points shown represent single animals; the bars indicate the mean and the standard deviation. DPI inhalation with <b>15m</b> (black dots) reduced the edema by 39–109% (<i>p</i> < 0.001) with a significant effect already at the lowest dose (0.6 μg/kg, <i>p</i> < 0.002). Significant effects of <b>15m</b> were observed on the weight of the thymus only at the highest dose (47.9 μg/kg, <i>p</i> = 0.041). Two doses of <b>3</b> (gray dots) were included as a control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01215/20171020/images/large/jm-2017-01215g_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01215&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01215/20171020/images/medium/jm-2017-01215g_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01215/20171020/images/large/jm-2017-01215g_0005.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Duration of effect for inhibiting Sephadex-induced lung edema. <b>15m</b> (black dots) showed a full inhibition effect when predosed 9 h prior to challenge (<i>p</i> < 0.001) and 76% inhibition when dosed 24 h prior to challenge (<i>p</i> < 0.001). <b>3</b> (gray dots) inhibited the challenge-induced lung edema by 61% when dosed 9 h prior to challenge (<i>p</i> < 0.01) but had no significant inhibitory effect when dosed 24 h prior to challenge.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01215/20171020/images/large/jm-2017-01215g_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01215&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i44">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82106" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82106" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 30 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Hirschmann, R.</span><span> </span><span class="NLM_article-title">Medicinal chemistry in the golden age of biology: lessons from steroid and peptide research</span> <span class="citation_source-journal">Angew. Chem., Int. Ed. Engl.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">1278</span><span class="NLM_x">–</span> <span class="NLM_lpage">1301</span><span class="refDoi"> DOI: 10.1002/anie.199112781</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=10.1002%2Fanie.199112781" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1991&pages=1278-1301&author=R.+Hirschmann&title=Medicinal+chemistry+in+the+golden+age+of+biology%3A+lessons+from+steroid+and+peptide+research&doi=10.1002%2Fanie.199112781"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1002%2Fanie.199112781&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.199112781%26sid%3Dliteratum%253Aachs%26aulast%3DHirschmann%26aufirst%3DR.%26atitle%3DMedicinal%2520chemistry%2520in%2520the%2520golden%2520age%2520of%2520biology%253A%2520lessons%2520from%2520steroid%2520and%2520peptide%2520research%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%2520Engl.%26date%3D1991%26volume%3D30%26spage%3D1278%26epage%3D1301%26doi%3D10.1002%2Fanie.199112781" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Barnes, P. J.</span><span> </span><span class="NLM_article-title">Glucocorticosteroids: current and future directions</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">163</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="NLM_x">–</span> <span class="NLM_lpage">43</span><span class="refDoi"> DOI: 10.1111/j.1476-5381.2010.01199.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=10.1111%2Fj.1476-5381.2010.01199.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=21198556" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=1%3ACAS%3A528%3ADC%252BC3MXls1GjtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=163&publication_year=2011&pages=29-43&author=P.+J.+Barnes&title=Glucocorticosteroids%3A+current+and+future+directions&doi=10.1111%2Fj.1476-5381.2010.01199.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Glucocorticosteroids: current and future directions</span></div><div class="casAuthors">Barnes, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">163</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">29-43</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Glucocorticoids are the most effective anti-inflammatory therapy for asthma yet are relatively ineffective in chronic obstructive pulmonary disease.  Glucocorticoids suppress inflammation via several mol. mechanisms.  Glucocorticoids suppress the multiple inflammatory genes that are activated in chronic inflammatory diseases, such as asthma, by reversing histone acetylation of activated inflammatory genes through binding of ligand-bound glucocorticoid receptors (GR) to co-activator mols. and recruitment of histone deacetylase-2 to the activated inflammatory gene transcription complex (trans-repression).  At higher concns. of glucocorticoids GR homodimers interact with DNA recognition sites to activate transcription through increased histone acetylation of anti-inflammatory genes and transcription of several genes linked to glucocorticoid side effects (trans-activation).  Glucocorticoids also have post-transcriptional effects and decrease stability of some pro-inflammatory mRNA species.  Decreased glucocorticoid responsiveness is found in patients with severe asthma and asthmatics who smoke, as well as in all patients with chronic obstructive pulmonary disease.  Several mol. mechanisms of glucocorticoid resistance have now been identified which involve post-translational modifications of GR.  Histone deacetylase-2 is markedly reduced in activity and expression as a result of oxidative/nitrative stress so that inflammation becomes resistant to the anti-inflammatory actions of glucocorticoids.  Dissocd. glucocorticoids and selective GR modulators which show improved trans-repression over trans-activation effects have been developed to reduce side effects, but so far it has been difficult to dissoc. anti-inflammatory effects from adverse effects.  In patients with glucocorticoid resistance alternative anti-inflammatory treatments are being investigated as well as drugs that may reverse the mol. mechanisms of glucocorticoid resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrws5bc7ZkJ1rVg90H21EOLACvtfcHk0lgqr4_5CmXKmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXls1GjtL4%253D&md5=98b6a1ef4f61f1155ce876645b9c38e1</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2010.01199.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2010.01199.x%26sid%3Dliteratum%253Aachs%26aulast%3DBarnes%26aufirst%3DP.%2BJ.%26atitle%3DGlucocorticosteroids%253A%2520current%2520and%2520future%2520directions%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2011%26volume%3D163%26spage%3D29%26epage%3D43%26doi%3D10.1111%2Fj.1476-5381.2010.01199.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Goulding, N. J.</span><span> </span><span class="NLM_article-title">The molecular complexity of glucocorticoid actions in inflammation - a four-ring circus</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">629</span><span class="NLM_x">–</span> <span class="NLM_lpage">636</span><span class="refDoi"> DOI: 10.1016/j.coph.2004.06.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=10.1016%2Fj.coph.2004.06.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=15525555" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptl2ktrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=629-636&author=N.+J.+Goulding&title=The+molecular+complexity+of+glucocorticoid+actions+in+inflammation+-+a+four-ring+circus&doi=10.1016%2Fj.coph.2004.06.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">The molecular complexity of glucocorticoid actions in inflammation - a four-ring circus</span></div><div class="casAuthors">Goulding, Nicolas J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">629-636</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Glucocorticoids have been the mainstay of anti-inflammatory therapy for the past 50 years despite the significant risks assocd. with their long-term use.  Recent research into the mol. mechanisms of action of these compds. can be aggregated into two major themes: first, those that focus on the involvement of the glucocorticoid receptor in regulating the transcription of pro-inflammatory genes; and second, studies that seek to identify alternative pathways of glucocorticoid action either via the induction of anti-inflammatory mediators or through rapid non-genomic mechanisms.  Understanding the temporal-spatial patterns of these multiple mechanisms on relevant cell types will be key to explaining the profound effects that these four-ring steroids exert on the inflammatory process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp41TxF3Gx54LVg90H21EOLACvtfcHk0lgqr4_5CmXKmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptl2ktrs%253D&md5=967a99d4e315bec670914f905893bb13</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2004.06.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2004.06.009%26sid%3Dliteratum%253Aachs%26aulast%3DGoulding%26aufirst%3DN.%2BJ.%26atitle%3DThe%2520molecular%2520complexity%2520of%2520glucocorticoid%2520actions%2520in%2520inflammation%2520-%2520a%2520four-ring%2520circus%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2004%26volume%3D4%26spage%3D629%26epage%3D636%26doi%3D10.1016%2Fj.coph.2004.06.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Barnes, P. J.</span><span> </span><span class="NLM_article-title">Molecular mechanisms and cellular effects of glucocorticosteroids</span> <span class="citation_source-journal">Immunol. Allergy Clin. North Am.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">451</span><span class="NLM_x">–</span> <span class="NLM_lpage">468</span><span class="refDoi"> DOI: 10.1016/j.iac.2005.05.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=10.1016%2Fj.iac.2005.05.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=16054537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=1%3ACAS%3A280%3ADC%252BD2MzpsFymsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=451-468&author=P.+J.+Barnes&title=Molecular+mechanisms+and+cellular+effects+of+glucocorticosteroids&doi=10.1016%2Fj.iac.2005.05.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanisms and cellular effects of glucocorticosteroids</span></div><div class="casAuthors">Barnes Peter J</div><div class="citationInfo"><span class="NLM_cas:title">Immunology and allergy clinics of North America</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">451-68</span>
        ISSN:<span class="NLM_cas:issn">0889-8561</span>.
    </div><div class="casAbstract">GCSs exert their anti-inflammatory effects through influencing multiple signal transduction pathways.  Their most important action is switching off multiple activated inflammatory genes through inhibition of HAT and recruitment of HDAC2 activity to the inflammatory gene transcriptional complex.  In addition, GCSs may activate several anti-inflammatory genes and increase the degradation of mRNA encoding certain inflammatory proteins.  This broad array of actions may account for the striking effectiveness of GCSs in complex inflammatory diseases such as asthma and the difficulty in finding alternative anti-inflammatory drugs.  There is now a better understanding of how the responsiveness to GCSs is reduced in patients who have severe asthma, who have asthma and smoke, and who have COPD.  An important mechanism now emerging is a reduction in HDAC2 activity as a result of oxidative stress.  These new insights into GCS action may lead to new approaches to treating inflammatory lung diseases and in particular to increasing effectiveness of steroids in situations where they are less effective.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSix-AbkCPCprt7lRqEFUJVfW6udTcc2eZ4CtJUp5AgZbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2MzpsFymsw%253D%253D&md5=0cab7e9cf2da0d15262d989d57359721</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1016%2Fj.iac.2005.05.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.iac.2005.05.003%26sid%3Dliteratum%253Aachs%26aulast%3DBarnes%26aufirst%3DP.%2BJ.%26atitle%3DMolecular%2520mechanisms%2520and%2520cellular%2520effects%2520of%2520glucocorticosteroids%26jtitle%3DImmunol.%2520Allergy%2520Clin.%2520North%2520Am.%26date%3D2005%26volume%3D25%26spage%3D451%26epage%3D468%26doi%3D10.1016%2Fj.iac.2005.05.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Weikum, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knuesel, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortlund, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, K. R.</span><span> </span><span class="NLM_article-title">Glucocorticoid receptor control of transcription: precision and plasticity via allostery</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">159</span><span class="NLM_x">–</span> <span class="NLM_lpage">174</span><span class="refDoi"> DOI: 10.1038/nrm.2016.152</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=10.1038%2Fnrm.2016.152" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=28053348" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjs1Khsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2017&pages=159-174&author=E.+R.+Weikumauthor=M.+T.+Knueselauthor=E.+A.+Ortlundauthor=K.+R.+Yamamoto&title=Glucocorticoid+receptor+control+of+transcription%3A+precision+and+plasticity+via+allostery&doi=10.1038%2Fnrm.2016.152"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3cR"><div class="casContent"><span class="casTitleNuber">3c</span><div class="casTitle"><span class="NLM_cas:atitle">Glucocorticoid receptor control of transcription: precision and plasticity via allostery</span></div><div class="casAuthors">Weikum, Emily R.; Knuesel, Matthew T.; Ortlund, Eric A.; Yamamoto, Keith R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">159-174</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The glucocorticoid receptor (GR) is a constitutively expressed transcriptional regulatory factor (TRF) that controls many distinct gene networks, each uniquely detd. by particular cellular and physiol. contexts.  The precision of GR-mediated responses seems to depend on combinatorial, context-specific assembly of GR-nucleated transcription regulatory complexes at genomic response elements.  In turn, evidence suggests that context-driven plasticity is conferred by the integration of multiple signals, each serving as an allosteric effector of GR conformation, a key determinant of regulatory complex compn. and activity.  This structural and mechanistic perspective on GR regulatory specificity is likely to extend to other eukaryotic TRFs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCbT51NeMMPbVg90H21EOLACvtfcHk0liKrb2MdlFBUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjs1Khsw%253D%253D&md5=70ab0a72fa2297038493fe68ba609594</span></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=10.1038%2Fnrm.2016.152&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm.2016.152%26sid%3Dliteratum%253Aachs%26aulast%3DWeikum%26aufirst%3DE.%2BR.%26aulast%3DKnuesel%26aufirst%3DM.%2BT.%26aulast%3DOrtlund%26aufirst%3DE.%2BA.%26aulast%3DYamamoto%26aufirst%3DK.%2BR.%26atitle%3DGlucocorticoid%2520receptor%2520control%2520of%2520transcription%253A%2520precision%2520and%2520plasticity%2520via%2520allostery%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2017%26volume%3D18%26spage%3D159%26epage%3D174%26doi%3D10.1038%2Fnrm.2016.152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Fardet, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feve, B.</span><span> </span><span class="NLM_article-title">Systemic glucocorticoid therapy: a review of its metabolic and cardiovascular adverse events</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">1731</span><span class="NLM_x">–</span> <span class="NLM_lpage">1745</span><span class="refDoi"> DOI: 10.1007/s40265-014-0282-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=10.1007%2Fs40265-014-0282-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2014&pages=1731-1745&author=L.+Fardetauthor=B.+Feve&title=Systemic+glucocorticoid+therapy%3A+a+review+of+its+metabolic+and+cardiovascular+adverse+events&doi=10.1007%2Fs40265-014-0282-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1007%2Fs40265-014-0282-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40265-014-0282-9%26sid%3Dliteratum%253Aachs%26aulast%3DFardet%26aufirst%3DL.%26aulast%3DFeve%26aufirst%3DB.%26atitle%3DSystemic%2520glucocorticoid%2520therapy%253A%2520a%2520review%2520of%2520its%2520metabolic%2520and%2520cardiovascular%2520adverse%2520events%26jtitle%3DDrugs%26date%3D2014%26volume%3D74%26spage%3D1731%26epage%3D1745%26doi%3D10.1007%2Fs40265-014-0282-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Uings, I. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrow, S. N.</span><span> </span><span class="NLM_article-title">A pharmacological approach to enhancing the therapeutic index of corticosteroids in airway inflammatory disease</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">221</span><span class="NLM_x">–</span> <span class="NLM_lpage">226</span><span class="refDoi"> DOI: 10.1016/j.coph.2004.12.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=10.1016%2Fj.coph.2004.12.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=15907906" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=1%3ACAS%3A528%3ADC%252BD2MXktlejtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=221-226&author=I.+J.+Uingsauthor=S.+N.+Farrow&title=A+pharmacological+approach+to+enhancing+the+therapeutic+index+of+corticosteroids+in+airway+inflammatory+disease&doi=10.1016%2Fj.coph.2004.12.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">A pharmacological approach to enhancing the therapeutic index of corticosteroids in airway inflammatory disease</span></div><div class="casAuthors">Uings, Iain J.; Farrow, Stuart N.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">221-226</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Inhaled corticosteroids are highly effective agents for the treatment of asthma and chronic obstructive pulmonary disease.  Although local delivery to the lung has led to significant progress towards minimizing side effects assocd. with systemic exposure, addnl. opportunities exist for further enhancement of the therapeutic index.  Recent developments in the mol. and structural understanding of corticosteroid biol. have made it increasingly clear that novel corticosteroids with intrinsically different pharmacol. can be designed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpk4sVgiAxHWrVg90H21EOLACvtfcHk0liKrb2MdlFBUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXktlejtLs%253D&md5=de853f43df4395ba06a7b5da80bc2ea7</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2004.12.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2004.12.003%26sid%3Dliteratum%253Aachs%26aulast%3DUings%26aufirst%3DI.%2BJ.%26aulast%3DFarrow%26aufirst%3DS.%2BN.%26atitle%3DA%2520pharmacological%2520approach%2520to%2520enhancing%2520the%2520therapeutic%2520index%2520of%2520corticosteroids%2520in%2520airway%2520inflammatory%2520disease%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2005%26volume%3D5%26spage%3D221%26epage%3D226%26doi%3D10.1016%2Fj.coph.2004.12.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">White, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crisalida, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Economides, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaliner, M.</span><span> </span><span class="NLM_article-title">Effects of long-term inhaled corticosteroids on adrenal function in patients with asthma</span> <span class="citation_source-journal">Ann. Allergy, Asthma, Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">437</span><span class="NLM_x">–</span> <span class="NLM_lpage">444</span><span class="refDoi"> DOI: 10.1016/S1081-1206(10)60911-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=10.1016%2FS1081-1206%2810%2960911-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=16597078" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=1%3ACAS%3A528%3ADC%252BD28XjsFyjtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2006&pages=437-444&author=M.+Whiteauthor=T.+Crisalidaauthor=H.+Liauthor=A.+Economidesauthor=M.+Kaliner&title=Effects+of+long-term+inhaled+corticosteroids+on+adrenal+function+in+patients+with+asthma&doi=10.1016%2FS1081-1206%2810%2960911-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of long-term inhaled corticosteroids on adrenal function in patients with asthma</span></div><div class="casAuthors">White, Martha; Crisalida, Tera; Li, Henry; Economides, Athena; Kaliner, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Allergy, Asthma, & Immunology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">437-444</span>CODEN:
                <span class="NLM_cas:coden">ALAIF6</span>;
        ISSN:<span class="NLM_cas:issn">1081-1206</span>.
    
            (<span class="NLM_cas:orgname">American College of Allergy, Asthma, & Immunology</span>)
        </div><div class="casAbstract">Background: Inhaled corticosteroids (ICSs) are effective asthma controllers, but long-term use could lead to adverse effects.  Objective: To examine adrenal responsiveness of patients with persistent asthma treated with long-term ICSs.  Methods: Morning plasma cortisol levels before and 30 min after adrenocorticotropic hormone (ACTH) (1 μg i.v.) stimulation were compared.  Primary end points included mean prestimulation and poststimulation cortisol levels; secondary end points included morning cortisol level of 5 μg/dL or less, post-ACTH stimulation cortisol level of 18 μg/dL or less, and/or a net change of 7 μg/dL or less from baseline.  Results: A total of 103 asthmatic patients (29 in the triamcinolone acetonide group, 18 in the flunisolide group, 45 in the fluticasone propionate group, and 11 in the oral corticosteroids group [pos. controls]) completed the study.  Mean daily ICS doses and durations were as follows: triamcinolone acetonide: 448 μg for 36 mo; flunisolide: 1,181 μg for 41 mo; and fluticasone propionate: 745 μg for 19 mo.  Eleven of 30 patients taking high-dose ICSs (10 of 28 taking fluticasone propionate and 1 of 2 taking flunisolide) had both low morning cortisol levels and abnormal post-ACTH stimulation cortisol levels.  Few patients taking lower doses of any ICS had abnormal results.  Conclusions: Patients who require long-term treatment with high-dose ICSs may have abnormal morning plasma cortisol levels and reduced responsiveness to ACTH stimulation.  Careful monitoring of adrenal function should be considered in such patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodWqQIKyWcaLVg90H21EOLACvtfcHk0liKrb2MdlFBUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjsFyjtL0%253D&md5=e0685d108913770f6f4fbbb859700637</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2FS1081-1206%2810%2960911-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1081-1206%252810%252960911-8%26sid%3Dliteratum%253Aachs%26aulast%3DWhite%26aufirst%3DM.%26aulast%3DCrisalida%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DEconomides%26aufirst%3DA.%26aulast%3DKaliner%26aufirst%3DM.%26atitle%3DEffects%2520of%2520long-term%2520inhaled%2520corticosteroids%2520on%2520adrenal%2520function%2520in%2520patients%2520with%2520asthma%26jtitle%3DAnn.%2520Allergy%252C%2520Asthma%252C%2520Immunol.%26date%3D2006%26volume%3D96%26spage%3D437%26epage%3D444%26doi%3D10.1016%2FS1081-1206%2810%2960911-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Allen, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bielory, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derendorf, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dluhy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colice, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szefler, S. J.</span><span> </span><span class="NLM_article-title">Inhaled corticosteroids: past lessons and future issues</span> <span class="citation_source-journal">J. Allergy Clin. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">S1</span><span class="NLM_x">–</span> <span class="NLM_lpage">40</span><span class="refDoi"> DOI: 10.1016/S0091-6749(03)01859-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=10.1016%2FS0091-6749%2803%2901859-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=14515117" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=1%3ACAS%3A528%3ADC%252BD3sXotFCrtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2003&pages=S1-40&author=D.+B.+Allenauthor=L.+Bieloryauthor=H.+Derendorfauthor=R.+Dluhyauthor=G.+L.+Coliceauthor=S.+J.+Szefler&title=Inhaled+corticosteroids%3A+past+lessons+and+future+issues&doi=10.1016%2FS0091-6749%2803%2901859-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">Inhaled corticosteroids: past lessons and future issues</span></div><div class="casAuthors">Allen, David B.; Bielory, Leonard; Derendorf, Hartmut; Dluhy, Robert; Colice, Gene L.; Szefler, Stanley J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Allergy and Clinical Immunology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">3, Suppl.</span>),
    <span class="NLM_cas:pages">S1-S40</span>CODEN:
                <span class="NLM_cas:coden">JACIBY</span>;
        ISSN:<span class="NLM_cas:issn">0091-6749</span>.
    
            (<span class="NLM_cas:orgname">Mosby, Inc.</span>)
        </div><div class="casAbstract">A review.  Inhaled corticosteroids play a pivotal role in the treatment of asthma.  Inhalation permits effective delivery of the corticosteroid in high concn. to target sites within the lung while minimizing systemic exposure.  Consequently, the safety profile of inhaled corticosteroids is markedly better than that of oral corticosteroid therapy.  However, although it was first thought that direct delivery might eliminate systemic adverse effects, this has not been confirmed by clin. trials and experience.  Inhaled corticosteroids are absorbed from the lungs into the systemic circulation, in which they can acutely decrease growth velocity in children, an effect that fortunately appears to be temporary and might have no effect on final adult height.  In sufficient dosages, they also produce bone mineral loss leading to osteoporosis and might increase the risk of cataracts, glaucoma, skin atrophy, and vascular changes that increase the risk of ecchymoses.  Effective evaluation of the severity and significance of these complications is challenging because highly sensitive tests do not reliably predict clin. significant events, and short-term observations do not predict long-term consequences.  Also, compliance wanes with long-term treatment, and susceptibility to a particular adverse event can vary over time, even in the same individual, because of developmental or hormonal changes.  This journal supplement will review what has been learned about the safety of inhaled corticosteroids during the past decade, discussing some of the questions that remain and considering the characteristics of an "ideal" inhaled corticosteroid: one with high local activity in the lung and minimal or no adverse systemic effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoslEtGgUTTFbVg90H21EOLACvtfcHk0ljSFZKaaHHd4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXotFCrtrc%253D&md5=09b1486992216963aef367dc3a3705d4</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1016%2FS0091-6749%2803%2901859-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0091-6749%252803%252901859-1%26sid%3Dliteratum%253Aachs%26aulast%3DAllen%26aufirst%3DD.%2BB.%26aulast%3DBielory%26aufirst%3DL.%26aulast%3DDerendorf%26aufirst%3DH.%26aulast%3DDluhy%26aufirst%3DR.%26aulast%3DColice%26aufirst%3DG.%2BL.%26aulast%3DSzefler%26aufirst%3DS.%2BJ.%26atitle%3DInhaled%2520corticosteroids%253A%2520past%2520lessons%2520and%2520future%2520issues%26jtitle%3DJ.%2520Allergy%2520Clin.%2520Immunol.%26date%3D2003%26volume%3D112%26spage%3DS1%26epage%3D40%26doi%3D10.1016%2FS0091-6749%2803%2901859-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Pruteanu, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chauhan, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prietsch, S. O. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ducharme, F. M.</span><span> </span><span class="NLM_article-title">Inhaled corticosteroids in children with persistent asthma: is there a dose response impact on growth? An overview of Cochrane reviews</span> <span class="citation_source-journal">Paediatr. Respir. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">51</span><span class="NLM_x">–</span> <span class="NLM_lpage">52</span><span class="refDoi"> DOI: 10.1016/j.prrv.2014.10.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=10.1016%2Fj.prrv.2014.10.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=25458795" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=1%3ACAS%3A280%3ADC%252BC2Mzjt1entg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2015&pages=51-52&author=A.+I.+Pruteanuauthor=B.+F.+Chauhanauthor=L.+Zhangauthor=S.+O.+M.+Prietschauthor=F.+M.+Ducharme&title=Inhaled+corticosteroids+in+children+with+persistent+asthma%3A+is+there+a+dose+response+impact+on+growth%3F+An+overview+of+Cochrane+reviews&doi=10.1016%2Fj.prrv.2014.10.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7bR"><div class="casContent"><span class="casTitleNuber">7b</span><div class="casTitle"><span class="NLM_cas:atitle">Inhaled corticosteroids in children with persistent asthma: is there a dose response impact on growth? An overview of Cochrane reviews</span></div><div class="casAuthors">Pruteanu Aniela I; Chauhan Bhupendrasinh F; Zhang Linjie; Prietsch Silvio O M; Ducharme Francine M</div><div class="citationInfo"><span class="NLM_cas:title">Paediatric respiratory reviews</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">51-2</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ7IjhC0TlLzdK0qsdY6Nc1fW6udTcc2eYyICK9CQbp6rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2Mzjt1entg%253D%253D&md5=1060330585109c1e3963e3ac982f4746</span></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1016%2Fj.prrv.2014.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.prrv.2014.10.002%26sid%3Dliteratum%253Aachs%26aulast%3DPruteanu%26aufirst%3DA.%2BI.%26aulast%3DChauhan%26aufirst%3DB.%2BF.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DPrietsch%26aufirst%3DS.%2BO.%2BM.%26aulast%3DDucharme%26aufirst%3DF.%2BM.%26atitle%3DInhaled%2520corticosteroids%2520in%2520children%2520with%2520persistent%2520asthma%253A%2520is%2520there%2520a%2520dose%2520response%2520impact%2520on%2520growth%253F%2520An%2520overview%2520of%2520Cochrane%2520reviews%26jtitle%3DPaediatr.%2520Respir.%2520Rev.%26date%3D2015%26volume%3D16%26spage%3D51%26epage%3D52%26doi%3D10.1016%2Fj.prrv.2014.10.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Rossi, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zanardi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamboni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossi, A.</span><span> </span><span class="NLM_article-title">Optimizing treatment of elderly COPD patients: what role for inhaled corticosteroids?</span> <span class="citation_source-journal">Drugs Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">679</span><span class="NLM_x">–</span> <span class="NLM_lpage">687</span><span class="refDoi"> DOI: 10.1007/s40266-015-0291-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=10.1007%2Fs40266-015-0291-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=26297533" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVSqs7%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2015&pages=679-687&author=A.+P.+Rossiauthor=E.+Zanardiauthor=M.+Zamboniauthor=A.+Rossi&title=Optimizing+treatment+of+elderly+COPD+patients%3A+what+role+for+inhaled+corticosteroids%3F&doi=10.1007%2Fs40266-015-0291-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7cR"><div class="casContent"><span class="casTitleNuber">7c</span><div class="casTitle"><span class="NLM_cas:atitle">Optimizing Treatment of Elderly COPD Patients: What Role for Inhaled Corticosteroids?</span></div><div class="casAuthors">Rossi, Andrea P.; Zanardi, Erika; Zamboni, Mauro; Rossi, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Drugs & Aging</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">679-687</span>CODEN:
                <span class="NLM_cas:coden">DRAGE6</span>;
        ISSN:<span class="NLM_cas:issn">1170-229X</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">The most recent international documents on the management and therapy of chronic obstructive pulmonary disease (COPD) recommend inhaled corticosteroids (ICS) in addn. to long-acting bronchodilators as maintenance treatment for patients at high risk of exacerbations, namely patients with forced expiratory vol. in 1 s (FEV1) of <50 % predicted and/or more than one exacerbation per yr.  However, ICS are widely used in up to 70 % of COPD patients, including those at low risk of exacerbations.  In recent years, concerns about the potential adverse effects of this drug category have been raised, and both observational and clin. studies have shown that elderly subjects with COPD treated with ICS are at high risk of developing cataracts and diabetes and more severe and life-threatening conditions such as pneumonia and osteoporotic fractures.  Moreover, aging is characterized by memory impairment, decline in muscle strength and body mass impaired coordination, as well as alterations in eyesight and hearing that can impede proper use of devices currently available for ICS administration.  Thus, regular use of ICS in more elderly patients with COPD should follow guideline recommendations, be considered with caution, and be based upon carefully weighing up expected benefits with the risk of undesired, adverse effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjjaBcy_MZNrVg90H21EOLACvtfcHk0ljSFZKaaHHd4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVSqs7%252FP&md5=3082998a6532fd79b28011ae3c09b18c</span></div><a href="/servlet/linkout?suffix=cit7c&amp;dbid=16384&amp;doi=10.1007%2Fs40266-015-0291-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40266-015-0291-8%26sid%3Dliteratum%253Aachs%26aulast%3DRossi%26aufirst%3DA.%2BP.%26aulast%3DZanardi%26aufirst%3DE.%26aulast%3DZamboni%26aufirst%3DM.%26aulast%3DRossi%26aufirst%3DA.%26atitle%3DOptimizing%2520treatment%2520of%2520elderly%2520COPD%2520patients%253A%2520what%2520role%2520for%2520inhaled%2520corticosteroids%253F%26jtitle%3DDrugs%2520Aging%26date%3D2015%26volume%3D32%26spage%3D679%26epage%3D687%26doi%3D10.1007%2Fs40266-015-0291-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Barnes, P. J.</span><span> </span><span class="NLM_article-title">Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease</span> <span class="citation_source-journal">J. Allergy Clin. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">131</span><span class="NLM_x">, </span> <span class="NLM_fpage">636</span><span class="NLM_x">–</span> <span class="NLM_lpage">645</span><span class="refDoi"> DOI: 10.1016/j.jaci.2012.12.1564</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=10.1016%2Fj.jaci.2012.12.1564" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=23360759" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFWmtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2013&pages=636-645&author=P.+J.+Barnes&title=Corticosteroid+resistance+in+patients+with+asthma+and+chronic+obstructive+pulmonary+disease&doi=10.1016%2Fj.jaci.2012.12.1564"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease</span></div><div class="casAuthors">Barnes, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Allergy and Clinical Immunology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">636-645</span>CODEN:
                <span class="NLM_cas:coden">JACIBY</span>;
        ISSN:<span class="NLM_cas:issn">0091-6749</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Reduced responsiveness to the anti-inflammatory effects of corticosteroids is a major barrier to effective management of asthma in smokers and patients with severe asthma and in the majority of patients with chronic obstructive pulmonary disease (COPD).  The mol. mechanisms leading to steroid resistance are now better understood, and this has identified new targets for therapy.  In patients with severe asthma, several mol. mechanisms have been identified that might account for reduced steroid responsiveness, including reduced nuclear translocation of glucocorticoid receptor (GR) α after binding corticosteroids.  This might be due to modification of the GR by means of phosphorylation as a result of activation of several kinases (p38 mitogen-activated protein kinase α, p38 mitogen-activated protein kinase γ, and c-Jun N-terminal kinase 1), which in turn might be due to reduced activity and expression of phosphatases, such as mitogen-activated protein kinase phosphatase 1 and protein phosphatase A2.  Other mechanisms proposed include increased expression of GRβ, which competes with and thus inhibits activated GRα; increased secretion of macrophage migration inhibitory factor; competition with the transcription factor activator protein 1; and reduced expression of histone deacetylase (HDAC) 2.  HDAC2 appears to mediate the action of steroids to switch off activated inflammatory genes, but in patients with COPD, patients with severe asthma, and smokers with asthma, HDAC2 activity and expression are reduced by oxidative stress through activation of phosphoinositide 3-kinase δ.  Strategies for managing steroid resistance include alternative anti-inflammatory drugs, but a novel approach is to reverse steroid resistance by increasing HDAC2 expression, which can be achieved with theophylline and phosphoinositide 3-kinase δ inhibitors.  Long-acting β2-agonists can also increase steroid responsiveness by reversing GRα phosphorylation.  Identifying the mol. mechanisms of steroid resistance in asthmatic patients and patients with COPD can thus lead to more effective anti-inflammatory treatments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7NxvF8RwhRrVg90H21EOLACvtfcHk0lhRVWuDD2P1Dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFWmtrY%253D&md5=b9f464c23387722c42b85280cc106d07</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.jaci.2012.12.1564&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jaci.2012.12.1564%26sid%3Dliteratum%253Aachs%26aulast%3DBarnes%26aufirst%3DP.%2BJ.%26atitle%3DCorticosteroid%2520resistance%2520in%2520patients%2520with%2520asthma%2520and%2520chronic%2520obstructive%2520pulmonary%2520disease%26jtitle%3DJ.%2520Allergy%2520Clin.%2520Immunol.%26date%3D2013%26volume%3D131%26spage%3D636%26epage%3D645%26doi%3D10.1016%2Fj.jaci.2012.12.1564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Hemmerling, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lepisto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ivanova, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahmen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rehwinkel, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendrickx, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dearman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wissler, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansson, T.</span><span> </span><span class="NLM_article-title">Discovery of indazole ethers as novel, potent, non-steroidal glucocorticoid receptor modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">5741</span><span class="NLM_x">–</span> <span class="NLM_lpage">5748</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2016.10.052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=10.1016%2Fj.bmcl.2016.10.052" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=27810243" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslygurvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=5741-5748&author=M.+Hemmerlingauthor=K.+Edmanauthor=M.+Lepistoauthor=A.+Erikssonauthor=S.+Ivanovaauthor=J.+Dahmenauthor=H.+Rehwinkelauthor=M.+Bergerauthor=R.+Hendrickxauthor=M.+Dearmanauthor=T.+J.+Jensenauthor=L.+Wisslerauthor=T.+Hansson&title=Discovery+of+indazole+ethers+as+novel%2C+potent%2C+non-steroidal+glucocorticoid+receptor+modulators&doi=10.1016%2Fj.bmcl.2016.10.052"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of indazole ethers as novel, potent, non-steroidal glucocorticoid receptor modulators</span></div><div class="casAuthors">Hemmerling, Martin; Edman, Karl; Lepistoe, Matti; Eriksson, Anders; Ivanova, Svetlana; Dahmen, Jan; Rehwinkel, Hartmut; Berger, Markus; Hendrickx, Ramon; Dearman, Matthew; Jensen, Tina Jellesmark; Wissler, Lisa; Hansson, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">5741-5748</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A structure-based design approach led to the identification of a novel class of indazole ether based, non-steroidal glucocorticoid receptor (GR) modulators.  Several examples were identified that displayed cell potency in the picomolar range, inhibiting LPS-induced TNF-α release by primary peripheral blood mononuclear cells (PBMCs).  Addnl., an improved steroid hormone receptor binding selectivity profile, compared to classical steroidal GR agonists, was demonstrated.  The indazole ether core tolerated a broad range of substituents allowing for modulation of the physiochem. parameters.  A small sub-set of indazole ethers, with pharmacokinetic properties suitable for oral administration, was investigated in a rat antigen-induced joint inflammation model and demonstrated excellent anti-inflammatory efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvuqQEmlkDK7Vg90H21EOLACvtfcHk0lhRVWuDD2P1Dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslygurvM&md5=e380906833269e83d54ca04b96b74dfc</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.10.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.10.052%26sid%3Dliteratum%253Aachs%26aulast%3DHemmerling%26aufirst%3DM.%26aulast%3DEdman%26aufirst%3DK.%26aulast%3DLepisto%26aufirst%3DM.%26aulast%3DEriksson%26aufirst%3DA.%26aulast%3DIvanova%26aufirst%3DS.%26aulast%3DDahmen%26aufirst%3DJ.%26aulast%3DRehwinkel%26aufirst%3DH.%26aulast%3DBerger%26aufirst%3DM.%26aulast%3DHendrickx%26aufirst%3DR.%26aulast%3DDearman%26aufirst%3DM.%26aulast%3DJensen%26aufirst%3DT.%2BJ.%26aulast%3DWissler%26aufirst%3DL.%26aulast%3DHansson%26aufirst%3DT.%26atitle%3DDiscovery%2520of%2520indazole%2520ethers%2520as%2520novel%252C%2520potent%252C%2520non-steroidal%2520glucocorticoid%2520receptor%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D5741%26epage%3D5748%26doi%3D10.1016%2Fj.bmcl.2016.10.052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Biggadike, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uings, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrow, S. N.</span><span> </span><span class="NLM_article-title">Designing corticosteroid drugs for pulmonary selectivity</span> <span class="citation_source-journal">Proc. Am. Thorac. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">352</span><span class="NLM_x">–</span> <span class="NLM_lpage">355</span><span class="refDoi"> DOI: 10.1513/pats.200409-048TA</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=10.1513%2Fpats.200409-048TA" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=16113457" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsFGjsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2004&pages=352-355&author=K.+Biggadikeauthor=I.+Uingsauthor=S.+N.+Farrow&title=Designing+corticosteroid+drugs+for+pulmonary+selectivity&doi=10.1513%2Fpats.200409-048TA"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10aR"><div class="casContent"><span class="casTitleNuber">10a</span><div class="casTitle"><span class="NLM_cas:atitle">Designing corticosteroid drugs for pulmonary selectivity</span></div><div class="casAuthors">Biggadike, Keith; Uings, Iain; Farrow, Stuart N.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the American Thoracic Society</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">352-355</span>CODEN:
                <span class="NLM_cas:coden">PATSBB</span>;
        ISSN:<span class="NLM_cas:issn">1546-3222</span>.
    
            (<span class="NLM_cas:orgname">American Thoracic Society</span>)
        </div><div class="casAbstract">A review.  Inhaled corticosteroids have become indispensable for the treatment of asthma and chronic obstructive pulmonary disease.  Significant progress has been made toward minimizing side effects through the use of increasingly selective mols., and through a variety of lung targeting strategies.  Many of these developments have occurred in advance of a greatly improved understanding of corticosteroid biol. at the mol. and pharmacol. level, and it has become clear that addnl. opportunities exist for the further enhancement of therapeutic index.  This article discusses significant recent developments in the chem., biol., and pharmacol. of corticosteroids, and considers the implications for the future use of inhaled corticosteroids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIFZ3xjxbEJbVg90H21EOLACvtfcHk0lhRVWuDD2P1Dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsFGjsLY%253D&md5=096a442d16e6fb9a3bf5203846348d9d</span></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1513%2Fpats.200409-048TA&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1513%252Fpats.200409-048TA%26sid%3Dliteratum%253Aachs%26aulast%3DBiggadike%26aufirst%3DK.%26aulast%3DUings%26aufirst%3DI.%26aulast%3DFarrow%26aufirst%3DS.%2BN.%26atitle%3DDesigning%2520corticosteroid%2520drugs%2520for%2520pulmonary%2520selectivity%26jtitle%3DProc.%2520Am.%2520Thorac.%2520Soc.%26date%3D2004%26volume%3D1%26spage%3D352%26epage%3D355%26doi%3D10.1513%2Fpats.200409-048TA" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Millan, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunnage, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butcher, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodd, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairman, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kilty, I. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemaitre, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewthwaite, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahnke, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathias, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philip, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefaniak, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeadon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, C.</span><span> </span><span class="NLM_article-title">Design and synthesis of inhaled p38 inhibitors for the treatment of chronic obstructive pulmonary disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">7797</span><span class="NLM_x">–</span> <span class="NLM_lpage">7814</span><span class="refDoi"> DOI: 10.1021/jm200677b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200677b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlOqu73E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=7797-7814&author=D.+S.+Millanauthor=M.+E.+Bunnageauthor=J.+L.+Burrowsauthor=K.+J.+Butcherauthor=P.+G.+Doddauthor=T.+J.+Evansauthor=D.+A.+Fairmanauthor=S.+J.+Hughesauthor=I.+C.+Kiltyauthor=A.+Lemaitreauthor=R.+A.+Lewthwaiteauthor=A.+Mahnkeauthor=J.+P.+Mathiasauthor=J.+Philipauthor=R.+T.+Smithauthor=M.+H.+Stefaniakauthor=M.+Yeadonauthor=C.+Phillips&title=Design+and+synthesis+of+inhaled+p38+inhibitors+for+the+treatment+of+chronic+obstructive+pulmonary+disease&doi=10.1021%2Fjm200677b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10bR"><div class="casContent"><span class="casTitleNuber">10b</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of Inhaled p38 Inhibitors for the Treatment of Chronic Obstructive Pulmonary Disease</span></div><div class="casAuthors">Millan, David S.; Bunnage, Mark E.; Burrows, Jane L.; Butcher, Kenneth J.; Dodd, Peter G.; Evans, Timothy J.; Fairman, David A.; Hughes, Samantha J.; Kilty, Iain C.; Lemaitre, Arnaud; Lewthwaite, Russell A.; Mahnke, Axel; Mathias, John P.; Philip, James; Smith, Robert T.; Stefaniak, Mark H.; Yeadon, Michael; Phillips, Christopher</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7797-7814</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This paper describes the identification and optimization of a novel series of DFG-out binding p38 inhibitors as inhaled agents for the treatment of chronic obstructive pulmonary disease.  Structure based drug design and "inhalation by design" principles have been applied to the optimization of the lead series exemplified by compd. I.  Analogs have been designed to be potent and selective for p38, with an emphasis on slow enzyme dissocn. kinetics to deliver prolonged lung p38 inhibition.  Pharmacokinetic properties were tuned with high intrinsic clearance and low oral bioavailability in mind, to minimize systemic exposure and reduce systemically driven adverse events.  High CYP mediated clearance and glucuronidation were targeted to achieve high intrinsic clearance coupled with multiple routes of clearance to minimize drug-drug interactions.  Furthermore, pharmaceutical properties such as stability, crystallinity, and soly. were considered to ensure compatibility with a dry powder inhaler.  P38 Inhibitor II (PF-03715455) was subsequently identified as a clin. candidate from this series with efficacy and safety profiles confirming its potential as an inhaled agent for the treatment of COPD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzy5ivwDBL6rVg90H21EOLACvtfcHk0lgi-crbtEGvVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlOqu73E&md5=9bc6cccf04a78831f50fb402bf7cb4b1</span></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.1021%2Fjm200677b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200677b%26sid%3Dliteratum%253Aachs%26aulast%3DMillan%26aufirst%3DD.%2BS.%26aulast%3DBunnage%26aufirst%3DM.%2BE.%26aulast%3DBurrows%26aufirst%3DJ.%2BL.%26aulast%3DButcher%26aufirst%3DK.%2BJ.%26aulast%3DDodd%26aufirst%3DP.%2BG.%26aulast%3DEvans%26aufirst%3DT.%2BJ.%26aulast%3DFairman%26aufirst%3DD.%2BA.%26aulast%3DHughes%26aufirst%3DS.%2BJ.%26aulast%3DKilty%26aufirst%3DI.%2BC.%26aulast%3DLemaitre%26aufirst%3DA.%26aulast%3DLewthwaite%26aufirst%3DR.%2BA.%26aulast%3DMahnke%26aufirst%3DA.%26aulast%3DMathias%26aufirst%3DJ.%2BP.%26aulast%3DPhilip%26aufirst%3DJ.%26aulast%3DSmith%26aufirst%3DR.%2BT.%26aulast%3DStefaniak%26aufirst%3DM.%2BH.%26aulast%3DYeadon%26aufirst%3DM.%26aulast%3DPhillips%26aufirst%3DC.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520inhaled%2520p38%2520inhibitors%2520for%2520the%2520treatment%2520of%2520chronic%2520obstructive%2520pulmonary%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D7797%26epage%3D7814%26doi%3D10.1021%2Fjm200677b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Cooper, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferguson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grime, K.</span><span> </span><span class="NLM_article-title">Optimisation of DMPK by the inhaled route: challenges and approaches</span> <span class="citation_source-journal">Curr. Drug Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">457</span><span class="NLM_x">–</span> <span class="NLM_lpage">473</span><span class="refDoi"> DOI: 10.2174/138920012800166571</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=10.2174%2F138920012800166571" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=22299825" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=1%3ACAS%3A528%3ADC%252BC38XmsVeitbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=457-473&author=A.+E.+Cooperauthor=D.+Fergusonauthor=K.+Grime&title=Optimisation+of+DMPK+by+the+inhaled+route%3A+challenges+and+approaches&doi=10.2174%2F138920012800166571"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10cR"><div class="casContent"><span class="casTitleNuber">10c</span><div class="casTitle"><span class="NLM_cas:atitle">Optimisation of DMPK by the inhaled route: challenges and approaches</span></div><div class="casAuthors">Cooper, Anne E.; Ferguson, Douglas; Grime, Ken</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">457-473</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The renewed interest in inhalation delivery over recent years has led to an expansion in the understanding of lung pharmacokinetics.  Historically optimization of inhaled drugs focused largely on development of material properties, consistent with achieving a good lung deposition, alongside demonstrating appropriate in vivo efficacy with little understanding of the relationship to pharmacokinetics in the lung.  Recent efforts have led to an increased understanding of lung concns. and how to maximize exposure to achieve the desired pharmacol. response at a dose consistent with development of an inhaled product.  Although there is a prerequisite for excellent potency in inhalation delivery, it is essential that this be combined with pharmacokinetic properties that allow sufficient free concn. at the effect site in lung to exert the pharmacol. response for an appropriate dosing interval.  Increases in basicity, polarity and/or decreases in aq. soly. can extend pharmacokinetic duration and assist in finding the right balance between lung and systemic exposure.  Current evidence suggests there are similarities in lung retention in rat and dog and that animal lung concn. data can enable pharmacokinetic-pharmacodynamic relationships to be derived thus providing more confidence in the requirements for man.  Although inhaled delivery is challenging from a pharmacokinetic point of view, direct evaluation of exposure in the target organ has enabled further understanding of the drivers for drug disposition and highlighted the need for further development of predictive lung pharmacokinetic tools in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxztkVtHyCeLVg90H21EOLACvtfcHk0lgi-crbtEGvVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmsVeitbg%253D&md5=1dec4f52aeda55fe6ea888c289216d94</span></div><a href="/servlet/linkout?suffix=cit10c&amp;dbid=16384&amp;doi=10.2174%2F138920012800166571&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138920012800166571%26sid%3Dliteratum%253Aachs%26aulast%3DCooper%26aufirst%3DA.%2BE.%26aulast%3DFerguson%26aufirst%3DD.%26aulast%3DGrime%26aufirst%3DK.%26atitle%3DOptimisation%2520of%2520DMPK%2520by%2520the%2520inhaled%2520route%253A%2520challenges%2520and%2520approaches%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2012%26volume%3D13%26spage%3D457%26epage%3D473%26doi%3D10.2174%2F138920012800166571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Tayab, Z. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hochhaus, G.</span><span> </span><span class="NLM_article-title">Pharmacokinetic/pharmacodynamic evaluation of inhalation drugs: application to targeted pulmonary delivery systems</span> <span class="citation_source-journal">Expert Opin. Drug Delivery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">519</span><span class="NLM_x">–</span> <span class="NLM_lpage">532</span><span class="refDoi"> DOI: 10.1517/17425247.2.3.519</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=10.1517%2F17425247.2.3.519" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=519-532&author=Z.+R.+Tayabauthor=G.+Hochhaus&title=Pharmacokinetic%2Fpharmacodynamic+evaluation+of+inhalation+drugs%3A+application+to+targeted+pulmonary+delivery+systems&doi=10.1517%2F17425247.2.3.519"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10d&amp;dbid=16384&amp;doi=10.1517%2F17425247.2.3.519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425247.2.3.519%26sid%3Dliteratum%253Aachs%26aulast%3DTayab%26aufirst%3DZ.%2BR.%26aulast%3DHochhaus%26aufirst%3DG.%26atitle%3DPharmacokinetic%252Fpharmacodynamic%2520evaluation%2520of%2520inhalation%2520drugs%253A%2520application%2520to%2520targeted%2520pulmonary%2520delivery%2520systems%26jtitle%3DExpert%2520Opin.%2520Drug%2520Delivery%26date%3D2005%26volume%3D2%26spage%3D519%26epage%3D532%26doi%3D10.1517%2F17425247.2.3.519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Claus, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiewe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friess, W.</span><span> </span><span class="NLM_article-title">How can we bring high drug doses to the lung?</span> <span class="citation_source-journal">Eur. J. Pharm. Biopharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">6</span><span class="refDoi"> DOI: 10.1016/j.ejpb.2013.11.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=10.1016%2Fj.ejpb.2013.11.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=24300444" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=1%3ACAS%3A528%3ADC%252BC3sXitVSgsrzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2014&pages=1-6&author=S.+Clausauthor=C.+Weilerauthor=J.+Schieweauthor=W.+Friess&title=How+can+we+bring+high+drug+doses+to+the+lung%3F&doi=10.1016%2Fj.ejpb.2013.11.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">How can we bring high drug doses to the lung?</span></div><div class="casAuthors">Claus, Sarah; Weiler, Claudius; Schiewe, Joerg; Friess, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutics and Biopharmaceutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-6</span>CODEN:
                <span class="NLM_cas:coden">EJPBEL</span>;
        ISSN:<span class="NLM_cas:issn">0939-6411</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  In the last decades, dry powder inhalation has become a very attractive option for pulmonary drug delivery to treat lung diseases like cystic fibroses and lung infections.  In contrast to the traditional pulmonary application of drugs for asthma and chronic obstructive pulmonary disease, these therapies require higher lung doses to be administered.  The developments and improvements toward high dose powder pulmonary drug delivery are summarized and discussed in this chapter.  These include the invention and improvement of novel inhaler devices as well as the further development of formulation principles and new powder engineering methods.  The implementation of these strategies is subsequently described for some prototypes and formulations in research and development stage as well as for already marketed dry powder products.  Finally, possible adverse effects that can occur after inhalation of high powder doses are shortly addressed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqV5Llh5PaWsrVg90H21EOLACvtfcHk0lgi-crbtEGvVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXitVSgsrzN&md5=a0bd5801e0c672b787282b3c2636a1df</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.ejpb.2013.11.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejpb.2013.11.005%26sid%3Dliteratum%253Aachs%26aulast%3DClaus%26aufirst%3DS.%26aulast%3DWeiler%26aufirst%3DC.%26aulast%3DSchiewe%26aufirst%3DJ.%26aulast%3DFriess%26aufirst%3DW.%26atitle%3DHow%2520can%2520we%2520bring%2520high%2520drug%2520doses%2520to%2520the%2520lung%253F%26jtitle%3DEur.%2520J.%2520Pharm.%2520Biopharm.%26date%3D2014%26volume%3D86%26spage%3D1%26epage%3D6%26doi%3D10.1016%2Fj.ejpb.2013.11.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blomgren, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ekholm, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edsbaecker, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hochhaus, G.</span><span> </span><span class="NLM_article-title">Budesonide and ciclesonide: effect of tissue binding on pulmonary receptor binding</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">1421</span><span class="NLM_x">–</span> <span class="NLM_lpage">1426</span><span class="refDoi"> DOI: 10.1124/dmd.108.026039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=10.1124%2Fdmd.108.026039" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2009&pages=1421-1426&author=K.+Wuauthor=A.+L.+Blomgrenauthor=K.+Ekholmauthor=B.+Weberauthor=S.+Edsbaeckerauthor=G.+Hochhaus&title=Budesonide+and+ciclesonide%3A+effect+of+tissue+binding+on+pulmonary+receptor+binding&doi=10.1124%2Fdmd.108.026039"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=10.1124%2Fdmd.108.026039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.108.026039%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DK.%26aulast%3DBlomgren%26aufirst%3DA.%2BL.%26aulast%3DEkholm%26aufirst%3DK.%26aulast%3DWeber%26aufirst%3DB.%26aulast%3DEdsbaecker%26aufirst%3DS.%26aulast%3DHochhaus%26aufirst%3DG.%26atitle%3DBudesonide%2520and%2520ciclesonide%253A%2520effect%2520of%2520tissue%2520binding%2520on%2520pulmonary%2520receptor%2520binding%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2009%26volume%3D37%26spage%3D1421%26epage%3D1426%26doi%3D10.1124%2Fdmd.108.026039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Schmidt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derendorf, H.</span><span> </span><span class="NLM_article-title">Significance of protein binding in pharmacokinetics and pharmacodynamics</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">1107</span><span class="NLM_x">–</span> <span class="NLM_lpage">1122</span><span class="refDoi"> DOI: 10.1002/jps.21916</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=10.1002%2Fjps.21916" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=19852037" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmvVGisA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2010&pages=1107-1122&author=S.+Schmidtauthor=D.+Gonzalezauthor=H.+Derendorf&title=Significance+of+protein+binding+in+pharmacokinetics+and+pharmacodynamics&doi=10.1002%2Fjps.21916"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12bR"><div class="casContent"><span class="casTitleNuber">12b</span><div class="casTitle"><span class="NLM_cas:atitle">Significance of protein binding in pharmacokinetics and pharmacodynamics</span></div><div class="casAuthors">Schmidt, Stephan; Gonzalez, Daniel; Derendorf, Hartmut</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1107-1122</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  The significance of plasma protein binding on drug efficacy and, subsequently, the clin. relevance of changes in protein binding has been controversially discussed for decades.  The uncertainty concerning the impact of plasma protein binding on a drug's pharmacol. activity is, in part, related to the approach used when investigating and interpreting protein binding effects in vitro and in vivo.  Frequently, a generalized one-size-fits-all approach, such as "protein binding does matter/does not matter," may not be applicable.  An appropriate anal. requires careful consideration of both pharmacokinetic and pharmacodynamic processes, as they both contribute to the safety and efficacy of drugs.  Therefore, the aim of this article is to provide a concise review of the theor. concepts of protein binding, and to discuss relevant examples where applicable. © 2009 Wiley-Liss, Inc. and the American Pharmacists Assocn. J Pharm Sci 99: 1107-1122, 2010.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohMNppQyZR1rVg90H21EOLACvtfcHk0lhkEtbVQs9gUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmvVGisA%253D%253D&md5=5de129d76e3beb35b73d31de0bc831d2</span></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=10.1002%2Fjps.21916&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.21916%26sid%3Dliteratum%253Aachs%26aulast%3DSchmidt%26aufirst%3DS.%26aulast%3DGonzalez%26aufirst%3DD.%26aulast%3DDerendorf%26aufirst%3DH.%26atitle%3DSignificance%2520of%2520protein%2520binding%2520in%2520pharmacokinetics%2520and%2520pharmacodynamics%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2010%26volume%3D99%26spage%3D1107%26epage%3D1122%26doi%3D10.1002%2Fjps.21916" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Belvisi, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bundschuh, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoeck, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wicks, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Underwood, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Battram, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haddad, E. -B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webber, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, M. L.</span><span> </span><span class="NLM_article-title">Preclinical profile of ciclesonide, a novel corticosteroid for the treatment of asthma</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">314</span><span class="NLM_x">, </span> <span class="NLM_fpage">568</span><span class="NLM_x">–</span> <span class="NLM_lpage">574</span><span class="refDoi"> DOI: 10.1124/jpet.105.085217</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=10.1124%2Fjpet.105.085217" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=15878996" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=1%3ACAS%3A528%3ADC%252BD2MXntVSisr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=314&publication_year=2005&pages=568-574&author=M.+G.+Belvisiauthor=D.+S.+Bundschuhauthor=M.+Stoeckauthor=S.+Wicksauthor=S.+Underwoodauthor=C.+H.+Battramauthor=E.+-B.+Haddadauthor=S.+E.+Webberauthor=M.+L.+Foster&title=Preclinical+profile+of+ciclesonide%2C+a+novel+corticosteroid+for+the+treatment+of+asthma&doi=10.1124%2Fjpet.105.085217"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical profile of ciclesonide, a novel corticosteroid for the treatment of asthma</span></div><div class="casAuthors">Belvisi, Maria G.; Bundschuh, Daniela S.; Stoeck, Michael; Wicks, Sharon; Underwood, Stephen; Battram, Clifford H.; El-Bdaoui, Haddad; Webber, Stephen E.; Foster, Martyn L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">314</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">568-574</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Ciclesonide is a novel, inhaled corticosteroid under development for the treatment of asthma.  Ciclesonide is activated to desisobutyryl-ciclesonide (des-CIC) in the lungs to provide potent anti-inflammatory activity.  The investigations herein compared the activity of ciclesonide with fluticasone in animal models to assess efficacy/potency as an airway anti-inflammatory and the comparative side effect potential to consider the therapeutic ratio of each compd.  In radioligand binding assays, des-CIC and fluticasone exhibited comparable high-affinity binding to the glucocorticoid receptor, whereas ciclesonide exhibited 100-fold less binding affinity.  In the Brown Norway rat model of antigen-induced airway eosinophilia and in a model of Sephadex-induced lung edema, ciclesonide and fluticasone exhibited comparable efficacy.  Interestingly, following 7-day intratracheal administration, ciclesonide elicited adrenal involution with a potency that was 44-fold less than fluticasone.  Furthermore, ciclesonide was 22-fold less active than fluticasone in eliciting hypoplasia of the femoral growth plate.  These data support the concept that ciclesonide acts as a parent compd. that, when delivered to the airways, can be transformed into the active metabolite des-CIC, resulting in local high anti-inflammatory activity.  Furthermore, ciclesonide possesses equiv. anti-inflammatory efficacy through pulmonary activation with a significantly improved safety profile in preclin. animal models compared with fluticasone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocDeoKkmEWTrVg90H21EOLACvtfcHk0lhkEtbVQs9gUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXntVSisr8%253D&md5=c883d33797cddbcdcb0188f355e9ba0e</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1124%2Fjpet.105.085217&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.105.085217%26sid%3Dliteratum%253Aachs%26aulast%3DBelvisi%26aufirst%3DM.%2BG.%26aulast%3DBundschuh%26aufirst%3DD.%2BS.%26aulast%3DStoeck%26aufirst%3DM.%26aulast%3DWicks%26aufirst%3DS.%26aulast%3DUnderwood%26aufirst%3DS.%26aulast%3DBattram%26aufirst%3DC.%2BH.%26aulast%3DHaddad%26aufirst%3DE.%2B-B.%26aulast%3DWebber%26aufirst%3DS.%2BE.%26aulast%3DFoster%26aufirst%3DM.%2BL.%26atitle%3DPreclinical%2520profile%2520of%2520ciclesonide%252C%2520a%2520novel%2520corticosteroid%2520for%2520the%2520treatment%2520of%2520asthma%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2005%26volume%3D314%26spage%3D568%26epage%3D574%26doi%3D10.1124%2Fjpet.105.085217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Conrad, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsiao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, R.</span><span> </span><span class="NLM_article-title">A practical one-pot process for α-amino aryl ketone synthesis</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">8587</span><span class="NLM_x">–</span> <span class="NLM_lpage">8589</span><span class="refDoi"> DOI: 10.1016/j.tetlet.2005.09.183</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=10.1016%2Fj.tetlet.2005.09.183" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFOrs7fM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2005&pages=8587-8589&author=K.+Conradauthor=Y.+Hsiaoauthor=R.+Miller&title=A+practical+one-pot+process+for+%CE%B1-amino+aryl+ketone+synthesis&doi=10.1016%2Fj.tetlet.2005.09.183"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">A practical one-pot process for α-amino aryl ketone synthesis</span></div><div class="casAuthors">Conrad, Karen; Hsiao, Yi; Miller, Ross</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">8587-8589</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">An efficient, convenient, high-yielding synthesis of α-amino aryl ketones (S)-RCOCHMeNHCbz (R = Ph, 2-MeC6H4, 3-MeOC6H4, 4-NCC6H4, 3-pyridyl, 2-thiazolyl, etc., Cbz = PhCH2O2C) is described, involving the one-pot deprotonation-transmetalation-arylation of Weinreb amide (S)-MeONMeCOCHMeNHCbz while retaining chirality of the original amide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSZrNG15mhfrVg90H21EOLACvtfcHk0lhkEtbVQs9gUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFOrs7fM&md5=9c915b629f1c7c42b56a78ace525a9ae</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2005.09.183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2005.09.183%26sid%3Dliteratum%253Aachs%26aulast%3DConrad%26aufirst%3DK.%26aulast%3DHsiao%26aufirst%3DY.%26aulast%3DMiller%26aufirst%3DR.%26atitle%3DA%2520practical%2520one-pot%2520process%2520for%2520%25CE%25B1-amino%2520aryl%2520ketone%2520synthesis%26jtitle%3DTetrahedron%2520Lett.%26date%3D2005%26volume%3D46%26spage%3D8587%26epage%3D8589%26doi%3D10.1016%2Fj.tetlet.2005.09.183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Yin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huffman, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conrad, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armstrong, J. D.,  3rd</span><span> </span><span class="NLM_article-title">Highly diastereoselective catalytic Meerwein-Ponndorf-Verley reductions</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">840</span><span class="NLM_x">–</span> <span class="NLM_lpage">843</span><span class="refDoi"> DOI: 10.1021/jo052121t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo052121t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2006&pages=840-843&author=J.+Yinauthor=M.+A.+Huffmanauthor=K.+M.+Conradauthor=J.+D.+Armstrong&title=Highly+diastereoselective+catalytic+Meerwein-Ponndorf-Verley+reductions&doi=10.1021%2Fjo052121t"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjo052121t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo052121t%26sid%3Dliteratum%253Aachs%26aulast%3DYin%26aufirst%3DJ.%26aulast%3DHuffman%26aufirst%3DM.%2BA.%26aulast%3DConrad%26aufirst%3DK.%2BM.%26aulast%3DArmstrong%26aufirst%3DJ.%2BD.%26atitle%3DHighly%2520diastereoselective%2520catalytic%2520Meerwein-Ponndorf-Verley%2520reductions%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2006%26volume%3D71%26spage%3D840%26epage%3D843%26doi%3D10.1021%2Fjo052121t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Davies, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doisneau, G. J.-M.</span><span> </span><span class="NLM_article-title">Base induced C-5 epimerisation of 4-methyl-5-phenyl oxazolidinones: chiral auxiliaries derived from norephedrine and norpseudoephedrine</span> <span class="citation_source-journal">Tetrahedron: Asymmetry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">2513</span><span class="NLM_x">–</span> <span class="NLM_lpage">2516</span><span class="refDoi"> DOI: 10.1016/S0957-4166(00)82231-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=10.1016%2FS0957-4166%2800%2982231-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1993&pages=2513-2516&author=S.+G.+Daviesauthor=G.+J.-M.+Doisneau&title=Base+induced+C-5+epimerisation+of+4-methyl-5-phenyl+oxazolidinones%3A+chiral+auxiliaries+derived+from+norephedrine+and+norpseudoephedrine&doi=10.1016%2FS0957-4166%2800%2982231-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2FS0957-4166%2800%2982231-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0957-4166%252800%252982231-4%26sid%3Dliteratum%253Aachs%26aulast%3DDavies%26aufirst%3DS.%2BG.%26aulast%3DDoisneau%26aufirst%3DG.%2BJ.-M.%26atitle%3DBase%2520induced%2520C-5%2520epimerisation%2520of%25204-methyl-5-phenyl%2520oxazolidinones%253A%2520chiral%2520auxiliaries%2520derived%2520from%2520norephedrine%2520and%2520norpseudoephedrine%26jtitle%3DTetrahedron%253A%2520Asymmetry%26date%3D1993%26volume%3D4%26spage%3D2513%26epage%3D2516%26doi%3D10.1016%2FS0957-4166%2800%2982231-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Job, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchwald, S. L.</span><span> </span><span class="NLM_article-title">Copper-catalyzed arylation of beta-amino alcohols</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">3703</span><span class="NLM_x">–</span> <span class="NLM_lpage">3706</span><span class="refDoi"> DOI: 10.1021/ol026655h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol026655h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2002&pages=3703-3706&author=G.+E.+Jobauthor=S.+L.+Buchwald&title=Copper-catalyzed+arylation+of+beta-amino+alcohols&doi=10.1021%2Fol026655h"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fol026655h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol026655h%26sid%3Dliteratum%253Aachs%26aulast%3DJob%26aufirst%3DG.%2BE.%26aulast%3DBuchwald%26aufirst%3DS.%2BL.%26atitle%3DCopper-catalyzed%2520arylation%2520of%2520beta-amino%2520alcohols%26jtitle%3DOrg.%2520Lett.%26date%3D2002%26volume%3D4%26spage%3D3703%26epage%3D3706%26doi%3D10.1021%2Fol026655h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Edsbacker, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonsson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindberg, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryrfeldt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thalen, A.</span><span> </span><span class="NLM_article-title">Metabolic pathways of the topical glucocorticoid budesonide in man</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">590</span><span class="NLM_x">–</span> <span class="NLM_lpage">596</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1983&pages=590-596&author=S.+Edsbackerauthor=S.+Jonssonauthor=C.+Lindbergauthor=A.+Ryrfeldtauthor=A.+Thalen&title=Metabolic+pathways+of+the+topical+glucocorticoid+budesonide+in+man"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEdsbacker%26aufirst%3DS.%26aulast%3DJonsson%26aufirst%3DS.%26aulast%3DLindberg%26aufirst%3DC.%26aulast%3DRyrfeldt%26aufirst%3DA.%26aulast%3DThalen%26aufirst%3DA.%26atitle%3DMetabolic%2520pathways%2520of%2520the%2520topical%2520glucocorticoid%2520budesonide%2520in%2520man%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D1983%26volume%3D11%26spage%3D590%26epage%3D596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit18b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hughes, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shardlow, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollis, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Motivaras, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rousell, V. M.</span><span> </span><span class="NLM_article-title">Metabolism and disposition of fluticasone furoate, an enhanced-affinity glucocorticoid, in humans</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">2337</span><span class="NLM_x">–</span> <span class="NLM_lpage">2344</span><span class="refDoi"> DOI: 10.1124/dmd.108.022137</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=10.1124%2Fdmd.108.022137" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=18694910" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlWiu77L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2008&pages=2337-2344&author=S.+C.+Hughesauthor=P.+C.+Shardlowauthor=F.+J.+Hollisauthor=R.+J.+Scottauthor=D.+S.+Motivarasauthor=A.+Allenauthor=V.+M.+Rousell&title=Metabolism+and+disposition+of+fluticasone+furoate%2C+an+enhanced-affinity+glucocorticoid%2C+in+humans&doi=10.1124%2Fdmd.108.022137"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18bR"><div class="casContent"><span class="casTitleNuber">18b</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolism and disposition of fluticasone furoate, an enhanced-affinity glucocorticoid, in humans</span></div><div class="casAuthors">Hughes, Stephen C.; Shardlow, Peter C.; Hollis, Frank J.; Scott, Rebecca J.; Motivaras, Dimple S.; Allen, Ann; Rousell, Victoria M.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2337-2344</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The purpose of this study was to investigate the metab. and disposition of fluticasone furoate, an enhanced-affinity glucocorticoid receptor agonist, in humans.  In a two-part, open-label design study, five healthy male subjects received a p.o. dose of 2 mg of [14C]fluticasone furoate, followed 4 wk later by an i.v. dose of 0.25 mg of [14C]fluticasone furoate (as a 30-min infusion).  Oral absorption was rapid and estd. at approx. 30%, although the oral bioavailability was markedly lower at 1.6%, limited by extensive first-pass metab.  Plasma clearance was 58.3 L/h, with a vol. of distribution of 642 L and a terminal elimination half-life of 15.3 h.  The major circulating component identified in plasma exts. after i.v. and p.o. dosing was unchanged parent compd., with 17β-carboxylic acid (GW 694301X) also being notable after p.o. administration.  Mean recovery of radioactivity was approx. 92 and 102% at 216 and 168 h after i.v. and p.o. administration, resp., with most (at least 90%) recovered in the feces.  Fluticasone furoate was extensively metabolized, with only trace amts. of unchanged parent compd. obsd. in feces following either route of administration.  The predominant pathway was removal of the S-fluoromethyl carbothioate group to yield GW 694301X.  Other pathways included oxidative defluorination to yield a hydroxyl at the C6 position.  There was no evidence for metabolic loss of the furoate group from fluticasone furoate or any of its metabolites.  Evidence presented suggests that enterocytes have a role in the metab. of unabsorbed fluticasone furoate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTOa3bL8acNrVg90H21EOLACvtfcHk0lhmLo-M7TJLPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlWiu77L&md5=d51c628e6fdc783fa5fd8dc58d4cdaa6</span></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=10.1124%2Fdmd.108.022137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.108.022137%26sid%3Dliteratum%253Aachs%26aulast%3DHughes%26aufirst%3DS.%2BC.%26aulast%3DShardlow%26aufirst%3DP.%2BC.%26aulast%3DHollis%26aufirst%3DF.%2BJ.%26aulast%3DScott%26aufirst%3DR.%2BJ.%26aulast%3DMotivaras%26aufirst%3DD.%2BS.%26aulast%3DAllen%26aufirst%3DA.%26aulast%3DRousell%26aufirst%3DV.%2BM.%26atitle%3DMetabolism%2520and%2520disposition%2520of%2520fluticasone%2520furoate%252C%2520an%2520enhanced-affinity%2520glucocorticoid%252C%2520in%2520humans%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2008%26volume%3D36%26spage%3D2337%26epage%3D2344%26doi%3D10.1124%2Fdmd.108.022137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Jacobson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middleton, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmgren, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eirefelt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frojd, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blomgren, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustavsson, L.</span><span> </span><span class="NLM_article-title">An optimized automated assay for determination of metabolic stability using hepatocytes: assay validation, variance component analysis, and in vivo relevance</span> <span class="citation_source-journal">Assay Drug Dev. Technol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">403</span><span class="NLM_x">–</span> <span class="NLM_lpage">415</span><span class="refDoi"> DOI: 10.1089/adt.2007.059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=10.1089%2Fadt.2007.059" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2007&pages=403-415&author=L.+Jacobsonauthor=B.+Middletonauthor=J.+Holmgrenauthor=S.+Eirefeltauthor=M.+Frojdauthor=A.+Blomgrenauthor=L.+Gustavsson&title=An+optimized+automated+assay+for+determination+of+metabolic+stability+using+hepatocytes%3A+assay+validation%2C+variance+component+analysis%2C+and+in+vivo+relevance&doi=10.1089%2Fadt.2007.059"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1089%2Fadt.2007.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fadt.2007.059%26sid%3Dliteratum%253Aachs%26aulast%3DJacobson%26aufirst%3DL.%26aulast%3DMiddleton%26aufirst%3DB.%26aulast%3DHolmgren%26aufirst%3DJ.%26aulast%3DEirefelt%26aufirst%3DS.%26aulast%3DFrojd%26aufirst%3DM.%26aulast%3DBlomgren%26aufirst%3DA.%26aulast%3DGustavsson%26aufirst%3DL.%26atitle%3DAn%2520optimized%2520automated%2520assay%2520for%2520determination%2520of%2520metabolic%2520stability%2520using%2520hepatocytes%253A%2520assay%2520validation%252C%2520variance%2520component%2520analysis%252C%2520and%2520in%2520vivo%2520relevance%26jtitle%3DAssay%2520Drug%2520Dev.%2520Technol.%26date%3D2007%26volume%3D5%26spage%3D403%26epage%3D415%26doi%3D10.1089%2Fadt.2007.059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Sellers, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horodnik, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">House, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wylie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mauser, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donovan, B.</span><span> </span><span class="NLM_article-title">The in vitro and in vivo investigation of a novel small chamber dry powder inhalation delivery system for preclinical dosing to rats</span> <span class="citation_source-journal">Inhalation Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">706</span><span class="NLM_x">–</span> <span class="NLM_lpage">716</span><span class="refDoi"> DOI: 10.3109/08958378.2015.1089959</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=10.3109%2F08958378.2015.1089959" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=26452700" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVGmsrnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2015&pages=706-716&author=S.+Sellersauthor=W.+Horodnikauthor=A.+Houseauthor=J.+Wylieauthor=P.+Mauserauthor=B.+Donovan&title=The+in+vitro+and+in+vivo+investigation+of+a+novel+small+chamber+dry+powder+inhalation+delivery+system+for+preclinical+dosing+to+rats&doi=10.3109%2F08958378.2015.1089959"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">The in vitro and in vivo investigation of a novel small chamber dry powder inhalation delivery system for preclinical dosing to rats</span></div><div class="casAuthors">Sellers, Shari; Horodnik, Walter; House, Aileen; Wylie, Jennifer; Mauser, Peter; Donovan, Brent</div><div class="citationInfo"><span class="NLM_cas:title">Inhalation Toxicology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">706-716</span>CODEN:
                <span class="NLM_cas:coden">INHTE5</span>;
        ISSN:<span class="NLM_cas:issn">0895-8378</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Purpose: This research describes a novel "minitower" dry powder delivery system for nose-only delivery of dry powder aerosols to spontaneously breathing rats.  Methods: The minitower system forces pressurized air through pre-filled capsules to deliver aerosolized drug to four nose ports; three of which house spontaneously breathing rats, with the fourth used as a control.  Within each port are vent filters which capture drug that was not inhaled for further quantitation.  These vent filters along with a novel control system referred to as the "artificial rat lung", allow for the theor. amt. of drug delivered and subsequently inhaled by each rat to be calcd.  Results: In vitro and in vivo studies have demonstrated this system's ability to deliver aerosolized drug to rats.  The in vitro study showed that ∼30% of the starting dose reached the 4 ports and was available for inhalation.  During in-vivo studies, rats inhaled ∼34% of the delivered dose.  Of the estd. inhaled dose, 12-18% was detectable in the various tissue samples, with over 30% of the recovered dose found in the rat's lungs.  Conclusion: Results show that this system is capable of reproducibly delivering drug to the lungs of spontaneously breathing rats.  Advantages over current delivery methods include being amenable to the administration of multiple doses and using less (milligram) amt. of starting material.  In addn., this technique avoids anesthesia which is typically required for instillation or insufflation, and thus has the potential as an efficient and noninvasive aerosol delivery method for preclin. drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2YJ_QMSJKIrVg90H21EOLACvtfcHk0lgYhaX25WQmYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVGmsrnP&md5=2dca00844e7a2b54dc608c0139b122d6</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.3109%2F08958378.2015.1089959&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F08958378.2015.1089959%26sid%3Dliteratum%253Aachs%26aulast%3DSellers%26aufirst%3DS.%26aulast%3DHorodnik%26aufirst%3DW.%26aulast%3DHouse%26aufirst%3DA.%26aulast%3DWylie%26aufirst%3DJ.%26aulast%3DMauser%26aufirst%3DP.%26aulast%3DDonovan%26aufirst%3DB.%26atitle%3DThe%2520in%2520vitro%2520and%2520in%2520vivo%2520investigation%2520of%2520a%2520novel%2520small%2520chamber%2520dry%2520powder%2520inhalation%2520delivery%2520system%2520for%2520preclinical%2520dosing%2520to%2520rats%26jtitle%3DInhalation%2520Toxicol.%26date%3D2015%26volume%3D27%26spage%3D706%26epage%3D716%26doi%3D10.3109%2F08958378.2015.1089959" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Valotis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hogger, P.</span><span> </span><span class="NLM_article-title">Human receptor kinetics and lung tissue retention of the enhanced-affinity glucocorticoid fluticasone furoate</span> <span class="citation_source-journal">Respir. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">54</span><span class="refDoi"> DOI: 10.1186/1465-9921-8-54</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=10.1186%2F1465-9921-8-54" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=17650349" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=1%3ACAS%3A280%3ADC%252BD2svpsVagsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=54&author=A.+Valotisauthor=P.+Hogger&title=Human+receptor+kinetics+and+lung+tissue+retention+of+the+enhanced-affinity+glucocorticoid+fluticasone+furoate&doi=10.1186%2F1465-9921-8-54"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Human receptor kinetics and lung tissue retention of the enhanced-affinity glucocorticoid fluticasone furoate</span></div><div class="casAuthors">Valotis Anagnostis; Hogger Petra</div><div class="citationInfo"><span class="NLM_cas:title">Respiratory research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">54</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Fluticasone furoate (FF)--USAN approved name, a new topically active glucocorticoid has been recently identified.  The aim of this study was to characterise the binding affinity of this compound to the human lung glucocorticoid receptor in relation to other glucocorticoids.  Additionally, we sought to determine the binding behaviour of fluticasone furoate to human lung tissue.  The glucocorticoid receptor binding kinetics of fluticasone furoate revealed a remarkably fast association and a slow dissociation resulting in a relative receptor affinity (RRA) of 2989 +/- 135 with reference to dexamethasone (RRA: 100 +/- 5).  Thus, the RRA of FF exceeds the RRAs of all currently clinically used corticosteroids such as mometasone furoate (MF; RRA 2244), fluticasone propionate (FP; RRA 1775), ciclesonide's active metabolite (RRA 1212 - rat receptor data) or budesonide (RRA 855).  FP and FF displayed pronounced retention in human lung tissue in vitro.  Lowest tissue binding was found for MF.  There was no indication of instability or chemical modification of FF in human lung tissue.  These advantageous binding attributes may contribute to a highly efficacious profile for FF as a topical treatment for inflammatory disorders of the respiratory tract.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRu0ZxK3zk3vAwxfk_AGB-EfW6udTcc2eYEgGwdWoCdWLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2svpsVagsA%253D%253D&md5=f10e38e08cf94837bbe1969c193d8dcb</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1186%2F1465-9921-8-54&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1465-9921-8-54%26sid%3Dliteratum%253Aachs%26aulast%3DValotis%26aufirst%3DA.%26aulast%3DHogger%26aufirst%3DP.%26atitle%3DHuman%2520receptor%2520kinetics%2520and%2520lung%2520tissue%2520retention%2520of%2520the%2520enhanced-affinity%2520glucocorticoid%2520fluticasone%2520furoate%26jtitle%3DRespir.%2520Res.%26date%3D2007%26volume%3D8%26spage%3D54%26doi%3D10.1186%2F1465-9921-8-54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kallstrom, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brattsand, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovgren, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensjo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roempke, K.</span><span> </span><span class="NLM_article-title">A rat model for testing anti-inflammatory action in lung and the effect of glucocorticosteroids (GCS) in this model</span> <span class="citation_source-journal">Agents Actions</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">355</span><span class="NLM_x">–</span> <span class="NLM_lpage">357</span><span class="refDoi"> DOI: 10.1007/BF01982644</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=10.1007%2FBF01982644" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=3962784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=1%3ACAS%3A280%3ADyaL287otlersQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1986&pages=355-357&author=L.+Kallstromauthor=R.+Brattsandauthor=U.+Lovgrenauthor=E.+Svensjoauthor=K.+Roempke&title=A+rat+model+for+testing+anti-inflammatory+action+in+lung+and+the+effect+of+glucocorticosteroids+%28GCS%29+in+this+model&doi=10.1007%2FBF01982644"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22aR"><div class="casContent"><span class="casTitleNuber">22a</span><div class="casTitle"><span class="NLM_cas:atitle">A rat model for testing anti-inflammatory action in lung and the effect of glucocorticosteroids (GCS) in this model</span></div><div class="casAuthors">Kallstrom L; Brattsand R; Lovgren U; Svensjo E; Roempke K</div><div class="citationInfo"><span class="NLM_cas:title">Agents and actions</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">355-7</span>
        ISSN:<span class="NLM_cas:issn">0065-4299</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQSxDcBZCv6NwyMywPm6HgQfW6udTcc2eY3dwwsz8lparntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL287otlersQ%253D%253D&md5=c92c87e53e7e0e7674c365e06b593e24</span></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=10.1007%2FBF01982644&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF01982644%26sid%3Dliteratum%253Aachs%26aulast%3DKallstrom%26aufirst%3DL.%26aulast%3DBrattsand%26aufirst%3DR.%26aulast%3DLovgren%26aufirst%3DU.%26aulast%3DSvensjo%26aufirst%3DE.%26aulast%3DRoempke%26aufirst%3DK.%26atitle%3DA%2520rat%2520model%2520for%2520testing%2520anti-inflammatory%2520action%2520in%2520lung%2520and%2520the%2520effect%2520of%2520glucocorticosteroids%2520%2528GCS%2529%2520in%2520this%2520model%26jtitle%3DAgents%2520Actions%26date%3D1986%26volume%3D17%26spage%3D355%26epage%3D357%26doi%3D10.1007%2FBF01982644" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit22b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kubin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deschl, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linssen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilhelms, O. H.</span><span> </span><span class="NLM_article-title">Intratracheal application of Sephadex in rats leads to massive pulmonary eosinophilia without bronchial hyperreactivity to acetylcholine</span> <span class="citation_source-journal">Int. Arch. Allergy Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">266</span><span class="NLM_x">–</span> <span class="NLM_lpage">272</span><span class="refDoi"> DOI: 10.1159/000236196</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=10.1159%2F000236196" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2004&pages=266-272&author=R.+Kubinauthor=U.+Deschlauthor=M.+Linssenauthor=O.+H.+Wilhelms&title=Intratracheal+application+of+Sephadex+in+rats+leads+to+massive+pulmonary+eosinophilia+without+bronchial+hyperreactivity+to+acetylcholine&doi=10.1159%2F000236196"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=10.1159%2F000236196&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000236196%26sid%3Dliteratum%253Aachs%26aulast%3DKubin%26aufirst%3DR.%26aulast%3DDeschl%26aufirst%3DU.%26aulast%3DLinssen%26aufirst%3DM.%26aulast%3DWilhelms%26aufirst%3DO.%2BH.%26atitle%3DIntratracheal%2520application%2520of%2520Sephadex%2520in%2520rats%2520leads%2520to%2520massive%2520pulmonary%2520eosinophilia%2520without%2520bronchial%2520hyperreactivity%2520to%2520acetylcholine%26jtitle%3DInt.%2520Arch.%2520Allergy%2520Immunol.%26date%3D2004%26volume%3D98%26spage%3D266%26epage%3D272%26doi%3D10.1159%2F000236196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Gomez-Sanchez, C. E.</span><span> </span><span class="NLM_article-title">Glucocorticoid production and regulation in thymus: of mice and birds</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">150</span><span class="NLM_x">, </span> <span class="NLM_fpage">3977</span><span class="NLM_x">–</span> <span class="NLM_lpage">3979</span><span class="refDoi"> DOI: 10.1210/en.2009-0615</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=10.1210%2Fen.2009-0615" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=150&publication_year=2009&pages=3977-3979&author=C.+E.+Gomez-Sanchez&title=Glucocorticoid+production+and+regulation+in+thymus%3A+of+mice+and+birds&doi=10.1210%2Fen.2009-0615"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23a&amp;dbid=16384&amp;doi=10.1210%2Fen.2009-0615&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fen.2009-0615%26sid%3Dliteratum%253Aachs%26aulast%3DGomez-Sanchez%26aufirst%3DC.%2BE.%26atitle%3DGlucocorticoid%2520production%2520and%2520regulation%2520in%2520thymus%253A%2520of%2520mice%2520and%2520birds%26jtitle%3DEndocrinology%26date%3D2009%26volume%3D150%26spage%3D3977%26epage%3D3979%26doi%3D10.1210%2Fen.2009-0615" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit23b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Bar-Dayan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Afek, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bar-Dayan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopolovic, J.</span><span> </span><span class="NLM_article-title">Proliferation, apoptosis and thymic involution</span> <span class="citation_source-journal">Tissue Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">391</span><span class="NLM_x">–</span> <span class="NLM_lpage">396</span><span class="refDoi"> DOI: 10.1054/tice.1999.0001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=10.1054%2Ftice.1999.0001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=10522388" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=1%3ACAS%3A280%3ADyaK1MvltFyrtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1999&pages=391-396&author=Y.+Bar-Dayanauthor=A.+Afekauthor=Y.+Bar-Dayanauthor=I.+Goldbergauthor=J.+Kopolovic&title=Proliferation%2C+apoptosis+and+thymic+involution&doi=10.1054%2Ftice.1999.0001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23bR"><div class="casContent"><span class="casTitleNuber">23b</span><div class="casTitle"><span class="NLM_cas:atitle">Proliferation, apoptosis and thymic involution</span></div><div class="casAuthors">Bar-Dayan Y; Afek A; Bar-Dayan Y; Goldberg I; Kopolovic J</div><div class="citationInfo"><span class="NLM_cas:title">Tissue & cell</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">391-6</span>
        ISSN:<span class="NLM_cas:issn">0040-8166</span>.
    </div><div class="casAbstract">The thymus reaches its maximal size at the age of 1 month in ICR mice and thereafter, the thymic cortex undergoes an exponential decline.  This study was designed to compare the proliferation and apoptosis of thymocytes in different parts of the thymus of ICR female mice at the beginning and after the rapid phase of decline of the thymic cortical cellularity.  The pattern of proliferation and apoptosis of the thymus was studied in situ in 1-month-old ICR female mice (10 mice) compared to mice at 7 months of age (10 mice).  Staining for argyrophylic nucleolar organizer region by histochemistry was used to determine the proportion of type 2 thymocytes, which are considered as cells at S phase of the cell cycle.  The mean number of type 2 cells in four random samples of 50 cells in each part of the thymus was defined as the proliferation index of this part of the thymus.  In situ detection of apoptosis of thymocytes was carried out using the Apoptag kit, which can detect a single cell apoptosis.  The mean number of apoptotic cells in five randomly selected fields of each part of the thymus was defined as the apoptotic index of this part of the thymus.  The proliferation index of the peripheral cortex of the 1-month-old mice was 3.6 times higher than the proliferation index of the deep cortex and 5.8 times higher than the proliferation index of the medulla (P < 0.0001).  The proliferation index of the peripheral cortex of the 7-month-old mice was reduced by 45% compared to the 1-month-old mice (P < 0.005).  The apoptotic index of the corticomedullary junction of the 1-month-old mice was six times higher than the apoptotic index of the cortex and 18 times higher than the apoptotic index of the medulla.  The apoptotic index of the thymic cortex was elevated by 66% in the 7-month-old mice compared to the 1-month-old mice (P < 0.0001).  We conclude that there is a reduction of the proliferation index and an elevation of the apoptotic index of the thymic cortex in adult mice compared to young mice.  These changes might account for the reduction of thymic cortical cellularity during thymic involution.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRBDY3296f5KpggzHGM8X5CfW6udTcc2eY3dwwsz8lparntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1MvltFyrtA%253D%253D&md5=0386c67a288c64cae3c3f27509377852</span></div><a href="/servlet/linkout?suffix=cit23b&amp;dbid=16384&amp;doi=10.1054%2Ftice.1999.0001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1054%252Ftice.1999.0001%26sid%3Dliteratum%253Aachs%26aulast%3DBar-Dayan%26aufirst%3DY.%26aulast%3DAfek%26aufirst%3DA.%26aulast%3DBar-Dayan%26aufirst%3DY.%26aulast%3DGoldberg%26aufirst%3DI.%26aulast%3DKopolovic%26aufirst%3DJ.%26atitle%3DProliferation%252C%2520apoptosis%2520and%2520thymic%2520involution%26jtitle%3DTissue%2520Cell%26date%3D1999%26volume%3D31%26spage%3D391%26epage%3D396%26doi%3D10.1054%2Ftice.1999.0001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit23c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Vacchio, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashwell, J. D.</span><span> </span><span class="NLM_article-title">Glucocorticoids and thymocyte development</span> <span class="citation_source-journal">Semin. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">475</span><span class="NLM_x">–</span> <span class="NLM_lpage">485</span><span class="refDoi"> DOI: 10.1006/smim.2000.0265</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=10.1006%2Fsmim.2000.0265" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=11085180" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=1%3ACAS%3A528%3ADC%252BD3cXot1Cksb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2000&pages=475-485&author=M.+S.+Vacchioauthor=J.+D.+Ashwell&title=Glucocorticoids+and+thymocyte+development&doi=10.1006%2Fsmim.2000.0265"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23cR"><div class="casContent"><span class="casTitleNuber">23c</span><div class="casTitle"><span class="NLM_cas:atitle">Glucocorticoids and thymocyte development</span></div><div class="casAuthors">Vacchio, Melanie S.; Ashwell, Jonathan D.</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Immunology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">475-485</span>CODEN:
                <span class="NLM_cas:coden">SEIME2</span>;
        ISSN:<span class="NLM_cas:issn">1044-5323</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">A review with 84 refs.  The thymus has a central role in the differentiation and selection of functional T cells.  The cells that ultimately differentiate into mature T cells are derived from pluripotent hematopoietic stem cells that migrate into the thymus from either the fetal liver or bone marrow.  This review will focus on the role glucocorticoids play in mediating the cell differentiation that occurs within the thymocyte.  (c) 2000 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquUTCX2bAAdrVg90H21EOLACvtfcHk0li5NYmYgAfk_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXot1Cksb0%253D&md5=ff20d9c489239c2c53c07c5f3c0370c0</span></div><a href="/servlet/linkout?suffix=cit23c&amp;dbid=16384&amp;doi=10.1006%2Fsmim.2000.0265&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fsmim.2000.0265%26sid%3Dliteratum%253Aachs%26aulast%3DVacchio%26aufirst%3DM.%2BS.%26aulast%3DAshwell%26aufirst%3DJ.%2BD.%26atitle%3DGlucocorticoids%2520and%2520thymocyte%2520development%26jtitle%3DSemin.%2520Immunol.%26date%3D2000%26volume%3D12%26spage%3D475%26epage%3D485%26doi%3D10.1006%2Fsmim.2000.0265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Gauvreau, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boulet, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leigh, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cockcroft, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Killian, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deschesnes, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swystun, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mardh, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wessman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jorup, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aurivillius, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Byrne, P. M.</span><span> </span><span class="NLM_article-title">A nonsteroidal glucocorticoid receptor agonist inhibits allergen-induced late asthmatic responses</span> <span class="citation_source-journal">Am. J. Respir. Crit. Care Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">191</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">167</span><span class="refDoi"> DOI: 10.1164/rccm.201404-0623OC</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=10.1164%2Frccm.201404-0623OC" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=25473939" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=1%3ACAS%3A528%3ADC%252BC2MXislWht7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=191&publication_year=2015&pages=161-167&author=G.+M.+Gauvreauauthor=L.+P.+Bouletauthor=R.+Leighauthor=D.+W.+Cockcroftauthor=K.+J.+Killianauthor=B.+E.+Davisauthor=F.+Deschesnesauthor=R.+M.+Watsonauthor=V.+Swystunauthor=C.+K.+Mardhauthor=P.+Wessmanauthor=C.+Jorupauthor=M.+Aurivilliusauthor=P.+M.+O%E2%80%99Byrne&title=A+nonsteroidal+glucocorticoid+receptor+agonist+inhibits+allergen-induced+late+asthmatic+responses&doi=10.1164%2Frccm.201404-0623OC"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24aR"><div class="casContent"><span class="casTitleNuber">24a</span><div class="casTitle"><span class="NLM_cas:atitle">A nonsteroidal glucocorticoid receptor agonist inhibits allergen-induced late asthmatic responses</span></div><div class="casAuthors">Gauvreau, Gail M.; Boulet, Louis-Philippe; Leigh, Richard; Cockcroft, Donald W.; Killian, Kieran J.; Davis, Beth E.; Deschesnes, Francine; Watson, Richard M.; Swystun, Veronica; Mardh, Carina Karrman; Wessman, Peter; Jorup, Carin; Aurivillius, Magnus; O'Byrne, Paul M.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory and Critical Care Medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">191</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">161-167, 7 pp.</span>CODEN:
                <span class="NLM_cas:coden">AJCMED</span>;
        ISSN:<span class="NLM_cas:issn">1073-449X</span>.
    
            (<span class="NLM_cas:orgname">American Thoracic Society</span>)
        </div><div class="casAbstract">Rationale: Effective antiinflammatory therapies are needed for the treatment of asthma, but preferably without the systemic adverse effects of glucocorticosteroids.  Objectives: We evaluated the effect of an inhaled nonsteroidal glucocorticoid receptor agonist, AZD5423, on allergen-induced responses.  Methods: Twenty subjects with mild allergic asthma were randomized to receive 7 days of treatment with nebulized AZD5423 (75 or 300 μg) once daily, budesonide 200 μg twice daily via Turbuhaler, or placebo in a double-blind, four-period, crossover design study.  Allergen challenge was performed on Day 6.  Measurements and Main Results: FEV1 was measured repeatedly for 7 h after allergen challenge for early and late asthmatic responses.  Sputum inflammatory cells was measured before and at 7 and 24 h after allergen challenge, and methacholine airway responsiveness was measured before and 24 h after allergen challenge.  AZD5423 significantly attenuated the fall in FEV1 during the late asthmatic response (both doses led to an 8.7% fall) vs. placebo (14% fall) (P < 0.05) with no effect of budesonide (12.5% fall) vs. placebo (P > 0.05).  There was no effect on the fall in FEV1 during early asthmatic response.  AZD5423 300 and 75 μg significantly attenuated allergen-induced sputum eosinophilia by 63 and 61% at 7 h, resp., and by 46 and 34% at 24 h after allergen challenge, resp., vs. placebo (all P < 0.05).  Budesonide did not reduce allergen-induced sputum eosinophilia vs. placebo.  AZD5423 at 300 μg significantly attenuated allergen-induced airway hyperresponsiveness at 24 h after allergen challenge vs. placebo (P < 0.05).  Both doses of AZD5423 were well tolerated.  Conclusions: Seven-day treatment with inhalation of the nonsteroidal glucocorticoid receptor agonist AZD5423 effectively reduced allergen-induced responses in subjects with mild allergic asthma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeWRfg5pVQxLVg90H21EOLACvtfcHk0li5NYmYgAfk_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXislWht7Y%253D&md5=78fce39c7b6b2577ad8d3ae29eff52d8</span></div><a href="/servlet/linkout?suffix=cit24a&amp;dbid=16384&amp;doi=10.1164%2Frccm.201404-0623OC&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1164%252Frccm.201404-0623OC%26sid%3Dliteratum%253Aachs%26aulast%3DGauvreau%26aufirst%3DG.%2BM.%26aulast%3DBoulet%26aufirst%3DL.%2BP.%26aulast%3DLeigh%26aufirst%3DR.%26aulast%3DCockcroft%26aufirst%3DD.%2BW.%26aulast%3DKillian%26aufirst%3DK.%2BJ.%26aulast%3DDavis%26aufirst%3DB.%2BE.%26aulast%3DDeschesnes%26aufirst%3DF.%26aulast%3DWatson%26aufirst%3DR.%2BM.%26aulast%3DSwystun%26aufirst%3DV.%26aulast%3DMardh%26aufirst%3DC.%2BK.%26aulast%3DWessman%26aufirst%3DP.%26aulast%3DJorup%26aufirst%3DC.%26aulast%3DAurivillius%26aufirst%3DM.%26aulast%3DO%25E2%2580%2599Byrne%26aufirst%3DP.%2BM.%26atitle%3DA%2520nonsteroidal%2520glucocorticoid%2520receptor%2520agonist%2520inhibits%2520allergen-induced%2520late%2520asthmatic%2520responses%26jtitle%3DAm.%2520J.%2520Respir.%2520Crit.%2520Care%2520Med.%26date%3D2015%26volume%3D191%26spage%3D161%26epage%3D167%26doi%3D10.1164%2Frccm.201404-0623OC" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit24b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Berger, M.; Dahmen, J.; Eriksson, A.; Gabos, B.; Hansson, T.; Hemmerling, M.; Henriksson, K.; Ivanova, S.; Lepistoe, M.; McKerrecher, D.; Munck Af Rosenschoeld, M.; Nilsson, S.; Rehwinkel, H.; Taflin, C.</span><span> </span><span class="NLM_article-title">Indazolyl ester and amide derivatives for the treatment of glucocorticoid receptor mediated disorders and their preparation</span>. Patent WO 2008076048, June 26,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=M.+Berger&author=J.+Dahmen&author=A.+Eriksson&author=B.+Gabos&author=T.+Hansson&author=M.+Hemmerling&author=K.+Henriksson&author=S.+Ivanova&author=M.+Lepistoe&author=D.+McKerrecher&author=M.+Munck+Af+Rosenschoeld&author=S.+Nilsson&author=H.+Rehwinkel&author=C.+Taflin&title=Indazolyl+ester+and+amide+derivatives+for+the+treatment+of+glucocorticoid+receptor+mediated+disorders+and+their+preparation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBerger%26aufirst%3DM.%26atitle%3DIndazolyl%2520ester%2520and%2520amide%2520derivatives%2520for%2520the%2520treatment%2520of%2520glucocorticoid%2520receptor%2520mediated%2520disorders%2520and%2520their%2520preparation%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Edman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahlgren, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bengtsson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bladh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Backstrom, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahmen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henriksson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hillertz, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hulikal, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jerre, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinchin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kase, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lepisto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mile, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smailagic, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tjornebo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wissler, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansson, T.</span><span> </span><span class="NLM_article-title">The discovery of potent and selective non-steroidal glucocorticoid receptor modulators, suitable for inhalation</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">2571</span><span class="NLM_x">–</span> <span class="NLM_lpage">2577</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2014.03.070</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=10.1016%2Fj.bmcl.2014.03.070" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=2571-2577&author=K.+Edmanauthor=R.+Ahlgrenauthor=M.+Bengtssonauthor=H.+Bladhauthor=S.+Backstromauthor=J.+Dahmenauthor=K.+Henrikssonauthor=P.+Hillertzauthor=V.+Hulikalauthor=A.+Jerreauthor=L.+Kinchinauthor=C.+Kaseauthor=M.+Lepistoauthor=I.+Mileauthor=S.+Nilssonauthor=A.+Smailagicauthor=J.+Taylorauthor=A.+Tjorneboauthor=L.+Wisslerauthor=T.+Hansson&title=The+discovery+of+potent+and+selective+non-steroidal+glucocorticoid+receptor+modulators%2C+suitable+for+inhalation&doi=10.1016%2Fj.bmcl.2014.03.070"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.03.070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.03.070%26sid%3Dliteratum%253Aachs%26aulast%3DEdman%26aufirst%3DK.%26aulast%3DAhlgren%26aufirst%3DR.%26aulast%3DBengtsson%26aufirst%3DM.%26aulast%3DBladh%26aufirst%3DH.%26aulast%3DBackstrom%26aufirst%3DS.%26aulast%3DDahmen%26aufirst%3DJ.%26aulast%3DHenriksson%26aufirst%3DK.%26aulast%3DHillertz%26aufirst%3DP.%26aulast%3DHulikal%26aufirst%3DV.%26aulast%3DJerre%26aufirst%3DA.%26aulast%3DKinchin%26aufirst%3DL.%26aulast%3DKase%26aufirst%3DC.%26aulast%3DLepisto%26aufirst%3DM.%26aulast%3DMile%26aufirst%3DI.%26aulast%3DNilsson%26aufirst%3DS.%26aulast%3DSmailagic%26aufirst%3DA.%26aulast%3DTaylor%26aufirst%3DJ.%26aulast%3DTjornebo%26aufirst%3DA.%26aulast%3DWissler%26aufirst%3DL.%26aulast%3DHansson%26aufirst%3DT.%26atitle%3DThe%2520discovery%2520of%2520potent%2520and%2520selective%2520non-steroidal%2520glucocorticoid%2520receptor%2520modulators%252C%2520suitable%2520for%2520inhalation%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D2571%26epage%3D2577%26doi%3D10.1016%2Fj.bmcl.2014.03.070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit25b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Sheppeck, J. E.,  2nd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilmore, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhar, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nirschl, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doweyko, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sack, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corbett, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malley, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gougoutas, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKay, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cunningham, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habte, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodd, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nadler, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Somerville, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrish, J. C.</span><span> </span><span class="NLM_article-title">Discovery of potent and selective nonsteroidal indazolyl amide glucocorticoid receptor agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">5442</span><span class="NLM_x">–</span> <span class="NLM_lpage">5447</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2013.06.089</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=10.1016%2Fj.bmcl.2013.06.089" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=5442-5447&author=J.+E.+Sheppeckauthor=J.+L.+Gilmoreauthor=H.+Y.+Xiaoauthor=T.+G.+Dharauthor=D.+Nirschlauthor=A.+M.+Doweykoauthor=J.+S.+Sackauthor=M.+J.+Corbettauthor=M.+F.+Malleyauthor=J.+Z.+Gougoutasauthor=L.+McKayauthor=M.+D.+Cunninghamauthor=S.+F.+Habteauthor=J.+H.+Doddauthor=S.+G.+Nadlerauthor=J.+E.+Somervilleauthor=J.+C.+Barrish&title=Discovery+of+potent+and+selective+nonsteroidal+indazolyl+amide+glucocorticoid+receptor+agonists&doi=10.1016%2Fj.bmcl.2013.06.089"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.06.089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.06.089%26sid%3Dliteratum%253Aachs%26aulast%3DSheppeck%26aufirst%3DJ.%2BE.%26aulast%3DGilmore%26aufirst%3DJ.%2BL.%26aulast%3DXiao%26aufirst%3DH.%2BY.%26aulast%3DDhar%26aufirst%3DT.%2BG.%26aulast%3DNirschl%26aufirst%3DD.%26aulast%3DDoweyko%26aufirst%3DA.%2BM.%26aulast%3DSack%26aufirst%3DJ.%2BS.%26aulast%3DCorbett%26aufirst%3DM.%2BJ.%26aulast%3DMalley%26aufirst%3DM.%2BF.%26aulast%3DGougoutas%26aufirst%3DJ.%2BZ.%26aulast%3DMcKay%26aufirst%3DL.%26aulast%3DCunningham%26aufirst%3DM.%2BD.%26aulast%3DHabte%26aufirst%3DS.%2BF.%26aulast%3DDodd%26aufirst%3DJ.%2BH.%26aulast%3DNadler%26aufirst%3DS.%2BG.%26aulast%3DSomerville%26aufirst%3DJ.%2BE.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26atitle%3DDiscovery%2520of%2520potent%2520and%2520selective%2520nonsteroidal%2520indazolyl%2520amide%2520glucocorticoid%2520receptor%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D5442%26epage%3D5447%26doi%3D10.1016%2Fj.bmcl.2013.06.089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit25c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Yates, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patten, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holt, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maglich, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angell, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasse, R. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uings, I. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trump, R. P.</span><span> </span><span class="NLM_article-title">Structure guided design of 5-arylindazole glucocorticoid receptor agonists and antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">4531</span><span class="NLM_x">–</span> <span class="NLM_lpage">4544</span><span class="refDoi"> DOI: 10.1021/jm100447c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100447c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=4531-4544&author=C.+M.+Yatesauthor=P.+J.+Brownauthor=E.+L.+Stewartauthor=C.+Pattenauthor=R.+J.+Austinauthor=J.+A.+Holtauthor=J.+M.+Maglichauthor=D.+C.+Angellauthor=R.+Z.+Sasseauthor=S.+J.+Taylorauthor=I.+J.+Uingsauthor=R.+P.+Trump&title=Structure+guided+design+of+5-arylindazole+glucocorticoid+receptor+agonists+and+antagonists&doi=10.1021%2Fjm100447c"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25c&amp;dbid=16384&amp;doi=10.1021%2Fjm100447c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100447c%26sid%3Dliteratum%253Aachs%26aulast%3DYates%26aufirst%3DC.%2BM.%26aulast%3DBrown%26aufirst%3DP.%2BJ.%26aulast%3DStewart%26aufirst%3DE.%2BL.%26aulast%3DPatten%26aufirst%3DC.%26aulast%3DAustin%26aufirst%3DR.%2BJ.%26aulast%3DHolt%26aufirst%3DJ.%2BA.%26aulast%3DMaglich%26aufirst%3DJ.%2BM.%26aulast%3DAngell%26aufirst%3DD.%2BC.%26aulast%3DSasse%26aufirst%3DR.%2BZ.%26aulast%3DTaylor%26aufirst%3DS.%2BJ.%26aulast%3DUings%26aufirst%3DI.%2BJ.%26aulast%3DTrump%26aufirst%3DR.%2BP.%26atitle%3DStructure%2520guided%2520design%2520of%25205-arylindazole%2520glucocorticoid%2520receptor%2520agonists%2520and%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D4531%26epage%3D4544%26doi%3D10.1021%2Fjm100447c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit25d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Biggadike, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bledsoe, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coe, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">House, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iannone, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madauss, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLay, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shipley, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uings, I. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weller, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, S. P.</span><span> </span><span class="NLM_article-title">Design and x-ray crystal structures of high-potency nonsteroidal glucocorticoid agonists exploiting a novel binding site on the receptor</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">18114</span><span class="NLM_x">–</span> <span class="NLM_lpage">18119</span><span class="refDoi"> DOI: 10.1073/pnas.0909125106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=10.1073%2Fpnas.0909125106" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=18114-18119&author=K.+Biggadikeauthor=R.+K.+Bledsoeauthor=D.+M.+Coeauthor=T.+W.+Cooperauthor=D.+Houseauthor=M.+A.+Iannoneauthor=S.+J.+Macdonaldauthor=K.+P.+Madaussauthor=I.+M.+McLayauthor=T.+J.+Shipleyauthor=S.+J.+Taylorauthor=T.+B.+Tranauthor=I.+J.+Uingsauthor=V.+Wellerauthor=S.+P.+Williams&title=Design+and+x-ray+crystal+structures+of+high-potency+nonsteroidal+glucocorticoid+agonists+exploiting+a+novel+binding+site+on+the+receptor&doi=10.1073%2Fpnas.0909125106"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25d&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0909125106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0909125106%26sid%3Dliteratum%253Aachs%26aulast%3DBiggadike%26aufirst%3DK.%26aulast%3DBledsoe%26aufirst%3DR.%2BK.%26aulast%3DCoe%26aufirst%3DD.%2BM.%26aulast%3DCooper%26aufirst%3DT.%2BW.%26aulast%3DHouse%26aufirst%3DD.%26aulast%3DIannone%26aufirst%3DM.%2BA.%26aulast%3DMacdonald%26aufirst%3DS.%2BJ.%26aulast%3DMadauss%26aufirst%3DK.%2BP.%26aulast%3DMcLay%26aufirst%3DI.%2BM.%26aulast%3DShipley%26aufirst%3DT.%2BJ.%26aulast%3DTaylor%26aufirst%3DS.%2BJ.%26aulast%3DTran%26aufirst%3DT.%2BB.%26aulast%3DUings%26aufirst%3DI.%2BJ.%26aulast%3DWeller%26aufirst%3DV.%26aulast%3DWilliams%26aufirst%3DS.%2BP.%26atitle%3DDesign%2520and%2520x-ray%2520crystal%2520structures%2520of%2520high-potency%2520nonsteroidal%2520glucocorticoid%2520agonists%2520exploiting%2520a%2520novel%2520binding%2520site%2520on%2520the%2520receptor%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2009%26volume%3D106%26spage%3D18114%26epage%3D18119%26doi%3D10.1073%2Fpnas.0909125106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Salter, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biggadike, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haase, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrow, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uings, I. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, D. W.</span><span> </span><span class="NLM_article-title">Pharmacological properties of the enhanced-affinity glucocorticoid fluticasone furoate in vitro and in an in vivo model of respiratory inflammatory disease</span> <span class="citation_source-journal">Am. J. Physiol.. Lung Cell. Mol. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">293</span><span class="NLM_x">, </span> <span class="NLM_fpage">L660</span><span class="NLM_x">–</span> <span class="NLM_lpage">667</span><span class="refDoi"> DOI: 10.1152/ajplung.00108.2007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=10.1152%2Fajplung.00108.2007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=17575011" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVOqsbbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=293&publication_year=2007&pages=L660-667&author=M.+Salterauthor=K.+Biggadikeauthor=J.+L.+Matthewsauthor=M.+R.+Westauthor=M.+V.+Haaseauthor=S.+N.+Farrowauthor=I.+J.+Uingsauthor=D.+W.+Gray&title=Pharmacological+properties+of+the+enhanced-affinity+glucocorticoid+fluticasone+furoate+in+vitro+and+in+an+in+vivo+model+of+respiratory+inflammatory+disease&doi=10.1152%2Fajplung.00108.2007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26aR"><div class="casContent"><span class="casTitleNuber">26a</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological properties of the enhanced-affinity glucocorticoid fluticasone furoate in vitro and in an in vivo model of respiratory inflammatory disease</span></div><div class="casAuthors">Salter, Mark; Biggadike, Keith; Matthews, Joyce L.; West, Michael R.; Haase, Michael V.; Farrow, Stuart N.; Uings, Iain J.; Gray, David W.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Physiology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">293</span>
        (<span class="NLM_cas:issue">3, Pt. 1</span>),
    <span class="NLM_cas:pages">L660-L667</span>CODEN:
                <span class="NLM_cas:coden">AJPHAP</span>;
        ISSN:<span class="NLM_cas:issn">0002-9513</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">Fluticasone furoate (FF) is a novel enhanced-affinity glucocorticoid that has been developed as topical therapy for allergic rhinitis.  The pharmacol. properties of FF have been investigated using a no. of in vitro exptl. systems.  FF demonstrated very potent glucocorticoid activity in several key pathways downstream of the glucocorticoid receptor (GR) as follows: the transrepression nuclear factor-κB (NF-κB) pathway, the transactivation glucocorticoid response element pathway, and inhibition of the proinflammatory cytokine tumor necrosis factor-α.  Furthermore, FF showed the greatest potency compared with other glucocorticoids for preserving epithelial integrity and reducing epithelial permeability in response to protease- and mech.-induced cell damage.  FF showed a 30- to >330,000-fold selectivity for GR-mediated inhibition of NF-κB vs. the other steroid hormone receptors, substantially better than a no. of other clin. used glucocorticoids.  In studies examg. the respiratory tissue binding properties of glucocorticoids, FF had the largest cellular accumulation and slowest rate of efflux compared with other clin. used glucocorticoids, consistent with greater tissue retention.  The in vivo anti-inflammatory activity of FF was assessed in the Brown Norway rat ovalbumin-induced lung eosinophilial model of allergic lung inflammation.  At a dose of only 30 μg, FF achieved almost total inhibition of eosinophil influx in the lung, an inhibition that was greater than that seen with the same dose of fluticasone propionate.  In conclusion, the potent and selective pharmacol. profile of FF described here could deliver an effective, safe, and sustained topical treatment of respiratory inflammatory diseases such as allergic rhinitis and asthma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIRSsUJqaLP7Vg90H21EOLACvtfcHk0lhVwFGUz29p4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVOqsbbN&md5=897a0c672a28ff0b3102825b2dcc5300</span></div><a href="/servlet/linkout?suffix=cit26a&amp;dbid=16384&amp;doi=10.1152%2Fajplung.00108.2007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajplung.00108.2007%26sid%3Dliteratum%253Aachs%26aulast%3DSalter%26aufirst%3DM.%26aulast%3DBiggadike%26aufirst%3DK.%26aulast%3DMatthews%26aufirst%3DJ.%2BL.%26aulast%3DWest%26aufirst%3DM.%2BR.%26aulast%3DHaase%26aufirst%3DM.%2BV.%26aulast%3DFarrow%26aufirst%3DS.%2BN.%26aulast%3DUings%26aufirst%3DI.%2BJ.%26aulast%3DGray%26aufirst%3DD.%2BW.%26atitle%3DPharmacological%2520properties%2520of%2520the%2520enhanced-affinity%2520glucocorticoid%2520fluticasone%2520furoate%2520in%2520vitro%2520and%2520in%2520an%2520in%2520vivo%2520model%2520of%2520respiratory%2520inflammatory%2520disease%26jtitle%3DAm.%2520J.%2520Physiol..%2520Lung%2520Cell.%2520Mol.%2520Physiol.%26date%3D2007%26volume%3D293%26spage%3DL660%26epage%3D667%26doi%3D10.1152%2Fajplung.00108.2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit26b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Grossmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scholz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rochel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bumke-Vogt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oelkers, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfeiffer, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diederich, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bahr, V.</span><span> </span><span class="NLM_article-title">Transactivation via the human glucocorticoid and mineralocorticoid receptor by therapeutically used steroids in CV-1 cells: a comparison of their glucocorticoid and mineralocorticoid properties</span> <span class="citation_source-journal">Eur. J. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">151</span><span class="NLM_x">, </span> <span class="NLM_fpage">397</span><span class="NLM_x">–</span> <span class="NLM_lpage">406</span><span class="refDoi"> DOI: 10.1530/eje.0.1510397</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=10.1530%2Feje.0.1510397" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=15362971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=1%3ACAS%3A528%3ADC%252BD2cXot1Khtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=151&publication_year=2004&pages=397-406&author=C.+Grossmannauthor=T.+Scholzauthor=M.+Rochelauthor=C.+Bumke-Vogtauthor=W.+Oelkersauthor=A.+F.+Pfeifferauthor=S.+Diederichauthor=V.+Bahr&title=Transactivation+via+the+human+glucocorticoid+and+mineralocorticoid+receptor+by+therapeutically+used+steroids+in+CV-1+cells%3A+a+comparison+of+their+glucocorticoid+and+mineralocorticoid+properties&doi=10.1530%2Feje.0.1510397"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26bR"><div class="casContent"><span class="casTitleNuber">26b</span><div class="casTitle"><span class="NLM_cas:atitle">Transactivation via the human glucocorticoid and mineralocorticoid receptor by therapeutically used steroids in CV-1 cells: A comparison of their glucocorticoid and mineralocorticoid properties</span></div><div class="casAuthors">Grossmann, Claudia; Scholz, Tim; Rochel, Marina; Bumke-Vogt, Christiane; Oelkers, Wolfgang; Pfeiffer, Andreas F. H.; Diederich, Sven; Baehr, Volker</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Endocrinology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">151</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">397-406</span>CODEN:
                <span class="NLM_cas:coden">EJOEEP</span>;
        ISSN:<span class="NLM_cas:issn">0804-4643</span>.
    
            (<span class="NLM_cas:orgname">BioScientifica Ltd.</span>)
        </div><div class="casAbstract">Background: Glucocorticoids (GCs) are commonly used for long-term medication in immunosuppressive and anti-inflammatory therapy.  However, the data describing gluco- and mineralo-corticoid (MC) properties of widely applied synthetic GCs are often based on diverse clin. observations and on a variety of in vitro tests under various conditions, which makes a quant. comparison questionable.  Method: We compared MC and GC properties of different steroids, often used in clin. practice, in the same in vitro test system (luciferase transactivation assay in CV-1 cells transfected with either hMR or hGRα expression vectors) complemented by a system to test the steroid binding affinities at the hMR (protein expression in T7-coupled rabbit reticulocyte lysate).  Results and Conclusions: While the potency of a GC is increased by an 11-hydroxy group, both its potency and its selectivity are increased by the Δ1-dehydro-configuration and a hydrophobic residue in position 16 (16-methylene, 16α-Me or 16β-Me group).  Almost ideal GCs in terms of missing MC effects, as defined by our in vitro assay, are therefore prednylidene, budesonide, beclomethasone and betamethasone.  The MC potency of a steroid is increased by a 9α- or a 6α-fluoro substituent.  A hydrophilic substituent in position 16 (like 16-hydroxylation in triamcinolone) decreases both MC and GC properties.  As no substituent that leads to an isolated redn. of GC activity could be characterized in our expts., 9α-fluorocortisol, the most frequently used steroid for MC substitution, seems to be the best choice of available steroids for this purpose.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUHzxUe-TpIbVg90H21EOLACvtfcHk0ljud6N6bLpmLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXot1Khtr0%253D&md5=7fec132cbded41ca9ebf940c1f292e63</span></div><a href="/servlet/linkout?suffix=cit26b&amp;dbid=16384&amp;doi=10.1530%2Feje.0.1510397&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1530%252Feje.0.1510397%26sid%3Dliteratum%253Aachs%26aulast%3DGrossmann%26aufirst%3DC.%26aulast%3DScholz%26aufirst%3DT.%26aulast%3DRochel%26aufirst%3DM.%26aulast%3DBumke-Vogt%26aufirst%3DC.%26aulast%3DOelkers%26aufirst%3DW.%26aulast%3DPfeiffer%26aufirst%3DA.%2BF.%26aulast%3DDiederich%26aufirst%3DS.%26aulast%3DBahr%26aufirst%3DV.%26atitle%3DTransactivation%2520via%2520the%2520human%2520glucocorticoid%2520and%2520mineralocorticoid%2520receptor%2520by%2520therapeutically%2520used%2520steroids%2520in%2520CV-1%2520cells%253A%2520a%2520comparison%2520of%2520their%2520glucocorticoid%2520and%2520mineralocorticoid%2520properties%26jtitle%3DEur.%2520J.%2520Endocrinol.%26date%3D2004%26volume%3D151%26spage%3D397%26epage%3D406%26doi%3D10.1530%2Feje.0.1510397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Boger, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chappell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundqvist, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ewing, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigenborg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friden, M.</span><span> </span><span class="NLM_article-title">Systems pharmacology approach for prediction of pulmonary and systemic pharmacokinetics and receptor occupancy of inhaled drugs</span> <span class="citation_source-journal">CPT: Pharmacometrics Syst. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">201</span><span class="NLM_x">–</span> <span class="NLM_lpage">210</span><span class="refDoi"> DOI: 10.1002/psp4.12074</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=10.1002%2Fpsp4.12074" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=27104089" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=1%3ACAS%3A528%3ADC%252BC28XmtVSns7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2016&pages=201-210&author=E.+Bogerauthor=N.+Evansauthor=M.+Chappellauthor=A.+Lundqvistauthor=P.+Ewingauthor=A.+Wigenborgauthor=M.+Friden&title=Systems+pharmacology+approach+for+prediction+of+pulmonary+and+systemic+pharmacokinetics+and+receptor+occupancy+of+inhaled+drugs&doi=10.1002%2Fpsp4.12074"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Systems Pharmacology Approach for Prediction of Pulmonary and Systemic Pharmacokinetics and Receptor Occupancy of Inhaled Drugs</span></div><div class="casAuthors">Boger, E.; Evans, N.; Chappell, M.; Lundqvist, A.; Ewing, P.; Wigenborg, A.; Friden, M.</div><div class="citationInfo"><span class="NLM_cas:title">CPT: Pharmacometrics & Systems Pharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">201-210</span>CODEN:
                <span class="NLM_cas:coden">CPSPBR</span>;
        ISSN:<span class="NLM_cas:issn">2163-8306</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Pulmonary drug disposition after inhalation is complex involving mechanisms, such as regional drug deposition, dissoln., and mucociliary clearance.  This study aimed to develop a systems pharmacol. approach to mechanistically describe lung disposition in rats and thereby provide an integrated understanding of the system.  When drug- and formulation-specific properties for the poorly sol. drug fluticasone propionate were fed into the model, it proved predictive of the pharmacokinetics and receptor occupancy after i.v. administration and nose-only inhalation.  As the model clearly distinguishes among drug-specific, formulation-specific, and system-specific properties, it was possible to identify key determinants of pulmonary selectivity of receptor occupancy of inhaled drugs: slow particle dissoln. and slow drug-receptor dissocn.  Hence, it enables assessment of factors for lung targeting, including mol. properties, formulation, as well as the physiol. of the animal species, thereby providing a general framework for rational drug design and facilitated translation of lung targeting from animal to man.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOGLFgvgeHpbVg90H21EOLACvtfcHk0ljud6N6bLpmLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmtVSns7c%253D&md5=2f63b8d5445f8294dd4c6d6fdb269003</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1002%2Fpsp4.12074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpsp4.12074%26sid%3Dliteratum%253Aachs%26aulast%3DBoger%26aufirst%3DE.%26aulast%3DEvans%26aufirst%3DN.%26aulast%3DChappell%26aufirst%3DM.%26aulast%3DLundqvist%26aufirst%3DA.%26aulast%3DEwing%26aufirst%3DP.%26aulast%3DWigenborg%26aufirst%3DA.%26aulast%3DFriden%26aufirst%3DM.%26atitle%3DSystems%2520pharmacology%2520approach%2520for%2520prediction%2520of%2520pulmonary%2520and%2520systemic%2520pharmacokinetics%2520and%2520receptor%2520occupancy%2520of%2520inhaled%2520drugs%26jtitle%3DCPT%253A%2520Pharmacometrics%2520Syst.%2520Pharmacol.%26date%3D2016%26volume%3D5%26spage%3D201%26epage%3D210%26doi%3D10.1002%2Fpsp4.12074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Berger, M.; Dahmen, J.; Edman, K.; Eriksson, A.; Hansson, T.; Hemmerling, M.; Hossain, N.; Klingstedt, T.; Lepistö, M.; Nilsson, S.; Rehwinkel, H.</span><span> </span><span class="NLM_article-title">Phenyl and benzodioxinyl substituted indazole derivatives</span>. Patent WO 2009142571, November 26,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=M.+Berger&author=J.+Dahmen&author=K.+Edman&author=A.+Eriksson&author=T.+Hansson&author=M.+Hemmerling&author=N.+Hossain&author=T.+Klingstedt&author=M.+Lepist%C3%B6&author=S.+Nilsson&author=H.+Rehwinkel&title=Phenyl+and+benzodioxinyl+substituted+indazole+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBerger%26aufirst%3DM.%26atitle%3DPhenyl%2520and%2520benzodioxinyl%2520substituted%2520indazole%2520derivatives%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Kuna, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aurivillius, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jorup, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prothon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taib, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edsbacker, S.</span><span> </span><span class="NLM_article-title">Efficacy and tolerability of an inhaled selective glucocorticoid receptor modulator - AZD5423 - in COPD patients: Phase II Study Results</span> <span class="citation_source-journal">Basic Clin. Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">121</span><span class="NLM_x">, </span> <span class="NLM_fpage">279</span><span class="refDoi"> DOI: 10.1111/bcpt.12768</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=10.1111%2Fbcpt.12768" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=28212463" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFOis7vP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2017&pages=279&author=P.+Kunaauthor=M.+Aurivilliusauthor=C.+Jorupauthor=S.+Prothonauthor=Z.+Taibauthor=S.+Edsbacker&title=Efficacy+and+tolerability+of+an+inhaled+selective+glucocorticoid+receptor+modulator+-+AZD5423+-+in+COPD+patients%3A+Phase+II+Study+Results&doi=10.1111%2Fbcpt.12768"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy and Tolerability of an Inhaled Selective Glucocorticoid Receptor Modulator - AZD5423 - in Chronic Obstructive Pulmonary Disease Patients: Phase II Study Results</span></div><div class="casAuthors">Kuna, Piotr; Aurivillius, Magnus; Jorup, Carin; Prothon, Susanne; Taib, Ziad; Edsbaecker, Staffan</div><div class="citationInfo"><span class="NLM_cas:title">Basic & Clinical Pharmacology & Toxicology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">279-289</span>CODEN:
                <span class="NLM_cas:coden">BCPTBO</span>;
        ISSN:<span class="NLM_cas:issn">1742-7835</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">AZD5423 is a novel, inhaled, selective glucocorticoid receptor modulator (SGRM), which in an allergen challenge model in asthma patients improved lung function and airway hyper-reactivity.  In the current trial, AZD5423 was for the first time tested in patients with chronic obstructive pulmonary disease (COPD).  In this double-blind, randomized and parallel group study, we examd. airway and systemic effects of two doses of AZD5423, inhaled via Turbuhaler for 12 wk, in 353 symptomatic patients with COPD (av. pre-bronchodilator forced expiratory vol. in one-second (FEV1) at screening was 50-52% of predicted normal).  Pre-bronchodilator FEV1 was primary variable, with other lung function parameters plus symptoms and 24-h plasma cortisol being secondary variables.  Plasma concns. of AZD5423 were also measured.  Effects were compared against placebo and a ref. glucocorticoid receptor agonist control.  Neither AZD5423, at doses which have shown to be efficacious in allergen-induced asthma, nor the ref. control, at double the approved dose, had any clin. meaningful effect in the patient population studied in regard to lung function or markers of inflammation.  Both GR modulators were well tolerated and did suppress 24-h cortisol.  This study suggests that the selected population of patients with COPD does not respond to treatment with AZD5423 as regards lung function, while showing the expected systemic effects.  It cannot be ruled out that a favorable lung function response of AZD5423 can be evoked using another exptl. setting and/or within a different population of patients with COPD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoS0vLqoJJ0_bVg90H21EOLACvtfcHk0ljud6N6bLpmLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFOis7vP&md5=4ec796ea03402874bc9b02ae59d5bfaa</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1111%2Fbcpt.12768&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbcpt.12768%26sid%3Dliteratum%253Aachs%26aulast%3DKuna%26aufirst%3DP.%26aulast%3DAurivillius%26aufirst%3DM.%26aulast%3DJorup%26aufirst%3DC.%26aulast%3DProthon%26aufirst%3DS.%26aulast%3DTaib%26aufirst%3DZ.%26aulast%3DEdsbacker%26aufirst%3DS.%26atitle%3DEfficacy%2520and%2520tolerability%2520of%2520an%2520inhaled%2520selective%2520glucocorticoid%2520receptor%2520modulator%2520-%2520AZD5423%2520-%2520in%2520COPD%2520patients%253A%2520Phase%2520II%2520Study%2520Results%26jtitle%3DBasic%2520Clin.%2520Pharmacol.%2520Toxicol.%26date%3D2017%26volume%3D121%26spage%3D279%26doi%3D10.1111%2Fbcpt.12768" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span>ClinicalTrials.gov identifier NCT02479412. A multiple dosing (14 days) study to assess efficacy and safety of three dosing levels of AZD7594, given once daily by inhalation, in patients with mild to moderate asthma. <a href="https://clinicaltrials.gov/show/NCT02479412" class="extLink">https://clinicaltrials.gov/show/NCT02479412</a> (accessed September 13,<span class="NLM_x"> </span><span class="NLM_year">2017</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ClinicalTrials.gov+identifier+NCT02479412.+A+multiple+dosing+%2814+days%29+study+to+assess+efficacy+and+safety+of+three+dosing+levels+of+AZD7594%2C+given+once+daily+by+inhalation%2C+in+patients+with+mild+to+moderate+asthma.+https%3A%2F%2Fclinicaltrials.gov%2Fshow%2FNCT02479412+%28accessed+September+13%2C+2017%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i39"><a href="/doi/suppl/10.1021/acs.jmedchem.7b01215">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_73631"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b01215">10.1021/acs.jmedchem.7b01215</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Additional synthetic procedures and analytical data; X-ray structure determination; hormone receptor binding assays; in vitro pharmacology; dry powder inhalation protocol; protocol for pharmacokinetic studies in a rat; rat Sephadex model; cross-species in vitro metabolism (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01215/suppl_file/jm7b01215_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01215/suppl_file/jm7b01215_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01215/suppl_file/jm7b01215_si_001.pdf">jm7b01215_si_001.pdf (675.16 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01215/suppl_file/jm7b01215_si_002.csv">jm7b01215_si_002.csv (3.06 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Authors will release the atomic coordinates and experimental data upon article publication for 5NFP (compound <b>2</b>) and 5NFT (compound <b>1b</b>).</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b01215&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-20%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b01215%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b01215" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799475f2e433d6c","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
